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How are neuromodulatory networks organised to adapt sensory discrimination 
for different contexts? I hypothesised that neurons within a sensory circuit 
express different neuromodulatory receptors for differential modulation. Here I 
aimed to use the simple and genetically amenable Drosophila larval Mushroom 
Body (MB) calyx, a higher order processing area involved in learned odour 
discrimination, as a model to map octopamine (OA) neuromodulatory circuitry.  
I first identified olfactory projection neurons (PNs), a GABAergic 
feedback neuron and cholinergic extrinsic neurons as putative postsynaptic 
partners to OA neurons in the MB calyx using GFP reconstitution across 
synaptic partners.  
Next, I used novel EGFP-tagged OA receptors generated from 
recombination-mediated cassette exchange with MiMIC insertions in receptor 
genes to visualise endogenous expression patterns of OA receptors. Most 
notably, this is the first report of α2-adrenergic-like OA receptor localisation in 
any insect.  
For the first time, I showed that the α1-adrenergic-like OAMB localised to 
PN presynaptic terminals in the calyx; while Octβ1R localised diffusely in the 
calyx, resembling the innervation pattern of MB neuron dendrites. I detected 
EGFP-tagged Octα2R and Octβ2R in some PN cell bodies but not in neuron 
terminals – suggesting that Octα2R and Octβ2R may be expressed in some 
PNs, provided the misfolded fusion proteins are retained in the cell bodies of the 
neurons they are normally expressed in. Furthermore, I found that Octα2R and 
GABAAR fusion proteins localised to OA cell bodies but not to neuronal 
terminals, suggesting that OA neurons are subjected to inhibition, again given 
that these are not artefacts of the fusion proteins.  
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To obtain tools to study OA modulation in the larval calyx, I then 
confirmed the expression patterns of driver lines that more specifically labelled 
calyx-innervating OA and extrinsic neurons, and tested the efficacy of three 
OAMB receptor knockdown lines.  
This initial attempt of mapping OA receptors, while subjected to further 
verification and development, is consistent with my hypothesis that a single 
neuromodulatory source can regulate multiple neuronal types in the same 
circuit through the distribution of different types of neuromodulatory receptors. 
This provides a new perspective in how the anatomical organisation of 
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Chapter 1. Introduction  
  
1.1. Neuromodulation of higher order sensory discrimination circuits  
  
1.1.1. Sensory discrimination in the higher brain 
Animals are constantly exposed to sensory information in their environment. 
Therefore, they need to learn to recognise sensory cues that are biologically 
relevant to their survival, such as signals for food, mates or danger; and 
disregard other stimuli present in the background. Before an animal can learn to 
associate a stimulus with its appropriate valence, it must first be able to 
perceive the difference between two or more sensory stimuli – a process known 
as sensory discrimination. Sensory discrimination is also required for identifying 
a novel stimulus, which could signal unpredictability or danger, from previously 
experienced stimuli. 
 In order for an animal to discriminate between sensory stimuli, each 
stimulus must have a unique representation in the brain. Sensory stimuli are 
represented in the higher brain by populations of highly selective neurons which 
fire in response to a limited number of stimuli. Only a few neurons in the 
population respond to each stimulus, generating non-overlapping 
representations for a large number of stimuli, which allows for successful 
discrimination between similar cues. This is known as selective and sparse 
coding, and can be observed across a variety of sensory systems: from odours 
in the insect olfactory learning centre (Perez-Orive et al., 2002), to vocalisations 
in the zebra finch auditory cortex (Schneider and Woolley, 2013), and face 
recognition in the human medial temporal lobe (Quian Quiroga et al., 2005).  
Selectivity is driven by the convergence of sensory inputs onto higher 
brain neurons from broadly responsive input neurons. In mammalian and insect 
olfactory systems, anatomical and physiological data have proposed that the 
spiking of a higher brain neuron requires the simultaneous activation of multiple 
olfactory inputs (Perez-Orive et al., 2002; Masuda-Nakagawa et al., 2005; 
Franks and Isaacson, 2006; Gruntman and Turner, 2013).  
Inhibition is also required for maintaining neuronal selectivity and sparse 
coding in sensory representations. Global synaptic inhibition by odour-
responsive GABAergic interneurons required to maintain sparse odour 
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representations is conserved in mammals and insects (Poo and Isaacson, 
2009; Papadopoulou et al., 2011). In Drosophila, blocking such GABAergic 
inhibition reduces sparseness and increases overlap in odour response, 
resulting in impaired odour discrimination behaviour (Lin et al., 2014).  
 
1.1.2. Context-dependent adaptation of sensory discrimination 
While sparse and selective coding mechanisms allow a large number of stimuli 
to be represented in the higher brain, there is still a physical limit to the number 
of stimuli that can be differentiated. However, it is not necessary for an animal 
to be able to discriminate all the stimuli they encounter at all times. For 
example, the ability to recognise the smell of food is more important to a hungry 
animal than to a satiated animal. Therefore, it is important that sensory circuits 
can be adapted depending on the physiological state and external context of the 
animal.  
 In humans, attention and reward can enhance the ability to successfully 
discriminate visual, somatosensory and auditory cues (Gutnisky et al., 2009; 
Baldassi and Simoncini, 2011; Aton, 2013). Pairing an odour with reward allows 
rats to discriminate odours that they were previously unable to spontaneously 
discriminate, that is to recognise a novel odour from a previously habituated 
odour (Linster et al., 2001, 2002). Fruit flies are only able to discriminate a 
rewarded odour when they are starved, suggesting that sensory discrimination 
is also modulated by satiety states (Krashes and Waddell, 2008).  
 Animals are also capable of generalising their responses to a previously 
learned stimulus to a novel stimulus that is perceptually similar. This is 
important for producing the most appropriate response to a novel stimulus, and 
also ensures that the correct responses to learned stimuli are reproduced 
despite noisy backgrounds.  
Whether an animal generalises or discriminates particular stimuli 
depends on how the stimuli are presented. This is manifested behaviourally in 
different associative learning tasks. When a conditional stimulus (CS+) is paired 
with an unconditional stimulus (US), an untrained stimulus perceptually similar 
to the CS+ could elicit the same response as that of the CS+, resulting in 
generalisation. However, when the other similar stimulus is explicitly unpaired 
from the reward (CS-) in a differential training task, the animal would instead 
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learn to discriminate between the two similar stimuli (Mishra et al., 2010; Chen 
et al., 2011a).  
Both generalisation and discrimination behaviours can be predicted by 
the activation pattern of a population of highly selective neurons in the 
Drosophila learning centre (Campbell et al., 2013); but the decorrelation of 
odour representations only occurs in differential training tasks required for 
discrimination (Barth et al., 2014). This suggests the same cue could be 
differentially represented in the brain depending on the context it was presented 
in and result in alternative behavioural responses.  
 
1.1.3. Neuromodulators confer context 
Neuromodulators are chemicals that can alter neuronal excitability and synaptic 
strength in neural circuits. Classical neuromodulators include acetylcholine, 
dopamine, serotonin, noradrenaline and its insect counterpart octopamine, 
histamine, adenosine, and numerous neuropeptides (Brezina, 2010). Although 
each neuromodulatory system is associated with particular general functions, 
for example dopamine with reward or noradrenaline with arousal; they are in 
fact closely interconnected and share overlapping and/or antagonistic functions 
(Brezina, 2010; Sara and Bouret, 2012).  
As the activity of neuromodulatory neurons varies with the internal states 
or external environments of the animal, they are ideal for conferring contextual 
information to sensory circuits. Internal signals such as arousal or satiety can 
change neuromodulatory activity. Mammalian noradrenergic neurons are 
inactive in sleep, show tonic activity in quiet wake and increase phasic firing in 
active wake and stressful states (Table 1.1; Rajkowski et al., 1994; Atzori et al., 
2016). In Drosophila, dopamine levels increase in response to starvation 
(Inagaki et al., 2012), and this increases sugar sensitivity in starved flies 
(Inagaki et al., 2014). Starvation in Drosophila also increases expression of the 
short neuropeptide F receptor whose signalling mediates starvation-mediated 
food search behaviour (Root et al., 2011). External signals such as food, mates 
or stress also influence neuromodulator levels and activity. Serotonin 
concentration increases when female mice are interacting with male mice, or 




Table 1.1. A model for the relationship between arousal state, noradrenergic neuron 
firing and receptor activation proposed in Atzori et al. (2016). The relationship between 
arousal state and the firing modes of noradrenergic neurons in the locus coeruleus, based on 
electrophysiological data from primates and rodents. State-dependent functions of 
noradrenaline (NA) are mediated by the concentration-dependent activation of different types of 
adrenoceptors.  
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(Hanson and Hurley, 2014). In cockroaches and locusts, octopamine 
concentration in the haemolymph increases in response to stressful stimuli 
(Davenport and Evans, 1984). Furthermore, light intensity can regulate the 
membrane potentials and spontaneous firing rates of Drosophila neurons that 
express the neuropeptide PDF (Sheeba et al., 2008). The wide range of 
contexts that can be communicated to neural circuits by various 
neuromodulatory systems could therefore allow animals to adapt and generate 
the best response under constantly changing circumstances.  
 
1.1.4. Neuromodulation of sensory discrimination pathways 
Neuromodulatory systems have widespread projections in the brain, including 
many sensory processing regions in the higher brain. Retrograde tracing has 
shown that cholinergic and noradrenergic neurons innervated the mouse 
primary visual, auditory and somatosensory cortices (Kim et al., 2016). 
Noradrenergic innervation has also been observed in the mammalian piriform 
cortex (Linster & Hasselmo, 2001) and amygdala (Sara & Bouret, 2012) – 
higher brain structures involved in olfactory processing. Moreover, the fly 
olfactory learning centre known as the mushroom body (MB) (Heisenberg et al., 
1985; Heisenberg, 2003) is also immunoreactive for dopamine, serotonin, 
octopamine, and the neuropeptide sNPF (Nässel et al., 2008; Pech et al., 
2013). In fact, putative synaptic contacts have been observed between intrinsic 
MB neurons with dopaminergic, serotonergic and octopaminergic neurons; 
suggesting that MB neurons are heavily subjected to neuromodulation (Pech et 
al., 2013).  
There is also direct evidence linking neuromodulation to higher order 
sensory discrimination pathways. Learned odour discrimination in rats is 
disrupted by pharmacologically blocking muscarinic acetylcholine receptors 
(Fletcher and Wilson, 2002). Optogenetically inducing the release of the 
neuropeptide oxytocin improved the ability of rats to recognise the smell from a 
familiar conspecific versus a novel one (Oettl et al., 2016). The representation 
of tones in the rodent primary auditory cortex, and therefore auditory 
discrimination behaviour, can be altered by pairing tones with dopaminergic 
activation (Aton, 2013). In the mouse auditory thalamus, blocking adenosine 
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production or A1-adenosine receptor signalling can also affect cortical auditory 
representation and improve discrimination (Blundon et al., 2017).  
In fact, a single neuromodulator, such as noradrenaline, may impair or 
improve discrimination in different sensory pathways. Blocking adrenoceptors in 
the rat anterior piriform cortex impaired odour discrimination (Shakhawat et al., 
2015). In the mouse visual cortex, systemic injection of α1-adrenoceptor 
agonists induced long term depression in the inputs to excitatory cortical 
neurons, leading to impaired visual discrimination (Treviño et al., 2012). On the 
other hand, noradrenaline injection at the guinea pig auditory cortex improved 
discrimination between natural vocalisations by decorrelating firing patterns in 
auditory cortical neurons that had previously showed increased activity in 
response to noradrenaline (Gaucher and Edeline, 2015). The diverse effects of 
a specific neuromodulator, therefore, make it challenging to understand its 
functions and mechanisms.  
 Furthermore, much of our understanding of neuromodulation of sensory 
discrimination pathways has been through studying the effects of applying 
agonists and antagonists against neuromodulatory receptors. However, it is 
difficult to control spatial and temporal specificity of injected drugs to match the 
physiological activity of neuromodulators – which can act both tonically and 
phasically depending on the context, and also affect longer range targets. 
Moreover, there is a large heterogeneity of neuronal types in a given brain 
region, such that activating neuromodulatory receptors on all neurons 
simultaneously would obscure the neural mechanisms in which individual 
neurons affect the overall circuitry.  
This issue of temporal specificity could be partially resolved by the 
activation of neuromodulatory neurons using electrophysiology and 
optogenetics. Electrophysiological recording and calcium imaging can also be 
used to monitor how neuromodulation affects neuronal activity. While these 
methods have been used to study individual synapses, it is still extremely 
challenging to generate a network-level understanding of neuromodulation in 
the higher brain without the knowledge of the anatomical connections or 
neuromodulatory targets in a sensory discrimination circuit. For this reason, little 
is known about how neuromodulation regulates component neurons within a 
sensory discrimination circuit, and how this could affect the circuit as a whole.  
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1.2. The Drosophila larval olfactory system as a model for sensory 
processing 
Here I aimed to study octopamine modulation of the Drosophila larval olfactory 
pathway in order to investigate the anatomical organisation of sensory 
discrimination circuitry subjected to neuromodulation in the higher brain. In this 
section, I will first outline the model system, along with its similarities and 
differences to mammalian systems, followed by why it is a good model for 
studying sensory neuromodulation.  
 
1.2.1. The mushroom body – the insect olfactory learning centre 
The Mushroom Bodies (MBs) are higher brain sensory processing centres in 
insects – most well-known for their involvement in odour discrimination learning 
– which is impaired when the MBs are absent (Heinsenberg et al., 1985; 
Heisenberg, 2003). In the MBs, the sparse and selective activity of the 
population of intrinsic MB neurons (Kenyon Cells or KCs) is thought to maintain 
non-overlapping odour representations and underlie odour discrimination 
(Perez-Orive et al., 2002; Gruntman and Turner, 2013; Lin et al., 2014). KC 
dendrites receive olfactory inputs at the MB calyx, where the sparseness and 
selectivity of KCs is thought to be regulated (Masuda-Nakagawa et al., 2005, 
2014; Lin et al., 2014). KC axons project to the MB lobes, where the 
convergence of CS+/CS- and US required for associative olfactory learning is 
thought to occur (Schwaerzel et al., 2003; Aso et al., 2014; Hige et al., 2015). 
The structure of the Drosophila larval MBs are shown in Figures 1.1 and 1.2; 
while the innervation pattern of fly larval KCs is shown in Figure 1.3.  
The MB is often considered to be analogous to the mammalian olfactory 
cortex, in particular the piriform cortex, as they share anatomical and functional 
principles of sensory coding (Wilson and Sullivan, 2011). Odour representations 
in the MB and piriform cortex both rely on the sparse and distributed population 
response of their intrinsic neurons – KCs and pyramidal neurons respectively 
(Perez-Orive et al., 2002; Turner et al., 2008; Stettler and Axel, 2009). In both 
instances, this is facilitated by the random convergence of olfactory inputs from 
second order projection neurons, projection neurons in insects and mitral/tufted 
cells in mammals (Masuda-Nakagawa et al., 2005; Stettler and Axel, 2009; 
Caron et al., 2013; Gruntman and Turner, 2013). This sparse activation pattern  
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Figure 1.1. The Drosophila larval Mushroom Body visualised from the dorsal orientation. 
(A) Schematic of the Drosophila third instar larval brain visualised from the dorsal orientation. 
The Mushroom Bodies (MBs) are labelled and indicated in blue. (B-C) Confocal projection of 
the right third instar larval brain lobe (B) and MB calyx (C) from the dorsal orientation, where 
posterior (P) is up and medial (M) is right. Neuropils are labelled by anti-Discs Large (Dlg) and 
shown in blue. (D) The first instar larval MB reconstructed from electron microscopy (EM) data 
oriented dorsally. Figure 1.1D is obtained from https://neuronlp.larva.fruitflybrain.org/. 




Figure 1.2. The Drosophila larval Mushroom Body and Antennal Lobe visualised from the 
frontal orientation. (A) Schematic of the Drosophila third instar larval brain visualised from the 
frontal orientation. The MBs and Antennal Lobes (ALs) are labelled and indicated in blue. (B-C) 
Confocal projection of the right third instar larval brain lobe (B) and AL (C) from the frontal 
orientation, where dorsal (D) is up and medial (M) is right. Neuropils are labelled by anti-Dlg and 
shown in blue. (D) The first instar larval MB and AL reconstructed from EM data oriented 
frontally. Figure 1.2D is obtained from https://neuronlp.larva.fruitflybrain.org/. Abbreviations: 
iACT, inner antenna-cerebral tract; SOG, suboesophageal ganglion. Scale bar: 50 μm in (B) 




Figure 1.3. Innervation pattern of larval KCs. (A) Confocal projection of the third instar larval 
brain lobe oriented dorsally; where posterior (P) is up and medial (M) is right. Larval KCs are 
visualised using KC driver H406-IT.GAL4>UAS-mCD8::GFP in green, and MB neuropils are 
labelled by anti-Dlg in blue. Scale bar: 10 μm. (B) Innervation pattern of KCs in the first instar 
larval MB reconstructed from EM data. Figure 1.3B is obtained from 
https://neuronlp.larva.fruitflybrain.org/. Abbreviations: KC, Kenyon Cell.  
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is further regulated by global inhibition by GABAergic interneurons in the 
piriform cortex and insect MBs (Poo and Isaacson, 2009; Papadopoulou et al., 
2011; Lin et al., 2014; Masuda-Nakagawa et al., 2014). Moreover, both the MB 
and piriform cortex receive extensive neuromodulatory inputs: most notably 
aminergic and peptidergic inputs to the MB; and cholinergic and noradrenergic 
inputs to the piriform cortex (Heuer et al., 2012; Pech et al., 2013; Linster and 
Cleland, 2016). On the other hand, it is unknown whether the compartmentally 
discrete innervation pattern of extrinsic input and output neurons observed in 
the MB (Aso et al., 2014) applies to the mammalian olfactory cortex. However, 
this may be due to the lack of tools for distinguishing individual neuronal types 
in mammalian cortices, as opposed to the tools currently available to study the 
fly MBs. Nevertheless, the shared coding principles with the mammalian 
olfactory cortex suggest that the insect MB may be a useful model for studying 
principles of the broad anatomical principles of neuromodulation in sensory 
circuitries.  
 
1.2.2. The Drosophila larval olfactory pathway 
While the MBs are integral to olfactory learning in both adults and larval 
Drosophila (Heisenberg et al., 1985), the number of KCs in Drosophila – around 
2,500 in adults and 600 in larvae – is considerably lower than that of other 
insects, for example 170,000 in honeybees and 200,000 in cockroaches 
(Heisenberg, 2003; Ramaekers et al., 2005). The numerical simplicity of the fruit 
fly MB, together with the extensive genetic tools available for its manipulation 
(Section 1.2.8), are the main reasons why the Drosophila olfactory pathway is 
such an attractive model system.  
 In addition to the conserved coding principles between the fly MB and the 
mammalian olfactory cortex discussed above, the olfactory pathway in the fly 
adult and larvae also share a similar architecture to that of the mammalian 
olfactory system (Fig. 1.4; Tanaka et al., 2004; Ramaekers et al., 2005): 
In fly larvae, odours are first detected by 21 olfactory sensory neurons at 
the dorsal organ. This is analogous to the peripheral detection of odours at the 
olfactory epithelium in mammals and the antenna in fly adults. Each olfactory 




Figure 1.4. Mammals, Drosophila adults and larvae share a conserved pathway for odour 
recognition. Odours are first detected by olfactory receptors on olfactory receptor neurons in 
the periphery. Olfactory information from the same type of olfactory receptors converges at 
glomeruli in the primary olfactory center, and then delivered to secondary and higher olfactory 
processing regions by projection neurons. Estimated numbers of neurons and glomeruli 
involved at each step shown in brackets. Figure redrawn from data in Ramaekers et al. (2005) 
and Masuda-Nakagawa et al. (2005).  
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single glomerulus in the Antennal Lobe (AL) – the primary olfactory centre 
analogous to the mammalian olfactory bulb. Larval olfactory projection neurons 
(PNs), analogous to mitral/tufted cells, then carry olfactory information from a  
single AL glomerulus to 1-2 glomeruli in the MB calyx stereotypically (Fig. 1.5A-
B). KCs integrate information from multiple PNs by sending dendrites to around 
6 calyx glomeruli non-stereotypically (Masuda-Nakagawa et al., 2005, 2009). 
This is comparable to the convergence of olfactory inputs from mitral/tufted cells 
to pyramidal neurons in the piriform cortex (Stettler and Axel, 2009). Moreover,  
a single GABAergic APL neuron activated by KC output at the MB lobes sends 
feedback inhibition to KC dendrites at the MB calyx (Fig. 1.5C-D; Lin et al., 
2014; Masuda-Nakagawa et al., 2014). This feedback inhibition motif is also 
observed in GABAergic interneurons in the piriform cortex (Poo and Isaacson, 
2009). This suggests that many features of the olfactory pathway are conserved 
between mammals and Drosophila larvae.  
Besides KCs, PNs and the GABAergic APL neuron, the larval MB calyx 
is also innervated by cholinergic MB output neurons known as Odd/Odd-like 
neurons discussed below (Slater et al., 2015) and neuromodulatory 
octopaminergic (OA) neurons discussed in the following section (Honjo and 
Furukubo-Tokunaga, 2009; Selcho et al., 2014).  
Clonal analysis revealed that there are 2 or 3 calyx-innervating Odd 
neurons, all of which have cell bodies located dorso-posterior to the calyx and 
innervate the centroposterior medial compartment (CPM) – a neuropil 
surrounding the MB lobes (Fig. 1.5E-F; Slater et al., 2015). Odd neurons are 
postsynaptic in the larval MB calyx, appear to form putative synapses with PNs, 
and are involved in odour intensity discrimination (Slater et al., 2015). However, 
as the Odd-GAL4 line used in Slater et al. (2015) labels many KCs in addition to 
Odd neurons (L. Masuda-Nakagawa, personal communication), it is unclear 
whether the putative synapses with PNs and the olfactory behaviours observed 
are attributed to Odd neurons or KCs. Odd-like neurons labelled in the OK263-
GAL4 driver are similar in morphology and innervation pattern to Odd neurons 
(Slater et al., 2015; M.T., Part II Report 2015; L. Masuda-Nakagawa, personal 
communication). Therefore, neurons that show similar morphology and 







Figure 1.5. Innervation patterns of PNs, the APL neuron and Odd-like neurons in the 
larval brain. (A,C,E) Confocal projections of the third instar larval brain lobe. Neuropils labelled 
by anti-Dlg is blue. Medial (M) is right; dorsal (D) is up for (A,C) and posterior (P) is up for (E). 
(A) A subset of PNs labelled by NP225-GAL4 (green) innervating the Antennal Lobe (AL), the 
MB calyx via the inner antenna-cerebral tract (iACT), and the lateral horn (LH) which is 
associated with innate olfactory behaviour. (C) The APL neuron labelled in NP732-GAL4 
(green) innervates the MB calyx and lobes. (E) Odd-like neurons labelled by OK263-GAL4 
(green) innervate the MB calyx and the centroposterior medial compartment (CPM), a neuropil 
around the MB lobes. (B,D,F) Innervation patterns of a subset of PNs (B), the APL neuron (D) 
and Odd-like neurons (F) in the first instar larval MB reconstructed from EM data. Figure 1.5E 
was imaged from a sample prepared by Magdalene Ting. Figures 1.5B,D,F are obtained from 
https://neuronlp.larva.fruitflybrain.org/. Scale bar: 10 μm for (A), 50 μm for (C,E).  
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1.2.3. OA neurons in the larval MB calyx 
Like other higher sensory processing centres, the larval MB calyx is subjected 
to neuromodulatory inputs. While the adult calyx shows immunoreactivity to 
octopamine, dopamine, serotonin and neuropeptide sNPF (Nässel et al., 2008; 
Pech et al., 2013), the larval MB calyx appears to only receive octopaminergic 
and peptidergic neuromodulatory innervation (Nässel et al., 2008; Honjo and 
Furukubo-Tokunaga, 2009; Selcho et al., 2014). As the larval MB calyx shows 
little immunoreactivity against serotonin (Huser et al., 2012), no innervation of 
dopaminergic neurons labelled by TH-GAL4 (Honjo and Furukubo-Tokunaga, 
2009) or other GAL4 lines labelling dopaminergic pPAM neurons (Rohwedder et 
al., 2016); OA neurons are most likely the main source of aminergic 
neuromodulation in the larval MB calyx.  
Not only is OA innervation of the MB calyx conserved between adult and 
larval Drosophila, it is conserved across insects, including in honeybees, 
locusts, blowflies, cockroaches and moths (Bräunig and Burrows, 2004; Dacks 
et al., 2005; Sinakevitch et al., 2005; Sinakevitch and Strausfeld, 2006; Selcho 
et al., 2014). This suggests a functionally conserved role for OA 
neuromodulation of the MB calyx circuitry. Yet, it is still unclear what the 
functions and mechanisms of OA neuromodulation are in the MB calyx, and 
how this in turn affects odour discrimination. 
 OA innervation of the larval MB calyx was first observed using the Tdc2-
GAL4 line, which labels OA- and tyramine (TA)-positive neurons in the 
Drosophila brain (Cole et al., 2005; Busch et al., 2009; Honjo and Furukubo-
Tokunaga, 2009). I have previously confirmed that the Tdc2 processes 
innervating the larval calyx are immunoreactive against OA (Fig. 1.6A-C; H.W., 
MPhil Thesis 2014). This suggested that the neuromodulator OA is released in 
the larval MB calyx.   
 Clonal analysis has since revealed two types of OA neurons innervating 
the larval MB calyx – sVUMmd1 and sVUMmx1 neurons – collectively known as 
the sVUM1 neurons (Selcho et al., 2014). sVUM1 cell bodies are located at the 
ventral median of the suboesophageal ganglion (SOG) region (also known as 





Figure 1.6. Calyx-innervating OA neurons and their cell body location in the larval brain. 
mCD8::GFP driven by Tdc2-GAL4 or Tdc2-LexA is green, anti-OA is magenta and anti-Dlg is 
blue. (A,D) Tdc2-GAL4>UAS-mCD8::GFP, (B,E) Tdc2-LexA(II)>LexAOp-mCD8::GFP and (C,F) 
Tdc2-LexA(III)>LexAOp-mCD8::GFP. (A-C) are confocal projections of the calyx, where medial 
is right and anterior is up. Arrows indicate KC cell bodies. (D-F) are confocal projections of the 
ventral SOG, where anterior is up and medial is at the vertical midline. SOG ventral median 
mandibular (sVMmd) and SOG ventral median maxillary (sVMmx) cell body clusters, and 




cluster and sVUMmx1 is in the maxillary (mx) cluster (Fig. 1.6D-F; Selcho et al., 
2014). In addition to the MB calyx, sVUM1 neurons also innervate the AL and 
the SOG (Selcho et al., 2014). The innervation pattern of the sVUM1 neurons is 
shown in Fig. 1.7. Electron microscopy (EM) reconstruction data show that 
sVUMmd1 and sVUMmx1 (named OAN-a1 and OAN-a2 respectively) have 
non-overlapping innervation patterns in the first instar larval (L1) MB calyx (Fig. 
1.7D; Eichler et al., 2017; https://neuronlp.larva.fruitflybrain.org/). However, it is 
unknown whether sVUMmd1 and sVUMmx1 are functionally equivalent.  
 Tdc2 processes colocalise with postsynaptic markers at the SOG region, 
but predominantly colocalise with presynaptic markers in the calyx (H.W., 
L.M.N., unpublished). This suggests that sVUM1 neurons receive inputs at the 
SOG region, where the primary gustatory centre is located (Colomb et al., 
2007); and send outputs to modulate the calyx. This is in agreement with the 
presynaptic terminals of sVUM1 neurons observed in the L1 calyx using EM 
(Eichler et al., 2017). EM data also revealed that sVUM1 neurons contained 
both small clear vesicles and dense core vesicles in their L1 calyx terminals – 
suggesting that sVUM1 neurons may release OA or possible co-transmitters 
both synaptically and via volume transmission (Eichler et al., 2017). On the 
other hand, it is unclear whether sVUM1 neurons are pre- and/or post-synaptic 
in the AL. While both pre- and post-synaptic markers are observed at the AL 
(H.W., L.M.N., unpublished), the Tdc2-GAL4 line used to assess polarity labels 
tyraminergic lAL neurons as well as the sVUM1 neurons in the AL (Selcho et 
al., 2014).  
 The OA-VUMa2 neurons in adult flies and the VUMmx neurons in 
honeybees share the same innervation pattern as larval sVUM1 neurons 
(Hammer, 1993; Kreissl et al., 1994; Hammer and Menzel, 1998; Busch et al., 
2009). This suggests that these neurons may have conserved functions in 
olfactory processing in the MB calyx – possibly in olfactory rewarding learning, 
in which honeybee VUMmx neurons are involved in (Hammer, 1993; Hammer 
and Menzel, 1998).  
 
1.2.4. Connectivity of OA neurons in the larval MB calyx  
To identify the potential synaptic partners of sVUM1 neurons in the calyx, I  
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Figure 1.7. Innervation pattern of octopaminergic sVUM1 neurons in the larval brain. (A) 
Confocal projection of the third instar larval brain lobe and SOG oriented ventrally; where 
anterior is up and medial is at the vertical mid-line. A sVUM1 neuron clone is visualised using 
Tdc2-GAL4>FLP-out in green. Anti-Dlg is blue. (C) Confocal projection of the dorsal MB calyx, 
where posterior (P) is up and medial (M) is right. sVUM1 neurons are labelled by Tdc2-LexA 
(green), anti-OA is magenta and anti-Dlg is blue. (B,D) Innervation pattern of sVUM1 neurons – 
sVUMmd1 (blue) and sVUMmx1 (green) in the first instar larval brain (B) and MB calyx (D) 
reconstructed from EM data. Figures 1.7B,D are obtained from 
https://neuronlp.larva.fruitflybrain.org/. Scale bar: 20 μm. Abbreviations: AL, antennal lobe; 
SOG, suboesophageal ganglion.  
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previously conducted GFP reconstitution across synaptic partners (GRASP) 
(Gordon and Scott, 2009) as part of my MPhil Thesis. I found that while sVUM1 
neurons had very few synaptic connections with KCs, there were putative 
synaptic connections between sVUM1 neurons and PNs, the APL neuron, and 
Odd-like neurons (Fig. 1.8; H.W., MPhil Thesis 2014). Using the single cell 
GRASP method (Karuppudurai et al., 2014) to isolate GRASP signals from 
neuronal clones, my colleague additionally found that sVUMmd1 and sVUMmx1 
neurons both individually formed putative synapses with Odd-like neurons 
(A.W., MPhil Thesis 2015). This suggested that OA signalling from sVUM1 
neurons modulate PNs, the APL neuron and Odd-like neurons in the calyx 
circuitry. As PNs and the APL neuron synapse with KCs (Masuda-Nakagawa et 
al., 2014), sVUM1 signalling may be indirectly modulating odour representations 
in KCs via these two types of neurons.  
Interestingly, the limited GRASP connections observed between KCs and 
sVUM1 neurons in the larval calyx is contrary to the dense GRASP signals 
observed between KCs and OA neurons in the adult MB calyx (Zhou et al., 
2012; Pech et al., 2013). Moreover, EM data from the first instar larva indicated 
that there were synaptic connections between KCs and sVUM1 neurons 
(Eichler et al., 2017), most likely in the L1 calyx – the only neuropil both KCs 
and sVUM1 neurons innervate. Therefore, it is unclear whether the limited 
GRASP between KCs and sVUM1 neurons in the third instar larval (L3) calyx is 
a developmental anomaly or an experimental artefact. On the other hand, 
sVUM1 connectivity with Odd-like neurons is consistent with L1 EM data 
(Eichler et al., 2017; Https://neuronlp.larva.fruitflybrain.org/); although 
connections between sVUM1 neurons and non-KC calyx-innervating neurons 
have not been explicitly explored in the L1 or adult calyx.  
It is also unclear how neuromodulatory neurons are connected in 
mammalian sensory cortices, such as the piriform cortex. The connectivity of 
sVUM1 neurons with multiple potential synaptic partners in the larval MB calyx 
suggests that neuromodulation may affect a heterogeneous population of 
interconnected cortical neurons, which will have consequences in our 
understanding of the neuromodulatory circuitry and output. However, different 





 Figure 1.8. Calyx-innervating neurons and their connectivity in the larval MB calyx. 
Summary schematic of the known innervation patterns and connectivity of calyx-innervating 
neurons in the larval MB calyx based on data from Masuda-Nakagawa et al., 2005, 2014; 
Selcho et al., 2014; Slater et al., 2015; Barnstedt et al., 2016; H.W., MPhil Thesis 2014. 
Putative synapses identified using GRASP (H.W., MPhil Thesis 2014) are indicated with 
double-ended arrows as the direction of neurotransmission is unknown. Approximate numbers 
of each neuronal type are as indicated. Main neurotransmitter for each neuronal type are as 
labelled: Acetylcholine (ACh) in yellow, GABA in orange and OA in red. Abbreviations: AL, 
antennal lobe; CPM, centroposterior medial compartment; KC, Kenyon Cell; LH, lateral horn; 
MB, mushroom body; N, number; OA, octopamine; PN, projection neuron. 
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This is why understanding neuromodulatory networks in a well-characterised 
and simpler model like the Drosophila larval MB calyx may be beneficial.  
 
1.2.5. Towards an OA neuromodulatory connectome in the larval MB calyx 
While GRASP and EM data are useful in studying connectivity in the larval MB 
calyx, they are not without limitations. GRASP can only be used to detect 
membrane contacts but not actual synapses. Moreover, the direction of 
neurotransmission is not specified at GRASP contacts. Therefore, it is unclear 
whether potential synaptic partners identified in this method are indeed 
subjected to OA signalling by sVUM1 neurons, or are in fact providing inputs to 
the sVUM1 neurons. There are slightly more information collected using EM 
data; which can reveal the location of pre- and post-synapses as well as that of 
dense core vesicles which are related to volume transmission (Meinertzhagen 
and Lee, 2012). However, the process of obtaining EM data is difficult, labour-
intensive and time-consuming. For example, the current data we have on the L1 
connectivity are obtained from a single larva (Berck et al., 2016; Eichler et al., 
2017). Therefore, it is unclear whether the connectivity obtained can be 
replicated and thus representative of the L1 brain. There are also other reasons 
why synaptic connectivity data may still be insufficient in mapping the OA 
neuromodulatory circuitry in the MB calyx.  
sVUM1 neurons display immunoreactivity to both OA and its precursor 
TA (Selcho et al., 2014), which itself is a neurotransmitter that has been shown 
to modulate larval locomotion (Saraswati et al., 2004). OA neurons also contain 
large dense core vesicles (Grygoruk et al., 2014; Eichler et al., 2017), 
traditionally associated with neuropeptide co-transmission (Karhunen et al., 
2001; Nässel, 2009). As OA neurons in locusts co-label with FMFRamide and 
locustatachykinin-related peptides (Stevenson and Pflüger, 1994; Vitzthum and 
Homberg, 1998), this suggests that OA neurons in Drosophila may also co-
release neuropeptides. Hence, even if synapses are observed between sVUM1 
neurons and their postsynaptic partners, it is possible that these neurons may 
be modulated by other neurotransmitters co-released by sVUM1 neurons such 
as TA or neuropeptides rather than OA.  
 Synaptic connectivity is also unable to reflect the potential extrasynaptic 
signalling of neuromodulators (Agnati et al., 1995; Brezina, 2010). Extrasynaptic 
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release sites and receptors have been observed for various neuromodulators 
(Trueta and De-Miguel, 2012). A diffusion model for dopamine in the substantia 
nigra pars compacta and striatum proposed that dopamine can act on receptors 
2-8 μm from its release site (Rice and Cragg, 2008); suggesting that 
neuromodulators are capable of long-range diffusion to reach non-synaptic 
targets. While extrasynaptic OA transmission in Drosophila has not yet been 
studied, extrasynaptic OA receptors in C.elegans (Bentley et al., 2016) and 
extrasynaptic NA varicosities in the mammalian cortices (Descarries et al., 
1977) have been well-documented. Additionally, OA can persist and travel for 
long distances as a neurohormone in the extracellular fluid of other insects 
(Goosey and Candy, 1980; Adamo et al., 1995). Feeding OA to Tβh mutant flies 
defective in OA synthesis can also rescue impaired olfactory reward learning 
(Schwaerzel et al., 2003), suggesting that ingested OA can travel long 
distances to reach its brain targets. The large dense core vesicles in Drosophila 
OA neurons express the vesicular monoamine VMAT (Grygoruk et al., 2014), 
which suggests that OA may also be loaded into dense core vesicles. Dense 
core vesicles are associated with extrasynaptic release, as EM data show that 
they are often localised outside of active zones (Zhu et al., 1986; Karhunen et 
al., 2001; Trueta and De-Miguel, 2012). This is supported by EM observations 
which show that sVUM1 terminals in the L1 calyx have both clear vesicles 
associated with synaptic transmission, as well as dense core vesicles 
associated with volume transmission (Eichler et al., 2017). Together, this 
suggests that OA may be released extrasynaptically via dense core vesicles. 
Thus, OA in the calyx may be able to diffuse to and act on neurons that do not 
synapse with sVUM1 neurons.  
Another characteristic of neuromodulation that cannot be revealed 
through synaptic connectivity is that a single neuromodulator is able to activate 
multiple types of neuromodulatory receptors – which are usually G-protein 
coupled receptors. For example, noradrenergic activation of β-adrenoceptors 
increases intracellular cAMP, while activating α2-adrenoceptors decreases 
cAMP levels. Therefore, the expression of β-adrenoceptors versus α2-
adrenoceptors would result in different, or even antagonising, effects on 
neuronal and synaptic activity (Hein et al., 1999; Marzo et al., 2009).  
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Therefore, to fully understand the anatomical organisation of the calyx 
OA neuromodulatory circuitry, it is not only necessary to confirm synaptic 
connectivity, but also to map all the possible OA receptors on calyx-innervating 
neurons to determine potential targets of sVUM1 signalling.  
 
1.2.6. Drosophila as a model organism 
The fruit fly Drosophila melanogaster is a well-established model organism for 
studying sensory neuromodulation (Taghert and Nitabach, 2012; Kim et al., 
2017; Sayin et al., 2018). As laboratory animals, they are small, cheap, easy to 
maintain and can reproduce in large numbers within a short time period. While 
the fly brain is thought to contain a million-fold fewer neurons than the human 
brain (Venken et al., 2011b), flies are still capable of displaying complex 
cognitive behaviours, most notably the ability to learn and form associative 
memories (Heisenberg et al., 1985). The Drosophila olfactory learning pathway 
has been particularly well-characterised (Schwaerzel et al., 2003; Burke et al., 
2012); especially in our understanding of how dopaminergic neuromodulation in 
the fly olfactory learning centre facilitates innate and learned olfactory 
behaviours (Cohn et al., 2015; Hige et al., 2015; Aso and Rubin, 2016). 
Neuromodulation of other behaviours, such as feeding, locomotion, courtship 
and aggression, have also been extensively studied in fruit flies (Andrews et al., 
2014; Inagaki et al., 2014; Yang et al., 2015; Schlegel et al., 2016).  
 As discussed in Sections 1.2.1 & 1.2.2., the Drosophila olfactory pathway 
is also a useful model because of its shared sensory coding principles with 
mammals, suggesting strong degrees of functional conservation. Moreover, the 
fruit fly shares many gene orthologues with mammals, including those for 
neuromodulatory receptors (Evans and Maqueira, 2005). In fact, mutations in fly 
orthologues have been used to model human diseases such as hereditary 
spastic paraplegia (Summerville et al., 2016).  
That said, the main attraction with working with fruit flies is the extensive 
toolkit and resources that are available and in development. Like many other 
organisms, the fruit fly genome has been fully sequenced and easily accessible 
online. The Flybase project (Gramates et al., 2017), in particular, provides an 
extensive online database that contains information on genes, sequences and 
reagents in Drosophila. There are also large-scale projects aimed at 
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reconstructing the synaptic connectivity of the entire fly brain from EM images, 
which would be useful for understanding neuromodulatory circuitry. This has 
begun to come into fruition for the olfactory learning centres in both adults 
(Takemura et al., 2017) and first instar larvae (Berck et al., 2016; Eichler et al., 
2017). So far, comparable efforts of generating a full connectome have only 
been made in the far simpler C.elegans (Bentley et al., 2016); which does not 
have a central nervous system. Most importantly, Drosophila is one of the most 
genetically tractable organisms available (Venken et al., 2011b), which I will 
discuss in Section 1.2.8.  
 
1.2.7. The Drosophila larva as a model organism 
Like adult flies, Drosophila larvae are also able to learn to discriminate between 
different odours (Scherer et al., 2003). As discussed in Sections 1.2.1. and 
1.2.2., the Drosophila larval olfactory pathway is not only well characterised, but 
also shares a similar structure and conserved coding principles to that of fly 
adults and mammals, albeit with fewer neurons and potentially less redundancy 
(Fig. 1.4; Masuda-Nakagawa et al., 2005; Ramaekers et al., 2005). Therefore, 
fly larvae present a numerically simple model system for elucidating the 
fundamental circuitry organisation of complex behaviours such as odour 
discrimination.  
In fact, the larval central nervous system (CNS) has been widely used to 
study the mechanisms of olfactory processing, reward learning and state-
dependent neuromodulation (Masuda-Nakagawa et al., 2005; Schroll et al., 
2006; Kreher et al., 2008; Selcho et al., 2009; Zhang et al., 2013a). Thus, 
experimental methods and behavioural assays, including associative olfactory 
learning, discrimination and generalisation tasks, in the fly larvae are very well-
established (Chen et al., 2011a; Honjo et al., 2012; Pauls et al., 2014). 
Furthermore, genetic tools available in fruit flies (Section 1.2.8) are applicable to 
both adult and larval stages.  
 Besides its numerical simplicity, fly larvae have two intrinsic advantages 
over adult flies: they are easier to handle experimentally as they do not fly; and 
their optical transparency is useful for optogenetic stimulation and imaging 
(Schroll et al., 2006; Honjo et al., 2012). It is disadvantageous that fly larvae are 
immature organisms whose neural circuits are still developing, although it can 
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also be argued that they are animals with their own specific needs independent 
of adult flies.  
   
1.2.8. Genetic tools in Drosophila  
The main advantage of using Drosophila as a model organism to study neural 
circuitry is undoubtedly the wealth of genetic tools that are available; compared 
to both mammals and other invertebrates, including classical neuromodulation 
models such as honeybees and crustaceans (Marder, 2012).  
 
1.2.8.1. Transcriptional driver lines  
The most valuable tools in Drosophila are binary transcriptional drivers, such as 
the GAL4 and LexA systems (Brand and Perrimon, 1993; Lai and Lee, 2006), 
for tissue-specific expression of reporters and effectors. The large number of 
transcriptional driver lines developed in Drosophila (Hayashi et al., 2002; Jenett 
et al., 2012) label many different neuronal types with various degrees of 
specificity.  
This allows for highly specific genetic manipulation not yet possible in 
most other models. For example, there are only a few tissue-specific transgenic 
mouse strains, such as ChAT-Cre, VGAT-ChR2-EYFP (Zhang et al., 2016) or 
ArcCreERT2 (Root et al., 2011), most of which label large populations of 
neurons. Otherwise, tissue-specific expression in rodents involves infecting 
neurons in a particular region non-specifically with adeno-associated virus 
vectors encoding the effector of choice (Root et al., 2011; Akerboom et al., 
2013). Even in honeybees, visualising ORNs and PNs require neurobiotin 
injection, which lacks specificity and cannot ensure the same neurons are 
labelled for each experiment (Sinakevitch et al., 2017).  
The expression pattern of Drosophila lines can be further refined through 
clonal analysis and genetic intersection to probe the morphology and function 
respectively of very specific subsets of neurons, sometimes even at a single 
neuron resolution (Lee and Luo, 1999; Wong et al., 2002; Venken et al., 2011b). 
This level of specificity is ideal for studying the effects of neuromodulation on 
component neurons in a sensory circuit.  
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While these methods are available, there is still much work to be done in 
obtaining specific drivers for neurons of interest. Currently, the lines used to 
investigate OA function in the MBs also label additional OA neurons that do not 
show MB innervation (Burke et al., 2012; Selcho et al., 2014) – making it difficult 
to isolate the functions of individual neurons, such as sVUM1 neurons. 
Therefore, it is necessary to obtain alternative drivers that label these neurons 
of interest. These lines may either be more specific; or can be used with an 
existing line that shares expression only in the neurons of interest to generate a 
genetic intersection to specifically label neurons expressed in both driver lines 
(Venken et al., 2011b).  
 
1.2.8.2. Tools for visualising and manipulating neurons 
To visualise neuronal morphology and innervation patterns, transcriptional 
drivers can be used to drive fluorescent reporters such as mCD8::GFP (Lee and 
Luo, 1999; Pfeiffer et al., 2010). The innervation patterns of single neurons 
labelled within a transcriptional driver can also be resolved using the multicolour 
FLP-out technique (Nern et al., 2015) developed from the mammalian Brainbow 
system (Livet et al., 2007). The polarity of specific neurons can be identified by 
tissue-specific expression of synaptic markers fused to fluorescent proteins, 
such as n-syb::GFP and DenMark for pre- and post-synaptic sites respectively 
(Sweeney et al., 1995; Nicolaï et al., 2010).  
 Gentically encoded functional imaging tools for measuring neuronal 
activity are also well-established in Drosophila. These include the calcium 
indicator GCaMP (Tian et al., 2009), cAMP sensors (Shafer et al., 2008), and 
synapto-pHluorin to assay neurotransmitter release (Ng et al., 2002). These 
tools make it easier to visualise activity in specific neurons, compared to the 
more traditional electrophysiological methods, with which is more difficult to 
consistently record from the same neurons; and can reflect cellular effects of 
neuronal or receptor activation, such as change in cAMP levels.   
On the other hand, effectors can be used for activating or blocking 
neuronal activity, overexpression or genetic rescue in a mutant background. In 
particular, there are many thermogenetic and optogenetic techniques developed 
in Drosophila for conditional neuronal manipulation. These include temperature-
sensitive inhibition and activation of neurons by shibirets and dTrpA1 
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respectively (Kitamoto, 2001; Rosenzweig et al., 2005), as well as light-
sensitive ion channels such as the ChR2 channelrhodopsin (Schroll et al., 
2006); all of which have been previously used to study the mechanisms of 
olfactory learning (Schwaerzel et al., 2003; Schroll et al., 2006; Burke et al., 
2012). While optogenetics are available in some vertebrate models, such as 
rodents and zebrafish (Boyden et al., 2005; Akerboom et al., 2013), it remains 
challenging to restrict tissue-specific expression patterns to neurons of interest. 
Drosophila larvae offer the additional advantage of optical transparency for 
effective optogenetic manipulation in freely behaving animals; and unlike 
mammalian models, require no surgical procedures (Schroll et al., 2006).  
There are also large collections of RNAi fly stocks for tissue-specific 
knockdown of gene expression from the Drosophila transgenic RNAi Project 
and the Vienna Drosophila Resource Center (Dietzl et al., 2007; Ni et al., 2008; 
Perkins et al., 2015). This is particularly useful for studying the functions of 
proteins such as neuromodulatory receptors in specific neurons in vivo, 
compared to the widespread and potentially off-target actions of 
pharmacological manipulation of neuromodulators and their receptors in 
mammalian systems.  
  
1.2.8.3. Tools for studying neuronal connectivity 
To understand neural connectivity, two or more transcriptional driver systems 
can be used together to investigate the anatomical or physiological interaction 
between two or more populations of neurons (Lai and Lee, 2006). This could be 
used to determine whether the two lines label the same neurons, or whether 
different neurons labelled by the two drivers innervated the same region, 
through colocalisation of two fluorescent reporters.  
Dual transcriptional driver systems can also be used to identify putative 
synaptic connections with the GRASP method (Gordon and Scott, 2009). Here, 
the split GFP halves are expressed at the membranes of two neuronal 
populations labelled by a GAL4 line and a LexA line respectively, such that GFP 
signal is only detected when split GFP is reconstituted at membrane contacts 
between these neurons, indicating at potential synapses. The single-cell 
GRASP method developed based on the FLP-out technique can even identify 
potential synapses between single neuronal clones (Wong et al., 2002; 
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Karuppudurai et al., 2014). This provides a high throughput method for mapping 
potential synaptic connections, and offers an economical and convenient 
alternative to EM. While GRASP has been adapted for the mouse brain (Feng 
et al., 2014), it is reliant on the successful injection of viral vectors due to the 
lack of transcriptional driver lines in mice – a time-consuming and technically 
challenging task that also lacks the specificity compared to the single neuron 
resolution capable in Drosophila models.  
 
1.2.8.4. Tools for visualising endogenous protein localisation 
Like many other organisms, CRISPR/Cas9-mediated genome editing methods 
have been rapidly developing in Drosophila (Gratz et al., 2013; Yu et al., 2014). 
This is particularly useful for visualising the endogenous expression patterns of 
proteins especially if specific antibodies are not yet available, such as 
neuromodulatory receptors.  
There are also insertion line collections in Drosophila that can be used to 
generate protein traps, such as the Minos-mediated integration cassette 
(MiMIC) collection (Venken et al., 2011a). The MiMIC construct is a Minos 
transposon carrying a gene trap flanked by two attP sites, which has been 
inserted in random locations of the Drosophila genome. When MiMIC is inserted 
in a coding region intron, it can be replaced with a protein trap containing a 
fluorescent reporter through φC31 integrase-mediated attP-attB recombination. 
This introduces an artificial exon encoding the fluorescent reporter within the 
protein of interest (Venken et al., 2011a; Nagarkar-jaiswal et al., 2015).  
While CRISPR knock-in in Drosophila was still at its early stages of 
development (Gratz et al., 2013; Xue et al., 2014), the MiMIC recombinase-
mediated cassette exchange (RMCE) method already had an established 
protocol, produced a higher frequency of successful knock-in recombinants and 
could be readily converted to different fluorescent reporters or gene-specific 
binary factor protein traps (Venken et al., 2011a; Diao et al., 2015; Gnerer et al., 
2015; Nagarkar-jaiswal et al., 2015). On the other hand, CRISPR allowed for 
targeted reporter insertion at any genomic location, and should be used if no 
suitable MiMIC line is available.  
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1.3. OA and noradrenergic modulation of olfactory discrimination 
 
1.3.1. OA as the insect counterpart of noradrenaline 
OA is a major biogenic amine often considered to be the insect analogue of the 
vertebrate neuromodulator noradrenaline (NA). This is predominantly due to the 
strong sequence similarities shared between OA receptors and mammalian 
adrenergic receptors (Maqueira et al., 2005; Qi et al., 2017). OA and NA also 
share similar chemical structures, although they are synthesised through slightly 
different biochemical pathways. While OA is synthesised from tyrosine using the 
enzymes tyrosine decarboxylase (Tdc) and tyramine-β-hydroxylase (Tβh) via 
TA, which can also act as a neurotransmitter; NA is instead synthesised from 
tyrosine via dopamine and dopamine-β-hydroxylase (Roeder, 1999).  
 While trace levels of OA have been detected in vertebrates, NA is absent 
from invertebrates. Instead, OA takes on many similar functions to NA in 
invertebrate nervous systems, such as arousal, motivation, learning and 
memory (Roeder, 1999). Notably, OA and NA may share conserved functions in 
modulating olfactory processing pathways. Similar to OA innervation of the 
insect AL and MB (Sinakevitch et al., 2005; Busch et al., 2009; Selcho et al., 
2014), noradrenergic (NA) fibres innervate their counterparts, the olfactory bulb 
and the piriform cortex respectively, where adrenergic receptors have also been 
identified (Shipley and Ennis, 1996).  
 
1.3.2. Noradrenergic modulation of higher olfactory processing 
Previous studies have shown that NA modulation acts on olfactory cortical 
neurons and affects olfactory learning and discrimination behaviours. In vivo 
activation of NA neurons increases odour responses of pyramidal cells in the 
piriform cortex (Bouret & Sara, 2002); while in vitro application of NA reduces 
excitatory synaptic potentials in the same neurons (Hasselmo et al., 1997). The 
late phase of cortical olfactory adaptation in the piriform cortex can also be 
blocked by activating β-adrenoceptors (Best and Wilson, 2004). Behaviourally, 
β-adrenoceptor activation in the anterior piriform cortex can substitute as an 
unconditional stimulus for olfactory preference learning in rat pups (Morrison et 
al., 2013). A more recent report showed for the first time that injecting 
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adrenergic receptor antagonists in the anterior piriform cortex impaired odour 
discrimination (Shakhawat et al., 2015).  
While many of the above studies do not differentiate between the types 
of the receptors activated and neuronal types they are activated on, NA 
modulation in the same pathway could result in opposite outcomes dependent 
on the type of receptor activated. For example, injecting β-adrenoceptor 
antagonists in the olfactory bulb improves odour discrimination, while α1-
adrenoceptor antagonists impairs odour discrimination (Mandairon et al., 2008). 
Moreover, NA application more strongly suppressed synaptic potentials at layer 
Ib of the piriform cortex (where pyramidal cells form reciprocal synapses) than 
in layer Ia (input region from olfactory bulb) (Hasselmo et al., 1997). This 
suggests that NA modulation is more sensitive at particular synapses. 
Therefore, receptor localisation, receptor affinity and local concentration of NA 
could all be contributing to differential effects of NA within a circuit.  
At the moment, as neuronal subtypes in the cortical regions of mammals 
remain elusive and difficult to isolate or manipulate, it is challenging to elucidate 
the organisation of the NA signalling network in the mammalian olfactory cortex. 
Therefore, studying OA circuits in the simpler and genetically tractable 
Drosophila larvae could shed light on conserved circuit mechanisms for 
noradrenergic-like neuromodulation of odour discrimination.  
 
1.3.3. The role of octopamine in the MB calyx 
Besides being a potentially conserved source of neuromodulation in the insect 
MB calyx, the main motivation for studying OA signalling arises from its known 
involvement in olfactory learning behaviours in the MBs. Traditionally, OA 
signalling in the MBs was proposed to convey the sugar reward signal required 
for associative olfactory learning to KCs (Schwaerzel et al., 2003). It was first 
discovered in honeybees that activation of a calyx-innervating OA neuron can 
be paired with an odour to form an artificial reward memory (Hammer, 1993). 
This was followed by studies in Drosophila larvae and adults that showed 
pairing OA activation with odours produced artificial appetitive memories 
(Schroll et al., 2006; Burke et al., 2012). Conversely, the lack of OA impaired 
olfactory reward memory in flies and larvae (Schwaerzel et al., 2003; Selcho et 
al., 2014).  
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Recent studies have refuted the classical model for associative olfactory 
learning in the MBs: in which OA conveys reward, while dopamine (DA) 
conveys punishment. Firstly, the disruption of OA signalling impairs reward 
memory formation only with sweet but non-nutritious sugars in adult and larval 
Drosophila (Burke et al., 2012; Selcho et al., 2014); suggesting that OA neurons 
only convey the sweetness aspect of reward rather than a general reward 
signal. This was supported by the discovery of rewarding dopaminergic (DA) 
neurons in adult and larval Drosophila that showed broader reward signalling 
than OA neurons (Burke et al., 2012; Rohwedder et al., 2016). Moreover, these 
rewarding DA neurons appeared to be downstream of OA neurons that do not 
appear to innervate adult fly MBs (Burke et al., 2012). Furthermore, the odour-
paired activation of MB-innervating neurons OA-VPM3, OA-VPM4 and OA-
VUMa2 (analogous to the larval sVUM1 neurons and the honeybee VUMmx 
neuron) was insufficient to induce appetitive learning (Burke et al., 2012). This 
is further complicated by the role of neuropeptide F (NPF) in appetitive olfactory 
behaviours: NPF signalling is required on DA neurons innervating the MB for 
appetitive memory in starved adult flies (Krashes et al., 2009); while activating 
dNPF neurons in fly larvae inhibited appetitive olfactory learning (Rohwedder et 
al., 2015). However, there is no evidence that NPF and OA share the same 
signalling pathway. Overall, these results suggested that OA neurons 
innervating the MBs may not be involved in reward US signalling at all; but 
instead have an alternative role in olfactory processing in the MBs.  
There is also more evidence suggesting that associative olfactory 
learning occurs at the MB lobes rather than the MB calyx. This idea was first 
proposed by Schwaerzel et al. (2003) who observed that cAMP machinery 
required for olfactory memory formation localised to the MB lobes but not to the 
MB calyx. In Drosophila larvae, DA neurons required for associative learning did 
not appear to innervate the larval MB calyx (Honjo and Furukubo-Tokunaga, 
2009; Rohwedder et al., 2016). On the other hand, the tiled innervation patterns 
of reinforcing DA neurons and MB output neurons in the MB lobe compartments 
identified in adult flies provide an anatomical framework for associative learning 
(Aso et al., 2014). This anatomical model was supported by the observation that 
pairing activation of an aversive DA neuron with an odour resulted in synaptic 
depression at KC output synapses at the MB lobes, but did not affect KC odour 
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responses (Hige et al., 2015). This has now led to the revised model that only 
DA neurons are responsible for modulating KC output synapses at the MB 
lobes for associative olfactory learning.   
 For these reasons, it is unlikely that OA neurons in the MB calyx are 
involved in signalling reward for associative learning. Nevertheless, the 
conserved OA inputs to the MB calyx indicated functional significance for OA 
modulation of the system. One of the hypotheses is that, similar to NA 
modulation of the piriform cortex, OA could be modulating odour responses of 
KC populations in the larval calyx that could be manifested in odour 
discrimination behaviour.  
 As the calyx is the MB input region, it is likely that OA is modulating 
inputs to the MB at the calyx. This is supported by putative synaptic connections 
between sVUM1 neurons with PNs and the APL neuron (H.W., MPhil Thesis 
2014), which both provide input to KCs in the calyx (Fig. 1.8). The output of the 
APL neuron in the calyx, in particular, has been known to control the 
sparseness of KC activation which is required for maintaining odour 
discrimination of similar odours (Lin et al., 2014). Therefore, OA signalling in the 
calyx could in turn affect how odours are represented by KCs, underlying a 
context-dependent change in odour discrimination ability.  
 
1.4. Adrenoceptors and OA receptors in olfactory processing 
The diverse actions of neuromodulators are mediated by receptors that are 
coupled to different cellular pathways (Nadim and Bucher, 2014). Therefore, to 
understand the OA neuromodulatory circuitry in the larval MB calyx, it is 
necessary to map the receptors that are involved.   
In mammals, there are three main types of adrenoceptors that respond to 
NA – α1-, α2- and β-adrenoceptors. Each receptor type is coupled to a different 
G-protein: α1-adrenoceptor with the excitatory Gq protein, which leads to the 
increase of IP3 and intracellular calcium levels; α2-adrenoceptor with the 
inhibitory Gi/o protein which decreases cAMP levels; and β-adrenoceptor with 
the excitatory Gs protein, which increases cAMP. The three types of 
adrenoceptors respond to NA with different affinities: α2-adrenoceptors shows 
the highest affinity to NA, followed by α1-adrenoceptors and finally β-
adrenoceptors (Ramos and Arnsten, 2007; Atzori et al., 2016). Therefore, the 
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context-dependent fluctuation of NA concentration would activate different types 
of adrenoceptors (Table 1.1), producing differential effects on its cellular targets 
correspondingly. All three types of adrenoceptors also localise to the piriform 
cortex, suggesting that they may have functional roles in modulating higher 
olfactory responses (Shipley and Ennis, 1996).  
OA receptors in Drosophila and other insects are classified with 
reference to adrenoceptor types based on their sequence similarities and 
signalling properties. To date, five OA receptors in Drosophila have been 
identified, based on their preferential activation by OA. These include the α1-
adrenergic-like octopamine receptor in mushroom bodies (OAMB) (Han et al., 
1998), the α2-adrenergic-like Octα2R (CG18208) (Qi et al., 2017), and three β-
adrenergic-like octopamine receptors – Octβ1R, Octβ2R and Octβ3R (Evans 
and Maqueira, 2005; Maqueira et al., 2005). In addition, there are also three 
known TA receptors that may be activated by OA, despite being preferentially 
activated by the OA precursor TA (Saudou et al., 1990; Bayliss et al., 2013).    
I will discuss the known physiology and functions of OA receptors in 
Drosophila, their known roles in olfactory processing in the MB, and 
hypothesise how they might contribute to the larval MB calyx olfactory circuitry.  
 
1.4.1. α1-adrenergic-like OAMB receptor 
OAMB is the first cloned OA receptor in Drosophila. It is considered to be α1-
adrenergic-like as its transmembrane domains show 52-55% sequence identity 
to human α1-adrenoceptors (Han et al., 1998; Evans and Maqueira, 2005). 
OAMB activation in cultured cells predominantly increases intracellular calcium 
levels, suggesting that like α1-adrenoceptors, it is also coupled to the Gq 
pathway (Han et al., 1998; Balfanz et al., 2005; Morita et al., 2006). A higher OA 
concentration can also increase intracellular cAMP in OAMB-expressing cells 
(Han et al., 1998; Balfanz et al., 2005; Morita et al., 2006). Although some 
papers have claimed that cAMP increase is only observed in the OAMB-
K3/DmOA1A isotype but not the OAMB-AS/DmOA1B isotype (Lee et al., 2003, 
2009; Balfanz et al., 2005); there is actually a slightly greater increase in cAMP 
upon OAMB-AS/DmOA1B compared to OAMB-K3/DmOA1A activation at the 
same OA concentration, when the same transfection protocol and cAMP assay 
was used (Balfanz et al., 2005).  
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 OAMB was first named due to its enrichment in the Drosophila adult 
MBs, including in KC cell bodies (Han et al., 1998). Later studies showed that 
oamb mutants failed to form appetitive olfactory memories in adult flies (Burke 
et al., 2012; Kim et al., 2013). Knocking down OAMB in dopaminergic PAM 
neurons impaired reward olfactory learning (Burke et al., 2012), while the 
specific expression of OAMB in KCs in oamb mutants rescued the learning 
impairment (Kim et al., 2013). This suggests that OAMB could be involved in 
reward learning on both KCs and reinforcing dopaminergic neurons.  
However, it is unclear if and how OAMB expression on KCs fits into the 
current model of associative olfactory learning which depends on DA 
modulation of KC output synapses. For example, does OAMB mediate an 
additional component of the reward signal conveyed by direct OA signalling to 
the MBs? Alternatively, does OAMB affect associative learning by conveying a 
non-reinforcing signal such as the novelty of a stimulus or the physiological 
state of the animal? Nevertheless, the presence of OA innervation in both the 
MB calyx and lobes suggests that OAMB is likely mediating OA signalling to 
KCs, even though its function is controversial; and this is likely to be conserved 
in larval KCs.  
In addition, the OAMB homologue AmOA1 localises to GABAergic 
feedback neurons in the MB calyx in honeybees (Sinakevitch et al., 2013). α1-
adrenergic modulation in the mammalian olfactory bulb also increases the 
activity of inhibitory granule cells (Nai et al., 2009). This suggests that OAMB 
could be expressed in the GABAergic larval APL neuron, which maintains the 
sparse responses of KCs required for similar odour discrimination (Lin et al., 
2014; Masuda-Nakagawa et al., 2014), and modulate inibition from the APL 
neuron to KCs in the larval MB calyx.  
On a cellular level, OAMB activation is most likely to increase the 
excitability of neurons it is expressed on. Upon OA activation, OAMB-
transfected rat cortical neurons in culture showed enhanced calcium response 
during depolarisation, increased spiking frequency in response to current 
injection and increased membrane resistance. The increase of membrane 
resistance is a result of OAMB suppression of leak currents, which would result 
in prolonged depolarisation (Morita et al., 2006). OAMB activation also inhibits 
Ca2+-dependent-K+ currents carried by Slowpoke channels in Drosophila pars 
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intercerebralis neurons (Crocker et al., 2010). This is consistent with α1-
adrenergic modulation of potassium currents in mammals (Marzo et al., 2009).     
Based on the known functions of α1-adrenoceptors, OAMB may also 
control presynaptic neurotransmitter release, especially from PNs or the APL 
neuron in the calyx. α1-adrenoceptors at the rodent prefrontal cortex enhance 
presynaptic glutamate release (Zhang et al., 2013b; Luo et al., 2015); while 
blocking α1-adrenoceptors decreases cocaine-induced dopamine release in the 
rat nucleus accumbens (Mitrano et al., 2012). On the other hand, α1-
adrenoceptor activation paired with intense visual stimulation induces long term 
depression at input synapses to the rat visual cortex, resulting in reduced 
orientation-specific visual discrimination (Treviño et al., 2012).  
 
1.4.2. α2-adrenergic-like Octα2R receptor 
Until recently, it was unclear whether Drosophila expressed an α2-adrenergic-
like OA receptor. Protein-BLAST (States and Gish, 1994) with the human α2-
adrenergic receptor sequence revealed an uncharacterised putative aminergic 
receptor CG18208 that showed high levels of sequence similarity (44-52%) with 
human α2 receptors. However, it was not until last year that the CG18208 
receptor was cloned and assayed for OA activation. CG18208 in transfected 
CHO cells preferentially responds to OA and higher concentrations of serotonin, 
resulting in a decrease of intracellular cAMP levels, similar to the physiological 
effects of the α2-adrenoceptor (Qi et al., 2017). CG18208 has now been 
renamed as Octα2R due to its sequence similarity and comparative 
pharmacological properties to the human α2-adrenoceptor (Qi et al., 2017).  
 This is the second α2-adrenergic-like OA receptor that has been 
identified in insects, following the characterisation of the CsOA3 receptor in the 
rice stem borer. While CsOA3 is also preferentially activated by OA and 
decreases intracellular cAMP in response, its activation also elicits a calcium 
increase. Unlike Octα2R, CsOA3 does not respond to serotonin activation (Wu 
et al., 2014). Two other α2-adrenergic-like receptors have been identified 
through sequence similarity to flour beetles and honeybees; although neither 
has been characterised (Wu et al., 2014; Qi et al., 2017).    
As Octα2R activation decreases intracellular cAMP levels, this suggests 
that it is probably coupled to the inhibitory Gi/o pathways like α2-adrenoceptors. 
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This suggests that like NA, OA signalling in Drosophila could also exert 
inhibitory cellular effects. However, little else is known about the function, 
physiology and localisation of Octα2R in Drosophila, or that of the other α2-
adrenergic-like OA receptors in insects.  
 Therefore, possible functions of Octα2R-mediated signalling in the larval 
MB calyx can only be predicted from the known effects of α2-adrenoceptors. 
Octα2R activation could reduce excitatory postsynaptic currents in neurons, 
such as the action of α2-adrenoceptor agonists in the rat medial prefrontal 
cortex (Yi et al., 2013); or cause hyperpolarisation and a decrease in firing in 
neurons, similar to α2-adrenoceptor action in granule cells in the mammalian 
olfactory bulb (Nai et al., 2010). Alternatively, Octα2R may also be able to 
enhance neuronal responses, as α2-adrenoceptor-induced decrease of cAMP 
could block hyperpolarisation-activated cyclic nucleotide gated cation (HCN) 
channels, and enhance both glutamatergic and cholinergic responses in the 
prefrontal cortex (Zhang et al., 2013b). Moreover, Octα2R may also act as an 
auto-inhibitory receptor on OA neurons; as the activation of α2-adrenoceptors 
caused hyperpolarisation and decreased input resistance in rat NA neurons 
(Williams et al., 1985).  
α2-adrenoceptors are also important for controlling neurotransmitter 
release, both as inhibitory autoreceptors on NA neurons, but also regulating DA 
and serotonin release (Scheibner et al., 2001; Bucheler et al., 2002). This 
suggests that Octα2R may regulate OA signalling at sVUM1 terminals, or 
modulate neurotransmitter release of other presynaptic terminals at the larval 
MB calyx. Furthermore, α2-adrenoceptors in the rat piriform cortex also regulate 
the number of neurons which express plasticity markers (Vadodaria et al., 
2017); suggesting that α2-adrenoceptors and its analogue Octα2R could be 
contributing to structural plasticity in neural circuits as well.  
 
1.4.3. β-adrenergic-like Octβ1R, Octβ2R and Octβ3R receptors 
Three β-adrenergic-like OA receptors (OctβRs) have been identified in 
Drosophila – Octβ1R, Octβ2R and Octβ3R – as their transmembrane domains 
showed 48-57% sequence similarity to human β-adrenoceptors (Maqueira et 
al., 2005). All three OctβRs are probably coupled to the excitatory Gs pathway, 
as in vitro activation of OctβRs increases cAMP levels (Balfanz et al., 2005; 
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Maqueira et al., 2005). The three receptors respond to similar ranges of OA 
concentration, but they have slightly different pharmacological profiles to other 
drugs (Maqueira et al., 2005). Moreover, their transcripts show different patterns 
of localisation in the Drosophila brain (Ohhara et al., 2012). Octβ1R also 
couples to the inhibitory Go pathway which inhibits cAMP levels at the larval 
neuromuscular junction in the regulation of synaptic growth (Koon and Budnik, 
2012); and might therefore mediate inhibitory signals as well.  
While there are contradictory reports as to whether any of the OctβRs 
are localised to the Drosophila MBs, at least Octβ2R and Octβ3R have been 
implicated in olfactory memory formation (Burke et al., 2012; Wu et al., 2013; 
Walkinshaw et al., 2015). Octβ2R knockdown in the α’β’ KCs failed to form 
anesthesia-resistant aversive olfactory memory (Wu et al., 2013). Octβ2R is 
also required for the artificial implantation of appetitive olfactory memories by 
activating Tdc2-GAL4 neurons in satiated flies but not for hungry flies (Burke et 
al., 2012). This indicates that Octβ2R may be differentially required for 
appetitive olfactory memory formation depending on the satiety state of the 
animals. However, artificial reward memory fails to form in hungry flies upon 
Tdc2-GAL4 activation when Octβ2R is knocked down in the dopaminergic MB-
MP1 neurons (Burke et al., 2012). As activating the MB-MP1 neuron induces 
aversive memory (Aso et al., 2010), this suggests Octβ2R may be negatively 
modulating MB-MP1 neurons in appetitive memory formation. Nevertheless, this 
suggests that Octβ2R plays an important role in the adult MB olfactory memory 
circuitry – a role that may be shared in larvae. On the other hand, a RNAi 
screen revealed that pan-neural RNAi knockdown of Octβ3R improved aversive 
learning (Walkinshaw et al., 2015). However, it is not known what neurons 
Octβ3R may be acting on.  
The role of β-adrenoceptors in olfactory processing is likely to be 
conserved in mammals. In the rat brain, β2-adrenoceptor transcripts are 
localised to olfactory and memory centres including the olfactory bulb, piriform 
cortex and hippocampus (Nicholas et al., 1993). Pharmacological studies have 
also shown the requirement of β-adrenoceptors in olfactory dishabituation in the 
rat piriform cortex (Best and Wilson, 2004), odour preference learning in rat 
pups (Harley et al., 2006; Morrison et al., 2013); and modulation of odour 
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discrimination in the mammalian olfactory bulb (Doucette et al., 2007; 
Mandairon et al., 2008). 
  The only reports of the cellular actions of OctβRs in Drosophila neurons 
are at the NMJ, where Octβ1R and Octβ2R have opposing roles in controlling 
synaptopod and synaptic bouton growth of glutamatergic and OA motorneurons 
(Koon et al., 2011; Koon and Budnik, 2012). Goα/+; octβ1R/+ transheterozygote 
mutants showed a non-additive increase of boutons, suggesting that Octβ1R 
and Goα are likely to act in the same pathway (Koon and Budnik, 2012). 
Disrupting the cAMP/CREB pathway in OA motorneurons prevents OA-induced 
synaptic growth, similar to the octβ2R mutant phenotype (Koon et al., 2011). In 
an octβ1R mutant background, where increased synaptic growth occurred, rut 
mutations (lacking adenyl cyclase required for cAMP production) and dnc 
overexpression (overexpressing phosphodiesterase required for cAMP 
breakdown) decreased synaptic growth – the same phenotype observed in rut 
mutation and dnc expression in a WT background. This suggested that rut and 
dnc were downstream to Octβ1R. Furthermore, the number of synaptopods in 
octβ1R; octβ2R double mutants reverted to wild type levels (Koon and Budnik, 
2012). Overall, this suggests that Octβ1R and Octβ2R both act in the same 
cAMP pathway to regulate synaptic growth at the NMJ; where Octβ2R is 
probably coupled to Gs and increases cAMP levels, while Octβ1R is coupled to 
Go and decreases cAMP.  
 More generally, cAMP signalling is known to regulate neuronal 
excitability and synaptic plasticity. cAMP activates protein kinase A (PKA), 
which can regulate the activity of Na+ and K+ channels, including inhibiting 
slowpoke (a voltage-gated calcium-dependent potassium channel) to prolong 
depolarisation (Gordon et al., 1990; Zhou et al., 2002). PKA phosphorylation of 
synapsin, which increases synaptic vesicles at the active zone (Michels et al., 
2011), and the transcription factor CREB required for protein synthesis 
(Perazzona et al., 2004), are both important in synaptic plasticity and memory 
formation in Drosophila. cAMP can also activate HCN channels in a PKA-
independent pathway resulting in synaptic potentiation (Pedarzani and Storm, 
1995; Cheung et al., 2006). Therefore, OctβR activation on calyx-innervating 
neurons is likely to increase neuronal excitability and induce synaptic 
potentiation via cAMP signalling mechanisms.  
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1.5. Aims    
While there have been many examples of context-dependent neuromodulation 
of higher sensory pathways, the lack of knowledge in the anatomical 
organisation of neuromodulatory circuits have impeded our understanding of the 
circuit mechanisms behind. Therefore, in this project, I endeavored to construct 
a neuromodulatory map of a higher order sensory discrimination pathway using 
the relatively simple model of OA signalling in the Drosophila larval MB calyx as 
a framework for identifying and testing the circuit mechanisms of 
neuromodulation.  
 Here, I aimed to address the following questions to build a 
neuromodulatory connectome for the larval MB calyx through identifying calyx-
innervating neurons that express OA receptors: 
 
1) What are the potential postsynaptic targets of OA neurons in the larval 
MB calyx?  
 
I previously identified PNs, the APL neuron and Odd-like neurons as putative 
synaptic partners of sVUM1 neurons using GRASP (H.W., MPhil Thesis 2014). 
However, as the GRASP method detects membrane contacts rather than actual 
synapses, it is unclear whether these neurons form functional synapses with 
sVUM1 neurons and what the direction of synaptic neurotransmission would be. 
Moreover, as sVUM1 neurons may co-release TA or neuropeptides, potential 
synaptic connections do not necessarily indicate OA signalling from sVUM1 
neurons.  
Therefore, in Chapter 3, I aimed to supplement classical GRASP 
(Gordon and Scott, 2009) experiments with anti-OA labelling to identify GRASP 
sites that coincide with OA release, in order to clarify the identity of postsynaptic 
OA targets in the calyx. In the same chapter, I also aimed to examine single cell 
GRASP connectivity (Karuppudurai et al., 2014) between sVUM1 neurons and 
APL neurons using a method optimised in the lab (A.W., MPhil Thesis 2015). 
This would show whether both sVUMmd1 and sVUMmx1 neurons form putative 
synapses with the APL neuron, but also identify GRASP sites that colocalise 
with sVUM1 presynaptic terminals using the single cell GRASP construct.  
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2) Which of the different OA receptor types localise to putative 
postsynaptic targets of sVUM1 neurons in the larval MB calyx?  
 
Neuromodulators act on slow metabotropic receptors which can mediate a wide 
range of downstream effects in target neurons – allowing for a large degree of 
flexibility in neuromodulation. As discussed in Section 1.4, the effects of OA 
signalling in calyx-innervating neurons are strongly dependent on the type of 
OA receptors they express, the secondary signalling mechanisms they are 
coupled to, as well as the downstream effectors found within each neuron.  
To understand how OA signalling from sVUM1 neurons may be mediated 
on their potential postsynaptic targets, I aimed to determine which of the five 
known OA receptors in Drosophila they express using novel protein traps of OA 
receptors generated by MiMIC recombinase-mediated cassette exchange in 
Chapters 4-6. I would first determine whether the localisation pattern of EGFP-
tagged OA receptors resembled that of the target neurons, followed by whether 
they colocalised with molecular markers or neurotransmitter immunolabelling of 
these neuronal types.  
 
3) Are OA receptors localised to neurons that do not form putative 
synapses with sVUM1 neurons in the larval MB calyx?  
 
As there is evidence suggesting that neuromodulators, including the OA sVUM1 
neurons are able to act extrasynaptically, I aimed to determine whether OA 
receptors localise to the calyx terminals of KCs. This is because KCs only 
showed few putative synapses with sVUM1 neurons according to GRASP 
results in the larval MB calyx, and is therefore a possible candidate for 
extrasynaptic OA receptor localisation. In Chapters 4-6, I examined whether 
EGFP-tagged OA receptors localised to KC cell bodies and in a diffuse manner 




4) Do sVUM1 neuron terminals express modulatory receptors in the larval 
MB calyx?  
 
The α2-adrenoceptor is a presynaptic autoreceptor in mammals (Langer, 1980). 
This suggests that the analogous Octα2R may play a similar role in OA neurons 
in Drosophila. Moreover, Octβ1R and Octβ2R are required on OA Type II 
motorneurons for regulating synaptic growth (Koon et al., 2011; Koon and 
Budnik, 2012), suggesting that OA neurons may express OA receptors and are 
therefore subjected OA modulation. There is also pharmacological evidence 
showing the presence of a presynaptic OA autoreceptor in locust neurons 
(Howell and Evans, 1998). Therefore, I aimed to determine whether any of the 
Octβ1R, Octβ2R or Octα2R localised to sVUM1 neurons in Chapters 5-6, using 
anti-OA labelling to identify sVUM1 cell bodies in the SOG and OA terminals in 
the larval calyx.  
In addition to autoregulation, sVUM1 neurons may be regulated by other 
calyx-innervating neurons, for example, the APL neuron which is also 
presynaptic in the calyx (Masuda-Nakagawa et al., 2014). Therefore, I aimed to 
determine whether sVUM1 neurons were subjected to GABAergic inhibition by 
examining GABA receptor localisation to the calyx terminals of sVUM1 neurons 
in Chapter 7 using MiMIC protein traps with anti-OA to label sVUM1 neurons.  
 
5) What are the genetic tools that can be used to validate the sVUM1 
neuromodulatory circuitry?  
 
To test the functionality of the sVUM1 connections identified in the 
neuromodulatory and anatomical map, and to understand the function of 
sVUM1 modulation in the larval MB calyx, it is essential to have the appropriate 
tools for genetic manipulation of specific subsets of neurons.  
To test the function of OA receptors in the larval MB calyx circuitry, it is 
necessary to have genetic tools for OA receptor knockdown on specific types of 
calyx-innervating neurons. In Chapter 4, I aimed to identify the strongest 
available UAS-OAMB-RNAi line for OAMB knockdown in calyx-innervating 
neurons by comparing the signal intensity of EGFP-tagged OAMB receptors in 
knockdown versus non-knockdown calyces.  
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It is also useful to have specific transcriptional driver lines to study the 
functions of sVUM1 neurons and their effects on other calyx-innervating 
neurons. While the Tdc2-GAL4 (Cole et al., 2005) driver line has been 
traditionally used to study OA neurons, it labels almost all the OA- and TA-
positive neurons in the larval CNS – a total of around 80 neurons (Selcho et al., 
2012). Therefore, to isolate the function of the calyx-innervating sVUM1 
neurons, it is necessary to obtain more specific sVUM1 driver lines. In Chapter 
8, I aimed to conduct anti-OA labelling of Janelia GAL4/LexA lines (Jenett et al., 
2012; L. Masuda-Nakagawa, personal communication) to confirm that they 
labelled sVUM1 neurons. I also examined the expression pattern of a specific 
driver line for sVUM1 neurons generated using genetic intersection (C. O’Kane, 
L. Masuda-Nakagawa, personal communication). In addition, I aimed to confirm 
the expression patterns of specific calyx-innervating neuron drivers identified 
from the Janelia GAL4/LexA collection (Jenett et al., 2012; L. Masuda-




Chapter 2. Materials and Methods 
 
2.1. Fly Stocks 
Flies were raised on standard cornmeal medium at 25°C and subjected to a 12 
hour day/night cycle unless stated otherwise. Fly stocks used are listed in Table 
2.1.  
MiMIC lines with insertions in a coding region intron of receptor genes 
were selected from the MiMIC collection (Venken et al., 2011a; 
http://flypush.imgen.bcm.tmc.edu/pscreen/). EGFP-tagged receptor lines were 
identified from the MiMIC RMCE collection (Nagarkar-Jaiswal et al., 2015; 
http://flypush.imgen.bcm.tmc.edu/pscreen/rmce/). 
GAL4-LexA double construct lines and the intersectional line used in this 
study were generated by Dr. Cahir O’Kane.  
 
2.2. FRT-GRASP 
Flies used in the FRT-GRASP experiment were raised at 18°C. FRT-GRASP 
crosses were set up in vials containing half the amount of cornmeal medium. 
The progeny was heat shocked 24-30 hours after egg laying at 37°C for 15 
minutes using a water bath (Grant Instruments); and subsequently kept at room 
temperature until dissection. Optimal heat shock conditions were established by 
Angela Wan (A.W., MPhil Thesis 2015).  
 
2.3. Verification of MiMIC insertion lines  
The location of the MiMIC insertion site within OA receptor protein isotypes was 
identified by aligning receptor protein sequences to genomic sequences using 
tblastn (Altschul et al., 1990) hosted on Flybase (http://flybase.org/blast/). 
TMHMM software (Sonnhammer et al., 1998; 
http://www.cbs.dtu.dk/services/TMHMM/) was used to predict the 
transmembrane domains (TM) of receptor proteins.  
PCR reactions were carried out to verify the 5’ and 3’ flanking ends of 





Genotype Source Reference Notes 
NP732-GAL4 DGRC 112307 
Masuda-Nakagawa et al., 
2014 
APL neuron line 
NP2631-GAL4 DGRC 104266 
Masuda-Nakagawa et al., 
2014 
APL neuron line 
NP225-GAL4 DGRC 112095 Tanaka et al., 2004 PN line 
H500-IT.GAL4 Hilary Wong 
H.W., MPhil Thesis 2014; 
Venken et al., 2011 
KC line 




Gift from Scott 
Waddell 
Cole et al., 2005 OA neuron line 
Tdc2-LexA (II) 
Gift from Scott 
Waddell 
Burke et al., 2012 OA neuron line 
Tdc2-LexA (III) 
Gift from Scott 
Waddell 
Burke et al., 2012 OA neuron line 
R68B12-GAL4  BDSC 39463 Jenett et al., 2012 Odd-like screen 
R68B12-LexA BDSC 54095 Jenett et al., 2012 Odd-like screen 
R68C01-GAL4 BDSC 39464 Jenett et al., 2012 Odd-like screen 
R74G04-GAL4 BDSC 47742 Jenett et al., 2012 Odd-like screen 
R76B09-GAL4 BDSC 46962 Jenett et al., 2012 Odd-like screen 
R76C06-GAL4 BDSC 39925 Jenett et al., 2012 Odd-like screen 
NP7088-GAL4  DGRC 105362 Tanaka et al., 2008 sVUM1 screen 
R34A11-GAL4 BDSC 49767 Jenett et al., 2012 sVUM1 screen 
R34A11-LexA BDSC 52755 Jenett et al., 2012 sVUM1 screen 
R43E08-GAL4  BDSC 47929 Jenett et al., 2012 sVUM1 screen 
R57F09-LexA BDSC 54716 Jenett et al., 2012 sVUM1 screen 
R61E08-GAL4 BDSC 39273 Jenett et al., 2012 sVUM1 screen 
R68A08-GAL4 BDSC 39450 Jenett et al., 2012 sVUM1 screen 
R76G06-GAL4 BDSC 39940 Jenett et al., 2012 sVUM1 screen 
R76G07-GAL4 BDSC 48331 Jenett et al., 2012 sVUM1 screen 
R76G11-GAL4 BDSC 48333 Jenett et al., 2012 sVUM1 screen 
R76H01-LexA BDSC 54075 Jenett et al., 2012 sVUM1 screen 
R76H03-LexA BDSC 54954 Jenett et al., 2012 sVUM1 screen 
R76H04-GAL4 BDSC 41306 Jenett et al., 2012 sVUM1 screen 
R77B01-GAL4 BDSC 46977 Jenett et al., 2012  sVUM1 screen 
R83G11-GAL4 BDSC 46764 Jenett et al., 2012 sVUM1 screen 




Table 2.1A. List of fly stocks used in this study. Sources: BDSC, Bloomington Drosophila 
Stock Center; COK, Cahir O’Kane; DGRC, Kyoto Stock Center; LMN, Liria Masuda-Nakagawa.  
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MiMIC lines (Venken et al., 2011) 

























 BDSC 43050 MI06217 
MiMIC RMCE lines (Venken et al., 2011; Nagarkar-Jaiswal et al., 2015) 
Genotype Source Notes 
Mi{PT-GFSTF.1}OAMB
MI12417-GFSTF.1
 Fly Facility OAMB::EGFP 
Mi{PT-GFSTF.2}Octβ1R
MI05807-GFSTF.2
 BDSC 60236 Octβ1R::EGFP 
Mi{PT-GFSTF.2}Octβ2R
MI13416-GFSTF.2
 Fly Facility Octβ2R::EGFP 
Mi{PT-GFSTF.0}Octβ3R
MI06217-GFSTF.0
 Fly Facility Octβ3R::EGFP (Phase 0) 
Mi{PT-GFSTF.1}Octβ3R
MI06217-GFSTF.1
 BDSC 60245 Octβ3R::EGFP (Phase 1) 
Mi{PT-GFSTF.0}CG18208
MI10227-GFSTF.0
 Fly Facility CG18208::EGFP 
Mi{PT-GFSTF.0}Rdl
MI02620-GFSTF.0
 BDSC 59796 Rdl::EGFP 
Mi{PT-GFSTF.0}GABA-B-R1
MI01930-GFSTF.0




Table 2.1B. List of fly stocks used in this study. Sources: BDSC, Bloomington Drosophila 





Genotype Source Reference Notes 
UAS-mCD8::GFP (III) BDSC 5130 










































hsFLP BDSC 1929  
Heat shock-induced 
Flippase (FLP) 

























































Table 2.1C. List of fly stocks used in this study. Sources: BDSC, Bloomington Drosophila 
Stock Center; LMN, Liria Masuda-Nakagawa; VDRC, Vienna Stock Center.  
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Primer Sequence 
Orientation-MiL-F (OriF) GCGTAAGCTACCTTAATCTCAAGAAGAG 
Orientation-MiL-R (OriR) CGCGGCGTAATGTGATTTACTATCATAC 
EGFPdo-Seq-F (EGFP-F) GGATGACGGCACCTACAAGAC 


















 Table 2.2. List of primers and sequences used in this study. Orientation-MiL-F, Orientation-
MiL-R, EGFPdo-Seq-F and EGFPdo-Seq-R were previously used in Venken et al. (2011a). The 
remaining primers were designed using Primer3 software (Untergasser et al., 2007; 
http://primer3.ut.ee/). 
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2.4. Generation and validation of EGFP-tagged receptor lines  
OAMB::EGFP, Octβ2R::EGFP, Octβ3R::EGFP (Phase 0) and CG18208::EGFP 
recombinant stocks were generated using MiMIC recombinase-mediated 
cassette exchange, as described in Venken et al. (2011a), by the University of 
Cambridge Department of Genetics Fly Facility for this study.  
 In brief, embryos from the selected MiMIC lines were injected with an 
EGFP-FlAsH-StrepII-TEV-3xFlag plasmid of the appropriate splice phase 
(Table 2.3; Venken et al., 2011a) and a helper φC31-integrase (Fig. 2.1). 
Injected embryos were left to hatch into adult flies and subsequently crossed to 
a double balancer stock in a y w background. RMCE events were identified by 
the loss of the yellow+ phenotype encoded by the MiMIC construct in the F1 
progeny. Finally, recombinant flies were balanced to establish a stock (Fig. 2.1; 
Venken et al., 2011a).  
Four PCR reactions (PCR1, PCR2, PCR3 and PCR4) were carried out to 
characterise the insertion orientation of the EGFP cassette in each of the 
recombinant stocks, as described in Venken et al. (2011a). The following primer 
pairs were used: Orientation-MiL-F (OriF)/EGFPdo-Seq-R (EGFP-R) for PCR1, 
OriF/EGFPdo-Seq-F (EGFP-F) for PCR2, Orientation-MiL-R (OriR)/EGFP-R for 
PCR3 and OriR/EGFP-F for PCR4. Primer sequences are listed in Table 2.2.  
 
2.5. Molecular methods  
 
2.5.1. Plasmid preparation  
Plasmids for MiMIC injections were obtained from the Drosophila Genomic 
Resource Center (DGRC) (Table 2.3). 1 μl of plasmid DNA (1-100 ng/ μl) was 
added to 50 μl of DN5α competent cells (gift from Liv Grant, Glover Group). The 
cells were incubated on ice for 30 minutes, heat shocked at 42⁰C for 45 
seconds in a water bath (Fisher Scientific) and then placed on ice for another 2 
minutes. 250 μl of warm sterile SOC medium (2% Tryptone, 0.5% Yeast extract, 
10mM NaCl, 2.5mM KCl, 10mM MgCl2, 20mM glucose; Genetics Media 
Service) was added to the cells and then placed at 37⁰C for 1 hour in a shaking 










































Table 2.3. List of plasmids used to generate MiMIC RMCE stocks in this study. DGRC, 
Drosophila Genomic Resource Center.  
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Figure 2.1. Generation of EGFP protein traps using MiMIC φC31-integrase-mediated 
cassette exchange. (A) Schematic for the generation of EGFP protein traps through MiMIC 
RMCE. (B) Possible EGFP cassette orientations after recombination. (C) Crossing scheme for 
MiMIC cassette exchange on the third chromosome. Abbreviations: MiL/R, MiMIC insertion 
sequences Left/Right; SA, splice acceptor site; SD, splice donor site. Figure reproduced from 
protocol described in Venken et al. (2011).  
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1.5% LB agar plates (1% NaCl, 1% Tryptone, 0.5% Yeast extract, 1.5% Agar; 
Genetics Media Service) with 100 μg/ ml ampicillin (Melford Labs, A0104), and 
incubated at 37°C overnight in a static incubator (Raven incubator).  
 A single colony of transformed bacteria was inoculated in 5 ml of LB 
medium (1% NaCl, 1% Tryptone, 0.5% Yeast extract; Genetics Media Service) 
with 100 μg/ ml ampicillin to form a starter culture. This was incubated for 8 
hours at 37°C in the shaker. 25 μl of the starter culture was then inoculated with 
25 ml of LB medium and incubated overnight at 37°C in the shaker. The 
resulting cells were harvested by centrifugation at 6000 x g for 15 minutes at 
4⁰C. Plasmid DNA was then purified from the cells using the Qiagen Plasmid 
Midi Kit (Qiagen 12143), dissolved in autoclaved milliQ water to use at a 
concentration of 0.4 μg/ μl, OD260/280: 1.8-1.9.  
 
2.5.2. DNA extraction 
Genomic DNA was extracted from 15-30 flies (1-7 days after eclosion) and 
homogenised in fly homogenisation buffer (100 mM Tris-HCl, 8.5; 80 mM NaCl, 
Sigma, 31434; 5% Sucrose, Sigma, S0389; 0.5% SDS, Sigma, L4509; 50 mM 
NaEDTA, Sigma, ED2SS, pH 8.0). The homogenate was incubated with RNase 
A (Roche, 10109142001) for 1 hour at 37°C, followed by Proteinase K (Roche, 
03115887001) for 1 hour at 50°C, and purified with phenol-chloroform (Sigma, 
77617) and chloroform (Sigma, C2432). DNA was then precipitated with 0.6 
volumes of isopropanol (Sigma, 59304) and washed with 75% ethanol (Sigma, 
E7023), dried overnight at room temperature and resuspended in 10 mM Tris-
HCl pH 8.0 (Sigma, T6066).  
 
2.5.3. PCR and sequencing 
For each PCR reaction (20 μl), 0.4 μl or 1 μl genomic DNA, 1 μl of each 10 μM 
primer (Sigma), 2μl 10X PCR buffer (Qiagen, 203203), 0.4 μl 10 μM dNTP mix 
(Roche, 11581295001), 0.08 μl 5 U/μl HotStarTaq DNA polymerase (Qiagen, 
203203) and 15.1 μl or 14.5 μl milliQ water were used. PCR cycling was 
conducted with a G-Storm Thermal Cycler (GS4) and the following conditions 
were used: initial denaturation at 95°C for 15 minutes, 40 cycles of denaturation 
at 94°C for 30s, annealing at 60°C for 30s and elongation at 72°C for 1 min, 
followed by a final elongation step at 72°C for 10 minutes. PCR products were 
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loaded together with 6X DNA gel loading dye (ThermoFisher, R0611) onto a 1% 
Agarose Gel (Ultrapure Agarose, Invitrogen, 16500500; 1X TBE buffer, 
Invitrogen, 15581044) with GelRed (Biotium, 41003-T) for gel electrophoresis. 
100 bp DNA ladder was used as a marker (Invitrogen, 15628019).  
 PCR products were purified using the Qiaquick PCR Purification Kit 
(Qiagen, 28104); and sequenced at the Department of Biochemistry 
Sequencing Facility (University of Cambridge). The sequenced products were 
aligned to Drosophila melanogaster and MiMIC sequences using nucleotide 
BLAST (Altschul et al., 1990; 
https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch).  
 
2.6. Immunohistochemistry  
Third instar wandering stage larvae (144-176 hours after egg laying) were 
dissected in cold PBS (Sigma, P4417), fixed in 4% Formaldehyde 
(Polysciences, 18814)/PEM buffer (0.1 M PIPES, Sigma, P1851; 2 mM EGTA, 
Sigma E3889; 1 mM MgSO4; NaOH) for 2 hours at 4°C, washed for 3x10 
minutes (or 4x15 minutes) in 0.3% Triton-X (Sigma, T8787) in PBS (PBT) and 
incubated in 10% NGS (Vector Labs, S-1000) in 0.3% PBT for 1 hour at room 
temperature. Brains were incubated in primary antibody in 10% NGS-0.3% PBT 
at 4°C for 2-3 days on a mini disk rotor (Biocraft, BC-710), washed for 3x15 
minutes with 0.3% PBT and further incubated in secondary antibody in blocking 
solution at 4°C for 2-3 days on the mini disk rotor. Brains were finally washed 
for 15 minutes with PBT, followed by 3x10 minutes with PBS, and left in 50% 
Glycerol/PBS at 4°C for at least one overnight prior to imaging. Primary and 
secondary antibodies used are listed in Table 2.4.  
To reduce background staining levels of the polyclonal chicken anti-GFP 
(Abcam, Ab13970) and polyclonal rabbit anti-GFP (Invitrogen, A11122), the 
antibodies were pre-incubated with MI12417 larval brains which did not express 
GFP. 50 MI12417 larval brains were incubated in 1:20 anti-GFP in 10% NGS in 
0.3% PBT at 4°C for 1 overnight. A further 50 MI12417 larval brains were added 
to the antibody solution and further incubated at 4°C for 2 overnights. The 






Antibody Host Source Working Dilution 
Anti-GFP Rat, monoclonal 
Nacalai 440426 
(Clone GF090R) 1:1000 
Anti-GFP Chicken, polyclonal Abcam, Ab13970 1:1000/1:2000 
Anti-GFP Rabbit, polyclonal Invitrogen, A11122 1:1000/1:2000 
Anti-GFP Rabbit, polyclonal Abcam, Ab6556 1:1000 
Anti-GFP Rabbit, polyclonal Abcam, Ab290 1:800 
Anti-DsRed Rabbit, polyclonal Clontech, 632496 1:1000 
Anti-GABA Rabbit, polyclonal Sigma, A2052 1:1000 
Anti-Octopamine (OA) Rabbit, polyclonal MoBiTec, 1003GE 1:1000 
Anti-Discs Large (Dlg) Mouse, monoclonal DSHB, 4F3 1:200 
Anti-Calnexin99A Mouse, monoclonal 
Gift from Munro Lab 
(Riedel et al., 2016) 1:10 
Secondary Antibodies 
Antibody Host Source Working Dilution 
Anti-Rat Alexa 488 Goat, polyclonal Invitrogen, A11006 1:200  
Anti-Chicken Alexa 488 Goat, polyclonal Invitrogen, A11039 1:200 
Anti-Rabbit Alexa 488 Goat, polyclonal Invitrogen, A11034 1:200  
Anti-Rabbit Alexa 568 Goat, polyclonal Invitrogen, A11036 1:200  
Anti-Mouse Alexa 647 Goat, polyclonal Invitrogen, A21236 1:200  
Table 2.4. List of antibodies used in this study.  
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2.7. Mounting, confocal imaging and image analysis 
Mounting and orientation of brains for image uptake were as described in the 
supplemental information in Masuda-Nakagawa et al. (2009). Schematics of 
larval brains orientations are shown in Fig. 1.1 and 1.2. The larval MB calyx was 
imaged from the dorsal orientation (Fig. 1.1), the larval AL was imaged from the 
frontal orientation (Fig. 1.2), and the larval SOG was imaged from the ventral 
orientation (Fig. 1.7A-B). Specific calyx-innervating neurons are imaged from 
the same orientations as shown in Figures 1.3, 1.5 and 1.7.  
Imaging was conducted using a Zeiss LSM710 Confocal Microscope with 
a 40X oil, NA 1.3 objective or with a 20X air, NA 0.8 objective. Images were 
processed using ImageJ software (Schneider et al., 2012; 
https://imagej.nih.gov/ij/download.html). All brains are shown in the right brain 
orientation. The intensity within a region of interest was quantified by measuring 
the mean grey value using the Analyse function on ImageJ. For a single calyx 
or AL, this was averaged across multiple confocal optical slices. Statisical 
descriptions were conducted using Microsoft Excel.  
 
2.8. L1 connectivity data and analysis 
L1 connectivity data were obtained from the NeuroNLP.larva server 
(https://neuronlp.larva.fruitflybrain.org/) maintained by the Fruit Fly Brain 
Observatory, where published EM reconstruction data from Berck et al. (2016) 
and Eichler et al. (2017) are compiled. L1 images were taken directly from 
NeuroNLP.larva website. The number of sVUM1 synapses with calyx-
innervating neurons was manually quantified and analysed from data available 





Chapter 3. GRASP connectivity of sVUM1 
neurons in the larval MB calyx 
 
3.1. Introduction  
To understand how the octopaminergic neuromodulatory circuitry is organised 
in the larval MB calyx, it is necessary to first identify the neurons postsynaptic to 
the octopaminergic sVUM1 neurons in the calyx.  
Using the GFP reconstitution across synaptic partners (GRASP) method 
(Gordon and Scott, 2009), I had previously identified olfactory PNs, the APL 
neuron and Odd-like neurons as putative synaptic partners of sVUM1 neurons 
in the larval MB calyx (Fig. 3.1; H.W., MPhil Thesis 2014). In addition, I 
observed limited GRASP between sVUM1 neurons and KCs in the calyx (H.W., 
MPhil Thesis 2014), suggesting that sVUM1 neurons and KCs were unlikely to 









Figure 3.1. Summary diagram of sVUM1 connectivity in the larval MB calyx.  Adapted from 
Fig. 1.8. in Chapter 1. Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, 
centroposterior medial compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; 
N, number; OA, octopamine; PN, projection neuron.  
56 
However, there were several limitations to these results:  
Firstly, the GRASP method detects the split-GFP reconstitution at the 
plasma membranes of two neuronal populations, rather than actual synaptic 
connections (Feinberg et al., 2008; Gordon and Scott, 2009). Therefore, 
GRASP may also detect membrane contacts that do not form synapses.  
Secondly, for the same reasons, GRASP is unable to detect the direction 
of neurotransmission. Therefore, it is unclear whether PNs, the APL neuron and 
Odd-like neurons are pre- and/or post-synaptic to sVUM1 neurons; and hence 
predict whether they are subjected to OA neuromodulation. This particularly 
applies to PNs and the APL neuron, as they are also predominantly presynaptic 
in the larval MB calyx (Masuda-Nakagawa et al., 2005, 2014; L. Masuda-
Nakagawa, personal communication).  
Thirdly, the Tdc2-GAL4 line previously used to investigate KC-sVUM1 
connections in the larval calyx labels KCs (H.W., MPhil Thesis 2014). 
Therefore, it was unclear whether the limited GRASP signal detected is 
between KC-sVUM1 or KC-KC, considering the complementary splitGFP halves 
are both expressed in KCs. Moreover, the limited GRASP between KC-sVUM1 
was contrary to what was expected from KC-OA GRASP results in the adult MB 
calyx (Zhou et al., 2012; Pech et al., 2013) and KC-sVUM1 synapses 
reconstructed from L1 EM data (Eichler et al., 2017). Given the experimental 
constraints, it cannot be confirmed whether the low number of possible KC-
sVUM1 contacts observed is an artefact.  
Finally, it was unclear whether one or both of the sVUM1 neurons – 
sVUMmd1 and sVUMmx1 – are responsible for the GRASP signals observed. 
EM data revealed that sVUMmd1 and sVUMmx1 show non-overlapping 
innervation in the L1 calyx (Fig. 1.7D; Eichler et al., 2017; 
https://neuronlp.larva.fruitflybrain.org/). This suggested that sVUMmd1 and 
sVUMmx1 may not share the same synaptic partners. Using the single cell 
GRASP method to restrict one of the splitGFP components to single cell clones 
generated by heat shock-induced FLP recombination (Karuppudurai et al., 
2014), my colleague found that both sVUM1 neurons showed GRASP with 
Odd-like neurons in the larval calyx (A.W., MPhil Thesis 2015). However, it is 
unclear whether this applies to other putative synaptic partners of sVUM1 
neurons.  
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With the above concerns in mind, I aimed to provide evidence for 
possible postsynaptic partners to sVUM1 neurons subjected to OA signalling in 
this chapter. I examined whether GRASP between sVUM1 neurons and each of 
its putative synaptic partners colocalised with anti-OA, with the assumption that 
GRASP localised to OA terminals suggested that these sites were postsynaptic 
to OA transmission from sVUM1 neurons. To confirm whether KCs are potential 
postsynaptic partners of sVUM1 neurons in the L3 calyx, I repeated the KC-
sVUM1 GRASP experiment using transcriptional drivers that specifically label 
KCs and sVUM1 neurons in the calyx respectively, using anti-OA to label OA 
terminals. In addition, I aimed to determine whether sVUMmd1 and/or 
sVUMmx1 neurons synapse with the APL neuron, by using the single cell 
GRASP method developed by Karuppudurai et al. (2014) and optimised for use 




3.2.1. sVUM1 GRASP with PNs, APL and Odd-like neurons colocalised 
with OA puncta 
To determine whether PNs, the APL neuron and Odd-like neurons are putative 
postsynaptic partners to sVUM1 neurons, I examined whether their GRASP 
signals with sVUM1 neurons colocalised with OA puncta in the larval MB calyx.  
To visualise potential synaptic contacts between PNs and sVUM1 
neurons, I expressed one part of the splitGFP using NP225-GAL4, which labels 
the majority of olfactory PNs (Masuda-Nakagawa et al., 2005), and the 
complementary part of the splitGFP using Tdc2-LexA (Burke et al., 2012), which 
labels the OA sVUM1 neurons in the larval MB calyx (H.W., MPhil Thesis 2014). 
Many of the GRASP signals between PNs and sVUM1 neurons colocalised with 
OA labelling (n=16; Fig. 3.2, filled arrowheads).  
The extent of colocalisation for individual puncta varied: some GRASP 
signals only localised to the periphery of OA puncta (Fig. 3.2C), while other 
GRASP signals showed more complete colocalisation (Fig. 3.2D,G). There may 
be a functional consequence for the differences observed in colocalisation 
patterns. For example, GRASP puncta localised to the periphery  
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Figure 3.2. Some PN-sVUM1 GRASP puncta colocalised with OA terminals. Single 
confocal optical sections of the calyx from two NP225-GAL4/LexAOp-CD4::spGFP11; Tdc2-
LexA/UAS-CD4::spGFP1-10 individuals. Green is PN-sVUM1 GRASP, red is anti-OA and blue 
is anti-Dlg. (B,F) are magnified from the rectangular box in (A) and (E) respectively. (C-D) and 
(G-H) are magnified puncta labelled in (B) and (F) respectively. Filled arrowheads indicate 
GRASP-OA colocalisation, and empty arrowheads indicate GRASP puncta negative for OA. 





of OA boutons may suggest these OA boutons have additional non-PN synaptic 
partners or are bi-directional synapses; although these possibilities cannot be 
validated at this resolution. Some GRASP signals do not colocalise with OA 
boutons (Fig. 3.2B,F,H, empty arrowheads). These could be sites where PNs 
are presynaptic to sVUM1 neurons, where sVUM1 neurons release a non-OA 
neurotransmitter to the postsynaptic PN, or non-synaptic membrane contacts 
detected as false positives with the GRASP method.  
16 ± 2.1 out of 24 ± 2.6 GRASP signals overlapped with OA puncta 
(n=16; Fig. 3.2, filled arrowheads; Table 3.1). As this accounted for around 65% 
of total GRASP signals, this suggested that PNs are possible postsynaptic 
partners of sVUM1 neurons in the calyx. As NP225-GAL4 labels most of the 21 
olfactory PNs (Masuda-Nakagawa et al., 2005), if GRASP signals are evenly 
distributed across PNs, this suggested each PN has approximately one 
postsynapse with sVUM1 neurons in the calyx.  
Next, I expressed the two halves of the splitGFP in the APL neuron using 
the NP2631-GAL4 driver (Masuda-Nakagawa et al., 2014), and in sVUM1 
neurons labelled by Tdc2-LexA. 29 ± 2.6 out of 40 ± 3.2 (around 72%) GRASP 
puncta colocalised with OA boutons (n=9; Fig. 3.3., filled arrowheads; Table 
3.2), where the APL neuron is probably postsynaptic to OA neurotransmission 
from sVUM1 neurons. I also observed variable patterns of GRASP-OA 
colocalisation (Fig. 3.3C-D, G-H), similar to those in PN-sVUM1 GRASP.  
 There were also GRASP signals that did not overlap with OA boutons 
(Fig. 3.3, empty arrowheads). This is consistent with the 50% of APL-sVUM1 
GRASP signals that colocalised with GABA boutons (H.W., MPhil Thesis 2014); 
and suggested that sVUM1 neurons were probably postsynaptic to the APL 
neuron at these sites, if the same logic was applied. The percentages of 
GRASP-OA puncta and GRASP-GABA puncta out of total GRASP signals – 
72% and 50% respectively – add up to more than 100%. Therefore, some 
GRASP signals may be at sites that are presynaptic for both GABA and OA. 
This suggested the presence of axo-axonal synapses between sVUM1 neurons 
and the APL neuron, as well as the possibility of bi-directional synapses.  
I then validated whether GRASP between Odd-like neurons labelled in 












Individual 1 24 88 15 17% 63% 
Individual 2 19 81 14 17% 74% 
Individual 3 15 79 8 10% 53% 
Individual 4 17 74 12 16% 71% 
Individual 5 15 69 8 12% 53% 
Individual 6 18 84 12 14% 67% 
Individual 7 12 82 8 10% 67% 
Individual 8 22 79 17 22% 77% 
Individual 9 32 80 23 29% 72% 
Individual 10 29 71 18 25% 62% 
Individual 11 15 69 4 6% 27% 
Individual 12 41 90 25 28% 61% 
Individual 13 21 65 15 23% 71% 
Individual 14 47 83 35 42% 74% 
Individual 15 37 78 30 38% 81% 
Individual 16 24 70 16 23% 67% 
N 16 16 16 16 16 
Mean 24 78 16 21% 65% 
S.D. 10.3 7.3 8.4 0.1 0.1 








Table 3.1. Numbers of PN-sVUM1 GRASP and OA puncta in NP225-GAL4;Tdc2-
LexA>GRASP calyces. Abbreviations: GRASP-OA overlap, GRASP puncta colocalised with 
OA labelling; %overlap/OA = number of puncta positive for both GRASP and OA divided by 
total number of OA puncta*100%; %overlap/GRASP = number of puncta positive for both 
GRASP and OA divided by total number of GRASP puncta*100%; N, number; S.D., standard 






















Figure 3.3. Many APL-sVUM1 GRASP puncta colocalised with OA terminals. Single 
confocal optical sections of the calyx from two NP2631-GAL4/LexAOp-CD4::spGFP11; Tdc2-
LexA/UAS-CD4::spGFP1-10 individuals. Green is APL-sVUM1 GRASP, red is anti-OA and blue 
is anti-Dlg. (B,F) are magnified from the rectangular box in (A) and (E) respectively. (C-D) and 
(G-H) are magnified puncta labelled in (B) and (F) respectively. Filled arrowheads indicate 
GRASP-OA colocalisation, and empty arrowheads indicate GRASP puncta negative for OA. 












Individual 1 29 43 23 53% 79% 
Individual 2 43 56 31 55% 72% 
Individual 3 42 53 27 51% 64% 
Individual 4 46 59 33 56% 72% 
Individual 5 47 60 30 50% 64% 
Individual 6 - 
Left Calyx 
45 55 32 58% 71% 
Individual 6 - 
Right Calyx 
20 37 13 35% 65% 
Individual 7 - 
Left Calyx 
50 55 40 73% 80% 
Individual 7 - 
Right Calyx 
40 47 34 72% 85% 
N 9 9 9 9 9 
Mean 40 52 29 56% 72% 
S.D. 9.6 7.7 7.7 0.1 0.1 
S.E.M. 3.2 2.6 2.6 0.0 0.0 
 
  Table 3.2. Numbers of APL-sVUM1 GRASP and OA puncta in NP2631-GAL4;Tdc2-
LexA>GRASP calyces. Abbreviations as Table 3.1.  
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neurons labelled in Tdc2-LexA colocalised with OA. 19 ± 1.4 out of 26 ± 1.8 
(around 75%) GRASP signals between Odd-like neurons and sVUM1 neurons 
colocalised with OA (n=19; Fig. 3.4, filled arrowheads; Table 3.3) – indicating 
that Odd-like neurons were putative postsynaptic partners to sVUM1 neurons. 
Again, there are varying degrees of GRASP-OA overlap at specific puncta (Fig. 
3.4C,F). The GRASP puncta that do not overlap with OA (Fig. 3.4, empty 
arrowheads) are probably not synaptic sites, as Odd-like neurons are 
predominantly postsynaptic in the larval calyx (L. Masuda-Nakagawa, personal 
communication). However, these may reflect Odd-like-sVUM1 synaptic 
connections in which sVUM1 neurons release non-OA neurotransmitters, such 
as TA or neuropeptides.  
 The above results suggested that PNs, the APL neuron and Odd-like 
neurons are all putative postsynaptic partners to sVUM1 neurons in the larval 
calyx. However, it is important to consider the large variation in the number of 
OA boutons observed between the three GRASP experiments, although this 
number remains relatively consistent (SEM < 3) within an experiment. This may 
be due to natural variation of OA boutons in different fly genotypes, or may be 
variations in the experimental conditions, such as antibody labelling batches. 
This may have led to over- or under-estimation of the number of OA boutons. 
Therefore, it is more beneficial to consider the relative rather than absolute 
number of GRASP-OA puncta out of the total GRASP puncta, with GRASP and 
OA puncta acting as internal controls for each other within a single calyx.  
 
3.2.2. KCs showed limited GRASP with sVUM1 neurons in the calyx  
To confirm that KCs were unlikely to be postsynaptic partners of sVUM1 
neurons in the calyx, I expressed the two halves of splitGFP in KCs, using the 
H500-IT.GAL4 KC driver which I generated and characterised (H.W., MPhil 
Thesis 2014), and in sVUM1 neurons using Tdc2-LexA. Unlike the Tdc2-GAL4 
driver previously used for this experiment, Tdc2-LexA does not label KCs in the 
larval calyx (H.W., MPhil Thesis 2014). Therefore, this ensures that any GRASP 
signals observed between H500-IT.GAL4 and Tdc2-LexA are attributed to KC-
















Figure 3.4. Many Odd-like-sVUM1 GRASP puncta colocalised with OA terminals. Single 
confocal optical sections of the calyx from two OK263-GAL4/LexAOp-CD4::spGFP11; Tdc2-
LexA/UAS-CD4::spGFP1-10 individuals. Green is Odd-like-sVUM1 GRASP, red is anti-OA and 
blue is anti-Dlg. (B,E) are magnified from the rectangular box in (A) and (D) respectively. (C,F) 
are magnified puncta labelled in (B) and (E) respectively. Filled arrowheads indicate GRASP-
OA colocalisation, and empty arrowheads indicate GRASP puncta negative for OA. Medial (M) 











Individual 1 19 48 13 28% 70% 
Individual 2 31 31 20 64% 63% 
Individual 3 17 26 14 54% 84% 
Individual 4 18 30 16 53% 89% 
Individual 5 33 53 23 43% 71% 
Individual 6 15 25 12 47% 77% 
Individual 7 24 38 22 58% 92% 
Individual 8 21 33 16 48% 74% 
Individual 9 12 39 10 25% 78% 
Individual 10 36 51 28 55% 78% 
Individual 11 21 44 16 37% 79% 
Individual 12 - Left 
Calyx 
27 47 17 36% 63% 
Individual 12 - 
Right Calyx 
30 48 17 35% 57% 
Individual 13 - Left 
Calyx 
38 44 30 68% 79% 
Individual 13 - 
Right Calyx 
37 46 26 57% 71% 
Individual 14 - Left 
Calyx 
27 42 23 54% 83% 
Individual 14 - 
Right Calyx 
28 43 17 39% 61% 
Individual 15 - Left 
Calyx 
32 52 25 49% 78% 
Individual 15 - 
Right Calyx 
32 58 27 47% 84% 
N 19 19 19 19 19 
Mean 26 42 19 47% 75% 
S.D. 7.7 9.4 5.9 0.1 0.1 
S.E.M. 1.8 2.2 1.4 0.0 0.0 
  
Table 3.3. Numbers of Odd-like-sVUM1 GRASP and OA puncta in OK263-GAL4;Tdc2-
LexA>GRASP calyces. Abbreviations as Table 3.1.  
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 I consistently observed 10 or less KC-sVUM1 GRASP puncta in larval 
calyces (n=16; Fig. 3.5, arrowheads); where 10 out of 16 calyces showed less 
than 5 GRASP puncta each (Table 3.4). This is consistent to the number of 
GRASP signals observed using Tdc2-GAL4 and MB247-LexA drivers (H.W., 
MPhil Thesis 2014). 3 ± 0.7 out of 4 ± 0.8 (or around 82%) GRASP puncta 
colocalised with OA boutons (Fig. 3.5, filled arrowheads; Table 3.4) – 
suggesting KCs were likely to have few postsynaptic contacts with sVUM1 
neurons in the calyx.  
 Neither H500-IT.GAL4>GRASP (n=2; Fig. 3.6A) nor Tdc2-LexA>GRASP 
(n=4; Fig. 3.6B) showed GRASP puncta on their own. Moreover, both H500-
IT.GAL4 and Tdc2-LexA were present in the H500-IT.GAL4;Tdc2-LexA line 
used for KC-sVUM1 GRASP, and specifically label KCs and sVUM1 neurons in 
the calyx respectively (Fig. 3.6C-D). These controls validate the GRASP signals 
observed in Fig. 3.5 result from splitGFP reconstitution between KCs and 
sVUM1 neurons in the larval calyx.  
 
3.2.3. sVUMmd1 and sVUMmx1 clones both showed GRASP with the APL 
neuron  
To determine whether one or both sVUM1 neurons are responsible for the 
GRASP observed with the APL neuron, I expressed spGFP1-10 in the APL 
neuron using NP2631-GAL4, and LexAOp2-IVS>stop>spGFP11::CD4::HA-
T2A-Brp::mCherry in Tdc2-LexA neurons to generate sVUMmd1 and sVUMmx1 
clones driving spGFP11 upon heat shock-induced FLP-out (Karuppudurai et al., 
2014). The optimal heat shock conditions to generate sVUM1 clones and 
method to identify sVUMmd1 and sVUMmx1 clones were established by Angela 
Wan (A.W., MPhil Thesis 2015).  
 I identified five individuals that labelled Tdc2-LexA clones innervating the 
larval calyx – all of which showed between 1-8 GRASP puncta per calyx (Fig. 
3.7, 3.8; Table 3.5). To distinguish between sVUMmd1 and sVUMmx1 clones, I 
measured the perpendicular distance between the cell body of the clone to the 
AL from the ventral orientation. This distance is 26.91 ± 3.89 μm for sVUMmd 
cell bodies and 49.27 ± 5.64 μm for sVUMmx cell bodies (A.W., MPhil Thesis 












Figure 3.5. Few GRASP puncta between KCs and sVUM1 neurons. Single confocal  optical 
sections of the calyx from two Tdc2-LexA/LexAOp-CD4::spGFP11; H500-IT.GAL4/UAS-
CD4::spGFP1-10 individuals. Green is KC-sVUM1 GRASP, red is anti-OA and blue is anti-Dlg. 
(B,D,F,H) are magnified puncta labelled in (A,C,E,G) respectively. Filled arrowheads indicate 
GRASP-OA colocalisation, and empty arrowheads indicate GRASP puncta negative for OA. 











Individual 1 1 70 1 1% 100% 
Individual 2 0 69 0 0% N/A 
Individual 3 2 72 2 3% 100% 
Individual 4 10 57 7 12% 70% 
Individual 5 - 
Left Calyx 
1 70 0 0% 0% 
Individual 5 - 
Right Calyx 
2 74 1 1% 20% 
Individual 6 - 
Left Calyx 
5 95 5 5% 100% 
Individual 6 - 
Right Calyx 
8 89 7 8% 88% 
Individual 7 - 
Left Calyx 
7 67 7 10% 100% 
Individual 7 - 
Right Calyx 
9 84 8 10% 89% 
Individual 8 - 
Left Calyx 
1 88 1 1% 100% 
Individual 8 - 
Right Calyx 
4 55 4 0% 100% 
Individual 9 - 
Left Calyx 
4 71 3 4% 75% 
Individual 9 - 
Right Calyx 
7 67 7 10% 100% 
Individual 10 - 
Left Calyx 
0 52 0 0% N/A 
Individual 10 - 
Right Calyx 
2 61 2 3% 100% 
N 16 16 16 16 14 
Mean 4 71 3 4% 82% 
S.D. 3.3 12.4 3.0 0.0 0.3 
S.E.M. 0.8 3.1 0.7 0.0 0.1 
 
  
Table 3.4. Numbers of KC-sVUM1 GRASP and OA puncta in Tdc2-LexA; H500-
IT.GAL4>GRASP calyces. Abbreviations as Table 3.1.  
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Figure 3.6. Negative and positive controls for KC-sVUM1 GRASP. (A-B) are single 
representative confocal optical sections of the calyx. No GRASP puncta observed in H500-
IT.GAL4>GRASP (green) (A) or Tdc2-LexA>GRASP (green) (B) negative control calyces. (C-
D) are confocal projections of the calyx. H500-IT.GAL4;Tdc2-LexA>UAS-mCD8::GFP (green) 
(C) and H500-IT.GAL4;Tdc2-LexA>LexAOp-mCD8::GFP (green) (D) validate the presence of 
KC driver H500-IT.GAL4 and sVUM1 driver Tdc2-LexA respectively in the H500-IT.GAL4;Tdc2-
LexA construct used for KC-sVUM1 GRASP. Red is anti-OA and blue is anti-Dlg. Medial (M) is 




Figure 3.7. GRASP puncta observed between APL and sVUMmd1 clone. (A) Confocal 
projection of the ventral larval brain and SOG of hsFLP; Tdc2-LexA/NP2631-GAL4; LexAOp2-
IVS>stop>spGFP11::CD4::HA-T2A-Brp::mCherry, UAS-spGFP1-10::CD4, UAS-HRP::CD2. 
Anterior is up, medial is at vertical mid-line. FLP-out clone is labelled with Brp::mCherry (red), 
anti-Dlg is blue. The perpendicular distance from the bottom end of the AL and the sVUMmd1 
cell body is indicated. (B,D) Single confocal optical sections of the calyx from the same 
individual. Medial (M) is right and posterior (P) is up. Green is APL-sVUMmd1 GRASP. (C,E-F) 
are magnified puncta from (B) and (D) respectively. Filled arrowheads indicate GRASP-

















Figure 3.8. GRASP puncta observed between APL and sVUMmx1 clone. (A) Confocal 
projection of the ventral larval brain of hsFLP; Tdc2-LexA/NP2631-GAL4; LexAOp2-
IVS>stop>spGFP11::CD4::HA-T2A-Brp::mCherry, UAS-spGFP1-10::CD4, UAS-HRP::CD2. 
Anterior is up, medial is at vertical mid-line. FLP-out clone is labelled with Brp::mCherry (red), 
anti-Dlg is blue. The perpendicular distance from the bottom end of the AL and the sVUMmx1 
cell body is indicated. (B,E) Single confocal optical sections of the calyx from the same 
individual. Medial (M) is right and posterior (P) is up. Green is APL-sVUMmx1 GRASP. (C-D,F-
G) are magnified puncta from (B) and (E) respectively. Filled arrowheads indicate GRASP-







No. of GRASP puncta 
sVUM1 clone 
Left Calyx Right Calyx 
Individual 1 28 1 4 sVUMmd1 
Individual 2 53 2 2 sVUMmx1 
Individual 3 51 3 2 sVUMmx1 
Individual 4 53 7 8 sVUMmx1 
Individual 5 
31 & 51 
(2 Cell Bodies) 
8 7 Undetermined 
Table 3.5. Numbers of APL-sVUMmd1 and APL-sVUMmx1 GRASP puncta in NP2631-
GAL4;Tdc2-LexA>FRT-GRASP calyces. Distance from AL is calculated from the bottom tip of 
the AL to the sVUM cell body. Abbrevations: No., number.  
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sVUMmd neurons was more horizontal while that for sVUMmx neurons was V-
shaped. Using these two criteria, I identified one individual that labelled a 
sVUMmd1 clone (Fig. 3.7) and three individuals that each labelled a sVUMmx1 
clone (Fig. 3.8; Table 3.5). The fifth individual labelled two cell bodies – one in 
the sVUMmd cluster and another in the sVUMmx cluster – and therefore it was 
not possible to distinguish whether it labelled sVUMmd1 and/or sVUMmx1 
(Table 3.5).  
 Both sVUMmd1 (n=1; Fig. 3.7B-F) and sVUMmx1 (n=3; Fig. 3.8B-G) 
clones showed GRASP with the APL Neuron. All of the GRASP puncta 
colocalised with Brp::mCherry puncta (Fig. 3.7B-F, 3.8B-G), which labelled 
presynaptic terminals of sVUM1 clones. This suggested the APL neuron was 
postsynaptic to both sVUMmd1 and sVUMmx1 clones at these sites.  
 The maximum sum of GRASP signals detected for sVUMmd1 and 
sVUMmx1 clones with the APL neuron is 12 per calyx (Table 3.5) – less than 
half of the average number of APL-sVUM1 GRASP signals that colocalised with 
OA (Table 3.2). The reason for this discrepancy is unclear. However, I 
speculate that this could be due to the lower expression levels of the spGFP 
components as these larvae were raised at room temperature rather than 25⁰C 
following the heat shock treatment to induce clones. An alternative speculation 
is that the heat shock treatment itself affected the development of sVUM1 
and/or APL synaptic terminals, such that they showed fewer GRASP contacts. 
There is also a large variation in the number of GRASP signals detected per 
calyx (Table 3.5). This is probably due to a small sample size, which was 
caused by the low frequency – 2.7% at optimal heat shock conditions – for 





3.3.1. OA colocalisation with sVUM1 GRASP 
To identify postsynaptic partners of sVUM1 neurons in the larval calyx, I used 
anti-OA labelling to identify sVUM1 terminals where OA is released. I assumed 
that 1) OA is mainly released at the presynaptic terminals of sVUM1 neurons; 2) 
GRASP-OA colocalisation indicated higher probability of synaptic contact; and 
3) neurons that show GRASP-OA colocalisation with sVUM1 neurons are 
putatively postsynaptic to sVUM1 neurons. However, there may be alternative 
interpretations for GRASP-OA colocalisation or the lack thereof.  
 OA boutons may not necessarily indicate pre-synaptic terminals of 
sVUM1 neurons, because OA can be released extrasynaptically via volume 
transmission as evidenced by the dense core vesicles observed in fly OA 
neurons (Grygoruk et al., 2014; Eichler et al., 2017). However, OA-GRASP 
contacts suggest that these neurons are in close enough proximity to receive 
OA signalling, whether it is via synaptic or non-synaptic transmission. Moreover, 
even if OA-GRASP colocalisation accurately marks presynaptic sVUM1 
terminals, their GRASP partners could instead be modulating presynaptic OA 
release from sVUM1 neurons. This is probable when sVUM1 GRASP partners 
are also predominantly presynaptic in the calyx, such as PNs or the APL 
neuron. It is also possible that these GRASP contacts show bi-directional axo-
axonal transmission. These different connectivity scenarios may be one of the 
reasons for the variable degree of overlap between GRASP and OA puncta.  
 While the absolute number of GRASP puncta detected vary depending 
on the putative synaptic partner, the percentage of GRASP-OA contacts out of 
total GRASP signals ranges between 65-82% (Fig. 3.9; Table 3.1, 3.2, 3.3, 3.4). 
There are several interpretations as to why some GRASP signals do not 
overlap with OA: 1) Some of the GRASP signals are not synaptic contacts, but 
are due to neuronal tracts crossing over each other; 2) Some GRASP puncta 
instead localised to the presynaptic terminals of the GRASP partners, such as 
GRASP-GABA colocalisation observed in APL-sVUM1 GRASP (H.W., MPhil 
Thesis 2014), indicating that sVUM1 neurons may sometimes be postsynaptic; 
and 3) GRASP puncta may be localised to sVUM1 terminals in which alternative 
neurotransmitters, such as neuropeptides, are released instead of OA.  
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Figure 3.9. Numbers of GRASP puncta between sVUM1 neurons and their putative 
synaptic partners in the third instar larval calyx. Light green indicates the number of 
GRASP-OA puncta, while dark green indicates the number of GRASP puncta that did not 
colocalise with OA. Error bars indicate standard error of the mean (S.E.M.). Abbreviations: L3, 
third instar larval; No., number.  
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3.3.2. Putative postsynaptic targets of sVUM1 neurons in the calyx 
Based on GRASP-OA colocalisation, PNs, the APL neuron and Odd-like 
neurons are putative postsynaptic partners of sVUM1 neurons in the calyx (Fig. 
3.10). Consistent with previous results (H.W., MPhil Thesis 2014), KCs showed 
limited GRASP with sVUM1 neurons, most of which overlapped with OA; 
suggesting that very few KCs are postsynaptic to sVUM1 neurons. To 
determine the distribution of OA synapses between its multiple putative 
postsynaptic partners, I quantified the percentage of OA-GRASP puncta out of 
total OA boutons. The APL neuron and Odd-like neurons showed the largest 
share of putative OA synapses at around 56% and 47% respectively (Table 3.2, 
3.3). This was followed by PNs at around 21% (Table 3.1), while KCs showed 
the smallest share at around 4% (Table 3.4). This suggested that the APL and 
Odd-like neurons were probably the main targets of OA signalling from sVUM1 
neurons in the calyx.  
 The single APL neuron shows the largest absolute number and share of 
OA-GRASP contacts with sVUM1 neurons (Fig. 3.9; Table 3.2). This suggested 
that the APL neuron is strongly modulated by OA signalling by sVUM1 neurons 
in the calyx. APL-sVUM1 GRASP also colocalised with GABA (H.W., MPhil 
Thesis 2014), suggesting that sVUM1 neurons are reciprocally modulated by 
the APL neuron in the calyx (Fig. 3.10). As both sVUM1 neurons and the APL 
neuron are predominantly presynaptic in the calyx (Masuda-Nakagawa et al., 
2014; L. Masuda-Nakagawa, personal communication), their synapses are 
likely to be axo-axonal and/or bi-directional. This suggested that the APL 
neuron inhibited OA release from sVUM1 terminals, while sVUM1 modulated 
GABA release from APL terminals, in the larval MB calyx. This provides an 
avenue for sVUM1-mediated control of the APL feedback inhibition onto KCs, 
and therefore the sparseness of odour representations in the MBs. However, 
whether OA signalling increases or decreases APL activity depends on the type 
of OA receptors expressed on the APL neuron.   
 Another instance of axo-axonal modulation by sVUM1 neurons is likely to 
be at PN terminals in the calyx. As putative postsynaptic partners to sVUM1 
neurons, sVUM1 signalling may modulate neurotransmitter release from 
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Figure 3.10. Revised sVUM1 connectivity diagram of the larval MB calyx.  Abbreviations: 
ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial compartment; KC, Kenyon 
Cell; LH, lateral horn; MB, mushroom body; N, number; OA, octopamine; PN, projection neuron. 
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presynaptic terminals of PNs onto KCs, which would also affect odour 
representations in KCs. If all PNs labelled by the NP225-GAL4 line show 
GRASP with sVUM1 neurons, they would each share one synapse with one of 
the sVUM1 neurons. Alternatively, only a subset of PNs may synapse with 
sVUM1 neurons. 
 Odd-like neurons also show a large share of OA-GRASP contacts. This 
is expected as Odd-like neurons are postsynaptic in the calyx (Slater et al., 
2015). As there are two or three Odd-like neurons in the larval calyx (Slater et 
al., 2015; Eichler et al., 2017), they may each form more than one synapse with 
sVUM1 neurons. This suggests that the activity of Odd-like neurons may be 
regulated by sVUM1 neurons.  
 Limited GRASP contacts were observed between KCs and sVUM1 
neurons using two different set of drivers suggested very few KCs – out of a 
larval population of around 600 (Ramaekers et al., 2005) – synapse with 
sVUM1 neurons. As mentioned above, KC activity may still be modulated by 
sVUM1 signalling via PNs and the APL neuron. Alternatively, KCs may also 
receive OA signalling via non-synaptic transmission if they expressed 
extrasynaptic OA receptors.  
 
3.3.3. GRASP connectivity of sVUMmd1 and sVUMmx1 neurons  
While sVUMmd1 and sVUMmx1 neurons innervate the same neuropils, they 
show largely non-overlapping innervation patterns (Fig. 3.11A-B), suggesting 
that they may not share the same synaptic partners. The evidence so far 
contradicts this prediction, as both sVUMmd1 and sVUMmx1 clones show 
single cell GRASP with Odd-like neurons (A.W., MPhil Thesis 2015) and the 
APL neuron in the calyx. This is in agreement with EM data from the L1 brain – 
which additionally show that sVUMmd1 and sVUMmx1 neurons each have 
similar number of synapses with PNs (Fig. 3.11C).  
 While sVUMmd1 and sVUMmx1 may show equivalent connectivity in the 
larval calyx, it is still unclear whether they are functionally redundant, as they 
may receive inputs from different neurons outside the MB, for which data are 
not yet available. In fact, ablating all the sVUM neurons in the mandibular (md) 
segment versus those in the maxillary (mx) segment in fly larvae resulted in 
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Figure 3.11. Synaptic connectivity of sVUM1 neurons in the first instar larval brain. (A-B) 
Innervation pattern of sVUMmd1 (blue) and sVUMmx1 (green) neurons in the first instar larval 
(L1) brain (A) and MB calyx (B) reconstructed from EM data. (C) Synaptic connectivity of 
sVUM1 neurons in the L1 larva based on EM data. The bar graph represents the total number 
of synapses between sVUMmd1 (blue) or sVUMmx1 (green) neurons and their synaptic 
partners in both of the brain lobes in the L1 brain. The numbers immediately above the x-axis 
indicate the number of neurons from each neuronal type that synapse with sVUM1 neurons; 
e.g. 6 KCs are presynaptic to sVUMmd1 neurons. The total number of each neuronal type is 
labelled below the x-axis, e.g. N=145 for KCs. Figure 3.11 is generated from data and images 
obtained from https://neuronlp.larva.fruitflybrain.org/ Abbreviations: AL, antennal lobe;  mPN, 
multiglomerular PN; N/No., number; OAN, OA neurons; Pre, presynaptic partner; Post, 




opposing satiety state-dependent feeding behaviours (Zhang et al., 2013a) – 
suggesting that there may be functional differences between OA neurons in the 
two segments.  
 On the other hand, the OA-VUMa2 neurons in the adult brain which 
innervate the same neuropils as the sVUM1 neurons (Busch et al., 2009; 
Selcho et al., 2014) are similarly divided into md and mx subtypes based on the 
locations of their cell bodies (Busch and Tanimoto, 2010). However, there is no 
evidence to suggest they show different connectivity patterns or functions.  
 
3.3.4. OA connectivity in the first instar larval and adult calyces  
The main difference between OA connectivity in the L3 compared to L1 and 
adult calyces is the lack of putative KC-OA synapses. Strong and dense 
GRASP signals have been observed between OA neurons and KCs in the adult 
calyx (Zhou et al., 2012; Pech et al., 2013); while more recent EM data have 
shown that L1 KCs synapse with sVUM1 neurons (Fig. 3.11C; Eichler et al., 
2017). This difference may be due to changes in neuronal connectivity over 
development: KCs initially form synapses with OA neurons in the L1 stage, 
these synapses get pruned at the L3 stage and regrown in adults. While the 
lineage of OA neurons is unclear, this could be linked to the pruning of larval 
KCs after the L3 stage that eventually become γ KCs, or the birth of the adult 
specific α/β KCs (Lee et al., 1999). In the adult, there are also two additional 
types of OA neurons innervating the calyx besides the sVUM1 analogue OA-
VUMa2 that do not have larval analogues (Busch et al., 2009); and therefore 
may instead be responsible for the OA-KC GRASP observed in the adult calyx. 
As a neuromodulator, OA may be required for functions specific to individual 
developmental stages. For example, courtship behaviour requires OA function 
in the adult MB (Zhou et al., 2012), but this circuit would be unnecessary in the 
third instar larvae, which is why third instar larvae may lack some of the 
connections found in the adult brain. Nevertheless, as third instar larvae are still 
capable of odour discrimination, this suggests that limited KC-OA synapses are 
not crucial for this conserved behaviour.   
 Besides KCs, there is little evidence for other synaptic partners of OA 
neurons in the adult calyx. However, EM reconstruction data in the first instar 
larva (Berck et al., 2016; Eichler et al., 2017) show that a subset of PNs, the 
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APL neuron and Odd-like neurons are all postsynaptic to sVUM1 neurons; while 
the APL neuron is also presynaptic to sVUM1 neurons (Fig. 3.11C). This is 
consistent with my deductions from GRASP-OA/GABA colocalisation 
experiments in the L3 calyx. This suggests that much of the sVUM1 synaptic 
connectivity is already in place at the L1 stage. Additionally, L1 EM data show 
that 1) sVUM1 neurons synapse with multiglomerular PNs (mPNs); 2) five PNs 
are presynaptic to the sVUMmx1 neuron; and 3) sVUMmd1 and sVUMmx1 
neurons have reciprocal connections with each other (Fig. 3.11C). This 
suggests strong interconnectivity between sVUM1 neurons with each other and 
other calyx-innervating neurons. However, we currently only have EM 
reconstruction data for one single larva (Berck et al., 2016; Eichler et al., 2017). 
This may not be representative of larval connectivity, as we do not know how 
synaptic connectivity may vary between individuals, or how this changes when 
larvae mature from L1 to L3 stages. 
 
3.3.5. Alternative methods to identify sVUM1 target neurons 
While GRASP is a convenient and high throughput method to identify putative 
synaptic partners of specific neurons, the main concern is that it does not 
directly detect synapses. Classical GRASP relies on the reconstitution of 
splitGFP fused to the human membrane protein CD4 (Feinberg et al., 2008; 
Gordon and Scott, 2009), such that CD4::spGFP is localised to the plasma 
membrane of the neurons they are expressed in, not just at synaptic terminals. 
Therefore, GRASP signals may be observed in the absence of synapses, such 
as when neuronal tracts cross over, provided that plama membrane-tethered 
spGFP halves are in close enough contact to reconstitute. This is also why 
GRASP cannot be used to detect the direction of neurotransmission.  
 Synaptic markers, such as Bruchpilot::mCherry in the FRT-GRASP 
construct (Karuppudurai et al., 2014), or neurotransmitter labelling, such as anti-
OA used in this chapter, can be used to determine whether GRASP signals 
localised to synaptic terminals. spGFP can also be tethered to a synaptic 
marker, such as synaptobrevin (Karuppudurai et al., 2014), to ensure spGFP 
localisation to synaptic terminals.  
  While these methods may improve the probability of identifying synaptic 
connections using GRASP, it is still not possible to directly visualise synapses 
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using confocal microscopy. Synaptic clefts are around 100 nm in the central 
nervous system (Feinberg et al., 2008), postsynaptic sites are less than 100 nm 
in size, while the diameter of synaptic vesicles are 5-30 nm (Meinertzhagen and 
Lee, 2012) – all of which are beyond the resolving limit of confocal microscopes, 
which is around 150-200 nm for a numerical aperture of 1.3. Currently, EM is 
the only method at a sufficiently high resolution (around 2 nm) for visualising 
synapses in the fly brain (Meinertzhagen and Lee, 2012).  
  Recent connectomics projects are utilising EM data to systematically 
reconstruct the synaptic connectivity of the fly adult and L1 brains (Berck et al., 
2016; Eichler et al., 2017; Takemura et al., 2017; Zheng et al., 2018). These 
projects have generated large amounts of data on the connectivity of neurons 
innervating the MBs already, including that of sVUM1 neurons in the L1 larva 
(Fig. 3.11; Eichler et al., 2017); and are expected to become extremely useful 
resources upon their completion.  
 As an unbiased method to map synapses, EM data can be used to 
identify novel synaptic partners that have not been previously identified. 
However, this may result in large amounts of data that we cannot yet interpret, 
as it is difficult to acquire the appropriate tools to characterise these neurons 
based on their morphology. Moreover, EM reconstruction and tracing is a time-
consuming and labour-intensive task. The current data are generated from a 
single L1 larval brain and a single adult brain (Berck et al., 2016; Eichler et al., 
2017; Takemura et al., 2017; Zheng et al., 2018); and cannot take into account 
of individual variability.  
 In the context of understanding neuromodulatory circuitry, EM 
connectivity data can show the location of dense core vesicles associated with 
volume transmission, for example in sVUM1 neurons in the L1 larva 
(Meinertzhagen and Lee, 2012; Eichler et al., 2017); but it cannot reveal their 
downstream extrasynaptic targets. The only comprehensive way of identifying 
all possible targets of neuromodulatory neurons is to identify where their 
receptors are localised. Therefore, in the following chapters, I aimed to identify 
the neurons subjected to OA signalling by the sVUM1 neurons in the calyx by 
systematically mapping OA receptor localisation.  
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Chapter 4. Expression of α1-adrenergic-like 
OAMB receptors in calyx-innervating neurons 
 
4.1. Introduction  
OAMB is a strong candidate for mediating OA signal in the larval MB calyx 
circuitry, based on its expression pattern in the adult MB (Han et al., 1998), and 
its known function in appetitive olfactory learning (Burke et al., 2012; Kim et al., 
2013).  
OAMB localisation to the MB calyx is likely to be conserved across 
insects, including in fly larvae. Based on immunostaining data, OAMB is 
enriched in the adult fly MB calyx (Han et al., 1998). Its honeybee homologue 
AmOA1 is similarly localised to the olfactory region (lip) of the honeybee calyx 
(Sinakevitch et al., 2011). Indeed, mRNA transcripts of α1-adrenoceptors 
localise to the rat piriform cortex and amygdala (Domyancic & Morilak, 1997). 
This suggests that α1-adrenoceptor localisation to higher brain olfactory centres 
may be conserved from insects to mammals, and therefore may share 
conserved functions in modulating olfactory processing circuits.   
oamb mutants cannot form appetitive olfactory memories in adult flies 
(Burke et al., 2012; Kim et al., 2013); which suggests that OAMB may be 
required on neurons in the MB olfactory learning circuitry. Kim et al. (2013) 
showed that driving OAMB expression in αβ and γ KCs was sufficient for 
rescuing the learning impairment in an oamb mutant background. However, this 
rescue phenotype may be due to ectopic rather than native OAMB expression 
in KCs, as the group did not show whether OAMB knockdown specifically in 
KCs impaired learning. Burke et al. (2012) claimed that OAMB is instead 
required in dopaminergic PAM neurons, which convey sugar reinforcement 
signals from upstream OA neurons to the MBs, as OAMB-RNAi in PAM neurons 
significantly impaired reward learning. While it is uncertain whether appetitive 
olfactory learning in adult flies requires OAMB on KCs, PAM neurons or both, 
OAMB expression in neurons involved in olfactory processing or learning is 
likely to be conserved in the larval MB circuitry.  
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 To understand whether and how OA signalling in the larval MB calyx is 
mediated by OAMB (Fig. 4.1), I aimed to address the following questions:  
 
1) Is OAMB expressed in any of the putative postsynaptic partners of sVUM1 
neurons?  
 
Kim et al. (2013) observed that the OAMB localised to MB extrinsic neurons 
innervating the adult fly calyx and not in KCs, but did not show data in support. 
This suggested that OAMB is likely to be expressed in non-KC neurons in the 
larval calyx as well. Therefore, as potential postsynaptic partners of the OA 
sVUM1 neurons, PNs, the APL neuron and Odd-like neurons (Chapter 3) are all 
candidates for OAMB expression in the larval calyx. 
  While it is not known which of the above neurons express OAMB in 
Drosophila, this could be predicted from the localisation of its honeybee 
homologue AmOA1. AmOA1 immunoreactivity colocalised with anti-GABA, but 
not with a uniglomerular PN marker at the lip (olfactory region) of the honeybee 
calyx (Sinakevitch et al., 2013). This suggested that AmOA1 was expressed in 
GABAergic PCT feedback neurons but not uniglomerular PNs. If the function of 
α1-adrenergic-like OA receptors in insect MB calyces is conserved, this 
suggests that OAMB is probably expressed in the larval GABAergic APL neuron 
but not larval olfactory PNs, the Drosophila counterparts of the PCT neurons 
and uniglomerular PNs respectively.  
 Therefore, I aimed to determine whether OAMB localised to larval PNs, 
APL and Odd-like neurons.  
 
2) Is OAMB localised to the presynaptic terminals of calyx-innervating neurons?  
 
α1-adrenoceptors are primarily enriched in the axon terminals of dopamine 
neurons in rats based on electron microscopy data (Mitrano et al., 2012). 
Several electrophysiological studies have also shown that presynaptic 
α1 receptors are involved in modulating glutamate and GABA release in the 
hypothalamus and prefrontal cortex (Chen et al., 2006; Luo et al., 2015; Zhang 
et al., 2013b). This suggests the α1-adrenergic-like OAMB may also be 




Figure 4.1.  Hypothetical OAMB localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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PNs and the APL neuron, which are predominantly presynaptic in the calyx 
(Masuda-Nakagawa et al., 2014). The subcellular localisation of OAMB to 
presynaptic terminals is expected to have functional consequences in regulating 
neurotransmitter release machinery. For example, it may enhance the 
probability of neurotransmitter release and increase the number of synaptic 
vesicles, as in the case of α1-adrenoceptor regulation of glutamate release in 
rat medial prefrontal cortex neurons (Luo et al., 2015). 
 Here I aimed to determine whether OAMB localised to the presynaptic 
terminals of PNs and the APL neuron in the larval MB calyx.  
 
3) Is OAMB expressed on KCs extrasynaptically in the larval calyx?  
 
OAMB transcripts observed in KC cell bodies in adult flies (Han et al., 1998), 
and anti-AmOA1 signal in honeybee KCs (Sinakevitch et al., 2011) suggests 
that OAMB localisation to KCs may be conserved in larvae. However, few 
synaptic connections between sVUM1 neurons and KCs in the larval calyx were 
detected using GRASP (H.W., MPhil Thesis 2014).  
Here I aimed to determine whether OAMB localised to KC dendrites in 
the larval MB calyx, and therefore whether KCs express extrasynaptic OA 
receptors in the larval calyx in response to sVUM1 signalling. 
 
  OAMB expression has previously been examined using mRNA in situ 
hybridisation (Han et al., 1998) and promoter-GAL4 lines (El-Kholy et al., 2015; 
Huetteroth et al., 2015; Watanabe et al., 2017). However, neither of these 
methods can show the subcellular localisation of OAMB. Additionally, promoter-
GAL4 lines may not accurately reflect the endogenous expression pattern of 
OAMB. There is a large variation in the neurons labelled in two GAL4 lines 
generated from different promoter fragments of the OAMB gene (Watanabe et 
al., 2017); and a third OAMB-GAL4 line generated using the complete promoter 
region of OAMB (El-Kholy et al., 2015). Even when the complete promoter 
region of OAMB was used to generate an OAMB-GAL4 line, this line still cannot 
guarantee endogenous OAMB expression which may be regulated by distal 
enhancer elements outside of the promoter region.  
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Anti-OAMB antibodies (Han et al., 1998; Lee et al., 2009; Kim et al., 
2013) have also been used to determine OAMB localisation. However, it is 
difficult to differentiate between signal and background in adult fly brains stained 
with anti-OAMB, due to the poor signal-to-noise ratio and high background 
staining in oamb  hypomorphic and null mutant controls (Kim et al., 2013). This 
suggests that the anti-OAMB antibodies are not specific. Anti-OAMB shows a 
much better signal when it is overexpressed using the GAL4/UAS system (Kim 
et al., 2013), suggesting that endogenous OAMB expression in the adult MB 
may be too low to be robustly visible with anti-OAMB.  
Here I used newly generated EGFP-tagged OAMB receptors to visualise 
the endogenous localisation pattern of OAMB. As the EGFP sequence was 
inserted along with RNA splicing signals in a coding intron of the OAMB gene, 
EGFP was expressed as an artificial exon under the control of the same 
promoters and regulators as OAMB. Therefore, EGFP was translated as a 
fusion with the OAMB protein, and should report the subcellular localisation of 
the OAMB protein. EGFP-tagged OAMB was used to report OAMB localisation 
in specific neurons identified using GAL4 lines or neurotransmitter antibody 
labelling, as well as to measure OAMB levels after RNAi or protein knockdown 
in specific neurons.  
 
4.2. Results  
  
4.2.1. Selection and generation of an EGFP-tagged OAMB line  
To visualise OAMB expression in the larval MB calyx, I selected the MI12417 
line from the MiMIC collection to generate an EGFP-tagged OAMB receptor 
stock. The MI12417 insertion is in a coding region intron of the OAMB gene 
(Venken et al., 2011a; Fig. 4.2, 4.3A). By aligning cDNA and protein sequences 
of OAMB, I mapped the location of the MI12417 insertion in coding region intron 
3 of the OAMB gene to amino acid position 338 (Fig. 4.3) in all OAMB protein 
isotypes. Amino acid position 338 was in the intracellular domain between TM V 
and VI for all OAMB isotypes according to the TM prediction software TMHMM 







Position Oamb - coding intron 
Phase 
Oamb-RB:1, Oamb-RC:1, Oamb-RD:1, Oamb-RE:1, 
Oamb-RF:1 
Release 6 Annotation 
Scaffold Coordinate Strand Site GBrowse Link 
3R 20697059 - 92F6 3R:20697059  
 
FlyBase Annotation Transposon 
FBti0162526  Mi{MIC} 
Stock Availability 
Donor/Collection Stockcenter Designation Stock No. 
















B1. OAMB-PB tblastn alignment to Drosophila sequences 
 
Exon 3 
Query:   284 PWKCELTNDRGYVLYSALGSFYIPMFVMLFFYWRIYRAAVRTTRAINQGFKTTKG 338 
  PWKCELTNDRGYVLYSALGSFYIPMFVMLFFYWRIYRAAVRTTRAINQGFKTTKG 
20698497  PWKCELTNDRGYVLYSALGSFYIPMFVMLFFYWRIYRAAVRTTRAINQGFKTTKG 20698333 
 
Exon 4 
Query:   338 GSPRESGNNRVDESQLILRIHRGRPCSTPQRTPLSVHSMSSTLSVNSNGGGGGAVASGLG 397 
GSPRESGNNRVDESQLILRIHRGRPCSTPQRTPLSVHSMSSTLSVNSNGGGGGAVASGLG 
20693849  GSPRESGNNRVDESQLILRIHRGRPCSTPQRTPLSVHSMSSTLSVNSNGGGGGAVASGLG 20693670 
 
B2. OAMB-PC tblastn alignment to Drosophila sequences 
 
Exon 3 
Query:   284 PWKCELTNDRGYVLYSALGSFYIPMFVMLFFYWRIYRAAVRTTRAINQGFKTTKG 338 
  PWKCELTNDRGYVLYSALGSFYIPMFVMLFFYWRIYRAAVRTTRAINQGFKTTKG 
20698497  PWKCELTNDRGYVLYSALGSFYIPMFVMLFFYWRIYRAAVRTTRAINQGFKTTKG 20698333 
 
Exon 4 
Query:   338 GSKGIGSRFEEQRLTLRIHRGRGSNQQDSMHSNGSTQSTTTTLGTPSPERLSKYATRRLH 397 
GSKGIGSRFEEQRLTLRIHRGRGSNQQDSMHSNGSTQSTTTTLGTPSPERLSKYATRRLH 







Figure 4.3. MI12417 insertion was in coding region intron 3 of the OAMB gene. (A) Map of 
MI12417 insertion site relative to OAMB gene and transcripts (Adapted from GBrowse). (B) 
Amino acid coordinates for the MI12417 insertion site based on tblastn alignment with OAMB 
transcripts. (C) Magnified map of MI12417 insertion in coding region intron 3 of OAMB 





 Figure 4.4. MI12417 insertion was between TM V and VI of OAMB proteins. MI12417 
insertion site relative to TMHMM predictions of TMs for OAMB isotypes: OAMB-PB (A) and 
OAMB-PC (B).   
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Therefore, a protein trap generated from MI12417 should not disrupt any TMs to 
cause protein mislocalisation.  
To verify the MI12417 insertion site, I conducted PCR reactions against 
the 5’ and 3’ flanking ends of the MiMIC insertion (Fig. 4.5A). PCR products 
were detected for the MI12417 stock but not for the non-MiMIC negative control 
(Fig. 4.5B). The sequenced PCR products contained both MiMIC sequences 
and flanking OAMB genomic sequences (Fig. S1, S2). This confirmed the 
location of the MI12417 insertion in a coding region intron of OAMB.  
 
4.2.2. Validation of OAMB::EGFP lines 
Nine OAMB::EGFP recombinant stocks were recovered after introducing the 
EGFP reporter cassette to the MI12417 line. As the EGFP reporter must be 
inserted in the same direction as the OAMB gene for expression, I determined 
the EGFP insertion orientation of the nine recombinant stocks using PCR 
reactions described in Venken et al. (2011a). Products observed for PCR1 and 
PCR4 reactions predicted correct EGFP insertion orientation for expression, 
while products for PCR2 and PCR3 reactions did not (Fig. 4.6A).  
Robust bands for PCR1 and PCR4 reactions were observed for six of the 
recombinant stocks (Fig. 4.6B). These stocks were therefore expected to 
express EGFP (Table 4.1). Two stocks produced strong bands for PCR2 and 
PCR3 reactions (Fig. 4.6B2), and were thus not expected to express EGFP 
(Table 4.1). One stock produced only a band for PCR1 but not for the other 
three PCR reactions (Fig. 4.6B3). As it was unclear whether EGFP was 
correctly inserted in this stock, it was not assayed for expression (Table 4.1).  
EGFP signal was detected in the MB calyces of non-fixed L3 brains for 
the six OAMB::EGFP stocks that contained EGFP in the correct orientation for 
expression, namely Stocks 2, 4, 5, 7, 8 and 9, but not in the two stocks that did 
not (Fig. 4.6, 4.7; Table 4.1). To visualise endogenous expression of OAMB 
receptors in the larval MB calyx, I used OAMB::EGFP Stock 9 because it 
contained the EGFP cassette in the correct orientation (Fig. 4.6B3) and 
expressed OAMB::EGFP signal in the MB calyx (Fig. 4.7F). This stock was 





Figure 4.5. PCR verification of MI12417 insertion in the OAMB gene. (A) Primers designed 
against 5’ and 3’ insertion flanking ends for validating MI12417 insertion in the OAMB gene. (B) 
PCR products were detected for 5’ and 3’ MI12417 insertion ends with MI12417 DNA but not 
with non-MiMIC control S576-IT.GAL4 (denoted as +) DNA. PCR products detected using 
primers against OAMB genomic flanking sequences (5’-3’ flanking control) suggested the 
absence of the MiMIC construct in the negative control, and heterozygosity of the MI12417 
insertion cassette in the MI12417 stock. Abbreviations: MiL/R, MiMIC insertion sequences 





Figure 4.6. PCR validation of EGFP orientation in recombinant OAMB::EGFP stocks. (A1) 
Products for PCR1 and PCR4 indicated EGFP cassette in the correct orientation for expression. 
(A2) Products for PCR2 and PCR3 indicated EGFP cassette in the incorrect orientation for 
expression. (B) Results for PCR reactions 1-4 for OAMB::EGFP Stock 8 (B1), Stocks 1, 2, 3 
(B2), Stocks 6, 9 (B3), and Stocks 4, 5, 7 (B4). Octβ3R::EGFP (Phase 1) (BDSC 60245, 
Venken et al., 2011a; Nagakar-Jaiswal et al., 2015) was used as a positive control for PCR1 
and PCR4 reactions (B1). Abbreviations: MiL/R, MiMIC sequences Left/Right; SA, splice 
acceptor site; SD, splice donor site; OriF, Orientation-MiL-F; OriR, Orientation-MiL-R; EGFP-F, 





  Table 4.1. Six out of nine recombinant OAMB::EGFP stocks contained EGFP in the 
correct orientation for expression. PCR products from each of the PCR reactions (PCR1, 
PCR2, PCR3 and PCR4) were scored as follows: -, no bands observed; +, weak band 
observed; ++, strong band observed. PCR results were used to determine whether 
OAMB::EGFP expression was expected (Expected Expression). This correlated with stocks that 




Figure 4.7. Six OAMB::EGFP stocks showed EGFP expression in Drosophila larval MB 
calyx. Single confocal optical sections of the calyx of non-fixed third instar larval OAMB::EGFP 
brains. White is bright field (BF) and green is OAMB::EGFP. (A-F) Six OAMB::EGFP stocks 
with EGFP signal: OAMB::EGFP Stock 2/TM6C (A), OAMB::EGFP Stock 4 (B), OAMB::EGFP 
Stock 5/TM6C (C), OAMB::EGFP Stock 7 (D), OAMB::EGFP Stock 8/TM6C (E), OAMB::EGFP 
Stock 9 (F). Individuals heterozygous for OAMB::EGFP (with TM6C balancers) showed a 
weaker signal (A,C,E) than individuals homozygous for OAMB::EGFP (without TM6C 
balancers) (B,D,F). (G-H) Two OAMB::EGFP stocks without EGFP signal: OAMB::EGFP Stock 
1/(TM6C) (G), OAMB::EGFP Stock 3/(TM6C) (H). Medial (M) is right, posterior (P) is up. Scale 
bar: 20 μm. 
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A previous study suggested that MI12417 is an oamb mutant stock, as the 
MI12417 insertion did not complement oamb mutant phenotypes in egg 
laying following chromosomal deletions in its homologous regions (Deady and 
Sun, 2015). Consistent with this, I observed that the MI12417 stock was 
homozygous infertile, as no viable progeny was produced by homozygous 
MI12417 flies. This supported the claim that OAMB protein function was 
disrupted in the MI12417 stock.  
 Homozygous infertility of MI12417 flies was not reverted to wild type in 
OAMB::EGFP, even though it contained the EGFP cassette in the correct 
orientation for expression. This suggested OAMB::EGFP produced an 
OAMB::EGFP fusion that was not a functional OAMB protein.  
  
4.2.3. Visualisation of EGFP-tagged receptors with antibody labelling 
To visualise OAMB localisation to neuropils and specific neurons, I conducted 
immunolabelling using GFP antibody to amplify the EGFP signal and Discs 
large (Dlg) antibody to label neuropil structures.  
Monoclonal rat anti-GFP (Nacalai, 440426, clone GF090R) – an antibody 
that our lab previously used to visualise mCD8::GFP and GRASP in the larval 
MB calyx (Masuda-Nakagawa et al., 2014) – failed to detect OAMB::EGFP 
signals in OAMB::EGFP calyces relative to the wild type CS negative control 
(Fig. 4.8A-B). This was unexpected as I observed OAMB::EGFP signal in the 
calyces of non-fixed OAMB::EGFP brains (Fig. 4.7F). Rat anti-GFP also did not 
recognise GABA-B-R1::EGFP signals in the calyces of GABA-B-R1::EGFP 
larvae (Fig. 4.8C) – another protein trap line generated using the MiMIC RMCE 
method that should contain EGFP signals in the larval calyx (Chapter 7) – 
compared to CS negative control (Fig. 4.8D).  
As a positive control, Tdc2-GAL4>mCD8::GFP was detected by rat anti-
GFP in the larval calyx (Fig. 4.8E). This suggested that the rat anti-GFP was 
functional, but did not recognise the EGFP protein tag used in protein traps 
generated by MiMIC RMCE. This may be because this EGFP tag did not 
contain the epitope recognised by the rat anti-GFP GF090R clone. 
Therefore, the signal observed in OAMB::EGFP, GABA-B-R1::EGFP and 





Figure 4.8. Monoclonal rat anti-GFP did not recognize EGFP-tagged receptors. Single  
confocal optical sections of the calyx from larvae of the following genotypes: 
OAMB::EGFP/(TM6C) (A), CS (B,D,F), GABA-B-R1::EGFP/(SM6a) (C) and Tdc2-GAL4/+; 
UAS-mCD8::GFP/+ (E). Blue is neuropil marker anti-Dlg. Green is rat anti-GFP (440426, clone 
GF090R; ratGFP) in (A-E). Anti-GFP is omitted in (F), where green is instead anti-rat Alexa 488 
(rat488). Medial (M) is right, posterior (P) is up. Scale bar: 20 μm. 
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background signal that may have been caused by non-specific antibody 
binding that was only detected when high laser conditions were applied during 
confocal imaging. A similar background signal was also observed when rat anti-
GFP was omitted in a secondary antibody control CS brain also taken at high 
laser power conditions (Fig. 4.8F). This suggested that this may be due to non-
specific binding of the anti-rat Alexa 488 secondary antibody.  
 To increase the probability of detecting the EGFP protein tag, I tested 
two polyclonal GFP antibodies which can recognise multiple epitopes on GFP 
proteins: a polyclonal rabbit anti-GFP (Invitrogen, A11122), used by Nagarkar-
Jaiswal et al. (2015) to visualise EGFP-tagged proteins generated from MiMIC 
RMCE; and a polyclonal chicken anti-GFP (Abcam, ab13970). Both rabbit and 
chicken anti-GFP were able to detect clear EGFP signals in the calyces of 
OAMB::EGFP and GABA-B-R1::EGFP larvae relative to MI12417 or CS  
negative controls (Fig. 4.9, 4.10). EGFP localisation patterns appeared to be 
consistent within the same genotype regardless of whether rabbit or chicken 
anti-GFP was used. This suggested that the rabbit anti-GFP (A11122) and 
chicken anti-GFP (Ab13970) can both detect EGFP protein traps generated 
from MiMIC lines.   
I chose to use chicken anti-GFP in favor of rabbit anti-GFP in the 
following sections for visualising EGFP protein traps unless stated otherwise, as 
chicken anti-GFP could be used in conjunction with other rabbit antibodies 
including rabbit anti-DsRed and rabbit anti-OA for co-labelling calyx-innervating 
neurons.  
 
4.2.4. OAMB::EGFP localisation to larval MB calyx glomeruli 
OAMB::EGFP larvae showed GFP localisation to calyx glomeruli (Fig. 4.11A-F), 
but not in the negative controls (Fig. 4.11G-L). EGFP localisation to synaptic 
regions suggested that GFP had been successfully fused to OAMB to form a 
correctly folded protein. This fusion was therefore designated as OAMB::EGFP. 
 However, OAMB::EGFP did not localise to all MB calyx glomeruli labelled 
with the neuropil marker anti-Dlg. By examining the slices of the confocal stack 
using ImageJ, I estimated the number of calyx glomeruli that did not contain 





Figure 4.9. EGFP-tagged receptors could be labelled using polyclonal rabbit anti-GFP. 
Single confocal optical sections of the calyx from larvae of the following genotypes: 
OAMB::EGFP (A), MI12417/(TM3,Sb) (B), GABA-B-R1::EGFP/(SM6a) (C), CS (D), and Tdc2-
GAL4/+; UAS-mCD8::GFP/+ (E). Blue is anti-Dlg and green is polyclonal rabbit anti-GFP 





Figure 4.10. EGFP-tagged receptors could be labelled using polyclonal chicken anti-GFP. 
Single confocal optical sections of the calyx from larvae of the following genotypes: 
OAMB::EGFP (A), MI12417/(TM3,Sb) (B), GABA-B-R1::EGFP/(SM6a) (C), CS (D), and Tdc2-
GAL4/+; UAS-mCD8::GFP/+ (E). Blue is anti-Dlg and green is polyclonal chicken anti-GFP 





Figure 4.11. OAMB::EGFP localised to many but not all MB calyx glomeruli. Single 
confocal optical sections of the calyx from three OAMB::EGFP individuals (A-F), with MI12417 
parental line negative controls (G-L). Green is OAMB::EGFP and blue is anti-Dlg. 
OAMB::EGFP-negative calyx glomeruli are indicated with empty arrowheads. OAMB::EGFP-




glomeruli (Masuda-Nakagawa et al., 2005), I estimated that around 6 (n=11) 
calyx glomeruli did not contain EGFP (Table 4.2). This suggested that 
OAMB::EGFP was present in around 28 calyx glomeruli – 80% of the total 
number of glomeruli.  
The calyx glomeruli that did not contain OAMB::EGFP (Fig. 4.11, empty 
arrowheads; Table 4.2) varied in position, but often included an anterior 
glomerulus (n=4; Fig. 4.11A,C), 1-2 lateral glomeruli (n=9; Fig. 4.11B,D) and 
several ventral glomeruli (n=11; Fig. 4.11E-F). As olfactory PNs innervate calyx 
glomeruli stereotypically (Masuda-Nakagawa et al., 2009), I expected that the 
glomerular localisation of OAMB::EGFP will also be stereotyped. Therefore, this 
variation is most likely caused by the difficulty of precisely orienting the fly larval 
calyx for imaging and the subsequent quantification of the number of glomeruli. 
Most of the OAMB::EGFP-positive glomeruli are likely to be innervated 
by olfactory PNs, which are responsible for innervating around two-thirds of all 
the calyx glomeruli (Masuda-Nakagawa et al., 2005). This will be validated 
using a PN marker in Section 4.2.5. The neurons that innervate the remaining 
one-third of calyx glomeruli have not yet been characterised. They are most 
likely to be multiglomerular PNs – PNs which innervate more than one AL 
glomerulus, three of which innervate the L1 calyx (Berck et al., 2016); or non-
olfactory PNs, such as thermosensory and photosensory PNs that send inputs 
to KCs, but whose calyx innervation patterns are unknown (Eichler et al., 2017). 
Therefore, OAMB::EGFP localisation may be associated with the neuronal type 
innervating calyx glomeruli – probably mainly olfactory PNs, but may also 
include PNs of specific modalities.  
There may also be some calyx glomeruli at the L3 stage that are not yet 
innervated by any larval PNs; but are innervated by later-born adult PNs. This is 
possible as some adult-specific PNs that have not yet developed processes are 
already present in third instar larvae (Das et al., 2013). It would not be 
necessary for OAMB to localise to calyx glomeruli that are not innervated by 
any neurons. Hence, the possible lack of PN innervation may explain why some 
calyx glomeruli are OAMB::EGFP-negative; and possibly why this number is 






Positions of OAMB-negative glomeruli 
Individual 1 5 1 dorsoposterior, 3 anterior, 1 ventrolateral 
Individual 2 6 1 anterior, 1 lateral, 4 ventral 
Individual 3 5 1 lateral, 4 ventral 
Individual 4 7 1 anterior, 1 lateral, 5 ventral 
Individual 5 7 1 posteromedial, 2 lateral, 4 lateral 
Individual 6 5 1 lateral, 1 anterior, 3 ventral 
Individual 7 7 1 anterior, 2 lateral, 4 ventral 
Individual 8 5 5 ventral 
Individual 9 7 1 lateral, 6 ventral 
Individual 10 7 1 dorsoposterior, 1 lateral, 5 ventral 
Individual 11 5 1 lateral, 4 ventral 
Table 4.2. Estimated numbers and positions of OAMB::EGFP-negative calyx glomeruli in 
OAMB::EGFP brains.   
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 I also observed tracts in the inter-glomerular region (Fig. 4.11A-C, 
arrows). These tracts entered the calyx medially (Fig. 4.11E-F, arrows) and 
terminated in calyx glomeruli; resembling the inner antennocerebral tracts 
(iACT) described in Masuda-Nakagawa et al. (2005) in which PNs innervate the 
MB calyx.  
 
4.2.5. OAMB::EGFP was expressed in olfactory projection neurons 
OAMB::EGFP signal in calyx glomeruli and medial tracts entering the calyx 
matched the axonal innervation pattern of calyx glomeruli by PNs via the iACT 
(Masuda-Nakagawa et al., 2005). To establish whether OAMB was expressed 
in PNs, I examined whether OAMB::EGFP signal colocalised with PNs labelled 
by NP225-GAL4 (Tanaka et al., 2004; Masuda-Nakagawa et al., 2005) in the 
larval calyx and AL.  
 OAMB::EGFP signal was observed in all calyx glomeruli expressing 
NP225-GAL4 (n=7; Fig. 4.12, arrows; Table 4.3). OAMB::EGFP further localised 
to 8 ± 0.7 NP225-negative calyx glomeruli identified using anti-Dlg staining (Fig. 
4.12, arrowheads; Table 4.3). This suggested that OAMB::EGFP localised to 
the presynaptic terminals of all the olfactory PNs labelled by NP225-GAL4, as 
well as to the terminals of neurons that innervated calyx glomeruli but were not 
labelled by NP225-GAL4.  
 OAMB::EGFP was also found in all AL glomeruli and in inter-glomerular 
regions of the AL (n=5; Fig. 4.13A-F; Table 4.4). This suggested that 
OAMB::EGFP may also localise to PN dendrites innervating AL glomeruli, as 
well as other neurons innervating the inter-glomerular regions of the AL.  
To confirm OAMB expression in PNs, I examined whether larval olfactory 
PN cell bodies were positive for OAMB::EGFP. It has been previously observed 
using another larval PN driver line, GH146-GAL4, that PN cell bodies are 
located dorso-anteriorally to the larval AL (Ramaekers et al., 2005). In addition 
to larger dorsoanterior cell bodies of primary PNs innervating the AL, GH146-
GAL4 also labelled smaller cell bodies of secondary adult-specific PNs which 
did not innervate neuropils at the larval stage, as well as non-PN cell bodies 






Figure 4.12. OAMB::EGFP colocalised with PN terminals labelled by NP225-GAL4 in calyx 
glomeruli. Single confocal optical sections of the calyx of NP225-GAL4/UAS-mCD8::RFP; 
OAMB::EGFP (A-C) and negative control NP225-GAL4/UAS-mCD8::RFP; TM6B/MKRS (D-F). 
Green is OAMB::EGFP, red is mCD8::RFP driven by PN driver NP225-GAL4 and blue is anti-
Dlg. Arrowheads indicate glomeruli or cell bodies positive for OAMB::EGFP but not NP225, and 
arrows indicate OAMB::EGFP and NP225>RFP colocalisation. Medial (M) is right, posterior (P) 
is up. Scale bar: 20 μm.  
106 
 











Individual 1 30 25 25 5 0 6 36
Individual 2 29 19 19 10 0 6 35
Individual 3 30 23 23 7 0 5 35
Individual 4 32 24 24 8 0 5 37
Individual 5 30 20 20 10 0 5 35
Individual 6 31 22 22 9 0 3 34
Individual 7 29 23 23 6 0 5 34
N 7 7 7 7 7 7 7
Mean 30 22 22 8 0 5 35
S.D. 1.1 2.1 2.1 2.0 0.0 1.0 1.1






Table 4.3. Numbers of calyx glomeruli positive for OAMB::EGFP and NP225-GAL4. 
Abbreviations: OAMB+, OAMB::EGFP-positive; OAMB-, OAMB::EGFP-negative; NP225+, 
NP225>RFP-positive; NP225-, NP225>RFP-negative; Total, number of calyx glomeruli 
observed with neuropil marker anti-Dlg; N, number; S.D., standard deviation; S.E.M., standard 





Figure 4.13. OAMB::EGFP colocalised with PN cell bodies and dendrites labelled by 
NP225-GAL4. Confocal optical sections of NP225-GAL4/UAS-mCD8::RFP; OAMB::EGFP (A-
C,G) and negative control NP225-GAL4/UAS-mCD8::RFP; TM6B/MKRS (D-F,H). Green is 
OAMB::EGFP, red is NP225>RFP and blue is anti-Dlg. (A-F) are confocal optical sections of the 
AL. (G-H) are confocal optical sections taken immediately anterior to the AL. Arrows indicate 
OAMB-NP225 colocalisation. Filled arrowheads indicate cell bodies positive for NP225 only, 
while empty arrowheads indicate cell bodies positive for OAMB::EGFP only. Medial (M) is right, 










Individual 1 0 3 22
Individual 2 0 5 21
Individual 3 0 2 21
Individual 4 0 4 20
Individual 5 0 4 20
N 5 5 5
Mean 0 4 21
S.D. 0.0 1.1 0.8




Table 4.4. Numbers of AL glomeruli and NP225-GAL4 cell bodies positive for 
OAMB::EGFP. Abbreviations: OAMB+, OAMB::EGFP-positive; OAMB-, OAMB::EGFP-
negative; NP225+, NP225>RFP-positive; NP225-, NP225>RFP-negative; N, number; S.D., 
standard deviation; S.E.M., standard error of the mean. 
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GAL4 labels 19 AL glomeruli (Masuda-Nakagawa et al., 2009), it is expected to 
label around 19 PNs. A similar number of PNs was expected to be labelled in 
NP225-GAL4, as both PN drivers label 23 calyx glomeruli (Masuda-Nakagawa 
et al., 2005, 2009). 
Similar to GH146-GAL4, NP225-GAL4 labelled two morphologically 
distinct types of cell bodies near the AL. The large (8-10 μm in diameter) 
strongly-labelled cell bodies that sent tracts to the AL, which were likely to be 
primary larval PNs, often colocalised with OAMB::EGFP (Figure. 4.13G; 
arrows). On the other hand, the smaller (4-5 μm in diameter) and weakly-
labelled cell bodies which did not extend tracts were likely to be secondary PNs; 
and did not colocalise with OAMB::EGFP (Fig. 4.13G-H; filled arrowheads). This 
suggested that OAMB::EGFP was probably expressed in primary larval PNs but 
not secondary adult-specific PNs in the larval brain. 
21 ± 0.4 NP225-positive cell bodies near the AL colocalised with 
OAMB::EGFP (n=5; Fig. 4.13G, arrows; Table 4.4). On the other hand, 4 ± 0.5 
AL glomeruli were not labelled by NP225-GAL4 (n=5; Table 4.4). As each PN 
innervates a single AL glomerulus, and there are 21 AL glomeruli in total, this 
suggested that around 17 PNs are labelled by NP225-GAL4. This further 
suggested that around 17 of the 21 cell bodies positive for both NP225 and 
OAMB::EGFP were likely to be primary larval PN cell bodies. The remaining cell 
bodies are likely to be AL interneurons also labelled by NP225-GAL4.  
As the OAMB::EGFP signal was strong in calyx glomeruli, it might have 
obscured OAMB::EGFP localisation to the terminals of other neurons besides 
PN axons, such as in KC dendrites. To confirm OAMB::EGFP localisation to the 
presynaptic terminals of PNs, and to determine whether this localisation 
obscured OAMB::EGFP localisation to other neurons, I selectively knocked 
down OAMB::EGFP using EGFP-shRNA.3 (Neumüller et al., 2012) in PNs 
labelled by NP225-GAL4. In NP225>EGFP-shRNA knockdown calyces, 6 ± 0.5 
calyx glomeruli were positive for OAMB::EGFP, compared to 31 ± 0.6 
OAMB::EGFP-positive glomeruli in non-knockdown controls (n=4; Fig. 4.14; 
Table 4.5). This was consistent with the predicted number of calyx glomeruli for 
a complete knockdown of OAMB::EGFP by NP225-GAL4>EGFP-shRNA based 
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Figure 4.14. OAMB::EGFP signal selectively knocked down in calyx glomeruli labelled by 
NP225-GAL4. Confocal optical sections of the calyx of NP225-GAL4/+; 
OAMB::EGFP/VALIUM20-EGFP-shRNA.3 (A-C,G,I), and non-knockdown control NP225-
GAL4/+; OAMB::EGFP/VALIUM10-Luciferase (D-F,H,J). Green is OAMB::EGFP, blue is anti-
Dlg. Filled arrowheads indicate OAMB::EGFP-positive calyx glomeruli in knockdown brains. 






Individual Knockdown Genotype OAMB+ OAMB- Total Control Genotype OAMB+ OAMB- Total
Individual 1 7 28 35 31 4 35
Individual 2 5 31 36 31 5 36
Individual 3 7 29 36 32 4 36
Individual 4 6 30 36 29 7 36
N 4 4 4 N 4 4 4
Mean 6 30 36 Mean 31 5 36
S.D. 1.0 1.3 0.5 S.D. 1.3 1.4 0.5









Table 4.5. Numbers of OAMB::EGFP-positive calyx glomeruli in NP225-GAL4>EGFP-
shRNA knockdown brains compared to non-knockdown controls. Abbreviations as Table 
4.3.  
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on the numbers of calyx glomeruli that were positive for OAMB::EGFP and 
NP225-GAL4 (Table 4.3). Therefore, this confirmed OAMB localised to the 
presynaptic terminals in the calyx of the majority of olfactory PNs.   
 In calyx glomeruli where OAMB::EGFP protein was knocked down by 
NP225>EGFP-shRNA, I did not observe any residual OAMB::EGFP signal (Fig. 
4.14). This suggested that OAMB::EGFP was only expressed in olfactory PNs 
labelled by NP225-GAL4 and not in other neuronal types innervating these 
particular glomeruli.  
OAMB::EGFP signal in NP225>EGFP-shRNA knockdown ALs (n=4; Fig. 
4.15A-B; Table 4.6) also appeared to be weaker than the non-knockdown 
controls (n=3; Fig. 4.15C-D; Table 4.6). This suggested that OAMB::EGFP 
localised to PN dendrites in the AL. The residual OAMB::EGFP signal observed 
in the AL was more likely due to OAMB::EGFP localisation to non-NP225 
neurons innervating the AL, rather than the efficacy of the EGFP-shRNA 
construct, as complete loss of OAMB::EGFP signal in knockdown larvae was 
observed in calyx glomeruli.  
 
4.2.6. OAMB::EGFP did not localise to KCs in the calyx 
As OAMB::EGFP was consistently absent in 5-6 calyx glomeruli (Table 4.2, 
4.3), and there was no residual signal in NP225-calyx glomeruli where 
OAMB::EGFP was knocked down (Fig. 4.14); it was unlikely that OAMB 
localised to KC dendrites, which randomly arborise throughout calyx glomeruli 
(Masuda-Nakagawa et al., 2005).  
To reconcile OAMB expression in adult KCs with the expected 
conservation of OAMB expression in larval KCs, I examined whether 
OAMB::EGFP was instead localised to the cell bodies or axons of larval KCs. 
Larval KC cell bodies are around 3-5 μm in diameter and are located dorsal to 
the calyx (Fig. 4.16A). OAMB::EGFP signal was observed in cell bodies that 
met these criteria in four out of eleven brains (Fig. 4.16B). The remaining seven 
brains only labelled cell bodies >5 μm in diameter which were too large to be 
KC cell bodies (Fig. 4.16C, empty arrowheads). Therefore, it was inconclusive 
as to whether KC cell bodies showed OAMB localisation. On the other hand, 





Figure 4.15. OAMB::EGFP signal partially knocked down in PN dendrites labelled by 
NP225-GAL4. Confocal optical sections of the AL of NP225-GAL4/+; OAMB::EGFP/VALIUM20-
EGFP-shRNA.3 (A-B), and non-knockdown control NP225-GAL4/+; OAMB::EGFP/VALIUM10-
Luciferase (C-D). Green is OAMB::EGFP, blue is anti-Dlg. Medial (M) is right, dorsal (D) is up. 












Individual 1 10.05 27.12 37%
Individual 2 4.67 N/A N/A
Individual 3 4.11 7.96 52%







Table 4.6. Mean OAMB::EGFP intensity in NP225>EGFP-shRNA knockdown ALs 
compared to non-knockdown controls. Mean intensity is the calculated average of three 
mean grey values (ImageJ) of the AL taken at the mid-AL confocal optical slice and 10 confocal 
optical slices above and below it. % knockdown/non-knockdown = (mean intensity in 
knockdown brain)/(mean intensity in non-knockdown brain)*100%.  
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Figure 4.16. OAMB::EGFP localised to KC cell bodies in some but not all brains. Confocal 
optical sections taken immediately dorsal to the calyx, where KC cell bodies (CB) are located: 
H406-IT.GAL4/UAS-mCD8::GFP (green) as a KC cell bodies reference image (A); two 
OAMB::EGFP (green) individuals (B-C), with corresponding MI12417 negative controls (D-E). 
Blue is anti-Dlg. Non-KC cell bodies indicated with empty arrowheads. Medial (M) is right, 
posterior (P) is up. Scale bar: 20 μm.  
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the larval MB (n=7; Fig. 4.17), regardless of whether OAMB::EGFP signal 
localised to KC cell bodies (Fig. 4.16B-C). This suggested that OAMB may be 
localised to KC axons in the MB lobes, even though it did not localise to KC 
dendrites in the MB calyx.  
 
4.2.7. OAMB::EGFP was not expressed in the GABAergic APL neuron 
To determine whether OAMB was expressed in the GABAergic APL neuron, I 
visualised the colocalisation of OAMB::EGFP with anti-GABA, which labels all 
the presynaptic GABA boutons of the APL neuron – the only GABAergic neuron 
innervating the MB calyx (Masuda-Nakagawa et al., 2014). OAMB::EGFP-
positive boutons in the calyx did not overlap with GABA-positive boutons (n=4; 
Fig. 4.18A-B, empty arrowheads). This suggested that OAMB did not localise to 
the presynaptic terminals of the APL neuron where GABA neurotransmitter is 
released.   
 The lack of colocalisation of OAMB::EGFP and the APL neuron marker 
NP732-GAL4 (Masuda-Nakagawa et al., 2014) in the calyx (n=3; Fig. 4.18C-D, 
empty arrowheads), further suggested that OAMB did not localise to any APL 
neuronal processes in the calyx. This was consistent with the previous 
observation that EGFP-shRNA knockdown of OAMB::EGFP in PNs did not 
reveal additional extra-glomerular OAMB::EGFP localisation (Fig. 4.14) 
characteristic of APL innervation in the calyx (Fig. 4.18C).  
 Moreover, the APL cell body identified from its innervation of the calyx 
and MB lobes did not express OAMB::EGFP (n=3; Fig. 4.19); further suggesting 
that the APL neuron did not express OAMB.  
 
4.2.8. OAMB::EGFP did not localise to Odd-like neurons in the calyx 
To determine whether OAMB was expressed in Odd-like neurons, I examined 
OAMB colocalisation with OK263-GAL4 (M.T., Part II Report 2015; L. Masuda-
Nakagawa, personal communication). This line labelled a cluster of cell bodies 
located dorsal-posterior to the calyx, including calyx-innervating Odd-like 
neurons (Fig. 4.20A). OAMB::EGFP signal was observed in two OK263-positive 





Figure 4.17. OAMB::EGFP localised to MB lobes. Confocal optical sections of the MB lobes 
of OAMB::EGFP (A-B) with corresponding MI12417 negative controls (C-D) from the same 
individuals in Fig. 4.16. Green is OAMB::EGFP and blue is anti-Dlg. Medial (M) is right, 
posterior (P) is up. Scale bar: 20 μm. Abbreviations: VL, MB vertical lobe; ML, MB medial lobe.  
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Figure 4.18. OAMB::EGFP did not colocalise with APL terminals in the calyx. (A-B) 
Confocal optical sections of the calyx of OAMB::EGFP (green), with anti-GABA (red) and anti-
Dlg (blue) labelling. (B) Enlarged from dotted square in (A). OAMB::EGFP puncta (empty 
arrowheads) did not overlap with GABA boutons (filled arrowheads). (C-D) Confocal optical 
section of the calyx of NP732-GAL4; UAS-mCD8::RFP/+; OAMB::EGFP/+. Green is 
OAMB::EGFP, red is NP732>RFP and blue is anti-Dlg. (D) Enlarged from dotted square in (C). 
OAMB::EGFP puncta (empty arrowheads) did not overlap with NP732 processes (filled 




Figure 4.19. OAMB::EGFP did not colocalise with APL cell body. Confocal projections of 
the frontal brain lobe of NP732-GAL4; UAS-mCD8::RFP/+; OAMB::EGFP/+ (A-B) and negative 
control NP732-GAL4; UAS-mCD8::RFP/+; MKRS/TM6B (C-D). Green is OAMB::EGFP, red is 
NP732>RFP and blue is anti-Dlg. Asterisks indicate the APL cell body and arrowheads indicate 
the APL tract. (B) and (D) are confocal projections of the APL cell body taken from the dotted 
boxes in (A) and (C) respectively. Medial (M) is right, dorsal (D) is up. Abbreviations: VL, 
vertical lobe; ML, medial lobe; CB, cell body. Scale bar: 20 μm. 
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Figure 4.20. OAMB::EGFP colocalised with two cell bodies labelled by OK263-GAL4. 
Confocal projection (A) and two confocal optical sections (B-E) of the dorsal brain lobe of 
OK263-GAL4/UAS-mCD8::RFP; OAMB::EGFP/+. OAMB::EGFP is green, OK263>RFP is red 
and anti-Dlg is blue. Arrows indicate colocalisation of OAMB::EGFP and OK263>RFP. (C,E) are 
enlarged from the dotted squares in (B,D). Dotted squares in (A,B,D) show the same region at 
different confocal optical slices. Medial (M) is right, posterior (P) is up. Abbreviations: CB, cell 
bodies. Scale bar: 20 μm in (A,B,D); 10 μm in (C,E). 
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However, as the tracts of these cell bodies merged together to form a single 
tract at the lateral edge of the pedunculus before entering the calyx (Fig. 4.20A), 
it was not possible to distinguish whether these OAMB-OK263-positive cell 
bodies projected to the calyx. 
On the other hand, there was no overlap between OAMB::EGFP with 
OK263 dendrites in the calyx labelled by OK263-GAL4 (n=2; Fig. 4.21A). This 
was again corroborated by the lack of extra-glomerular OAMB::EGFP signal 
characteristic of Odd-like innervation in calyces (Fig. 4.20A, 4.21A)  in which 
OAMB::EGFP had been knocked down in PNs (Fig. 4.14). This suggested that 
OAMB did not localise to Odd-like dendrites in the calyx.  
Furthermore, OAMB::EGFP signal did not localise to Odd-like axons 
innervating the neuropil around the medial lobe of the MB (n=2; Fig. 4.21B). As 
OAMB::EGFP did not localise to Odd-like processes in the calyx or MB lobes, 
the OK263-GAL4 cell bodies expressing OAMB::EGFP signal probably did not 
belong to the calyx-innervating Odd-like neurons.  
 
4.2.9. Testing RNAi lines for OAMB knockdown in PNs 
To investigate the function of OAMB in PNs, it is necessary to be able to 
manipulate OAMB activity on specific neurons. One of the methods for tissue-
specific knockdown OAMB function is through the use of RNAi. GFP-RNAi was 
previously used against OAMB::EGFP to show OAMB localisation to PN 
terminals in calyx glomeruli (Fig. 4.14). However, this method cannot be used to 
test OAMB function in PNs as the OAMB::EGFP fusion protein may itself be 
non-functional. Moreover, any non-EGFP-tagged OAMB proteins produced in a 
heterozygous animal will not be knocked down. Therefore, it was necessary to 
use UAS-OAMB-RNAi lines which targeted OAMB transcripts rather than EGFP 
sequences. 
There are four UAS-OAMB-RNAi lines that have been previously used in 
the literature: Stocks v2861 and v106511 from the Vienna Stock Center; and 
stocks UAS-OAMB-dsRNA (B31233) and UAS-OAMB-dsRNA (B31171) from 
the Bloomington Drosophila Stock Center (Burke et al., 2012; Wu et al., 2013; 
Luo et al., 2014; Deady and Sun, 2015). All four of these lines encode dsRNA 
against fragments of the OAMB transcript. The efficacy of these lines have been  
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Figure 4.21. OAMB::EGFP did not colocalise with Odd-like neuronal processes. (A-B) 
OK263-GAL4/UAS-mCD8::RFP; OAMB::EGFP/+ in MB calyx (A) and lobes (B). OAMB::EGFP 
is green, OK263>RFP is red and anti-Dlg is blue. Medial (M) is right; posterior (P) is up for (A) 
and dorsal (D) is up for (B). Abbreviations: VL, vertical lobe; ML, medial lobe. Scale bar: 20 μm. 
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compared in the context of ovulation phenotypes in Deady and Sun (2015), in 
which v2861 showed the strongest phenotypes, followed by v106511, B31233 
and finally B31171.  
 To select the strongest OAMB RNAi line to study the function of OAMB 
expression on PNs, I used OAMB::EGFP intensity in calyx glomeruli as a 
quantifiable indicator for OAMB knockdown levels for three UAS-OAMB-RNAi 
lines: v2861, v106511 and B31233. Using the ImageJ software, I measured the 
mean grey value of the GFP channel in calyx glomeruli marked as a region of 
interest. I was not able to differentiate between glomeruli based on whether they 
contained OAMB::EGFP originally or whether they expressed NP225-GAL4, 
and therefore chose to measure the intensity from all glomeruli marked with 
anti-Dlg for each confocal optical slice (Fig. 4.22, yellow dotted line). I took 
measurements from every fourth optical slice of the calyx for a total of 10 or 11 
optical slices – which I then averaged to produce a mean intensity value. I then 
generated a knockdown percentage by comparing the mean intensity value for 
NP225>OAMB-RNAi knockdown brains with their non-knockdown controls.  
I established a baseline reference using the NP225>EGFP-shRNA 
knockdown, because this line resulted in the strong knockdown of 
OAMB::EGFP signal in many calyx glomeruli, such that there were visibly less 
calyx glomeruli that contained OAMB::EGFP (Fig. 4.14; Table 4.5). Therefore, 
this served as a benchmark for near-complete knockdown of OAMB::EGFP 
signal. Table 4.7 shows the OAMB::EGFP intensity values for brains labelled 
with preincubated chicken anti-GFP – which were the antibody conditions used 
for v2861 and v106511 knockdown experiments. Table 4.8 shows the 
OAMB::EGFP intensity values for brains labelled with non-preincuabted chicken 
anti-GFP, matching the antibody conditions for the B31233 knockdown 
experiment.  
Although I used the same batch of antibodies and similar confocal 
conditions for the experimental and control individuals, they were not placed in 
the same tube during the immunolabelling process. Therefore, I also measured 
the intensity level of anti-Dlg labelling to serve as an internal control for variation 
between immunolabelling tubes as well as different individuals in the same 
tube. The average OAMB::EGFP intensity in NP225>EGFP-shRNA brains was 
around 20% to that of their corresponding non-knockdown NP225>Luciferase  
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Figure 4.22. Quantification of OAMB::EGFP knockdown in calyx glomeruli. Confocal 
optical section of the calyx of NP225-GAL4/+; OAMB::EGFP/VALIUM20-EGFP.shRNA.3 (A) 
and non-knockdown control NP225-GAL4/+; OAMB::EGFP/VALIUM10-Luciferase (B). 
OAMB::EGFP is green, anti-Dlg is blue. Yellow dotted lines mark region of interest for 










Table 4.7. Mean OAMB::EGFP intensity in NP225>EGFP-shRNA brains (chicken anti-GFP, 
preincubated) compared to non-knockdown controls. Reference knockdown with similar 
antibody conditions for NP225>v2861 and NP225>v106511 knockdowns. Mean intensity is the 
average of 10 or 11 mean grey values (ImageJ) taken at every four confocal optical slices of the 
calyx where the mid-calyx is set as the middle confocal optical slice. Calyx glomeruli were 
selected as the region of interest. % knockdown/non-knockdown = (mean intensity in 
knockdown brain)/(mean intensity in non-knockdown brain)*100%. Abbreviations: N, number; 
S.D., standard deviation; S.E.M., standard error of the mean.  
 
Table 4.8. Mean OAMB::EGFP intensity in NP225>EGFP-shRNA brains (chicken anti-GFP, 
non-preincubated) compared to non-knockdown controls. Reference knockdown with 
similar antibody conditions for NP225>B31233 knockdown. Calculations and abbreviations as 
Table 4.7.  
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controls (n=8; Table 4.7, 4.8). On the other hand, the average anti-Dlg intensity 
in NP225>EGFP-shRNA brains was around 100% of their non-knockdown 
controls (Table 4.7, 4.8). This suggested that there was GFP knockdown in the 
experimental brains.   
 I did not observe detectable OAMB::EGFP knockdown in the calyx 
glomeruli of NP225>v2861 brains (n=3; Fig. 4.23). Knockdown brains showed a 
mean OAMB::EGFP intensity of 11.3 ± 1.1 compared to 14.5 ± 1.9 in non-
knockdown controls – that is, knockdown brains showed around 80% 
OAMB::EGFP signal of non-knockdown controls (n=3; Table 4.9). Individual 2 
showed around 50% intensity compared to the corresponding non-knockdown 
control. However, after pooling the controls which were imaged at the same 
conditions, this individual was only around 65% of the averaged intensity of the 
non-knockdown control. Moreover, the percentage of experimental-to-control 
GFP intensity corresponded with that of anti-Dlg intensity (Table 4.9). 
Therefore, the difference in GFP intensity between experimental and control 
calyces were likely to be artefacts due to the individual variation in labelling.     
 As the v106511 OAMB-RNAi line was maintained over the CyO 
balancer, I was not able to pre-screen NP225>v106511 from CyO larvae in this 
experiment. Thus, only half of the progeny larvae dissected were expected to 
contain the NP225>v106511 knockdown genotype. Three out of four 
NP225>v106511 or CyO brains did not show visibly lower OAMB::EGFP signals 
compared to the non-knockdown control (Fig. 4.24A-F). The remaining 
NP225>v106511 or CyO brain showed visibly lower OAMB::EGFP signals in 
calyx glomeruli than the non-knockdown controls (Fig. 4.24G-L). This was 
reflected in the OAMB::EGFP intensity values, where individual 3 showed a 
much lower mean intensity (5.6) than the other 3 individuals, and showed 
around 50% lower signal than the average of the non-knockdown controls 
(Table 4.10). The difference in GFP intensity between experimental and control 
was also much greater (47%) than the corresponding difference in anti-Dlg 
intensity (85%) (Table 4.10) – suggesting that the knockdown genotype, rather 
than labelling variability, was responsible for the decrease in GFP signal. This 
further suggested that from the four individuals, only individual 3 had the 
NP225>v106511 knockdown genotype; and that NP225>v106511 showed  
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Figure 4.23. No detectable OAMB::EGFP knock down in calyx glomeruli of NP225>v2861 
brains. Confocal optical sections of the calyx from three NP225-GAL4/UAS-OAMB-RNAi 
(v2861); OAMB::EGFP/+ individuals (A-C,G,I), with non-knockdown control NP225-GAL4/+; 
OAMB::EGFP/VALIUM10-Luciferase (D-F,H,J). Green is OAMB::EGFP, blue is anti-Dlg. Medial 







Table 4.9. Mean OAMB::EGFP intensity in NP225>v2861 brains compared to non-
knockdown controls. Calculations and abbreviations as Table 4.7.  
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Figure 4.24. Variable levels of OAMB::EGFP knock down in calyx glomeruli of 
NP225>v106511 brains. Confocal optical sections of the calyx from two NP225-GAL4/UAS-
OAMB-RNAi (v106511); OAMB::EGFP/+ individuals (A-C,G-I) and non-knockdown control 
NP225-GAL4/+; OAMB::EGFP/VALIUM10-Luciferase (D-F,J-L). Individual 1 (A-C) did not show 
observable OAMB::EGFP knockdown, while individual 3 (G-I) showed partial OAMB::EGFP 
knockdown. Green is OAMB::EGFP, blue is anti-Dlg. Medial (M) is right and posterior (P) is up. 
Scale bar: 20 μm.  
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Table 4.10. Mean OAMB::EGFP intensity in NP225>v106511 brains compared to non-
knockdown controls. Individual 3 may show partial knockdown (indicated in yellow in table; 
Fig. 4.24G-I). Calculations and abbreviations as Table 4.7.  
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partial knockdown of the OAMB::EGFP protein. However, more samples are 
required to confirm this result.  
Finally, all of the NP225>B31233 brains showed a comparable level of 
mean OAMB::EGFP intensities at 26.1 ± 5.0 to their corresponding non-
knockdown controls at 20.5 ± 2.3 (n=5; Fig. 4.25; Table 4.11). As their anti-Dlg 
intensity levels were also comparable, this suggested that the B31233 line did 
not have a clear effect on knocking down OAMB proteins. 
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Figure 4.25. No observable OAMB::EGFP knock down in calyx glomeruli of 
NP225>B31233 brains. Confocal optical sections of the calyx from three NP225-GAL4/+; 
OAMB::EGFP/UAS-OAMB-dsRNA (B31233) individuals (A-C,G,I), with non-knockdown control 
NP225-GAL4/+; OAMB::EGFP/VALIUM10-Luciferase (D-F,H,J). Green is OAMB::EGFP, blue is 





Table 4.11. Mean OAMB::EGFP intensity in NP225>B31233 brains compared to non-
knockdown controls. Calculations and abbreviations as Table 4.7.  
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4.3. Discussion  
Using a novel OAMB protein trap line, I have shown that the OAMB::EGFP 
fusion protein localised to the Drosophila larval MB calyx. This was consistent 
with OAMB-GAL4 expression in the larval MB calyx (El-Kholy et al., 2015) – the 
only published study that investigated OAMB localisation in the larval brain. 
Although this suggested that OAMB-GAL4 was expressed in some calyx-
innervating neurons, unlike OAMB::EGFP fusion proteins, OAMB-GAL4 cannot 
show whether OAMB localised to the calyx terminals of these neurons. 
Furthermore, while OAMB-GAL4 is generated by OAMB promoter region fusion 
to GAL4 sequences; EGFP is inserted within OAMB coding sequences in the 
OAMB::EGFP fusion protein, and hence subjected to endogenous regulation of 
OAMB expression. This suggests that OAMB::EGFP is theoretically more 
accurate for reflecting OAMB localisation patterns than OAMB-GAL4 lines, and 
thus provide stronger evidence for OAMB localisation to larval calyx terminals.  
OAMB::EGFP localisation in the larval calyx is also conserved with 
OAMB localisation to the adult Drosophila MB calyx (Han et al., 1998), and the 
homologue AmOA1 in the honeybee localising to the olfactory input region of 
the honeybee calyx (Sinakevitch et al., 2011), identified using antibody staining. 
However, the Drosophila OAMB antibody signal was weak and non-specific 
based on published images of the adult fly brain (Kim et al., 2013). This was 
also the case when anti-AmOA1 was used to visualise OAMB localisation in the 
Drosophila adult and larval brains (Sinakevitch et al., 2013; H.W., unpublished 
observations); although this was probably because an AmOA1 peptide 
sequence that did not perfectly match its homologous OAMB sequence was 
used to generate the antibody (Sinakevitch et al., 2011). As there are no other 
antibodies available, this suggests that it may be difficult to produce strong and 
specific OAMB antibodies.  
 Similar to anti-OAMB, there were also difficulties in visualising 
OAMB::EGFP, which was eventually overcome by optimising the 
immunolabelling protocol. This is one of the advantages of using a fusion 
protein instead of antibodies, as its signal can be amplified by anti-GFP. 
OAMB::EGFP signal in homozygous larvae can also be detected in non-fixed 
brains for live imaging, which is not possible when antibodies are used. On the 
other hand, anti-OAMB would not interfere with OAMB receptor expression, and 
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therefore less likely to affect normal OAMB function and localisation compared 
to the OAMB::EGFP fusion. Moreover, as anti-OAMB is not genetically 
encoded, it is not necessary to construct new fly lines to validate OAMB 
colocalisation with calyx-innervating neurons.  
Nevertheless, conserved OAMB localisation to insect MB calyces 
suggests that OAMB is involved in mediating OA modulation of inputs to MB 
neurons.  
  
4.3.1. OAMB localisation to PNs but not to APL or Odd-like neurons  
From the three putative postsynaptic partners of sVUM1 neurons, I have shown 
that OAMB is expressed in PNs but not in the APL neuron or the calyx terminals 
of Odd-like neurons (Fig. 4.26). OAMB localisation to the calyx terminals of PNs 
suggests that PNs are able to receive OA signalling from sVUM1 neurons in the 
larval MB calyx, which supports the GRASP connectivity data (Chapter 3). On 
the other hand, the APL neuron and Odd-like neurons may express other OA 
receptors in order to respond to sVUM1 signalling (Chapters 5 & 6). It is also 
possible that the APL neuron may be modulating sVUM1 neurons in the calyx 
unidirectionally and therefore would not express any OA receptors.  
This is the first report of OAMB expression in PNs in Drosophila; 
although it remains consistent with the unpublished result mentioned in Kim et 
al. (2013) that OAMB localised to non-KC extrinsic neurons in the adult MB 
calyx. Unlike OAMB, the honeybee α1-adrenergic-like receptor AmOA1 is 
localised to GABAergic PCT feedback neurons (analogous to larval APL 
neurons), but not to uniglomerular PNs (analogous to larval PNs), in the 
honeybee calyx (Sinakevitch et al., 2013). Therefore, should OAMB and 
AmOA1 activation have similar downstream effects on excitatory PNs and 
inhibitory feedback neurons respectively, it would result in opposite effects on 
the olfactory inputs to the fly larval calyx versus the honeybee calyx. This 
suggests that while OAMB localisation to the MB calyx may be conserved, it 








 4.3.2. OAMB localisation to presynaptic terminals of olfactory PNs 
OAMB::EGFP is localised to around 30 out of 35 larval calyx glomeruli. As the 
NP225-GAL4 line labels olfactory PNs that innervate around 23 larval calyx 
glomeruli (Masuda-Nakagawa et al., 2005), OAMB::EGFP localisation on all 
NP225-GAL4-expressing glomeruli suggests that OAMB is likely to be 
expressed at the calyx terminals of most larval olfactory PNs. The remaining 
OAMB::EGFP-positive glomeruli are probably innervated by the two olfactory 
PNs not labelled by NP225-GAL4 (Masuda-Nakagawa et al., 2009, 2010); as 
well as multiglomerular PNs and/or non-olfactory PNs (Eichler et al., 2017), 
although their larval calyx innervation patterns are not yet known. This suggests 
that OA signalling in the calyx broadly and non-specifically targets a diverse 
group of olfactory PNs, each bringing olfactory input from a single olfactory 
sensory neuron (Masuda-Nakagawa et al., 2005, 2009). This implies the effects 
of OA signalling in the calyx is not restricted to particular odour qualities, but 
instead target many olfactory inputs simultaneously, as well as potentially some 
non-olfactory inputs.  
OAMB::EGFP localisation to larval calyx glomeruli suggests that OAMB 
is localised to the presynaptic terminals of olfactory PNs. This implies that OA 
could modulate olfactory inputs from PNs to KCs presynaptically. A possible 
method for presynaptic modulation is through the control of neurotransmitter 
release from PNs to KCs. For example, presynaptic α1-adrenoceptor 
Figure 4.26. Proposed OAMB localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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expression in the striatum and midbrain regulates dopaminergic transmission 
(Mitrano et al., 2012). α1-adrenoceptor activation has also been shown to 
increase glutamate release and decrease GABAergic input to hypothalamic 
neurons (Chen et al., 2006).  
OAMB increases intracellular Ca2+ concentration in cultured cells (Han et 
al., 1998; Balfanz et al., 2005; Morita et al., 2006). It is possible this could 
enhance calcium-mediated exocytosis of neurotransmitters. For example, OA-
induced increase of intracellular Ca2+ from the Endoplasmic Reticulum (ER) 
together with PKA activity can induce neuropeptide release at the Drosophila 
neuromuscular junction even when extracellular Ca2+ is absent (Shakiryanova 
et al., 2011). As OAMB is thought to be coupled to the Gq pathway, similar to its 
homologue α1-adrenoceptor, OAMB activation may also activate PKC via 
PLC/DAG activation. PKC is required for the presynaptic increase of the 
number of vesicles and probability of release in glutamate neurons of the rat 
medial prefrontal cortex (Luo et al., 2015). In the same system, presynaptic α1-
adrenoceptor activation also activates presynaptic N-type Ca2+ channels, as 
adrenergic enhancement of glutamate release is reduced when these Ca2+ 
channels are blocked (Luo et al., 2015). This suggests that OAMB expression 
on PNs may result in OA-induced intracellular Ca2+ signalling, which then 
increases the release of acetylcholine by PNs on KCs, possibly via PKA or 
PKC-dependent pathways.  
 
4.3.3. Possible OAMB localisation to olfactory PN dendrites 
sVUM1 neurons are the only known OA neurons innervating the larval AL 
(Selcho et al., 2014), where olfactory PN dendrites are also located. As 
OAMB::EGFP signal was partially knocked down in the AL by EGFP-shRNA 
expression in the olfactory PN driver NP225-GAL4, this suggested that 
OAMB::EGFP localised to the olfactory PN dendrites arborising in AL glomeruli, 
as well as to some non-PN neurons innervating the AL. Therefore, olfactory PN 
dendrites and other AL-innervating neurons may also respond to modulation by 
sVUM1 signalling in the AL via OAMB.  
If OAMB localised to olfactory PN dendrites, it would probably increase 
the neuronal excitability of olfactory PNs. OAMB activation increases 
spontaneous spiking in cultured rat cortical neurons (Morita et al., 2006). On the 
138 
other hand, OA reduction of outward hyperpolarising Ca2+-dependent-K+ 
currents in Drosophila pars intercerebralis neurons is blocked in oamb mutants 
(Crocker et al., 2010). This suggests that OAMB expression on PN dendrites 
could reduce hyperpolarisation in PNs and/or increase PN firing; and would 
hence increase olfactory inputs from PNs to the MB.  
 
4.3.4. Possible extrasynaptic localisation of OAMB  
In agreement with the unpublished observation that anti-OAMB signal did not 
localise to KCs in the adult calyx discussed in Kim et al. (2013), OAMB 
receptors did not localise to KC dendrites in the MB calyx. This suggests that 
OAMB does not mediate extrasynaptic signalling from sVUM1 neurons to KCs 
in the larval MB calyx.  
However, OAMB::EGFP signal is detected in the MB lobes and 
occasionally in KC cell bodies. This is consistent with anti-OAMB signal 
observed in the adult MB lobes (Han et al., 1998; Kim et al., 2013) and mRNA 
transcript localisation to KC cell bodies (Han et al., 1998). OAMB::EGFP signal 
in the MB lobes suggests that OAMB could be localised to KC axons in the 
larval MB lobes. This suggests that KC output may be presynaptic targets of OA 
signalling via OAMB. Alternatively, OAMB could be localised to extrinsic 
neurons innervating the larval MB lobes. Regardless, this does not provide 
evidence for extrasynaptic localisation of the OAMB receptor, as it is not known 
whether KCs or MB extrinsic neurons synapse with the OA neuron sVPM4, 
which innervates the MB lobes (Selcho et al., 2014).   
On the other hand, OAMB::EGFP signal on PNs appears to be broader 
than putative sVUM1-PN connections observed through GRASP (Chapter 3). 
While sVUM1-PN GRASP signals localised to the interglomerular region of the 
calyx or at the periphery of calyx glomeruli, OAMB localised to the core and 
periphery of calyx glomeruli as well as the iACT. This suggests that there are 
many sites where PNs could respond to OA signal from sVUM1 neurons in the 
absence of a synaptic connection. Therefore, this supports the hypothesis that 
OA may act synaptically and extrasynaptically in the larval brain. 
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4.3.5. OAMB::EGFP localisation to other calyx-innervating neurons  
In addition to PNs labelled by NP225-GAL4, OAMB::EGFP is observed in 
around five more calyx glomeruli than the total number of glomeruli expected to 
be innervated by all of the olfactory PNs. This implies that OAMB is localised to 
other non-characterised neurons which innervate the remaining calyx glomeruli.  
OAMB may be expressed in multiglomerular olfactory PNs which 
innervate multiple AL glomeruli, three of which project to the calyx in the L1 
brain (Berck et al., 2016), and have been shown by MARCM clonal analysis to 
innervate 1-2 calyx glomeruli in the third instar larvae (Das et al., 2013). While 
the role of multiglomerular PNs in the larval calyx is unclear, there is evidence 
from L1 connectomics data that they are post-synaptic to sVUM1 neurons 
(https://neuronlp.larva.fruitflybrain.org/; Eichler et al., 2017). Therefore, sVUM1 
neurons may modulate multiglomerular PNs via OAMB.  
OAMB may also be expressed in projection neurons which do not follow 
the canonical innervation pattern of olfactory PNs (Masuda-Nakagawa et al., 
2009; Das et al., 2013). An example of non-canonical projection neurons could 
be the S370b neurons described by Angela Wan in her MPhil thesis (2015). 
S370b neurons innervate 1-2 AL glomeruli and 3-4 calyx glomeruli, but their cell 
bodies are located posterior to the AL in the SOG region. They also send a 
medial tract to the AL and a lateral tract to the calyx, rather than following the 
canonical iACT (A.W., MPhil Thesis 2015). As S370b neurons innervate both 
the AL and SOG, the primary olfactory and gustatory centres respectively 
(Colomb et al., 2007), they may be multimodal projection neurons that carry 
both odour and taste inputs to calyx glomeruli. Alternatively, S370b neurons 
may be the larval equivalents to the adult bilateral ventral projection neuron 
(biVPN) that delivers carbon dioxide input to the MB calyx, as they share similar 
morphology and innervation patterns (Bräcker et al., 2013). However, the 
functions of the larval S370b neurons are yet to be characterised. 
Nevertheless, this suggests that some of the OAMB::EGFP-positive 
glomeruli may be innervated by non-olfactory PNs. In the L1 connectomics 
project, around 16 non-olfactory PNs, including thermosensory and 
photosensory PNs, have been identified by being downstream to known first 
order sensory neurons (Eichler et al., 2017). However, it is not clear whether 
and how these non-olfactory PNs innervate calyx glomeruli, especially the one-
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third that are not already innervated by olfactory PNs (Masuda-Nakagawa et al., 
2005). In adult flies, the carbon dioxide biVPN and possibly some gustatory PNs 
innervate the main adult calyx (Bräcker et al., 2013; Kirkhart and Scott, 2015); 
although most non-olfactory inputs appear to innervate the accessory calyces 
instead (Kirkhart and Scott, 2015; Vogt et al., 2016; Yagi et al., 2016). This 
suggests that the L3 calyx may also receive inputs from non-olfactory PNs – 
although this remains to be characterised in the future. As there are around 6 
calyx glomeruli that are OAMB::EGFP-negative, it is possible that OAMB 
expression correlates PNs carrying inputs of specific modalities.  
OAMB expression on non-olfactory PNs innervating calyx glomeruli 
would suggest that sVUM1 signalling also modulates non-olfactory inputs to 
KCs, probably by presynaptically increasing neurotransmitter release from non-
olfactory PNs via the α1-adrenergic-like OAMB, similar to the mechanisms 
proposed in Section 4.3.2. in olfactory PNs.  
 
4.3.6. OAMB knockdown efficacy of three UAS-OAMB-RNAi lines 
After identifying OAMB localisation to PNs, I tested three OAMB RNAi lines to 
validate the most effective line for knocking down OAMB proteins in PNs for use 
in future functional and behavioural experiments.  
By measuring OAMB::EGFP intensity I could quantify how each RNAi 
line knocked down OAMB::EGFP proteins at its area of interest – the calyx 
glomeruli labelled by NP225-GAL4. This is more representative than measuring 
the number of OAMB transcripts present after knockdown. However, it is 
important to consider that the levels of OAMB::EGFP proteins do not reflect the 
level of OAMB proteins that are not tagged by EGFP. This method was also 
impeded by the fact that NP225-GAL4 did not label all the OAMB::EGFP-
positive calyx glomeruli. Therefore, it was difficult to determine the glomeruli 
which expressed NP225>OAMB-RNAi from the glomeruli that did not. This may 
be resolved by co-expressing UAS-mCD8::RFP to identify NP225-positive 
glomeruli subjected to RNAi knockdown.  
 There was some variation of intensity levels within a genotype and 
antibody batch, despite the fact that the brains were dissected and imaged 
under the same conditions. I attempted to control for individual variation by 
comparing anti-Dlg intensity which should not be affected by EGFP knockdown. 
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However, it would have been better if knockdown and non-knockdown control 
larvae were immunolabelled in the same tube to ensure they were exposed to 
exactly the same antibody conditions. Other sources of variation are probably 
linked to the individual variability of GAL4/UAS expression, estimations in the 
quantification method or other human errors. 
 Additionally, there was a misrepresentation of NP225>v106511 
genotypes as I was not able to distinguish larvae that carried the v106511 
construct versus those that instead carried the CyO balancer. To resolve this 
problem, it would be necessary to rebalance the stock with a second 
chromosome balancer that is linked to a phenotype that can be selected against 
at the larval stage, for example CyO::EGFP.  
Through comparing the OAMB::EGFP intensity ratio between knockdown 
with non-knockdown controls, NP225>EGFP-shRNA remained the strongest 
line for knocking down OAMB::EGFP signal, and therefore EGFP-tagged OAMB 
proteins, at around 80%. From the UAS-OAMB-RNAi lines, v106511 showed 
the strongest knockdown of OAMB::EGFP signals at around 50%, provided that 
this can be consistently observed in more than one individual that definitely 
contains the v106511 construct. This was followed by the v2861 line at around 
20%, while B31233 did not show any OAMB::EGFP signal reduction at all. The 
efficacy of these OAMB RNAi lines in PNs was in a slightly different order to 
that previously observed in ovulation phenotypes by Deady and Sun (2015).  
 As none of these stocks appeared to show near complete knockdown of 
OAMB::EGFP signal, it is necessary to improve OAMB knockdown efficacy 
through additional measures. This could include using UAS-Dicer constructs to 
increase the efficiency of processing dsRNA into siRNA that are used to target 
mRNA transcripts. This was used alongside UAS-OAMB-RNAi lines in Deady 
and Sun (2015). An alternative method could be to raise the temperature to 
29⁰C to allow maximum GAL4 expression levels – which was used to increase 
RNAi knockdown efficacy in Nagarkar-Jaiswal et al. (2015).  
 The OAMB RNAi line with the strongest knockdown in PNs can be used 
to study the function of OAMB in PNs. For example, whether OAMB knockdown 
in PNs have a phenotype for odour discrimination, or how the activity of PNs or 
KCs would be affected when OAMB is knocked down in PNs.  
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4.3.7. Functionality of the OAMB::EGFP fusion protein 
As the EGFP cassette is inserted in the coding region intron of the OAMB gene, 
it should theoretically be translated as an artificial exon without affecting OAMB 
coding exon sequences. In fact, lethality caused by the MiMIC insertion is often 
reverted when the MiMIC gene trap is replaced with the EGFP protein trap; and 
that around 75% of resulting fusion proteins generated from this method are 
functional (Venken et al., 2011a; Nagarkar-jaiswal et al., 2015).  
 The OAMB::EGFP homozygote generated for this study is viable but 
sterile. As OAMB regulates normal ovulation (Lee et al., 2009; Deady and Sun, 
2015), this suggests that the OAMB::EGFP fusion protein is not fully functional. 
This appears contradictory to the successful OAMB::EGFP localisation to 
neuronal terminals, because misfolded proteins are usually detected post-
translation in the endoplasmic reticulum (ER), retained and later degraded (Sitia 
and Braakman, 2003). While OAMB::EGFP colocalised with ER markers 
(Section 6.3.4), there was no further evidence that this was at higher levels than 
expected from normal trafficking from the ER during translation to the plasma 
membrane. This suggests that OAMB::EGFP misfolding was probably not 
detected at the ER and its lack of functionality is not due to mislocalisation.  
 While the EGFP insertion site in the OAMB protein was not near any of 
the TMs, it was less than five amino acids away from two potential consensus 
sites for Protein Kinase C phosphorylation (Han et al., 1998). Therefore, EGFP 
insertion may disrupt normal OAMB function by preventing PKC 
phosphorylation, possibly via steric hindrance, while subcellular localisation is 
not affected.    
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Chapter 5. Expression of β-adrenergic-like OA 
receptors in calyx-innervating neurons 
 
5.1. Introduction 
The β-adrenergic-like OctβRs – Octβ1R, Octβ2R and Octβ3R – are another 
class of OA receptors that may mediate sVUM1 signalling in the larval calyx 
circuitry. Based on published literature, it is inconclusive as to whether any of 
the three OctβRs localised to the larval MB calyx. Despite this, the expression 
and function of OctβRs in the adult fly MB circuitry suggest that OctβRs could 
be involved in mediating OA modulation in the larval calyx as well. 
In situ hybridisation with Octβ1R, Octβ2R and Octβ3R antisense probes 
showed that the three OctβRs were expressed in different subsets of cells in the 
larval brain lobes (Ohhara et al., 2012). However, the authors did not attempt to 
identify the cell bodies expressing the OctβRs. It is also unclear whether any in 
situ hybridisation signals was detected in the larval MBs, even though OctβR 
expression was not observed in the adult MBs (Ohhara et al., 2012).  
Another group visualised OctβR expression in the larval CNS using 
promoter-GAL4 lines containing the full promoter region for each of the OctβRs 
(El-Kholy et al., 2015). All three OctβR-GAL4 lines showed expression in the 
brain lobes with distinctive patterns (El-Kholy et al., 2015). In particular, 
Octβ3R-GAL4 showed strong signals in the MB calyx and lobes, suggesting 
that Octβ3R may be expressed in neurons innervating the MB. However, due to 
the variability of promoter-GAL4 expression patterns (Chapter 8), these data 
may not accurately represent the endogenous expression of OctβRs in the 
larval brain.  
 Using cell-type-specific RNA sequencing, Octβ1R and Octβ2R 
transcripts have been detected in adult KCs (Crocker et al., 2016). Anti-Octβ2R 
has also been observed in α’β’ KCs in the MB lobes (Wu et al., 2013). Indeed, 
Octβ2R knockdown using a pan-KC driver and a specific α’β’ KC driver failed to 
form anesthesia-resistant aversive olfactory memory (Wu et al., 2013). This 
suggests that Octβ1R and Octβ2R are expressed in adult KCs, and that Octβ2R 
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is required in α’β’ KCs for olfactory memory; which is expected to be conserved 
in larval KCs.  
In adult flies, functional Octβ2R is also required for normal artificial 
olfactory reward memory implantation (Burke et al., 2012); whereas Octβ3R 
knockdown in neurons resulted in improved aversive olfactory memory 
(Walkinshaw et al., 2015). This suggests that the involvement of OctβRs in 
olfactory processing circuitry is likely to extend to the larval MB calyx circuitry.  
By examining the endogenous expression patterns of Octβ1R, Octβ2R 
and Octβ3R using EGFP-tagged receptors generated from MiMIC insertion 
lines, I aimed to address the following questions to understand OctβR 








1) Are OctβRs expressed extrasynaptically in larval KC dendrites?  
 
So far, there is no evidence that OA signalling from sVUM1 neurons in the larval 
calyx directly modulates KCs. KCs have very few synapses with sVUM1 
neurons (Chapter 3; H.W., MPhil Thesis 2014), and KC dendrites did not 
express OAMB (Chapter 4). According to the literature, Octβ1R is expressed in 
adult KCs based on transcriptome analysis (Crocker et al., 2016), Octβ2R has 
Figure 5.1. Hypothesised OctβR localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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been identified in adult KCs both through transcriptome analysis and anti-
Octβ2R immunostaining (Crocker et al., 2016; Wu et al., 2013), and Octβ3R-
GAL4 is strongly expressed in the larval MBs (El-Kholy et al., 2015). This 
suggests that larval KCs may express OA receptors, and thus facilitate 
extrasynaptic signalling from sVUM1 neurons in the calyx. Here I aimed to 
determine whether OctβRs are localised to larval KC dendrites. 
 
2) Are OctβRs expressed in the putative postsynaptic partners of sVUM1 
neurons?  
 
While OAMB localised to PNs in the larval calyx, the other two putative 
postsynaptic partners of sVUM1 neurons identified by GRASP – the APL 
neuron and Odd-like neurons – did not express OAMB at their calyx terminals. 
In order to respond to OA signalling from sVUM1 neurons, they would need to 
express another type of OA receptor, which may be one of the OctβRs. In 
particular, Odd-like neurons may express Octβ2R, as two Octβ2R-GAL4 lines 
generated from different promoter fragments of the Octβ2R gene both label 
Odd-like neurons (Chapter 8). Here I aimed to determine whether OctβRs 
localised to potential sVUM1 postsynaptic partners.  
 
3) Are there Octβ1R- or Octβ2R-autoreceptors at the presynaptic terminals of 
sVUM1 neurons in the larval calyx?  
 
Octβ1R and Octβ2R knockdown in Type II OA motorneurons using the Tdc2-
GAL4 line resulted in abnormal synaptic growth of OA terminals at the NMJ; 
suggesting that Octβ1R and Octβ2R might be acting as autoreceptors in OA 
neurons (Koon et al., 2011; Koon and Budnik, 2012). Using EGFP-tagged 
Octβ1R and Octβ2R, I aimed to determine whether Octβ1R and Octβ2R 
localised to the presynaptic terminals of sVUM1 neurons in the larval calyx, and 
consider the possibility of OA-OA communication or autoreceptor functions of 
Octβ1R and Octβ2R.  
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4) Are any of the OctβRs expressed in the same neurons as OAMB or each 
other? 
 
As discussed above, Octβ1R and Octβ2R may colocalise in Type II OA 
motorneurons; especially since octβ1R; octβ2R double mutants have wild type 
levels of synaptic growth as opposed to the abnormal phenotypes observed in 
single mutants (Koon et al., 2011). This suggests that a single neuronal type 
may express more than one type of OA receptor. For example, PNs may 
express both OAMB and another OctβR. In this chapter, I aimed to investigate 




5.2.1. Octβ1R::EGFP localisation in the larval MB calyx circuitry 
 
5.2.1.1. Selection and validation of an EGFP-tagged Octβ1R line 
To visualise the endogenous expression pattern of Octβ1R in the larval MB 
calyx, I selected the Octβ1R::EGFP line (Fig. 5.2) from the MiMIC RMCE 
collection (Nagarkar-Jaiswal et al., 2015) generated from the MI05807 MiMIC 
line (Fig. 5.3) by the Gene Disruption Project (Venken et al., 2011a).  
 MI05807 contained the MiMIC insertion within coding region intron 1 of 
the Octβ1R gene (Fig. 5.4). This corresponded to amino acid position 139 (Fig. 
5.4B-C), and therefore the intracellular domain between TM I and II, in all of the 
Octβ1R protein isotypes (Fig. 5.5). This suggested that the Octβ1R::EGFP 
protein trap at this location should not disrupt TMs. PCR reactions conducted 
against the 5’ and 3’ flanking ends of the MI05807 insertion site (Fig. 5.6), and 
subsequent sequencing of these PCR products (Fig. S3, S4), confirmed the 
MI05807 insertion was in an Octβ1R coding region intron. I also confirmed 
using PCR that the EGFP cassette in the Octβ1R::EGFP stock was in the 
correct orientation for expression (Fig. 5.7).  
 The Octβ1R::EGFP stock was homozygous lethal (Fig. 5.2), suggesting 
that the Octβ1R::EGFP fusion produced was not a functional Octβ1R protein, 
and that functional Octβ1R proteins were essential for fly survival.  
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RMCE Line MI05807 
Parental MI Line: 
Insertion Gene(s) Affected Location Position Phase 







Gene Trap Lethality 
YES viable 
RMCE Line: 
Insertion Gene Target Phase Method Tag 





lethal yes (stock used) 
 
BDSC Stock No. 
60236  
 
Images (antibody staining) 
  
  
Figure 5.2. Octβ1R::EGFP recombinant stock listed on the Gene Disruption Project 





Octbeta1R           
 
Position Octbeta1R - coding intron 
Phase 
Octbeta1R-RA:2, Octbeta1R-RB:2, Octbeta1R-RC:2, 
Octbeta1R-RE:2 
Release 6 Annotation 
Scaffold Coordinate Strand Site GBrowse Link 
3R 22511815 + 94B2 3R:22511815  
 
FlyBase Annotation Transposon 
FBti0149079  Mi{MIC} 
Stock Availability 
Donor/Collection Stockcenter Designation Stock No. 





























B. Octβ1R-PA tblastn alignment to Drosophila sequences 
 
Exon 1 
Query:   121 AILGNMLVIVSVMRHRKLR 139 
AILGNMLVIVSVMRHRKLR 
22510149  AILGNMLVIVSVMRHRKLR 22510205 
  
Exon 2 
Query:   139 RIITNYFVVSLAVADMLVALCAMTFNASVMISGKWMFGSVMCDMWNSFDVYFSTASIMHL 198 
 IITNYFVVSLAVADMLVALCAMTFNASVMISGKWMFGSVMCDMWNSFDVYFSTASIMHL 




Figure 5.4. MI05807 insertion was in coding region intron 1 of the Octβ1R gene. (A) Map 
of MI05807 insertion site relative to Octβ1R gene and transcripts (Adapted from GBrowse). (B) 
Amino acid coordinates for the MI05807 insertion site based on tblastn alignment with Octβ1R 
transcripts. (C) Magnified map of MI05807 insertion in coding region intron 1 of Octβ1R 






Figure 5.5. MI05807 insertion was between TM I and II of Octβ1R proteins. MI05807 






Figure 5.6. PCR verification of MI05807 insertion in the Octβ1R gene. (A) Primers designed 
against 5’ and 3’ insertion flanking ends for validating the MI05807 insertion in the Octβ1R 
gene. (B) PCR products were detected for 5’ and 3’ flanking ends with MI05807 DNA but not 
with non-MiMIC control S576-IT.GAL4 (denoted as +) DNA. Abbreviations: MiL/R, MiMIC 
insertion sequences Left/Right; SA, splice acceptor site; pA, polyA sequence; yellow+, yellow+ 





Figure 5.7. PCR validation of EGFP orientation in the Octβ1R::EGFP stock. (A1) Products 
for PCR1 and PCR4 indicated EGFP cassette in the correct orientation for expression. (A2) 
Products for PCR2 and PCR3 indicated EGFP cassette in the incorrect orientation for 
expression. (B) PCR results for PCR reactions 1-4 for Octβ1R::EGFP. It was loaded on the 
same gel as OAMB::EGFP Stocks 6 and 9. Abbreviations: MiL/R, MiMIC insertion sequences 
Left/Right; SA, splice acceptor site; SD, splice donor site;  OriF, Orientation-MiL-F; OriR, 
Orientation-MiL-R; EGFP-F, EGFPdo-Seq-F; EGFP-R, EGFPdo-Seq-R. 
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5.2.1.2. Octβ1R::EGFP localisation in the larval MB calyx and dorsal cell 
bodies 
Octβ1R::EGFP larvae showed a weak and diffuse smear throughout the calyx in 
both glomerular and inter-glomerular regions when compared to the MI05807 
parental line negative control (n=7; Fig. 5.8A-B). This pattern resembled that of 
KC dendrites which arborised randomly in the calyx. I also observed a localised 
signal at the ventral end of the calyx (Fig. 5.8C-D, arrowhead) stronger than that 
observed in the calyx, suggesting there was a higher density of Octβ1R proteins 
localised to this region. There were also more dorsal cell bodies that were less 
than 5 μm in diameter labelled in Octβ1R::EGFP larvae compared to the 
negative control (Fig. 5.8E-F); suggesting that Octβ1R::EGFP may localise to 
KC cell bodies.   
 As only weak Octβ1R::EGFP signals were observed using chicken anti- 
GFP (Ab13970), I tried to increase Octβ1R::EGFP signal by using an alternative 
anti-GFP antibody – a rabbit anti-GFP (A11122). Octβ1R::EGFP signals were 
stronger when visualised with rabbit anti-GFP, but showed a consistent pattern 
of localisation to the calyx, at the neuropil immediately ventral to the calyx and 
to small dorsal cell bodies (n=3; Fig. 5.9A-F), when compared to brains labelled 
with chicken anti-GFP (Fig. 5.8). Similar to chicken anti-GFP, rabbit anti-GFP 
also occasionally labelled few background cell bodies in the negative control 
(Fig. 5.8B,F; 5.9B,D,F).  
 The consistent observation of diffuse Octβ1R::EGFP signal in the calyx 
(Fig. 5.8A, 5.9A) in Octβ1R::EGFP brains labelled with either chicken or rabbit 
anti-GFP suggested Octβ1R may be expressed in KC dendrites in the calyx. 
This is further supported by the small (<5 μm in diameter) Octβ1R::EGFP-
positive cell bodies observed dorsal to the calyx (Fig. 5.8E, 5.9E), which 
resemble KC cell bodies.  
I also observed diffuse Octβ1R::EGFP signals in MB lobes (Fig. 5.9G-H; 
n=1 with rabbit anti-GFP; n=3 out of 6 with chicken anti-GFP). This suggested 
that Octβ1R might also localise to KC axons and/or MB extrinsic neurons 
innervating the MB lobes. This may be differentiated by determining whether the 
cell bodies of MB extrinsic neurons expressed Octβ1R::EGFP; and whether 




Figure 5.8. Octβ1R::EGFP localised diffusely to MB calyx and weakly to dorsal cell 
bodies in brains labelled with chicken anti-GFP. Single confocal optical sections of 
Octβ1R::EGFP/TM6C,Sb Tb (A,C,E) with MI05807/TM3,Sb parental line negative control 
(B,D,F). Green is Octβ1R::EGFP visualized with chicken anti-GFP (chGFP, Ab13970) and blue 
is anti-Dlg. Localised signal at ventral end of calyx marked with arrowhead. Possible KC cell 





Figure 5.9. Octβ1R::EGFP localised diffusely in MB calyx and lobes and dorsal cell 
bodies in brains labelled with rabbit anti-GFP. Single confocal optical sections of 
Octβ1R::EGFP/TM6C,Sb Tb (A,C,E,G) with MI05807/TM3,Sb negative controls (B,D,F,H). 
Green is Octβ1R::EGFP visualised with rabbit anti-GFP (rbGFP, A11122) and blue is anti-Dlg. 
Localised signal at ventral end of calyx marked with arrowhead. Possible KC cell bodies (CB) 
are indicated. Medial (M) is right and posterior (P) is up. Scale bar: 20 μm. 
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On the other hand, the diffuse pattern of Octβ1R::EGFP signal in the 
larval MB calyx suggested that Octβ1R was unlikely to be expressed in the 
calyx terminals of other calyx-innervating neurons. Octβ1R::EGFP did not show 
a distinctive glomerular pattern, which suggested that Octβ1R did not localise to 
PN presynaptic terminals in the calyx. As Octβ1R::EGFP did not localise to any 
interglomerular tracts in the calyx, Octβ1R was also unlikely to localise to APL 
neuron or Odd-like neuron terminals there. This also suggested that Octβ1R did 
not localise to the presynaptic terminals of sVUM1 neurons; and were therefore 
unlikely to act as autoreceptors in the calyx circuitry.  
 
5.2.1.3. Octβ1R::EGFP localisation to AL and nearby cell bodies 
To determine whether stronger Octβ1R::EGFP signal was observed elsewhere 
in the larval brain, I examined Octβ1R::EGFP localisation to the AL – where 
PNs and sVUM1 neurons also innervate.  
I observed stronger Octβ1R::EGFP signal in cell bodies near the AL 
region as well as throughout the AL (Fig. 5.10), compared to the weak diffuse 
signal observed in the calyx (Fig. 5.8A, 5.9A). As Octβ1R::EGFP localised to all 
AL glomeruli (n=11; Fig. 5.10), this suggested that Octβ1R localised to the 
terminals of AL-innervating neurons which may include PN dendrites.  
Some AL glomeruli showed stronger Octβ1R signal than others; for 
example, a medial AL glomerulus (Fig. 5.10B-E, arrowhead) showed a stronger 
signal than its neighbours. Based on the map of AL glomeruli, this AL 
glomerulus may be 35a, 42b, 67b or 74a (Masuda-Nakagawa et al., 2009). The 
cell bodies of PNs innervating three of these glomeruli (67b, 74a, 35a) are 
expected to be located more ventrally to the AL than most of the other PN cell 
bodies, including the PN innervating the 42b glomerulus (Berck et al., 2016). 
The 74a PN also innervates a ventral calyx glomerulus (Masuda-Nakagawa et 
al., 2010), which may match the stronger Octβ1R::EGFP signal observed at the 
ventral end of the calyx (Fig. 5.8C, 5.9C). The identity of this AL glomerulus 
needs to be verified with colocalisation with a specific PN marker.  
I next examined Octβ1R::EGFP localisation to PN cell bodies labelled by 
NP225-GAL4 (n=3; Fig. 5.11). Octβ1R::EGFP signal in cell bodies was weak 





Figure 5.10. Octβ1R::EGFP localised to AL and nearby cell bodies. Single confocal optical 
sections of the AL from three Octβ1R::EGFP/TM6C,Tb Sb individuals (A-E), with 
MI05807/TM3,Sb negative controls (F-J). Green is Octβ1R::EGFP visualised with rabbit anti-
GFP (rbGFP, A11122) and blue is anti-Dlg. Arrowhead indicates an AL glomerulus with stronger 




Figure 5.11. Octβ1R::EGFP colocalised with AL glomeruli and few cell bodies labelled by 
NP225-GAL4. Single confocal optical sections of the AL of NP225-GAL4/UAS-mCD8::RFP; 
Octβ1R::EGFP/+ (A-D) and negative control NP225-GAL4/UAS-mCD8::RFP; TM6B/MKRS (E-
H).  (I) is a second negative control individual. Green is Octβ1R::EGFP, red is NP225>RFP and 
blue is anti-Dlg. Arrows indicate Octβ1R-NP225 colocalisation. Empty arrowheads indicate 
Octβ1R-positive cell bodies which did not express NP225>RFP. Medial (M) is right and dorsal 
(D) is up. Scale bar: 20 μm. 
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(Fig. 5.11I, arrows). Therefore, I first identified all the cell bodies that were 
Octβ1R::EGFP-positive relative to the background (Fig. 5.11A-D, arrows and 
empty arrowheads), and then determined whether they co-expressed 
NP225>RFP (Fig. 5.11A-D, arrows). I found that Octβ1R::EGFP and 
NP225>RFP colocalised in 5 ± 0.6 AL cell bodies (Fig. 5.11A-D; Table 5.1). 
However, the Octβ1R::EGFP signals observed in these cell bodies were very 
weak. As background GFP signals were observed in three cell bodies in one of 
the three negative controls (Fig. 5.11I, arrows; Table 5.1), it cannot be clearly 
concluded whether Octβ1R was expressed in PNs based on Octβ1R::EGFP 
localisation to PN cell bodies.  
As each PN innervates one AL glomerulus (Masuda-Nakagawa et al., 
2009), Octβ1R::EGFP signal should only be observed in around four AL 
glomeruli if Octβ1R only localised to PN dendrites in the AL. Instead, 
Octβ1R::EGFP localised to all AL glomeruli (Fig. 5.10) and many NP225-
negative cell bodies nearby (Fig. 5.11A-D, empty arrowheads). This suggested 
that Octβ1R also localised to other neurons innervating AL glomeruli – 
potentially some of the GABAergic AL interneurons (Python and Stocker, 2002).  
Octβ1R::EGFP signal colocalised with many GABA-positive cell bodies 
near the AL (n=2; Fig. 5.12, arrows) and with GABA immunoreactivity in the AL 
(Fig. 5.12). This suggested that Octβ1R localised to the terminals of GABAergic 
AL interneurons. Furthermore, this suggested that the medial AL glomeruli that 
showed stronger Octβ1R::EGFP signals (Fig. 5.10B-E, arrowhead) could be 
innervated by more than one-type of Octβ1R-expressing neurons.   
 
5.2.2. Octβ2R::EGFP localisation in the larval MB calyx circuitry 
 
5.2.2.1. Generation and validation of an EGFP-tagged Octβ2R line 
To generate a novel Octβ2R::EGFP stock for visualising the endogenous 
expression pattern of Octβ2R in the larval MB calyx, I selected the MI13416 line 
which contained the MiMIC insertion in a coding region intron of the Octβ2R 
gene (Venken et al., 2011a; Fig. 5.13, 5.14A). The MI13416 insertion site in 
coding region intron 1 of Octβ2R corresponded to amino acid position 185 (Fig.  












Individual 1 4 Individual 1 0
Individual 2 6 Individual 2
3
Individual 3 5 Individual 3
0
N 3 N 3
Mean 5 Mean 1
S.D. 1.0 S.D. 1.7











Table 5.1. Numbers of NP225-GAL4 cell bodies positive for Octβ1R::EGFP. Abbreviations: 
Octβ1R +, Octβ1R::EGFP-positive; NP225+, NP22>RFP-positive; N, number; S.D., standard 
deviation; S.E.M., standard error of the mean.  
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Figure 5.12. Octβ1R::EGFP colocalised with anti-GABA in AL and some nearby cell 
bodies. Single confocal optical sections of the AL from two Octβ1R::EGFP/TM6C, Sb Tb 
individuals (A-F) and negative control MI12417 (G-L). Green is Octβ1R::EGFP, red is anti-
GABA and blue is anti-Dlg. Arrows indicate Octβ1R-GABA colocalisation. Medial (M) is right 




Affected Gene(s) Comments 
Octbeta2R           
Insertion is near the end of a copy of TE I-element that is 
within a coding intron of Octbeta2R gene. Mapped by 
unique segment of 3' flank 
 
Position Octbeta2R - coding intron 
Phase 
Octbeta2R-RA:2, Octbeta2R-RC:2, Octbeta2R-RD:2, 
Octbeta2R-RE:2, Octbeta2R-RF:2 
Release 6 Annotation 
Scaffold Coordinate Strand Site GBrowse Link 
3R 12557762 - 87C1 3R:12557762  
 
FlyBase Annotation Transposon 
FBti0166343  Mi{MIC} 
Stock Availability 
Donor/Collection Stockcenter Designation Stock No. 


























B. Octβ2R-PA tblastn alignment to Drosophila sequences 
 
Exon 1 
Query:   181 VRKLRVITNYFVVSLAMADIMVAI 204 
VRKLR +   F + L +     AI 
12560414 VRKLRCVYVIFQLLLLLISCEKAI 12560343 
  
Exon 2 
Query:   185 RVITNYFVVSLAMADIMVAIMAMTFNFSVQVTGR 218 
RVITNYFVVSLAMADIMVAIMAMTFNFSVQVTGR 





  Figure 5.14. MI13416 insertion was in coding region intron 1 of the Octβ2R gene. (A) Map 
of MI13416 insertion site relative to Octβ2R gene and transcripts (Adapted from GBrowse). (B) 
Amino acid coordinates for the MI13416 insertion site based on tblastn alignment with Octβ2R 
transcripts. (C) Magnified map of MI13416 insertion in coding region intron 1 of Octβ2R 
transcripts with genomic and amino acid coordinates.  
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and II in all Octβ2R protein variants – one amino acid away from the TM II (Fig. 
5.15). The proximity of the MI13416 insertion to a TM might potentially disrupt 
TM insertion and prevent the targeting of Octβ2R to membrane terminals.  
 I conducted PCR reactions to verify the MI13416 insertion site using 
primers against the 3’ and 5’ flanking ends of the insertion site (Fig. 5.16A). 
PCR products were obtained for the 3’ flanking end, but not for the 5’ end (Fig. 
5.16B). To resolve this, I attempted to repeat the 5’ flanking end PCR reactions 
with five different MI13416-5F primers. However, none of the MI13416-5F 
primers produced any PCR products with MiMIC-5R, which produced a robust 
product for the positive control using another MiMIC stock (Fig. 5.16C). This 
suggested that there was difficulty in designing suitable primers against 
genomic sequences at the 5’ MI13416 insertion end.  
Nevertheless, the sequenced PCR product for the 3’ MI13416 insertion 
end aligned to both MiMIC sequences and Octβ2R sequences (Fig. S5). This 
confirmed that the MI13416 insertion was in a coding region intron of the 
Octβ2R gene. I observed an extra unidentified 26 bp sequence between the 
MiMIC and genomic sequences (Fig. S5A, green) which was also listed in the 
Gene Disruption Project website (Fig. 5.13).  
 Seventeen Octβ2R::EGFP recombinants stocks were recovered from 
introducing the EGFP cassette to the MI13416 line. Only Octβ2R::EGFP Stock 
14 from the fourteen recombinant stocks validated showed robust bands for 
PCR1 and PCR4 reactions, but not for PCR2 and PCR3 reactions. This 
suggested Stock 14 contained the EGFP reporter in the correct orientation for 
expression (Fig. 5.17; Table 5.2). Consistent with expectation, Octβ2R::EGFP 
signal was observed in the recombinant Stock 14 but not in the negative control 
 (Fig. 5.18). Octβ2R::EGFP Stock 14 was henceforth designated as 
Octβ2R::EGFP.  
 
5.2.2.2. Octβ2R::EGFP localised to cell bodies but not to larval MB calyx 
or other neuropils 
In the Octβ2R::EGFP stock, Octβ2R::EGFP signal was detected in cell bodies 
around the larval MB calyx (Fig. 5.18, arrowheads), but not in the calyx itself 
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Figure 5.15. MI13416 insertion was between TM I and II of Octβ2R proteins. MI13416 
insertion site relative to TM predictions (TMHMM) for the Octβ2R-PA isotype as a 
representative example.  
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  Figure 5.16. PCR verification of MI13416 insertion in the Octβ2R gene. (A) Primers 
designed against 5’ and 3’ insertion flanking ends for validating the MI13416 insertion in the 
Octβ2R gene. (B) PCR product detected for MI13416 3’ but not 5’ insertion end with MI13416 
DNA. No products were detected using non-MiMIC control S576-IT.GAL4 (denoted as +) DNA. 
(C) No PCR products detected for MI13416 5’ MiMIC insertion end using different MI13416-5F 
primers with MiMIC-5R1. Negative control: CS (denoted as +). MiMIC-5R1 positive control: 
MI06217 5’ insertion end using MI06217 DNA. MI13416 DNA positive control: MI13416 3’ 




Figure 5.17. PCR validation of EGFP orientation in recombinant Octβ2R::EGFP stocks. 
(A1) Products for PCR1 and PCR4 indicated EGFP cassette in the correct orientation for 
expression. (A2) Products for PCR2 and PCR3 indicated EGFP cassette in the incorrect 
orientation for expression. (B) PCR results for PCR reactions 1-4 for Octβ2R::EGFP Stocks 1, 
2, 3 (B1); Stocks 4, 7 (B2); Stocks 8, 9, 10 (B3); Stocks 11, 12 (B4); Stock 14 (B5); Stocks 





Table 5.2. One out of fourteen recombinant Octβ2R::EGFP stocks contained EGFP in the 
correct orientation for expression. PCR products obtained for each of the PCR reactions 
(PCR1, PCR2, PCR3 and PCR4) were scored as follows: -, no bands observed; +, weak band 
observed; ++, strong band observed. PCR results were used to determine whether 





Figure 5.18. Octβ2R::EGFP signal in cell bodies in Octβ2R::EGFP Stock 14. Confocal 
optical sections of the dorsal brain of Octβ2R::EGFP Stock 14 (A) with MI12417 negative 
control (B). Green is Octβ2R::EGFP and blue is anti-Dlg. Arrowheads indicate Octβ2R::EGFP-
positive cell bodies. Medial (M) is right and posterior (P) is up. Scale bar: 20 μm.  
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(Fig. 5.18, 5.19). Octβ2R::EGFP signal was also absent in other major 
neuropils, including the MB lobes (Fig. 5.20A-B), AL (Fig. 5.20C-D) and SOG 
region (Fig. 5.20E-F); but present in cell bodies around these neuropils (Fig. 
5.20). Furthermore, there were no neuronal tracts or processes positive for 
Octβ2R::EGFP (Fig. 5.18, 5.19, 5.20). This suggested that Octβ2R::EGFP was 
expressed in cell bodies, but not targeted to neuronal terminals. This might be 
because the close proximity of the MI13416 insertion to TM II disrupted TM 
insertion and subsequent targeting to the plasma membrane.  
Therefore, the Octβ2R::EGFP line could be used to identify calyx-
innervating neurons that expressed Octβ2R, but not the subcellular localisation 
of Octβ2R in those neurons. This could be achieved by determining whether 
Octβ2R::EGFP-positive cell bodies matched the approximate size and location 
of the cell bodies of calyx-innervating neurons; and subsequently through 
colocalisation with molecular markers that label these neurons.   
 
5.2.2.3. Possible Octβ2R::EGFP localisation to KC and PN cell bodies 
Few Octβ2R::EGFP-positive cell bodies around 3-5 μm in diameter were 
observed dorsal to the calyx (n=6; Fig. 5.21, filled arrowheads). The size and 
location of these cell bodies suggested that Octβ2R may be expressed in KC 
cell bodies. However, there were relatively few Octβ2R::EGFP-positive cell 
bodies smaller than 5 μm in diameter (around five in each of the confocal optical 
slices presented in Fig. 5.21) compared to hundreds of KC cell bodies expected 
in that region (Fig. 4.16A). This suggested that Octβ2R was either selectively 
expressed in a small number of KC cell bodies, or expressed in non-KC cell 
bodies of a similar size also located dorsal to the calyx.  
To determine whether Octβ2R was expressed in PNs, I examined 
Octβ2R::EGFP colocalisation with NP225-GAL4-positive cell bodies near the AL 
(n=7; Fig. 5.22). 12 ± 1.1 cell bodies near the AL co-expressed Octβ2R::EGFP 
and NP225>RFP (Fig. 5.22A-D, arrows; Table 5.3), compared to 2 ± 1.0 
NP225>RFP-positive cell bodies that showed background GFP signal in the 
negative control (Fig. 5.22E-H; Table 5.3). As NP225-GAL4 labels the majority 
of a total of 21 PNs (Masuda-Nakagawa et al., 2005), this suggested that 
Octβ2R was expressed in around half of the PN cell bodies.  
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  Figure 5.19. Octβ2R::EGFP signal was not observed in MB calyx. Single confocal optical 
sections of the calyx from three Octβ2R::EGFP individuals (A-C) with corresponding negative 
controls (D-F). Green is Octβ2R::EGFP and blue is anti-Dlg. Medial (M) is right and posterior (P) 




Figure 5.20. Octβ2R::EGFP signal localised to cell bodies but not major neuropils in the 
larval brain. Single confocal optical sections of the larval brain of Octβ2R::EGFP (A,C,E) with 
corresponding MI12417 negative controls (B,D,F). Green is Octβ2R::EGFP and blue is anti-Dlg. 
SOG is within the dotted area. Medial (M) is right. Posterior (P) is up for (A-B); anterior (A) is up 
for (C-F). Abbreviations: ML, medial lobe; VL, vertical lobe. Scale bar: 20 μm. 
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Figure 5.21. Octβ2R::EGFP localised to dorsal cell bodies. Single confocal optical sections 
taken immediately dorsal to the calyx from three Octβ2R::EGFP individuals (A-C) with 
corresponding negative controls (D-F). Green is Octβ2R::EGFP and blue is anti-Dlg. Filled 
arrowheads indicate cell bodies <5 μm in diameter (around the size of KCs). Empty arrowheads 
indicate cell bodies >5 μm in diameter (larger than KCs). Medial (M) is right and posterior (P) is 






Figure 5.22. Octβ2R::EGFP colocalised with some PN cell bodies labelled by NP225-
GAL4. Single confocal optical sections of the AL of NP225-GAL4/UAS-mCD8::RFP; 
Octβ2R::EGFP (A-D) and negative control NP225-GAL4/UAS-mCD8::RFP; TM6B/MKRS (E-H). 
Green is Octβ2R::EGFP, red is NP225>RFP and blue is anti-Dlg. Arrows indicate Octβ2R-
NP225 colocalisation; while empty arrowheads indicate Octβ2R-positive cell bodies negative for 






























N 7 N 3
Mean 12 Mean 2
S.D. 2.8 S.D. 1.7










Table 5.3. Numbers of NP225-GAL4 cell bodies positive for Octβ2R::EGFP. Abbreviations: 
Octβ2R+, Octβ2R::EGFP-positive; NP225+, NP225>RFP-positive; N, number; S.D., standard 
deviation; S.E.M., standard error of the mean.  
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5.2.2.4. Ambiguous Octβ2R::EGFP localisation to Odd-like and sVUM1 cell 
bodies  
To determine whether Octβ2R was expressed in Odd-like neurons, I examined 
whether Octβ2R::EGFP localised to an Odd-like neuronal cell body labelled by 
R68B12-GAL4. R68B12-GAL4 was made by fusing GAL4 with a promoter 
fragment of the Octβ2R gene (Jenett et al., 2012); and therefore possibly labels 
some neurons that express Octβ2R. In Chapter 8, I showed that R68B12-GAL4 
labelled a calyx-innervating neuron that showed a similar innervation pattern to 
Odd neurons (Slater et al., 2015; L. Masuda-Nakagawa, personal 
communication). This Odd-like neuron cell body sends a clearly visible tract to 
the MB calyx.   
Octβ2R::EGFP signal colocalised with the Odd-like neuron cell body 
labelled by R68B12-GAL4 (n=3; Fig. 5.23A-B, filled arrowhead). However, GFP 
signal was also observed in the Odd-like neuron cell body in the negative 
control (Fig. 5.23C-D, arrowhead). This suggested that there may be bleed 
through of the R68B12>RFP signal to the GFP channel. Therefore, it was 
ambiguous as to whether Octβ2R::EGFP localised to the Odd-like neuron cell 
body labelled in this line.  
 Other cell bodies labelled by R68B12-GAL4 did not show Octβ2R::EGFP 
signal or clear background labelling (Fig. 5.23A, C). On the other hand, a medial 
cell body (Fig. 5.23A, empty arrowhead) that did not colocalise with 
68B12>RFP was consistently observed in Octβ2R::EGFP but not negative 
control brains (Fig. 5.23C). This suggested that Octβ2R::EGFP and R68B12-
GAL4 did not share overlapping expression patterns other than the Odd-like 
neuron cell body, despite the fact that R68B12-GAL4 is an Octβ2R-GAL4 line. 
As Octβ2R might be expressed in OA neurons at the NMJ (Koon et al., 
2011), I next examined whether Octβ2R::EGFP localised to OA neuron cell 
bodies, visualised using anti-OA, at the SOG ventral median. Some OA-positive 
neurons colocalised with Octβ2R::EGFP (Fig. 5.24, arrows), but this was not 
consistent across individuals. Moreover, it was difficult to discern 
Octβ2R::EGFP signal from background labelling, and there was a large 
variability in the signal to noise ratio across different individuals (n=7; Fig. 5.24). 
Therefore, it was inconclusive from these data whether OA sVUM1 neurons, 
whose cell bodies are in the SOG region, express Octβ2R.  
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Figure 5.23. EGFP signal detected in Odd-like cell body labelled by R68B12-GAL4 in 
Octβ2R::EGFP and negative control brains. Confocal projection of the brain lobe of UAS-
mCD8::RFP/+; Octβ2R::EGFP/R68B12-GAL4 (A-B) with UAS-mCD8::RFP/+; R68B12-GAL4/+ 
negative control (C-D). (B,D) are enlarged confocal projections of the Odd-like cell body. Green 
is Octβ2R::EGFP, red is 68B12>RFP and blue is anti-Dlg. Filled arrowheads indicate Odd-like 
cell body; empty arrowhead indicates Octβ2R::EGFP-positive cell body that is 68B12-negative. 
Medial (M) is right and dorsal (D) is up. Scale bar: 20 μm for (A,C); 10 μm for (B,D).  
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Figure 5.24. Octβ2R::EGFP may be localised to OA cell bodies at the SOG. Single confocal 
optical sections of the SOG from three Octβ2R::EGFP individuals (A-C) with MI12417 negative 
controls (D-F). Green is Octβ2R::EGFP and blue is anti-Dlg. Anterior is up and medial is at the 
vertical midline. Arrows indicate Octβ2R-NP225 colocalisation; while empty arrowheads indicate 
OA-positive cell bodies negative for Octβ2R::EGFP. Abbreviations: lb, labial cluster; md, 
mandibular cluster; mx, maxillary cluster. Scale bar: 10 μm.  
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5.2.3. Octβ3R::EGFP localisation in the larval MB calyx circuitry 
 
5.2.3.1. Selection, generation and validation of EGFP-tagged Octβ3R lines 
To visualise Octβ3R expression in the larval brain, I selected the MI06217 line 
from the MiMIC collection as it contained the MiMIC insertion in a coding region 
intron of the Octβ3R gene (Venken et al., 2011a; Fig. 5.25, 5.26). PCR 
reactions against the 5’ and 3’ flanking ends of the MI06217 insertion (Fig. 
5.27), and the sequences of these PCR products (Fig. S6, S7), confirmed that 
the MI06217 insertion was in the Octβ3R gene. 
Octβ3R encodes four transcriptional variants: Octβ3R-RF and Octβ3R-
RG in the Phase 1 reading frame, and Octβ3R-RJ and Octβ3R-RK in the Phase 
0 reading frame (Fig. 5.25, 5.26). In Octβ3R-RF and Octβ3R-RG, the MI06217 
insertion was in coding region intron 5. This corresponded to amino acid 
position 1012 and 1013 respectively, and therefore the intracellular domain 
between TM V and VI in both protein isotypes (Fig. 5.28, 5.29). In Octβ3R-RJ, 
the MI06217 insertion was in coding region intron 4, corresponding to amino 
acid position 351, and was therefore positioned in the intracellular domain 
between TM V and VI (Fig. 5.30). Finally, Octβ3R-RK did not encode a full 
length 7 TM receptor according to TMHMM predictions (Fig. 5.31), and was 
therefore not expected to be expressed.  
I identified Octβ3R::EGFP (Phase 1) from the MiMIC RMCE collection 
(Nagarkar-Jaiswal et al., 2015; Fig. 5.32). Using PCR, I confirmed that the 
EGFP cassette was inserted in the correct orientation for expression in this 
stock (Fig. 5.33A, B1). This stock could be used to visualise the expression 
patterns of Octβ3R-PF and Octβ3R-PG, as it contained the EGFP cassette in 
the Phase 1 reading frame (Fig. 5.32)  
To visualise the localisation of the Octβ3R-PJ protein, I introduced a Phase 0 
EGFP cassette to the MI06217 line to generate an Octβ3R::EGFP (Phase 0) 
protein trap. Nineteen Octβ3R::EGFP (Phase 0) recombinant stocks were 
recovered. Four out of the six recombinant stocks assayed showed stronger 
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Figure 5.27. PCR verification of MI06217 insertion in the Octβ3R gene. (A) Primers 
designed against 5’ and 3’ insertion flanking ends for validating MI06217 insertion in the 
Octβ3R gene. (B) PCR products were detected for 5’ and 3’ MI06217 insertion ends for 
MI06217 DNA but not for negative control CS (denoted as +) DNA. Abbreviations as Fig. 5.6.  
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A. Octβ3R-PF tblastn alignment to Drosophila sequences 
 
Exon 4 
Query:   989 INFSQENSDSRSYIPMGRV 1007 
INFSQENSDSRSYIPMGRV 
12516522 INFSQENSDSRSYIPMGRV 12516466 
  
Exon 5 








Figure 5.28. MI06217 insertion coordinates in Octβ3R-RF transcript and Octβ3R-PF 
protein isotype. (A) Amino acid coordinates for the MI06217 insertion site based on tblastn 
alignment with Octβ3R-RF. (B) Magnified map of MI06217 insertion in coding region intron 4 of 
Octβ3R-RF with genomic and amino acid coordinates. (C) MI06217 insertion was between TM 
V and VI based on TMHMM predictions for the Octβ3R-PF isotype.  
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A. Octβ3R-PG tblastn alignment to Drosophila sequences 
 
Exon 4 
Query:   989 INFSQENSDSRSYIPMGRVSTSSAS 1013 
INFSQENSDSRSYIPMGRVSTSSAS 
12516522 INFSQENSDSRSYIPMGRVSTSSAS 12516448 
  
Exon 5 
Query:   1006 RVSTSSASGSVRPAKGWKAEHKAARTLGIIMGVFLLCWLPFFLW  1049 
++S     GSVRPAKGWKAEHKAARTLGIIMGVFLLCWLPFFLW 





Figure 5.29. MI06217 insertion coordinates in Octβ3R-RG transcript and Octβ3R-PG 
protein isotype. (A) Amino acid coordinates for the MI06217 insertion site based on tblastn 
alignment with Octβ3R-RG. (B) Magnified map of MI06217 insertion in coding region intron 4 of 
Octβ3R-RG with genomic and amino acid coordinates. (C) MI06217 insertion was between TM 
V and VI based on TMHMM predictions for the Octβ3R-PG isotype.  
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A. Octβ3R-PJ tblastn alignment to Drosophila sequences 
 
Exon 3 
Query:   331 -----EAIRQRKALSRTSSNILLNSAE 352 
     EAIRQRKALSRTSSNILLNS   
12519086 LWFSREAIRQRKALSRTSSNILLNSVH 12519006 
 
Exon 4 
Query:   350 SAEHKAARTLGIIMGVFLLCWLPFFLW 376 
 AEHKAARTLGIIMGVFLLCWLPFFLW 






Figure 5.30. MI06217 insertion coordinates in Octβ3R-RJ transcript and Octβ3R-PJ 
protein isotype. (A) Amino acid coordinates for the MI06217 insertion site based on tblastn 
alignment with Octβ3R-RJ. (B) Magnified map of MI06217 insertion in coding region intron 3 of 
Octβ3R-RJ with genomic and amino acid coordinates. (C) MI06217 insertion was between TM 
V and VI based on TMHMM predictions for the Octβ3R-PJ isotype.  
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A. Octβ3R-PK tblastn alignment to Drosophila sequences 
 
Exon 3 
Query:   386 SNLEA  390 
SNLE 
12518906 SNLEV  12518892 
 
Exon 4 
Query:   384 ALSNLEAVPCDRPKDGRPNTRPPAPWASSWASFCSAGCPSFCG  426 
+LS  +AVPCDRPKDGRPNTRPPAPWASSWASFCSAGCPSFCG 






Figure 5.31. MI06217 insertion coordinates in Octβ3R-RK transcript and Octβ3R-PK 
protein isotype. (A) Amino acid coordinates for the MI06217 insertion site based on tblastn 
alignment with Octβ3R-RK. (B) Magnified map of MI06217 insertion in coding region intron 3 of 
Octβ3R-RK with genomic and amino acid coordinates. (C) MI06217 insertion was after TM V in 
C-terminal based on TMHMM predictions for the Octβ3R-PK isotype.  
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RMCE Line MI06217 
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Insertion Gene(s) 
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viable   
 
BDSC Stock No. 
60245  
 
Images (antibody staining) 
 
  
Figure 5.32. Octβ3R::EGFP recombinant stock listed on the Gene Disruption Project 




Figure 5.33. PCR validation of EGFP orientation for recombinant Octβ3R::EGFP stocks. 
(A1) Products for PCR1 and PCR4 indicated EGFP cassette in the correct orientation for 
expression. (A2) Products for PCR2 and PCR3 indicated EGFP cassette in the incorrect 
orientation for expression. (B) PCR results for PCR reactions 1-4 for Octβ3R::EGFP (Phase 1) 
(B1), Octβ3R::EGFP (Phase 0) Stocks 1, 2, 3; with Octβ3R::EGFP (Phase 1) as positive control 




therefore contained the EGFP cassette in the correct orientation for expression 
(Fig. 5.33A, B2-3; Table 5.4). As Octβ3R::EGFP (Phase 0) Stock 2 had the 
most defined PCR results (Fig. 5.33B2; Table 5.4), I selected it for subsequent 
expression analyses and designated it as Octβ3R::EGFP (Phase 0).  
 
5.2.3.2. No EGFP signal observed in Octβ3R::EGFP (Phase 1) stock 
Octβ3R::EGFP (Phase 1) larvae did not show any EGFP signal in the larval MB 
calyx visualised using chicken anti-GFP (Ab13970) (n=3; Fig. 5.34) or rabbit 
anti-GFP (Ab6556) (n=3; Fig. 5.35). Some GFP-positive cell bodies were 
labelled in both Octβ3R::EGFP (Phase 1) brains and MI06217 negative controls 
at similar levels of intensity (Fig. 5.34, 5.35). This suggested that these GFP-
positive cell bodies were probably background labelling rather than signal.  
No EGFP signal was observed elsewhere in either cell bodies or 
neuropils in the brain lobes of Octβ3R::EGFP (Phase 1) brains compared to 
negative controls (n=2; Fig. 5.36). Previous immunolabelling of Octβ3R::EGFP 
(Phase 1) larval brains conducted by the Gene Disruption Project also did not 
show defined Octβ3R::EGFP signals in cell bodies or neuropils; but instead 
showed homogeneous background labelling (Nagarkar-Jaiswal et al., 2015; Fig. 
5.32). However, this was probably because the image was taken at low 
resolution, as the comparable image for Octβ1R::EGFP also did not show clear 
signals (Nagarkar-Jaiswal et al., 2015; Fig. 5.2), even though I observed 
Octβ1R::EGFP signal in the larval brain. This suggested that either the 
Octβ3R::EGFP (Phase 1) stock did not produce a functional or correctly 
targeted Octβ3R::EGFP protein, or that neither Octβ3R-PF nor Octβ3R-PG 
protein isotypes localised to the larval brain lobes.   
To date, only one Octβ3R isotype has been cloned and functionally 
verified. This Octβ3R isotype was 440 amino acids in length and predicted to 
encode a seven TM receptor (Maqueira et al., 2005). This description fits only 
the Octβ3R-PJ protein isotype which is 445 amino acids in length; as both 
Octβ3R-PF and Octβ3R-PG were >1000 amino acids in length, and Octβ3R-PK 
only encoded five TMs. This suggested that it was probable that only the 
Octβ3R-PJ variant was functionally expressed. As no signals were 





Table 5.4. Octβ3R::EGFP (Phase 1) and four out of six recombinant Octβ3R::EGFP 
(Phase 0) stocks contained EGFP in the correct orientation for expression. PCR products 
obtained for each of the PCR reactions (PCR1, PCR2, PCR3 and PCR4) were scored as 
follows: -, no bands observed; +, weak band observed; ++, strong band observed. PCR results 
were used to determine whether Octβ3R::EGFP expression was expected (Expected 




  Figure 5.34. No EGFP signal observed in larval MB calyx in Octβ3R::EGFP (Phase 1) 
brains labelled with chicken anti-GFP. Single confocal optical sections of the calyx from three 
Octβ3R::EGFP (Phase 1) individuals (A-E), with corresponding MI06217 parental line negative 
controls (F-J). Green is chicken anti-GFP (chGFP, Ab13970) and blue is anti-Dlg. Medial (M) is 
right and posterior (P) is up. Scale bar: 20 μm. 
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Figure 5.35. No EGFP signal observed in larval MB calyx in Octβ3R::EGFP (Phase 1) 
brains labelled with rabbit anti-GFP. Single confocal optical sections of the calyx of 
Octβ3R::EGFP (Phase 1) (A-C), with MI06217 parental line negative control (D-F). Green is 
rabbit anti-GFP (rbGFP, Ab6556) and blue is anti-Dlg. Medial (M) is right and posterior (P) is up. 
Scale bar: 20 μm. 
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Figure 5.36. No EGFP signal observed in Octβ3R::EGFP (Phase 1) brain lobes. Single 
confocal optical sections of the dorsal larval brain of Octβ3R::EGFP (Phase 1) (A-D), with 
corresponding MI12417 negative control (E-I). Green is chicken anti-GFP (chGFP, Ab13970) 
and blue is anti-Dlg. Medial (M) is right and posterior (P) is up. Scale bar: 50 μm. Abbreviations: 
ML, medial lobe; ped, pedunculus cross-section; VL, vertical lobe. 
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experiments on Octβ3R::EGFP (Phase 0), which should reveal the expression 
pattern of the functional Octβ3R-PJ isotype.  
 
5.2.3.3. No EGFP signal observed in Octβ3R::EGFP (Phase 0) stocks  
Contrary to expectation, no EGFP signals were observed in Octβ3R::EGFP 
(Phase 0) larvae in the larval MB calyx (n=3; Fig. 5.37), AL (Fig. 5.38A-D) nor 
the SOG region (Fig. 5.38E-F). Similar to Octβ3R::EGFP (Phase 1) larvae, the 
GFP signals observed in cell bodies were comparable to background labelling 
of cell bodies in the negative control (Fig. 5.37, 5.38). Furthermore, I did not 
observe EGFP signals in the calyx, MB lobes, or in any nearby cell bodies using 
an alternative anti-GFP – the rabbit anti-GFP (A11122) – in Octβ3R::EGFP 
(Phase 0) larval brains (n=2; Fig. 5.39).  
 To ensure that this effect was not specific to the Octβ3R::EGFP (Phase 
0) stock selected, I examined the expression patterns of two other 
Octβ3R::EGFP (Phase 0) recombinant stocks that contained EGFP in the 
correct orientation for expression: Octβ3R::EGFP (Phase 0) Stock 1 and 
Octβ3R::EGFP (Phase 0) Stock 5 (Fig. 5.33B2-3; Table 5.4). Neither of thse 
stocks showed any EGFP signals in the larval calyx, MB lobes nor nearby cell 
bodies besides background labelling that was also seen in negative controls 
(Fig. 5.40). These results showed that the Octβ3R::EGFP (Phase 0) stocks did 
not show Octβ3R::EGFP signal in the larval brain lobes. However, it was 




  Figure 5.37. No EGFP signal observed in larval MB calyx in Octβ3R::EGFP (Phase 0) 
brains. Single confocal optical sections of the calyx from three Octβ3R::EGFP (Phase 0) 
individuals (A-E) with MI06217 negative controls (F-J). Green is chicken anti-GFP (chGFP, 





Figure 5.38. No EGFP signal observed in larval AL or SOG in Octβ3R::EGFP (Phase 0) 
brains. Single confocal optical sections of the larval brain of Octβ3R::EGFP (Phase 0) (A-B,E) 
with corresponding MI06217 negative controls (C-D,F). Green is chicken anti-GFP (chGFP, 
Ab13970) and blue is anti-Dlg. Medial (M) is right and dorsal (D) is up for (A-D); and anterior is 




Figure 5.39. No EGFP signal observed in larval MB calyx or lobes in Octβ3R::EGFP 
(Phase 0) brains labelled with rabbit anti-GFP. Single confocal optical sections of the dorsal 
larval brain of Octβ3R::EGFP (Phase 0) (A-B) with MI06217 negative controls (C-D). Green is 
rabbit anti-GFP (rbGFP, A11122) and blue is anti-Dlg. Medial (M) is right and posterior (P) is up. 








Figure 5.40. No EGFP signal observed in larval MB calyx or lobes in two other 
Octβ3R::EGFP (Phase 0) stocks. Single confocal optical sections of the MB calyx and lobes of 
Octβ3R::EGFP (Phase 0) Stock 1 (A,D); Octβ3R::EGFP (Phase 0) Stock 5 (B,E); and MI06217 
negative control (C,F). Green is chicken anti-GFP and blue is anti-Dlg. Medial (M) is right and 
posterior (P) is up. Scale bar: 20 μm. 
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5.3. Discussion  
While previous studies have shown that Octβ1R, Octβ2R and Octβ3R were 
expressed in the larval CNS using in situ hybridisation and promoter-GAL4 lines 
(Ohhara et al., 2012; El-Kholy et al., 2015), the neuronal types expressing these 
OctβRs had not been identified. Strong expression of Octβ3R-GAL4 in both 
adult and larval MBs (El-Kholy et al., 2015) suggest that Octβ3R localised to 
calyx-innervating neurons. On the contrary, Octβ1R-GAL4 and Octβ2R-GAL4 
were expressed in adult but not in larval MBs (El-Kholy et al., 2015), suggesting 
that Octβ1R and Octβ2R only localised to calyx-innervating neurons but not in 
larvae. Octβ1R and Octβ2R expression in adult KCs were confirmed in KC-
specific RNA sequencing (Crocker et al., 2016) and consistent with anti-Octβ2R 
labelling in α’β’ KCs in the MB lobes (Wu et al., 2013).  
In situ hybridisation, cell-type-specific RNA sequencing and GAL4 
expression can only be used to identify neuronal types expressing OctβRs, but 
not their subcellular localisation, unlike antibody labelling and protein traps. 
Moreover, promoter-GAL4 lines may not always faithfully represent endogenous 
expression of OA receptors (Chapter 4). As specific Octβ1R and Octβ3R 
antibodies were unavailable and difficult to develop (El-Kholy et al., 2015), and I 
did not have access to anti-Octβ2R (Wu et al., 2013), the best available method 
to examine subcellular localisation of OctβRs in calyx-innervating neurons was 
to use protein traps.  
By using the Octβ1R::EGFP fusion (Venken et al., 2011a; Nagarkar-
jaiswal et al., 2015), I directly showed Octβ1R subcellular localisation to the 
larval MB calyx for the first time. This result is consistent with Octβ1R 
expression in adult KCs (Crocker et al., 2016), but contradicts the lack of 
Octβ1R-GAL4 expression in larval MBs (El-Kholy et al., 2015). I also showed 
Octβ2R::EGFP, and possibly Octβ1R::EGFP, localisation to a subset of 
olfactory PN cell bodies, which has not been previously explored. I will discuss 
the implications of these findings on the calyx circuitry in the following sections.  
 Out of the four OctβR fusion proteins used in this chapter, only 
Octβ1R::EGFP localised to the neuronal terminals. Octβ2R::EGFP signal 
localised to cell bodies only, although this is expected to more accurately show 
Octβ2R-expressing neurons than promoter-GAL4 lines; and their identities can 
be verified using molecular markers which would be difficult to conduct with in 
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situ hybridisation. Finally, neither of the Octβ3R::EGFP fusions showed any 
signal in the larval brain, contrary to the expectations from in situ and promoter-
GAL4 results (Ohhara et al., 2012; El-Kholy et al., 2015). This will be further 
discussed in Section 5.3.6.  
  
5.3.1. Possible extrasynaptic regulation of KCs via Octβ1R 
The diffuse pattern of Octβ1R::EGFP localisation in the larval MB calyx best 
matches that of KC dendrites innervating the calyx, and not the innervation 
pattern of other calyx-innervating neurons, suggesting that Octβ1R localised to 
KC dendrites (Fig. 5.41). This may be validated in the future by knocking down 
Octβ1R::EGFP signal with EGFP RNAi in the calyx with a specific KC driver. 
Octβ1R::EGFP signal was also detected in small dorsal cell bodies resembling 
KC cell bodies; but their identity should be verified through colocalisation with a 
KC marker. This is consistent with Octβ1R transcripts detected in adult KC cell 
bodies through RNA sequencing (Crocker et al., 2016), and suggest that 
Octβ1R localisation to KCs may be conserved from larvae to adults.   
Octβ1R localisation to KC dendrites suggest that sVUM1 neurons 
innervating the larval MB calyx could directly target KC dendrites despite the 
limited KC-sVUM1 synaptic connections based on GRASP results (Chapter 3). 
Extrasynaptic Octβ1R on KCs would allow for the mass modulation of many 
KCs without the need for a large amount of synaptic connections.  
It is unclear whether Octβ1R would act as an inhibitory or excitatory 
receptor on KCs; as it has been shown to couple to an increase of cAMP levels 
which is associated with increase in neuronal excitability (Balfanz et al., 2005; 
Maqueira et al., 2005), as well as decrease in cAMP levels associated with 
hyperpolarisation (Koon and Budnik, 2012), in different cell types. Therefore, to 
determine the effects of sVUM1 signalling on KCs via Octβ1R, it is necessary to 
investigate how the absence of Octβ1R may impact KC activity using 
electrophysiological or calcium imaging methods. Nevertheless, this suggests 
that sVUM1 may directly modulate KC activity via Octβ1R, adjusting the 
sparseness of odour representations in KCs, and therefore whether odours can 





Figure 5.41. Proposed OctβR localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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 Octβ2R::EGFP localised to few dorsal cell bodies that may belong to 
KCs. This remains to be verified through colocalisation with a KC marker, as 
only a small number of Octβ2R::EGFP-positive cell bodies were observed, 
compared to the large number of KC cell bodies expected in that region. There 
is no further evidence that Octβ2R localised to KC dendrites, as the 
Octβ2R::EGFP stock did not show localisation to neuronal processes. This 
uncertain result is not necessarily contradictory to Octβ2R localisation to adult 
KCs. While Octβ1R transcripts were observed in α, β and γ KCs, Octβ2R 
transcripts appeared to more enriched in αβ KCs (Crocker et al., 2016). 
Moreover, anti-Octβ2R labelling has only been observed in the α’β’ MB lobes 
(Wu et al., 2013), suggesting that Octβ2R may specifically localise to α’β’ KCs. 
Only γ KCs are already born at the L3 stage, while α’β’ KCs are beginning to be 
born at this stage and αβ KCs will not be born until later (Lee et al., 1999). 
Therefore, the few small dorsal cell bodies expressing Octβ2R::EGFP may 
belong to newborn α’β’ KCs which are not yet fully developed.  
 
5.3.2. Possible co-expression of OA receptors in PNs 
In addition to OAMB localisation to the majority of PN terminals in the calyx, I 
found that around half of the PN cell bodies weakly expressed Octβ2R::EGFP 
(Fig. 5.41). As Octβ2R::EGFP did not localise to terminals, it is unclear whether 
OAMB and Octβ2R localised to the same compartments of the PNs they are co-
expressed in. If OAMB and Octβ2R both localised to calyx glomeruli, I 
hypothesise that OAMB and Octβ2R would be activated under different OA 
concentrations. This would therefore allow PNs co-expressing both receptors at 
their terminals to respond differently depending on fluctuations of OA 
concentration. On the other hand, co-expression of OAMB and Octβ2R in 
different PN compartments would allow PNs to produce a site-specific response 
to different sources of OA.   
Some PN dendrites may also express Octβ1R in the AL. While 
Octβ1R::EGFP only localised weakly to very few PN cell bodies, there was a 
medial AL glomerulus where Octβ1R::EGFP was strongly localised. This AL 
glomerulus may be 35a, 42b, 67b or 74a based on its position (Masuda-
Nakagawa et al., 2009). This suggests that Octβ1R localised to the dendrites of 
a specific PN. As sVUM1 neurons are the only source of OA innervation in the 
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larval AL (Selcho et al., 2014), it is likely that Octβ1R present on PN dendrites 
receive OA signalling from sVUM1 neurons. As Octβ1R::EGFP does not appear 
to localise to discrete calyx glomeruli, Octβ1R is unlikely to localise to 
presynaptic terminals of PNs in the calyx, and therefore unlikely to mediate 
sVUM1 signalling there.  
As Octβ1R and Octβ2R were expressed in a smaller subset of PNs 
compared to OAMB, differential OA receptor localisation may present a 
mechanism for restricting the action of widespread OA signalling to particular 
neurons. This also suggested that different PNs may respond to OA signalling 
in different ways based on the types of OA receptors they expressed.  
Possible OAMB, Octβ1R and Octβ2R co-expression in PNs is similar to 
the possible co-expression of Octβ1R and Octβ2R in OA/TA neurons (Koon et 
al., 2011; Koon and Budnik, 2012), and that of α1- and α2-adrenoceptors in the 
rat olfactory bulb (Nai et al., 2010). This suggests that receptor co-expression 
on the same neurons may be a common and important feature in 
noradrenergic-like neuromodulatory circuitry. This may allow octopamine or 
noradrenaline to exert a large range of effects on the same neurons depending 
on the type of receptor activated.  
 
5.3.3. OctβRs unlikely to be OA autoreceptors on sVUM1 neurons 
Contrary to expectation, I also did not find any evidence for OA autoreceptors 
on sVUM1 neurons. Octβ1R did not localise to calyx terminals of sVUM1 
neurons, while it was inconclusive whether Octβ2R localised to sVUM1 
neurons. 
The larval NMJ is the only system in which potential Octβ1R and Octβ2R 
autoreceptors have been reported in Drosophila. The antagonising effects on 
synaptic growth due to Octβ1R and Octβ2R knockdown in Tdc2-GAL4 line was 
used to infer the presence of these receptors on OA Type II motorneurons 
(Koon et al., 2011; Koon and Budnik, 2012). However, as Tdc2-GAL4 labelled 
the majority of OA/TA neurons, it is unknown whether Octβ1R and Octβ2R were 
expressed on all the OA and TA neurons labelled, only TA neurons or a subset 
of the neurons labelled. As the authors did not show whether Octβ1R and 
Octβ2R localised to the presynaptic terminals of OA neurons, it would be useful 
to explore whether Octβ1R::EGFP and Octβ2R::EGFP signal can be detected 
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in OA motorneurons in the larval NMJ in the future, to validate whether any of 
the OctβRs act as autoreceptors on OA neurons.  
 
5.3.4. OctβR localisation to APL or Odd-like neurons not yet identified 
I did not manage to determine whether any of the OctβR localised to the calyx 
terminals of the APL neuron or Odd-like neurons so far. The lack of 
Octβ1R::EGFP-positive tracts or boutons in the calyx suggest that Octβ1R is 
unlikely to be localised to the calyx terminals of APL or Odd-like neurons. 
However, I could not draw a conclusion as to whether Octβ2R or Octβ3R 
localised to APL or Odd-like neurons.  
Identifying Octβ2R colocalisation with calyx-innervating neuron drivers 
has been challenging thus far. Firstly, the Octβ2R::EGFP protein does not 
localise to terminals, so Octβ2R localisation can only be identified from 
Octβ2R::EGFP signal in cell bodies. This is problematic because it is unclear 
whether Octβ2R is normally localised to the calyx, and thus whether it may be 
involved in mediating sVUM1 signalling in the calyx circuitry. As the EGFP 
insertion prevented Octβ2R::EGFP targeting to terminals, it is possible that it 
also altered Octβ2R::EGFP expression patterns, such that Octβ2R::EGFP may 
not even be expressed in the same neurons as those expressing Octβ2R. This 
is possible but unlikely, as Octβ2R::EGFP remains under the control of the 
same promoter and regulatory elements as the native Octβ2R protein. Instead, 
Octβ2R::EGFP is probably transcribed and translated in neurons that express 
Octβ2R, but retained in the ER in the cell body as the EGFP fusion prevents 
correct folding of the protein.  
Next, the background GFP signal detected in the Odd-like neuron cell 
body labelled in R68B12>RFP negative control brains made it difficult to discern 
whether GFP signal detected in that of R68B12>RFP, Octβ2R::EGFP brains 
was signal or background. It may be possible to eliminate R68B12>RFP signal 
bleedthrough to the GFP channel by using an alternative driver line to label 
Odd-like neurons, a different red fluorescent reporter, omitting anti-DsRed 
amplification of the R68B12>RFP signal, or adjusting bandpass filters to further 
restrict the emission frequency range detected by the confocal microscope 
detector. Instead of using a red fluorescent reporter to label Odd-like neurons in 
R68B12-GAL4, a non-fluorescent epitode tag such as V5 or FLAG together with 
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a far-red secondary antibody such as Alexa 647, could further ensure that there 
is minimal spectral overlap between Octβ2R::EGFP and R68B12 signals to 
prevent signal bleed through.  
Furthermore, the signal from a single copy of Octβ2R::EGFP is weak. 
Therefore, it is necessary to ensure homozygosity of the Octβ2R::EGFP 
cassette on the third chromosome, as in the Octβ2R-PN colocalisation 
experiment. However, this limits the use of driver lines only to those on other 
chromosomes. For the Octβ2R-APL colocalisation, NP732-GAL4 on the X 
chromosome (Masuda-Nakagawa et al., 2014) should be used with 
homozygous Octβ2R::EGFP. For Octβ2R-Odd colocalisation, the third 
chromosome R68B12-GAL4 construct should be replaced with the second 
chromosome R68B12-LexA driver which also labels a single Odd-like neuron. 
However, R68B12-GAL4/LexA only label one Odd-like cell body, while OK263-
GAL4 cell bodies do not all project to the calyx. Hence, it is currently not 
possible to validate whether Octβ2R::EGFP localised to all the calyx-innervating 
Odd-like cell bodies.  
 Therefore, in the future, measures to maximise Octβ2R::EGFP signal 
and minimise bleed through together with appropriate negative controls must be 
used to validate the identity of Octβ2R-positive cell bodies.  
 
5.3.5. Other issues with Octβ1R::EGFP and Octβ2R::EGFP fusions  
As there are no Octβ1R antibodies available, the Octβ1R::EGFP fusion protein 
is currently the best and only tool to identify Octβ1R subcellular localisation. 
However, as Octβ1R::EGFP is homozygous lethal, the Octβ1R::EGFP fusion 
protein is not fully functional. This suggests that EGFP insertion interferes with 
Octβ1R function, and it is possible that this may cause Octβ1R::EGFP 
mislocalisation, such that it may not represent the normal localisation pattern of 
Octβ1R. This may be because EGFP insertion in Octβ1R::EGFP is within 5 
amino acids from a clathrin-associated binding motif which regulates 
internalisation and lysosomal targeting (Maqueira et al., 2005). However, 
Octβ1R::EGFP may still be initially targeted to the correct destination, but 
accumulate at these locations as it is prevented from internalisation and 
recycling. It is also plausible that Octβ1R::EGFP is non-functional because the 
EGFP insertion is disrupting other functional binding domains that do not affect 
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localisation. Ideally, multiple Octβ1R protein traps in which EGFP is inserted at 
different locations should be compared for consistency to best represent 
Octβ1R locazation. These may be generated by the existing MiMIC lines 
MI06725 and MI09054 which are inserted in coding region introns of some but 
not all of the Octβ1R protein isotypes (Venken et al., 2011a; Nagarkar-Jaiswal 
et al., 2015); or by targeted EGFP knock-in using CRISPR (Xue et al., 2014).  
 Provided that Octβ1R::EGFP is localised to the same targets as the 
functional Octβ1R protein, the other challenge is that Octβ1R::EGFP must be 
maintained heterozygously. Unlike OAMB::EGFP and Octβ2R::EGFP fusions, 
the weak Octβ1R::EGFP signal cannot be further amplified by using 
homozygous flies that have double the copy number of EGFP fusion proteins. 
Therefore, alternative methods must be used to increase Octβ1R::EGFP signal 
(Chapter 9).  
As discussed in Section 5.3.4., Octβ2R::EGFP signal is only observed in 
cell bodies and may also be at risk of misexpression. The lack of 
Octβ2R::EGFP membrane localisation is probably because the EGFP insertion 
is only one amino acid away from a TM, and hence affected TM insertion and 
subsequently membrane targeting. The EGFP insertion is also within 5 amino 
acids away from a clathrin-associated binding motif which may also affect 
subcellular localisation. As Octβ2R::EGFP does not reflect subcellular 
localisation, it may be useful to replace the EGFP cassette with T2A-GAL4 to 
map the identity of neurons Octβ2R may be expressed in, because T2A-GAL4 
shows stronger signals and the full innervation patterns of these neurons (Diao 
et al., 2015; Gnerer et al., 2015). As T2A-GAL4 is inserted in a coding region 
intron of Octβ2R, its expression is also controlled by the same regulatory 
elements, which should better represent Octβ2R expression than promoter-
GAL4 lines. The disadvantage for using the T2A-GAL4 system is that a non-
GAL4 transcriptional driver must be used for colocalisation experiments with 
calyx-innervating neurons; and this is not available for the APL neuron. At the 
moment, the best alternative to map Octβ2R localisation in the larval MB calyx 
is the Octβ2R antibody (Wu et al., 2013) which I did not manage to obtain for 
this study.  
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5.3.6. Lack of Octβ3R::EGFP in the larval brain 
The lack of EGFP signals in the larval brain in both Octβ3R::EGFP (Phase 1) 
and Octβ3R::EGFP (Phase 0) stocks was unexpected. Between the two EGFP 
insertion phases, all Octβ3R protein isotopes including the 5 TM Octβ3R-PK 
isotype should contain the EGFP tag in the correct orientation for expression. It 
is possible that not all Octβ3R isotypes were expressed; and therefore, 
Octβ3R::EGFP signal might not be observed for at least one of the stocks. 
Another reason could be that Octβ3R expression levels in the larval brain were 
absent or too low to be detected. However, this was contrary to the fact that 
Octβ3R transcripts were detected in the larval brain using in situ hybridisation 
(Ohhara et al., 2012; El-Kholy et al., 2015). Moreover, I did not detect any 
Octβ3R::EGFP signals in the adult brain (data not shown). However, as 
Drosophila embryos show much higher Octβ3R mRNA levels than larvae or 
adults (Ohhara et al., 2012), it may be useful to check whether Octβ3R::EGFP 
signal can be detected at the embryonic stages in the future to confirm whether 
the problem lies with the Octβ3R::EGFP stocks.  
The MiMIC insertion site in the MI06217 stock used to generate these 
protein traps was not predicted to disrupt TM insertion – one of the most likely 
causes of protein misfolding and prevention of correct receptor localisation. 
However, the MiMIC insertion might have disrupted another conserved site that 
was integral for Octβ3R expression or localisation. Nevertheless, as I cannot 
determine whether the Octβ3R::EGFP stocks are functional or not, another 
Octβ3R protein trap or antibodies against Octβ3R would be required to show 
whether Octβ3R proteins are expressed in the larval brain.  
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Chapter 6. Expression of α2-adrenergic-like 
Octα2R in calyx-innervating neurons 
 
6.1. Introduction 
In addition to excitatory α1- and β-adrenoceptors, NA can also act via inhibitory 
α2-adrenoceptors, which have been shown to cause hyperpolarisation. In the 
larval calyx circuitry, I hypothesise that OA signalling from sVUM1 neurons has 
the flexibility of increasing or decreasing neuronal excitability of different calyx-
innervating neurons mediated by both excitatory and inhibitory OA receptors.  
 It has recently come to our knowledge that the CG18208 gene encodes a 
receptor that not only shares strong sequence similarities to the human α2-
adrenoceptor, but is also preferentially activated by OA (Qi et al., 2017). Similar 
to the cellular effects observed upon α2-adrenergic activation, activating the 
CG18208-encoded receptor also decreases intracellular cAMP levels and does 
not appear to affect intracellular calcium concentration. This receptor has now 
been renamed as Octα2R (Qi et al., 2017); and is likely to be the main OA 
receptor that mediates inhibitory functions of OA signalling in Drosophila.  
As Octα2R is newly cloned and characterised, it is not known where it is 
expressed in the Drosophila adult or larval CNS. As an α2-adrenergic-like 
receptor, it is probably localised to both pre- and post-synaptic terminals (Aoki 
et al., 1994; Rosin et al., 1996); where its presynaptic localisation is likely to 
regulate neurotransmitter release (Hein, 2006). It may also be co-expressed 
with excitatory OA receptors to mediate opposing functions; similar to the co-
expression of α1- and α2-adrenocepters on granule cells of the mammalian 
olfactory bulb (Nai et al., 2009). In addition, the presence of α2-autoreceptors at 
the presynaptic terminals of NA neurons (Aoki et al., 1994) suggests that 
Octα2R may also be localised to presynaptic terminals of sVUM1 neurons in the 
larval MB calyx.  
In this chapter, I aimed to determine whether sVUM1 signalling could be 
mediated by the inhibitory Octα2R in the larval MB calyx to inhibit particular 
types of calyx-innervating neurons (Fig. 6.1):  
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Figure 6.1. Hypothesised Octα2R localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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I hypothesised that Octα2R may be localised to the APL neuron and Odd-like 
neurons – for which I have yet to identify OA receptors that localise to their 
calyx terminals. I further hypothesised that Octα2R, similar to its mammalian 
counterpart α2-adrenoceptor, may act as an autoreceptor for sVUM1 neurons 
themselves. To explore the endogenous localisation of Octα2R in calyx-
innervating neurons, I generated a novel Octα2R::EGFP protein trap in the first 




6.2.1. A novel EGFP-tagged CG18208(Octα2R) line  
To visualise the expression of Octα2R in the larval MB calyx, I generated a 
CG18208(Octα2R)::EGFP protein trap using the MI10227 line from the MiMIC 
collection (Venken et al., 2011a; Fig. 6.2).  
MI10227 contained the MiMIC cassette in coding region intron 1 of the 
CG18208 gene, which corresponded to amino acid position 268 (Fig. 6.3) and 
thus the extracellular domain between TM IV and V of CG18208 proteins (Fig. 
6.4). Therefore, the position of the MI10227 insertion was not expected to 
disrupt TMs. I confirmed the MI10227 insertion location in the CG18208 gene 
by PCR reactions against the 5’ and 3’ flanking ends of the MI10227 insertion 
site (Fig. 6.5) and subsequent sequencing of the PCR products (Fig. S8, S9).  
 Nine recombinant CG18208::EGFP stocks were recovered after 
introducing EGFP cassette to MI10227. To identify a recombinant stock that 
was expected to express EGFP, I conducted PCR reactions for four of the new 
recombinant stocks. As the MI10227 insertion was in the opposite direction to 
the CG18208 gene, PCR products detected for PCR2 and PCR3 reactions 
indicated the correct EGFP cassette orientation for expression (Fig. 6.6A).  
  CG18208::EGFP Stock 4 was the only recombinant stock out of the four 
stocks assayed to show robust bands for PCR2 and PCR3 reactions (Fig. 6.6B), 
and therefore predicted to express Octα2R::EGFP (Table 6.1). This stock was 
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B. CG18208-PA tblastn alignment to Drosophila sequences 
 
Exon 1 
Query:   241 IMSALICIPPLLGWKVKMPEGPLPKCELS  269 
IMSALICIPPLLGWKVKMPEGPLPKCE+S 
18847671 IMSALICIPPLLGWKVKMPEGPLPKCEVS  18847585 
  
Exon 2 
Query:   259 PEGPLPKCELSEDIGYVLYSALGSFYIPSCIMVFVYIRIYFAAKARARRGIKKHPRKTNN 318 






Figure 6.3. MI10227 insertion was in coding region intron 1 of the CG18208 gene. (A) Map 
of MI10227 insertion relative to CG18208 gene and transcripts (Adapted from GBrowse). (B) 
Amino acid coordinates for the MI10227 insertion site based on tblastn alignment with CG18208 
transcripts. (C) Magnified map of MI10227 insertion in coding region intron 1 of CG18208 




Figure 6.4. MI10227 insertion was between TM IV and V of CG18208/Octα2R proteins. 
MI10227 insertion site relative to TM predictions (TMHMM) for the CG18208/Octα2R-PA 





Figure 6.5. PCR verification of MI10227 insertion in the CG18208 gene. (A) Primers 
designed against 5’ and 3’ flanking ends of the MI10227 insertion site in the CG18208 gene. (B) 
PCR products were detected for 5’ and 3’ ends of the MI10227 insertion. CS (denoted as +) 
DNA was used as a wild type control.  
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Figure 6.6. PCR validation of EGFP orientation in recombinant CG18208::EGFP stocks. 
(A1) Products for PCR1 and PCR 4 indicate EGFP insertion in the incorrect orientation for 
expression. (A2) Products for PCR2 and PCR3 indicate EGFP insertion in the correct 
orientation for expression. (B) Results for PCR reactions 1-4 for CG18208::EGFP Stocks 3 and 
4 (B1); and Stocks 5 and 6 (B2). Octβ2R::EGFP Stock 9 was used as a positive control for 
PCR2 and PCR3 reactions. Abbreviations: MiL/R, MiMIC sequences Left/Right; SA, splice 
acceptor site; SD, splice donor site; OriF, Orientation-MiL-F; OriR, Orientation-MiL-R; EGFP-F, 




  Table 6.1. One out of four recombinant CG18208::EGFP stocks contained EGFP in the 
correct orientation for expression. PCR products obtained from each of the PCR reactions 
(PCR1, PCR2, PCR3 and PCR4) were scored as follows: -, no bands observed; +, weak band 
observed; ++, strong band observed. PCR results were used to determine whether 
Octα2R::EGFP expression was expected (Expected Expression).   
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6.2.2. Octα2R::EGFP localised to cell bodies but not to neuropils 
Octα2R::EGFP, the fusion protein produced from the CG18208::EGFP stock, 
did not localise to the larval MB calyx. Instead, I observed Octα2R::EGFP 
signals in cell bodies near the calyx (n=3; Fig. 6.7, arrowheads). The identity of 
these cell bodies was unclear. Many of them were larger than 5 μm in diameter 
(Fig. 6.7A-F, empty arrowheads), suggesting that they were not KC cell bodies.  
To determine whether the lack of signal in the calyx is due to the 
retention of Octα2R::EGFP in cell bodies, I examined whether Octα2R::EGFP 
localised to other neuropils in the larval brain. Octα2R::EGFP localised only to 
cell bodies; but not to neuropils labelled by anti-Dlg or to any neuronal tracts or 
processes in the larval brain lobes viewed from both dorsal and frontal 
orientations (Fig. 6.8). This suggested that Octα2R::EGFP was not targeted to 
neuronal terminals. However, the CG18208::EGFP stock would still be useful 
for identifying neuronal cell bodies that expressed Octα2R through 
colocalisation experiments using molecular markers which label calyx-
innervating neurons.  
 
6.2.3. Octα2R::EGFP did not localise to KC cell bodies  
I identified several Octα2R::EGFP-positive cell bodies immediately dorsal to the 
larval MB calyx (n=3; Fig. 6.9, arrowheads), where KC cell bodies are normally 
located (Fig. 4.16A). However, while KC cell bodies are usually 3-5 μm in 
diameter, most of the Octα2R::EGFP-positive cell bodies in the region 
were >5μm in diameter (Fig. 6.9, empty arrowheads). This suggested that 
Octα2R::EGFP was probably not expressed in KCs.   
 
6.2.4. Octα2R::EGFP localised to GABAergic and PN cell bodies near AL 
Octα2R::EGFP localised to cell bodies near the AL (Fig. 6.8B, 6.10). To 
differentiate cholinergic PN cell bodies from the cell bodies of GABAergic AL 
local neurons, I examined the colocalisation of Octα2R::EGFP with anti-GABA 
(Fig. 6.10). Anterior to the AL, I identified both Octα2R::EGFP-positive cell 
bodies that colocalised with anti-GABA (Fig. 6.10E, filled arrowheads) and 
others that did not (Fig. 6.10E, empty arrowheads). This suggested that Octα2R 




 Figure 6.7. Octα2R::EGFP localised to cell bodies but not the larval MB calyx. Confocal 
optical sections of the calyx from two CG18208::EGFP individuals (A-F) with corresponding 
MI12417 negative controls (G-L). Green is Octα2R::EGFP and blue is anti-Dlg. Cell bodies >5 
μm in diameter are indicated with empty arrowheads; cell bodies <5 μm in diameter are 




Figure 6.8. Octα2R::EGFP localised to cell bodies but not major neuropils in the larval 
brain. Confocal projections of the dorsal and frontal brain lobe of CG18208::EGFP (A-B) with 
corresponding MI12417 negative controls (C-D). Green is Octα2R::EGFP and blue is anti-Dlg. 
Medial (M) is right; posterior (P) is up for (A,C) and dorsal (D) is up for (B,D). Scale bar: 50 μm.  
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  Figure 6.9. Octα2R::EGFP did not localise to KC cell bodies. Confocal optical sections 
taken immediately dorsal to the first calyx glomerulus (marked with anti-Dlg in blue) of 
CG18208::EGFP larval brains (A-C), with MI12417 negative controls (D-F). Octα2R::EGFP is 
green. Many Octα2R::EGFP-positive cell bodies (empty arrowheads) are >5 µm in diameter, 
larger than KC cell bodies. Cell bodies <5 μm in diameter are indicated with filled arrowheads. 




Figure 6.10. Octα2R::EGFP localised to GABA-positive cell bodies near AL. Confocal 
projections of the AL of CG18208::EGFP (A-B) with MI12417 negative control (C-D). (E) is an 
enlarged image of the cell bodies from dotted square in (A). Green is Octα2R::EGFP, red is 
anti-GABA and blue is anti-Dlg. Octα2R-GABA colocalisation indicated with filled arrowheads; 
Octα2R-positive cell bodies negative for GABA indicated with empty arrowheads. Medial (M) is 
right and dorsal (D) is up. Scale bar: 20 μm. 
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GABAergic neurons that may include PNs.  
I then examined whether Octα2R::EGFP localised to PN cell bodies 
labelled by NP225-GAL4. 8 ± 2.5 NP225-positive cell bodies near the AL co-
expressed Octα2R::EGFP (n=3; Fig. 6.11, filled arrows; Table 6.2). There were 
also many Octα2R::EGFP-positive cell bodies that were NP225-negative (Fig. 
6.11, empty arrowheads). This is consistent with the Octα2R-GABA data (Fig. 
6.10), suggesting that Octα2R::EGFP localised to subsets of both PN and 
GABAergic cell bodies near the AL.  
 One out of three larvae showed much lower number of cell bodies co-
expressing Octα2R::EGFP and NP225>RFP than the two other individuals 
(Table 6.2). The sample size was too small to determine whether this was an 
experimental artefact. However, if this variation persisted with a larger sample 
size, there could be several explanations for it. Third instar larvae may be at a 
developmental stage where Octα2R expression in PNs is transitioning between 
an on and off state – such that some individuals have more PNs that express 
Octα2R. The difference may also be experience-dependent, for example, only 
PNs that have been previously activated by odourants may express Octα2R. 
This is less likely as the larvae dissected were raised in the same environment. 
On the other hand, it could also be due to different levels of bleed through from 
the NP225>RFP construct. In the previous chapter, I observed bleed through 
from upto three brightly labelled NP225-positive cell bodies in the GFP channel 
in negative control genotypes (Fig. 5.11; Table 5.1, 5.3). This suggested that 
Octα2R::EGFP may only be localised to around 5 PN cell bodies labelled by 
NP225-GAL4.  
  
6.2.5. Octα2R::EGFP localised to OA cell bodies 
As α2-adrenoceptors can act as autoreceptors on NA neurons (Aoki et al., 
1994), I examined whether Octα2R was expressed in OA cell bodies in the 
larval brain. All of the OA-positive cell bodies at the ventral median of the SOG 
colocalised with Octα2R::EGFP (n=3; Fig. 6.12). This suggested that Octα2R 
was expressed in all the OA neuron cell bodies at the SOG ventral median 
midline, where the cell bodies of calyx-innervating sVUM1 neurons are located.  
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Figure 6.11. Octα2R::EGFP colocalised with some PN cell bodies labelled by NP225-
GAL4. Single confocal optical sections of the AL of NP225-GAL4/UAS-mCD8::RFP; 
CG18208::EGFP. Green is Octα2R::EGFP and red is NP225>RFP. Octα2R-GABA 
colocalisation indicated with filled arrows; Octα2R-positive cell bodies negative for NP225>RFP 




Genotype Individual Octα2R+/NP225+ 
NP225-GAL4/UAS-mCD8::RFP; 
CG18208::EGFP 
Individual 1 10 
Individual 2 3 






Table 6.2. Numbers of NP225-GAL4 cell bodies positive for Octα2R::EGFP. Abbreviations: 
Octα2R+, Octα2R::EGFP-positive; NP225+, NP225>RFP-positive; N, number; S.D., standard 




Figure 6.12. Octα2R::EGFP localised to OA-positive cell bodies. Confocal projections of the 
SOG of CG18208::EGFP (A) with MI12417 negative control (B). (C-F) are enlarged single 
confocal optical sections from the dotted box in (A) showing all the OA-positive cell bodies at 
the SOG ventral median. Octα2R-OA colocalisation indicated with arrowheads. Green is 
Octα2R::EGFP and red is anti-OA. OA cell body clusters are labelled: md (mandibular), mx 
(maxillary) and lb (labial). Anterior is up and medial is at vertical midline. Scale bar: 20 μm in (A-
B); 5 μm in (C-F). 
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6.2.6. Subcellular localisation of Octα2R::EGFP and OAMB::EGFP  
None of the six OA receptor-EGFP fusion proteins generated using the MiMIC 
recombinase-mediated cassette exchange method appeared to be fully 
functional: OAMB::EGFP was homozygous infertile (Section 4.2.2.), 
Octβ1R::EGFP was homozygous lethal (Section 5.2.1.1.), Octβ2R::EGFP and 
Octα2R::EGFP localised to cell bodies but not to neuropils (Sections 5.2.2.2. & 
6.2.2.), and neither Octβ3R::EGFP fusions showed any signals in the larval 
brain (Sections 5.2.3.2. & 5.3.2.3.). Interestingly, OAMB::EGFP and 
Octβ1R::EGFP localised to neuropils, while Octβ2R::EGFP and Octα2R::EGFP 
were retained in cell bodies. This suggested the EGFP cassette insertion 
disrupted correct protein localisation for Octβ2R and Octα2R, but probably 
affected other aspects of protein function for OAMB and Octβ1R, such as OA 
binding or G-protein signalling.  
 At the endoplasmic reticulum (ER), where proteins are translated and 
folded, misfolded proteins are recognised, prevented from exiting and 
eventually degraded (Sitia and Braakman, 2003). As Octβ2R::EGFP and 
Octα2R::EGFP only localised to cell bodies, this suggested they may be 
retained in the ER, probably because they were not correctly folded.  
To determine whether OA receptor-EGFP fusion proteins accumulated in 
the ER, I examined whether Octα2R::EGFP colocalised with two ER membrane 
markers: a mouse monoclonal calnexin (Cnx99a) antibody (Riedel et al., 2016) 
and a genetically encoded Sec61β::tdTomato fusion protein (Summerville et al., 
2016). I also examined whether Octα2R::EGFP colocalised with the plasma 
membrane marker 10XUAS-IVS-mCD8::RFP (Pfeiffer et al., 2010). As a 
comparison, I examined whether OAMB::EGFP colocalised with the same 
markers, as OAMB::EGFP localised to neuronal terminals despite not being 
fully functional. As both OAMB::EGFP and Octα2R::EGFP localised to PN and 
other cell bodies near the AL, I focused on this area of interest and used the PN 
driver NP225-GAL4 with the genetically encoded markers.  
To visualise the ER structure, I imaged OAMB::EGFP- and 
Octα2R::EGFP-positive cell bodies at twice the optimal resolution of the 
confocal microscope at a pixel size of 50 nm, while noting the maximum 
resolution for the microscope using a 40X lens with a numerical aperture of 1.3 
is actually around 150 nm. Nevertheless, this is still not at a sufficiently high 
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resolution for observing ER structures, which is usually around 30-50 nm in 
diameter (Schwarz and Blower, 2016). While I only had access to a standard 
confocal microscope, a microscope with higher resolving power, such as a 
stimulated emission depletion (STED) microscope with a resolution of 50 nm 
(Riedel et al., 2016), should ideally be used instead.  
 I observed anti-Cnx99a labelling in all the cell bodies near the AL (n=6; 
Fig. 6.13). A few of these cell bodies showed stronger anti-Cnx99a labelling 
than their neighbours (Fig. 6.13, empty arrowheads). These are probably 
neurosecretory cells as they contain large amounts of rough ER (Smirle et al., 
2013).  
Both EGFP fusion proteins colocalised with the Cnx99a ER marker (n=3 
each; Fig. 6.13), although the EGFP signal in cell bodies were more punctate 
and less continuous than ER labelling (Fig. 6.13B,D,E). Some degree of fusion 
protein-ER colocalisation was expected, as membrane proteins are produced 
and trafficked through the ER before they reach their target membranes. As 
there was no observable difference between OAMB::EGFP and Octα2R::EGFP 
colocalisation with the Cnx99a ER marker in cell bodies, this suggested that 
either both or neither of these fusion proteins accumulated in the ER. If both of 
the fusion proteins accumulate in the ER, non-functional OAMB::EGFP must 
also be recognised by ER quality control mechanisms. On the other hand, if 
neither of the fusion proteins accumulated in the ER, this suggested that even 
though Octα2R::EGFP did not localise to neuronal terminals, misfolded 
Octα2R::EGFP were probably degraded in the ER before it had the opportunity 
to aggregate. At the current resolving limit, it was difficult to determine whether 
the EGFP fusion proteins mislocalised to ER structures in the cell body or are in 
the cytoplasm where ER is also present.  
Compared to the Cnx99a ER antibody, the Sec61β::tdTomato ER marker 
showed stronger signals and more defined ER structures (n=6; Fig. 6.14). 
OAMB::EGFP signal generally colocalised with the Sec61β::tdTom marker, 
although OAMB::EGFP again was more punctate and did not perfectly coincide 
with sites with slightly stronger Sec61β::tdTom signals (n=3; Fig. 6.14A-B). This 
suggested that OAMB::EGFP and the ER were both present in the cytoplasm, 







Figure 6.13. OAMB::EGFP and Octα2R::EGFP colocalisation with ER marker anti-
calnexin99a. Confocal optical sections of the AL of NP225-GAL4/UAS-mCD8::RFP; 
OAMB::EGFP (A-B) and NP225-GAL4/UAS-mCD8::RFP; CG18208::EGFP (C-E). (B) is an 
enlarged image of the cell bodies indicated in (A); while (D,E) are enlarged images of cell 
bodies indicated in (C). Red is NP225>RFP, blue is anti-calnexin99A (Cnx99a). Green is 
OAMB::EGFP in (A-B) and Octα2R::EGFP in (C-E). Empty arrowheads indicate cell bodies with 
strong Cnx99a labelling. Medial (M) is right and dorsal (D) is up. Scale bar: 20 μm in (A,C), 5 
μm in (B,D-E). 
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Figure 6.14. OAMB::EGFP and Octα2R::EGFP colocalisation with ER marker 
Sec61β::tdTom. Confocal optical sections of the AL of NP225-GAL4/UAS-Sec61β::tdTom; 
OAMB::EGFP/+ (A-B) and NP225-GAL4/UAS-Sec61β::tdTom; Octα2R::EGFP/+  (C-D). (B) and 
(D) are enlarged images of cell bodies indicated by filled arrowheads in (A) and (C) 
respectively. Red is NP225>Sec61β::tdTom. Green is OAMB::EGFP in (A-B) and 
Octα2R::EGFP in (C-D). Medial (M) is right and dorsal (D) is up. Scale bar: 20 μm in (A,C), 5 
μm in (B,D). 
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Octα2R::EGFP colocalised very well with all NP225>Sec61β::tdTom-positive 
cell bodies (n=3; Fig. 6.14C-D), even better than NP225>Sec61β::tdTom 
colocalisation with OAMB::EGFP (Fig. 6.14A-B). This was unexpected as 
Octα2R::EGFP only colocalised with a maximum of 11 NP225-positive cell 
bodies (Fig. 6.11; Table 6.2) in a previous experiment to determine 
Octα2R::EGFP localisation to PN cell bodies. This suggested that some of the 
Octα2R::EGFP signal observed may be caused by bleed through from the very 
bright Sec61β::tdTom marker. It was likely that NP225>Sec61β::tdTom also 
bled through in the OAMB::EGFP experiment; but the more robust 
OAMB::EGFP signal in most of the NP225-positive cell bodies obscured some 
of the bleed through signal. Given the possibility of bleed through, this renders 
the Octα2R::EGFP-Sec61β::tdTom colocalisation unreliable for interpretation, 
unless I could show that a NP225>Sec61β::tdTom negative control without any 
GFP constructs did not show any signal in the GFP channel.  
Finally, both of the fusion proteins also colocalised with the mCD8::RFP 
plasma membrane marker in the cytoplasm but not at the plasma membrane of 
cell bodies (Fig. 6.13B,D). This was unsurprising as I expected OA receptors to 
localise to the plasma membrane of terminals but not to that of cell bodies. 
Nevertheless, this was useful for showing that the fusion proteins and Cnx99a 
ER marker localised to the cytoplasm and not to the plasma membrane.   
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6.3. Discussion 
As the only tool available for Octα2R expression analyses, the newly generated 
CG18208::EGFP is not only useful for identifying Octα2R localisation to larval 
neuronal cell bodies, but could also be used to identify cells in other Drosophila 
tissues or developmental stages that may express Octα2R. There are currently 
no data on α2-adrenergic-like OA receptor localisation in other insects – making 
this the first and only known attempt in mapping α2-adrenergic-like OA 
receptors in insects.   
 Similar to Octβ2R::EGFP in Chapter 5, Octα2R::EGFP signal was 
detected in cell bodies but not membrane terminals, and therefore also shared 
possible risks of mislocalisation. The reason for Octα2R::EGFP retention in cell 
bodies is less obvious, as the EGFP insertion site is more than five amino acids 
away from any TMs or motifs for functional domains (Qi et al., 2017). This 
suggests that it is difficult to identify the optimal EGFP knock-in site, even when 
there is a choice such as CRISPR targeting, as a seemingly neutral insertion 
site could still prevent localisation to membrane terminals. I also used 
OAMB::EGFP and Octα2R::EGFP as examples to explore whether non-
functional fusion proteins accumulated in the endoplasmic reticulum – a 
subcellular organelle where misfolded proteins are often detected and retained. 
These results will be discussed in Section 6.3.4. 
 
6.3.1. Octα2R expression in sVUM1 neurons  
The localisation of Octα2R to all the OA neurons (Fig. 6.15) was unsurprising, 
as its homologue α2-adrenoceptor also localised to NA neurons (Aoki et al., 
1994). This supports the conservation between Octα2R and mammalian α2-
adrenoceptors; while simultaneously suggesting that Octα2R may regulate the 
activity of OA neurons in the larval brain. 
 Octα2R would most likely act as an auto-inhibitory receptor which exerts 
feedback control of OA release at presynaptic terminals, including that of 
sVUM1 neurons in the larval calyx. Octα2R may also mediate lateral inhibition 
between OA neurons, for example between sVUMmd1 and sVUMmx1 neurons 
in the calyx, that is OA signalling from sVUMmd1 may suppress the sVUMmx1 





Figure 6.15. Proposed Octα2R localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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observed in the L1 connectomics data (Eichler et al., 2017; NeuroFLP). 
However, whether Octα2R is localised to pre- and/or post-synaptic terminals of 
OA neurons remains to be identified through an alternative method, such as 
anti-Octα2R labelling. 
 
6.3.2. Possible Octα2R expression in some PN cell bodies  
Provided this was not an artefact from NP225>RFP bleed through, this 
observation would suggest that a subset of olfactory PN cell bodies of variable 
number is also positive for Octα2R::EGFP expression (Fig. 6.15). As speculated 
in Section 6.2.4., this variation may be due to developmental stochasticity or 
experience-depedent mechanisms.  
I did not expect Octα2R to be expressed in PNs, as PNs already 
expressed OAMB, Octβ2R and possibly Octβ1R (Chapters 4 & 5). It is currently 
unclear whether the different types of OA receptors are expressed on the same 
or different subsets of olfactory PNs. It is possible that they are grouped based 
on the odour quality encoded by individual PNs, as each PN relays olfactory 
information from a single type of olfactory receptor. Individual PNs can be 
identified by using specific driver lines that each label single PNs. Alternatively, 
OA receptors could be tagged with spectrally distinct fluorescent reporters to 
determine expression in common and distinct neurons, as well as, to explore 
the possibility of differential subcellular localisation.  
Octα2R localisation to PN axons would exert an additional layer of 
control over PN output by OA signalling depending on the OA signal given by 
the sVUM1 neurons, provided that different types of OA receptors are activated 
depending on OA concentration. When OAMB and/or Octβ2R are activated at 
PN axons, this would likely increase PN inputs to KCs; while Octα2R activation 
would reduce PN inputs.   
 
6.3.3. Possible Octα2R expression in other calyx-innervating neurons 
The lack of Octα2R in KCs could be because Octβ1R localisation to KC 
dendrites is already fulfilling the role of an inhibitory OA receptor there. While 
Octβ1R is considered to be mainly coupled to the excitatory Gs pathway, there 
is one example of its coupling to the inhibitory Go pathway which decreases 
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intracellular cAMP levels and act to inhibit synaptic growth at the NMJ (Koon 
and Budnik, 2012).  
Preliminary observations of Octα2R::EGFP localisation in the larval CNS 
suggest that Octα2R may also be expressed in the APL neuron and Odd-like 
neurons. Octα2R::EGFP localisation to GABAergic cell bodies near the AL, 
suggest that Octα2R may be able to modulate GABAergic inhibition. This may 
extend to the modulation of the GABAergic APL neuron. Octα2R::EGFP signals 
in dorsal cell bodies near the calyx larger than 5 μm in diameter suggests that 
Octα2R could be expressed in Odd-like neuron cell bodies as well. However, I 
have not managed to confirm the identity of Octα2R::EGFP-positive cell bodies 
yet with molecular markers for these neurons.  
Hypothetical Octα2R localisation to APL axons in the calyx might reduce 
the levels of inhibition from the APL neuron on KCs. This would lead to 
decreased sparseness of KC activity, increased correlation of odour 
representations and worse odour discrimination; similar to the effects observed 
when APL activity is genetically blocked (Lin et al., 2014; Masuda-Nakagawa et 
al., 2014). On the other hand, Octα2R localisation on Odd-like neurons would 
probably decrease the output signal carried by cholinergic output neurons from 
the calyx.   
 
6.3.4. Colocalisation of OAMB::EGFP and Octα2R::EGFP with ER markers 
Both OAMB::EGFP and Octα2R::EGFP colocalised with ER but not plasma 
membrane markers in cell bodies, even though OAMB::EGFP localised to 
membrane terminals while Octα2R::EGFP was retained in cell bodies. Due to 
the limited resolving power of the confocal microscope (around 150 nm), 
compared to the size of rough ER in the cell bodies (around 30-50 nm) 
(Schwarz and Blower, 2016), it was not possible to determine whether the 
fusion proteins localised to the ER itself, or if the ER and the fusion proteins 
merely occupy the cytoplasmic compartment of neuronal cell bodies. Therefore, 
a higher resolution microscope such as the STED (50 nm resolution) would be 
required to visualise ER structures.  
This was further hindered by the lack of clear and specific ER markers. 
Anti-Cnx99a signal was observed in the cytoplasm of all cell bodies which made 
it difficult to control for signal versus background, and only showed strong 
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labelling for cell bodies that contained a lot of rough ER. On the other hand, the 
genetically encoded Sec61β::tdTom suffered bleed through into the GFP 
channel, probably due to the wider emission spectrum of the red fluorescent 
tdTomato protein that displays substantial overlap with the Alexa 488 
fluorophore used to amplify GFP signals (ThermoFisher Fluorescence Spectral 
Viewer: https://www.thermofisher.com/).  
 OAMB::EGFP and Octα2R::EGFP signal in the cell body appear to be at 
similar intensities. As most proteins are translated at the ER before they are 
trafficked to the plasma membrane, a baseline level of fusion proteins are 
expected to be present at the ER. It is unknown what this baseline would be for 
OA receptors as it may vary depending on protein turnover rates; and how this 
correlates to the intensity of EGFP fusion proteins. The lack of OAMB::EGFP 
and Octα2R::EGFP colocalisation with the plasma membrane marker in the cell 
body is also expected; as receptor proteins probably localise to the plasma 
membrane at synaptic terminals but not cell bodies. Moreover, if misfolded 
proteins are rapidly recognised and degraded in the ER, there will also not be a 
difference in EGFP signal between fusion proteins that are functional or non-
functional. Therefore, it is impossible to quantify whether fusion proteins are 
accumulating in the ER. Alternatively, it might be useful to explore whether non-
functional fusion proteins accumulate in compartments where misfolded 
proteins are degraded – such as proteasomes or lysosomes; provided there is a 
baseline control to show that it is different to the turnover and degradation of its 
functional protein counterpart.  
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Chapter 7. Expression patterns of GABA 
receptors in sVUM1 neurons 
 
7.1. Introduction 
Putative synaptic connections have been detected between sVUM1 neurons 
and the GABAergic APL neuron using GRASP in the larval calyx. As the APL 
neuron is also presynaptic in the larval calyx (Masuda-Nakagawa et al., 2014), it 
is possible sVUM1 neurons are regulated by GABAergic inhibition by the APL 
neuron in the larval calyx. In this chapter, I aimed to determine whether sVUM1 
neurons expressed any GABA receptors which would allow sVUM1 neurons to 
respond to APL signalling in the larval MB calyx.  
 There are four known types of GABA receptors in Drosophila: an 
ionotropic GABAAR, a GABA-gated chloride channel (Hosie et al., 1997); and 
three metabotropic GABABRs – GABABR1, GABABR2 and GABABR3 (Mezler et 
al., 2001). GABABRs are G-protein coupled receptors which generally inhibit 
neuronal activity by presynaptically downregulating voltage-gated Ca2+ 
channels to inhibit neurotransmitter release (Bettler et al., 1998), or 
postsynaptically activating inward rectifying K+ channels resulting in 
hyperpolarisation (Kaupmann et al., 1998). In Drosophila, GABABR1 and 
GABABR2 are functional heterodimers that show co-expression; while 
GABABR3 is not co-expressed with the other two receptors (Mezler et al., 
2001).  
  Both GABAAR and GABABR are localised to the adult MBs (Enell et al., 
2007; Liu et al., 2007); where the GABAAR subunit Rdl has been shown to 
affect olfactory processing in KCs. The overexpression of Rdl in KCs inhibited 
calcium responses in the MB and impaired memory acquisition; while Rdl 
knockdown in KCs improved memory formation (Liu et al., 2007). The RNAi-
mediated knockdown of Rdl, but not GABABR, in KCs reduced the sparse and 
selective activity in KCs required for odour discrimination (Lei et al., 2013). As 
blocking APL activity results in the same phenotype as Rdl knockdown in KCs 
(Lei et al., 2013; Lin et al., 2014), this suggests that Rdl is mediating the 
signalling effects of APL on KCs. On the other hand, the function of GABABR in 
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the MB remains unknown, and may instead function on non-KC neurons in the 
MB. However, the localisation and requirement of GABA receptors on non-KC 
neurons innervating the MB calyx are yet to be tested. 
 In the larval CNS, the localisation of GABAAR and the 
GABABR1/GABABR2 complex has previously been visualised using antibodies 
against the GABAAR subunit Rdl and GABABR2 respectively (Enell et al., 2007). 
This has revealed that GABAAR and the GABABR1/GABABR2 complex localise 
to the larval MB calyx (Enell et al., 2007); and KC cell bodies are additionally 
immunoreactive to Rdl (Enell et al., 2007). On the other hand, it is unclear 
whether GABA receptors are expressed in sVUM1 neurons as well, as the 
strong immunoreactivity against both GABA receptors throughout the calyx 
might be overshadowing other populations of neurons to which these receptors 
are localised.  
 To determine whether sVUM1 neurons could be regulated by GABA 
signalling, here I used Rdl::EGFP and GABA-B-R1::EGFP protein traps to 
examine whether the GABAA receptor subunit Rdl and the GABABR1/R2 
complex were expressed in sVUM1 neurons (Fig. 7.1). 
 
 
Figure 7.1. Hypothesised GABA receptor localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 




7.2.1. Rdl::EGFP localisation in sVUM1 neurons 
To determine whether sVUM1 neurons expressed the ionotropic GABAA 
receptor, I used the Rdl::EGFP line from the MiMIC RMCE collection (Venken et 
al., 2011a; Nagarkar-Jaiswal et al., 2015; Fig. 7.2) to visualise the localisation of 
the GABAA receptor subunit Rdl.   
 As expected from immunolabelling data (Enell et al., 2007), Rdl::EGFP 
localised to KC cell bodies dorsal to the calyx (Fig. 7.3A). However, contrary to 
immunolabelling data, Rdl::EGFP did not localise to the MB calyx (Fig. 7.3B). 
This suggested that the Rdl::EGFP fusion protein from the Rdl::EGFP line was 
not targeted to synaptic terminals, and could only be used to identify cell bodies 
that express Rdl.  
While I could not determine whether Rdl localised to the calyx terminals 
of sVUM1 neurons, I detected Rdl::EGFP signal in all the OA-positive cell 
bodies at the ventral midline of the SOG region (n=4; Fig. 7.4, arrowheads). 
This suggested that Rdl was expressed in all OA neuronal cell bodies, including 
sVUM1 cell bodies, although its subcellular localisation is unknown.  
 
7.2.2. GABA-B-R1::EGFP did not localise to presynaptic calyx terminals of 
sVUM1 neurons 
To determine whether sVUM1 neurons expressed the metabotropic 
GABABR1/R2, I used a GABA-B-R1::EGFP line selected from the MiMIC RMCE 
collection (Venken et al., 2011a; Nagarkar-Jaiswal et al., 2015; Fig. 7.5) to 
visualise the localisation of the GABABR1/R2 heterodimer complex. 
  Consistent with anti-GABABR2 immunostaining, I observed strong GABA-
B-R1::EGFP signals throughout the calyx (n=4; Fig. 7.6). GABA-B-R1::EGFP 
localised diffusely in the interglomerular region and showed stronger localised 
signals in calyx glomeruli (Fig. 7.6A-D). The diffuse localisation pattern 
suggested that GABABR1 localised to KCs, while the glomerular localisation 
pattern suggested GABABR1 also localised to PNs. However, this requires 
confirmation with KC and PN markers.  
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Figure 7.3. Rdl::EGFP localised to KC and other dorsal cell bodies but not to MB calyx. 
Confocal optical sections of the calyx of Rdl::EGFP (A-B) with MI12417 negative control (C-D). 
Green is Rdl::EGFP and blue is anti-Dlg. Medial (M) is right and posterior (P) is up. Scale bar: 




Figure 7.4. Rdl::EGFP signal localised to OA neuron cell bodies at SOG. Confocal optical 
sections of the SOG from three Rdl::EGFP individuals (A-C) with MI12417 negative controls (D-
E). Green is Rdl::EGFP and red is anti-OA. (C) is enlarged from the dotted box in (B). 
Arrowheads indicate Rdl::EGFP-OA colocalisation. OA cell body clusters are labelled: md 
(mandibular), mx (maxillary) and lb (labial). Anterior is up, medial is vertical mid-line. Scale bar: 
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Figure 7.5. GABA-B-R::EGFP recombinant stock listed on the Gene Disruption Project 











Figure 7.6. GABA-B-R1::EGFP did not colocalise with OA puncta in MB calyx. Confocal 
optical sections of the calyx from two GABA-B-R1::EGFP individuals (A-D) with MI12417 
negative controls (E-F). Green is GABA-B-R1::EGFP, red is anti-OA and blue is anti-Dlg. 
GABA-B-R1::EGFP-positive puncta are indicated with filled arrowheads, while OA puncta are 
indicated with empty arrowheads. Medial (M) is right and posterior (P) is up. Scale bar: 20 μm in 




I also observed GABA-B-R1::EGFP-positive puncta in the interglomerular 
region (n=4; Fig. 7.6B,D, filled arrowheads). This suggested that another type of 
non-KC, non-PN neuron expresses GABABR1. None of the GABA-B-R1::EGFP-
positive puncta (Fig. 7.6B,D, filled arrowheads) colocalised with OA puncta (Fig. 
7.6B,D, empty arrowheads). This suggested that GABA-B-R1 did not localise to 
the presynaptic OA terminals of the sVUM1 neurons in the larval MB calyx.  
On the other hand, some but not all OA-positive cell bodies expressed 
GABA-B-R1::EGFP at the ventral midline of the SOG region (n=3; Fig. 7.7). 
While it was not possible to identify whether sVUM1 neurons were among the 
cell bodies that expressed GABA-B-R1::EGFP, the lack of colocalisation of 
GABA-B-R1::EGFP signal with OA puncta in the calyx suggested that the 
metabotropic GABABR1/R2 heterodimer was not responsible for mediating 
GABAergic modulation of sVUM1 neurons from the APL neuron in the calyx.  
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Figure 7.7. GABA-B-R1::EGFP localised to some OA neuron cell bodies at SOG. Confocal 
optical sections of the SOG from two GABA-B-R1::EGFP individuals (A-D) with MI12417 
negative controls (D-E). Green is GABA-B-R1::EGFP and red is anti-OA. Some OA cell bodies 
colocalised with GABA-B-R1::EGFP (filled arrowheads), others did not (empty arrowheads). 
Anterior is up, medial is vertical midline. OA cell body clusters are labelled: md (mandibular), mx 






7.3.1. GABA receptor localisation on sVUM1 neurons 
While it is known that Rdl and GABABRs localised to the larval MB calyx (Enell 
et al., 2007), this is the first study to consider GABA receptor localisation on 
calyx-innervating neurons besides KCs and PNs. I found that Rdl::EGFP was 
expressed in all OA neuronal cell bodies at the ventral midline of the SOG, 
suggesting that sVUM1 neurons may express the ionotropic GABAAR (Fig. 7.8). 
On the other hand, GABABR1::EGFP did not localise to the presynaptic 







GABAAR expression suggests that sVUM1 neurons are susceptible to 
fast and reversible ionotropic inhibition. While my data cannot show where 
Rdl::EGFP is localised subcelullarly, if Rdl (and therefore GABAAR) is indeed 
localised to the calyx terminals of sVUM1 neurons, this would suggest that 
sVUM1 neurons may be subjected to GABAergic signalling from the APL 
neuron. As the APL neuron receives input from KC axons (Lin et al., 2014; 
Masuda-Nakagawa et al., 2014), this suggests that if sVUM1 neurons contained 
calyx-localised GABAAR, they could be indirectly inhibited by KC outputs via the 
APL neuron. Functionally, this may form a feedback loop where KC outputs 
Figure 7.8. Proposed GABA receptor localisation pattern in larval MB calyx circuitry. 
Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, centroposterior medial 
compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron. 
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inactivate sVUM1 activity to maintain temporal resolution of OA signalling in the 
larval MB calyx.  
The pharmacological block of GABAAR neurotransmission in the 
honeybee MB calyx impairs reversal learning, in which honeybees learn to 
respond to a change in valence of the same stimulus (Boitard et al., 2015). 
Unlike the behavioural prediction from knocking down GABAAR in KCs in the 
adult fly (Lei et al., 2013), odour discrimination is not impaired when GABAAR is 
non-specifically blocked in the honeybee calyx (Boitard et al., 2015). This 
suggests GABAAR-mediated inhibition on non-KC neurons in the calyx, such as 
OA neurons, may be involved in reversal learning.  
On the other hand, GABAAR may also localise to the AL terminals of 
sVUM1 neurons (Selcho et al., 2014), as the AL receives a lot of GABAergic 
input from AL local neurons (Wilson and Laurent, 2005; Thum et al., 2011); or to 
sVUM1 dendrites in the SOG region. In this scenario, GABAergic inhibition from 
outside the MB would be important in controlling the activity of sVUM1 
modulation in the larval MB calyx.   
Although metabotropic GABABR1/R2 do not localise to sVUM1 terminals 
in the larval MB calyx, sVUM1 neurons may still be subjected to slower GABA 
modulation if the metabotropic GABABR3 localised to their calyx terminals 
instead. 
 
7.3.2. GABA-B-R1::EGFP localisation to other calyx-innervating neurons 
Although GABA-B-R1::EGPP did not colocalise with OA terminals in the larval 
MB calyx, its localisation pattern suggested that GABABR1 may be localised to 
multiple types of calyx-innervating neurons: including KC dendrites which may 
be responsible for the diffuse glomerular and interglomerular signal, PN 
terminals responsible for the stronger labelling in calyx glomeruli, as well as 
another type of extrinsic neurons, which may account for the GABA-B-
R1::EGFP-positive boutons observed in the interglomerular region of the calyx. 
This level of detail was probably not visible using anti-GABABR2, as Enell 
et al. (2007) had proposed that based on their staining results, GABABR1 was 
probably localised to KC dendrites in the calyx but did not discuss whether the 
receptor may also localise to other cell types in the calyx. Identifying GABA-B-
R1::EGFP-positive cell bodies with molecular markers, together with cell-type 
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specific knockdown of GABA-B-R1::EGFP, could potentially reveal the different 
types of calyx-innervating neurons that contain GABABR1 at their calyx 
terminals.  
 
7.3.3. EGFP-tagged GABA receptors as an alternative to antibodies 
The GABA receptor expression patterns in the larval CNS visualised through 
GABA receptor protein traps are generally in agreement with what was 
previously observed using antibodies against GABA receptors. For example, 
anti-GABABR2 and GABA-B-R1::EGFP both localised to the larval MB calyx; 
while anti-Rdl and Rdl::EGFP were both observed in KC cell bodies. This 
suggests that fusion proteins are generally able to recapitulate antibody 
expression patterns. However, there is always a risk that the EGFP insertion 
could cause misexpression or mislocalisation of functional receptors, as 
discussed in previous chapters. The other limitation of protein traps is that the 
fusion protein it produced, such as from Rdl::EGFP, did not always successfully 
localise to neuronal terminals. In this case, it may be useful to convert EGFP to 
T2A-GAL4 to visualise the full innervation patterns of neurons expressing Rdl 
(Diao et al., 2015; Gnerer et al., 2015).  
On the other hand, anti-GABABR2 did not label any cell bodies (Enell et 
al., 2007). Therefore, it was impossible to confirm the identities of the neurons 
expressing GABA receptors in a structure which shows strong anti-GABABR2, 
such as the larval MB calyx. As GABA-B-R1::EGFP localised to cell bodies as 
well as neuropils, it is more useful for identifying neurons expressing GABAB 
receptors and their subcellular localisation. Here, antibody labelling and protein 




Chapter 8. Genetic tools for testing the OA 
modulatory circuitry of the larval MB calyx 
 
8.1. Introduction 
To understand the OA modulatory circuitry in the larval MB calyx, it is necessary 
to test the functionality of the OA connections identified through anatomical 
methods. How do neurons expressing the different OA receptors in the calyx 
respond to OA signalling from the sVUM1 neurons? How are sVUM1 neurons 
themselves regulated by calyx-innervating neurons? How does sVUM1 
signalling modulate odour representations in the calyx; and how does this affect 
olfactory perception and odour discrimination behaviour in the larvae?  
 To address these questions, it is essential to have the appropriate tools 
to isolate each component of the OA modulatory calyx circuitry for genetic 
manipulation and assay for functionality or behaviour. The binary expression 
system in Drosophila is well-developed for a wide range of genetic 
manipulations from conditional neuronal activation and silencing, to imaging 
neuronal activity in vivo. The availability of strong and specific transcriptional 
drivers of the neurons of interest is integral for testing neuronal functions. Such 
drivers are required to ensure that any phenotypic effects observed are due to 
the neurons of interest, but not the other neurons labelled in the driver. In this 
chapter, I aimed to confirm the expression pattern of specific sVUM1 and Odd-
like neuron driver lines.  
 
8.1.1. Confirming specific sVUM1 expression in published lines 
To investigate the functions of OA signalling in the MB calyx, it is necessary to 
limit genetic manipulation to the calyx-innervating sVUM1 neurons without 
affecting other OA neurons.  
  Traditionally, the Tdc2-GAL4 line has been used to study OA neurons in 
Drosophila. Tdc2-GAL4 contains the yeast GAL4 transcription factor upstream 
to the coding start of the Tdc2 gene, which encodes the tyrosine decarboxylase 
enzyme required for TA and OA biosynthesis (Cole et al., 2005). Two Tdc2-
LexA::VP16 lines were later generated by inserting the regulatory region used in 
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Tdc2-GAL4 into a LexA cloning vector (Burke et al., 2012). In the adult fly brain, 
Tdc2-GAL4 and Tdc2-LexA label all OA-positive neurons. Tdc2-LexA also has 
additional labelling in the central complex (Burke et al., 2012).  
 Using clonal analysis, Selcho et al. (2014) has shown that two types of 
OA neurons innervate the larval MB calyx – sVUMmd1 and sVUMmx1 
(collectively known as sVUM1 neurons) – labelled by the Tdc2-GAL4 line. I 
have previously confirmed that the calyx-innervating neurons labelled in Tdc2-
GAL4 and Tdc2-LexA are responsible for all the anti-OA staining in the larval 
MB calyx (H.W., MPhil Thesis 2014).  
 The cell bodies of all 24 OA neurons innervating the Drosophila larval 
brain are located at the SOG region (Selcho et al., 2014). As Tdc2-GAL4 and 
Tdc2-LexA lines labelled all of the OA-positive cell bodies in the SOG (Selcho et 
al., 2014; H.W., MPhil Thesis 2014), these lines labelled many other OA 
neurons in addition to the calyx-innervating sVUM1 neurons. In addition, Tdc2-
GAL4 also labelled OA neurons in the ventral nerve cord, neurons that were 
solely TA-positive (Selcho et al., 2012, 2014), as well as KCs in the larval calyx 
(H.W., MPhil Thesis 2014). Although it has not been verified, it is likely that 
Tdc2-LexA also labels OA motorneurons and TA neurons, as its adult 
expression pattern overlaps with that of Tdc2-GAL4 (Burke et al., 2012). 
Therefore, it would be difficult to isolate the functions of sVUM1 neurons from 
other OA neurons using these lines, which is not ideal for investigating OA 
signalling in the larval calyx circuitry.  
 Here, I labelled a selection of Janelia Farm Fly Light GAL4/LexA lines 
(Jenett et al., 2012; L. Masuda-Nakagawa, personal communication) with OA to 
confirm whether these lines labelled sVUM1 neurons.  
 
8.1.2. Confirming expression of specific Odd-like neuron lines 
In addition to a specific sVUM1 line for manipulating OA signalling in the larval 
calyx, it is also useful to have specific lines to test the functions of potential 
synaptic partners of sVUM1 neurons in the calyx, such as Odd-like neurons.  
 The current driver lines available to label Odd-like neurons, OK263-GAL4 
(L. Masuda-Nakagawa, personal communication) and Odd-GAL4 (Slater et al., 
2015), both label a cluster of cell bodies whose tracts merge into a single tract 
before projecting to the calyx. Therefore, it was difficult to identify the cell bodies 
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that project to the calyx from those that do not, especially for determining 
whether Odd-like neurons expressed OA receptors in previous chapters. Here I 
aimed to confirm the expression patterns of Janelia Farm Fly Light GAL4/LexA 




8.2.1. OA labelling of candidate lines that label sVUM1 neurons  
Candidate transcriptional driver lines that strongly labelled sVUM1 neurons 
were identified from the Janelia FlyLight collection (Jenett et al., 2012; Li et al., 
2014; L. Masuda-Nakagawa, J. Truman, personal communication). To confirm 
the innervation pattern of the selected lines, I labelled these lines by crossing 
them to UAS-mCD8::GFP or LexAOp-mCD8::GFP and analysed resulting 
images to find out whether 1) there were OA-immunoreactive cell bodies near 
the SOG ventral median (sVM) mandibular (md) and sVM maxillary (mx) 
clusters, where the cell bodies of sVUMmd1 and sVUMmx1 are located 
respectively (Selcho et al., 2014); and 2) whether there was calyx innervation 
that colocalised with anti-OA staining. Using these criteria, five out of sixteen 
candidate lines labelled sVUM1 neurons (Table 8.1).  
 
8.2.1.1. R34A11-GAL4 and R34A11-LexA labelled sVUM1 neurons but few 
other OA neurons 
In the larval MB calyx, anti-OA labelling colocalised with both R34A11-
GAL4>mCD8::GFP (n=2; Fig. 8.1A) and R34A11-LexA>mCD8::GFP (n=2; Fig. 
8.1B-C) processes. This confirmed that these lines labelled the OA sVUM1 
neurons. In addition to sVUM1 neurons, R34A11-LexA also showed diffuse 
labelling in the larval calyx characteristic of KC dendrites (n=2; Fig. 8.1B-C).  
At the sVM, R34A11-GAL4>mCD8::GFP colocalised with five OA-
positive cell bodies (Fig. 8.2A): 2 sVMmd cell bodies, 2 sVMmx cell bodies, and 
1 cell body in the sVM labial (lb) cluster (n=2; Fig. 8.2B-E, arrowheads). 
R34A11-GAL4 also labelled many other OA-negative neurons in the SOG 
region (Fig. 8.2A). Therefore, R34A11-GAL4 would be a good candidate for 










Calyx innervation; 2 OA-positive cell 
bodies each in sVMmd and sVMmx 
clusters; some OA-negative cell 
bodies 
Yes 8.1, 8.2 
R34A11-LexA Sema-1a 
Calyx innervation; 1 OA-positive cell 
body each in sVMmd and sVMmx 
clusters; 2 OA-negative cell bodies in 
SOG region; weak KCs 
Yes 8.1, 8.3 
NP7088-GAL4 
 
Calyx innervation; all OA-positive cell 
bodies in SOG; some OA-negative 
cell bodies in SOG 
Yes 8.4, 8.5 
R76H04-GAL4 Tβh 
Calyx innervation; all OA-positive cell 
bodies in SOG;  some OA-negative 
cell bodies in SOG; weak KCs 
Yes 8.4, 8.6 
R57F09-LexA Tdc2 
Calyx innervation; all OA-positive cell 
bodies in SOG 
Yes 8.4, 8.7 
R76G06-GAL4 Tβh 
No calyx innervation; many OA-
positive cell bodies in the SOG 
No 8.8, 8.9 
R76H03-LexA Tβh No OA-positive neurons No 8.10 
R43E08-GAL4 dmrt93B 




R76G07-GAL4 Tβh KCs, no OA-positive neurons 
No 
 
R76G11-GAL4 Tβh KCs, no OA-positive neurons 
No 
 









Several OA-negative cell bodies 









1 OA-negative cell body near sVMmx 
cluster, 2 OA-negative cell bodies 










Table 8.1. Summary of anti-OA labelling of sVUM1 drivers. Reference for stocks: NP7088-






Figure 8.1. R34A11-GAL4 and R34A11-LexA colocalised with anti-OA in the larval calyx.  
mCD8::GFP is green, anti-OA is red and anti-Dlg is blue. (A) Confocal projection of the calyx of 
R34A11-GAL4>UAS-mCD8::GFP. (B-C) Confocal projection (B) and single confocal optical 
section (C) of the calyx of R34A11-LexA>LexAOp-mCD8::GFP. Anterior (A) is up, lateral (L) is 






Figure 8.2. R34A11-GAL4 colocalised with five OA-positive cell bodies in the SOG. 
R34A11-GAL4>UAS-mCD8::GFP is green, anti-OA is red, anti-Dlg is blue. (A) Confocal 
projection of the SOG. (B-E) Single confocal optical sections taken from dotted square in (A). 
R34A11-GAL4 colocalisation with OA is indicated with arrowheads. Anterior is up, medial is at 
vertical mid-line. OA cell body clusters are labelled: md (mandibular), mx (maxillary) and lb 
(labial). Scale bar: 50 µm in (A) and 20 μm in (B-E).  
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R34A11-LexA labelled only two OA-positive cell bodies in the SOG, one 
each in the sVMmd and sVMmx clusters (n=2; Fig. 8.3, arrowheads). Therefore, 
the only OA neurons labelled by R34A11-LexA were likely to be sVUMmd1 and 
sVUMmx1. However, as both R34A11-LexA (Fig. 8.1B-C) and Tdc2-GAL4 
labelled KCs, the intersection between R34A11-LexA and Tdc2-GAL4 would 
yield a line that labelled sVUM1 neurons as well as KCs, which could not be 
used for functional or behavioural studies.  
 
8.2.1.2. NP7088-GAL4, R76H04-GAL4 and R57F09-LexA labelled all OA 
neurons in SOG 
Three other candidate lines – NP7088-GAL4, R76H04(Tβh)-GAL4 and 
R57F09(Tdc2)-LexA – also labelled sVUM1 neurons; as their mCD8::GFP  
expression colocalised with all the OA-positive puncta in the calyx (Fig. 8.4). 
These three lines also labelled all the OA-positive cell bodies in the SOG (Fig. 
8.5, 8.6, 8.7, arrowheads). Therefore, an intersection of these lines with Tdc2-
GAL4/Tdc2-LexA would still label all the OA neurons in the SOG.  
 R76H04-GAL4 could not be used for an intersection with R34A11-LexA, 
as both lines label KCs in addition to sVUM1 neurons in the calyx (Fig. 8.1B-C, 
8.4B). NP7088-GAL4 could possibly be used for an intersection with R34A11-
LexA; provided that, unlike the NP7088-GAL4 and R34A11-LexA constructs, 
the LexAOp-FLP required for FLP-out intersection is not on the second 
chromosome. On the other hand, R57F09-LexA could be a good alternative to 
Tdc2-LexA for an intersection with R34A11-GAL4 to generate a more specific 
sVUM1 line.  
   
8.2.1.3. R76G06-GAL4 labelled some OA neurons but not sVUM1 neurons 
Contrary to expectation, not all of the lines containing Tβh regulatory fragments 
labelled all the OA neurons in the larval brain. R76G06(Tβh)-GAL4 did not label 
the calyx-innervating sVUM1 neurons, as R76G06-GAL4>mCD8::GFP did not 
colocalise with anti-OA in the calyx (Fig. 8.8). Instead, R76G06-GAL4 showed a 
more diffuse pattern in the calyx, resembling that of KC dendrites.  
 Even though R76G06-GAL4 did not label sVUM1 neurons, it labelled a 




Figure 8.3. R34A11-LexA colocalised with two OA-positive cell bodies in the SOG. 
R34A11-LexA>LexAOp-mCD8::GFP is green, anti-OA is red, Dlg is blue. (A) Confocal 
projection of the SOG. (B-C) Confocal optical sections taken from dotted box in (A). Anterior is 
up, medial is at vertical mid-line. R34A11-LexA colocalisation with OA indicated with 






Figure 8.4. NP7088-GAL4, R76H04-GAL4 and R57F09-LexA colocalised with anti-OA in 
the larval calyx.  mCD8::GFP is green, anti-OA is red and anti-Dlg is blue. Confocal projections 
of the calyx of NP7088-GAL4>UAS-mCD8::GFP (A), R76H04-GAL>UAS-mCD8::GFP (B) and 




   
Figure 8.5. NP7088-GAL4 colocalised with all OA-positive cell bodies in the SOG. 
NP7088-GAL4>UAS-mCD8::GFP is green, anti-OA is red, anti-Dlg is blue. (A) Confocal 
projection of the SOG. (B-C) Confocal optical sections of the SOG from the dotted box in (A). 
NP7088-GAL4 colocalisation with OA indicated with arrowheads. Anterior is up, medial is at 






Figure 8.6. R76H04-GAL4 colocalised with all OA-positive cell bodies in the SOG. 
R76H04-GAL4>UAS-mCD8::GFP is green, anti-OA is red, anti-Dlg is blue. (A) Confocal 
projection of the SOG. (B-D) Confocal optical sections of the SOG from the dotted box in (A). 
R76H04-GAL4 colocalisation with OA indicated with arrowheads. Anterior is up, medial is at 






Figure 8.7. R57F09-LexA colocalised with all OA-positive cell bodies in the SOG. R57F09-
LexA>LexAOp-mCD8::GFP is green, anti-OA is red, anti-Dlg is blue. (A) Confocal projection of 
the SOG. (B-D) Confocal optical sections of the SOG from the dotted box in (A). R57F09-LexA 
colocalisation with OA indicated with arrowheads. Anterior is up, medial is at vertical mid-line. 
Scale bar: 50 µm in (A) and 20 μm in (B-D). Abbreviations as Fig.8.2.  
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Figure 8.8. R76G06-GAL4 did not colocalise with anti-OA in the larval calyx. Confocal 
projection of the calyx of R76G06-GAL4>UAS-mCD8::GFP (green). Anti-OA is red and anti-Dlg 





Figure 8.9. R76G06-GAL4 colocalised with some OA-positive cell bodies in the SOG. 
R76G06-GAL4>UAS-mCD8::GFP is green, anti-OA is red, anti-Dlg is blue. (A) Confocal 
projection of the SOG. (B-E) Confocal optical sections of the SOG from the dotted box in (A). 
R76G06-GAL4 colocalisation with OA indicated with filled arrowheads, while OA cell bodies that 
did not colocalise with R76G06-GAL4 are indicted with empty arrowheads. Anterior is up, 




filled arrowheads). OA-positive cell bodies that were not labelled by R76G06-
GAL4, including sVUM1 neurons, are indicated by empty arrowheads (Fig. 8.9).   
  As R76G06-GAL4 labelled many OA neurons but not the sVUM1 
neurons, it could be used for the alternative FLP-in intersectional approach with 
Tdc2-LexA, which activates the GAL80 block only in neurons labelled by both 
parental driver lines (Bohm et al., 2010).  
 
8.2.1.4. Ten candidate lines did not label OA-positive cell bodies in SOG 
The ten remaining candidate lines did not label any OA-positive cell bodies in 
the SOG region (Table 8.1), an example of which is shown in Fig. 8.10. As 
many of these lines labelled OA-negative SOG cell bodies, they could be useful 
for generating FLP-in lines if they shared expression with another line that 
labelled the sVUM1 neurons, for example R34A11-GAL4.  
 Three of the lines that did not label any OA-positive SOG cell bodies 
were associated with the Tβh gene (Fig. 8.10; Table 8.1). This suggested that 
different fragments taken from the same promoter produced driver lines with 
very different expression patterns: R76H04(Tβh)-GAL4 labelled all OA-positive 
cell bodies (Fig. 8.4, 8.6), R76G06(Tβh)-GAL4 labelled a subset of OA-positive 
neurons excluding the sVUM1 neurons (Fig. 8.8, 8.9); and R76H03(Tβh)-LexA 
did not label any OA-positive neurons (Fig. 8.10). This suggested that 
GAL4/LexA lines generated from promoter fragments may not accurately 
represent gene expression patterns.  
 
8.2.2. Double reporter expression of sVUM1 driver lines 
Based on the above results, R34A11-GAL4 X Tdc2-LexA and R34A11-GAL4 X 
R57F09-LexA were chosen as two candidate combinations for generating a 
more specific sVUM1 line through genetic intersection. To compare the 
expression patterns of R34A11-GAL4 with Tdc2-LexA and 
R57F09-LexA, I used UAS-mCD8::RFP, LexAOp-mCD8::GFP (BDSC 32229; 
Pfeiffer et al., 2010) to simultaneously visualise GAL4 and LexA expression. 
 R34A11-GAL4>mCD8::RFP, Tdc2-LexA>mCD8::GFP colocalized 





Figure 8.10. R76H03-LexA did not label OA-positive neurons. R76H03-LexA>LexAOp-
mCD8::GFP is green, anti-OA is red, anti-Dlg is blue. (A) Confocal projection of the calyx. 
Anterior (A) is up, lateral (L) is right. (B) Confocal projection of the SOG. Anterior is up, medial 




 Figure 8.11. R34A11-GAL4 and Tdc2-LexA shared expression in sVUM1 neurons. 
Confocal projections and optical sections of UAS-mCD8::RFP, LexAOp-mCD8::GFP; Tdc2-
LexA/+; R34A11-GAL4/+. Tdc2-LexA>mCD8::GFP is green, R34A11-GAL4>mCD8::RFP is red, 
anti-Dlg is blue. (A-C) Confocal projections of the calyx (A), dorsal brain lobe (B) and SOG (C). 
(D-E) Confocal optical sections of the SOG. Anterior (A) is up. Lateral (L) is right in (A-B); 
medial is at vertical mid-line in (C-E). Scale bar: 20 µm in (A,D-E) and 50 µm in (B-C). 
Abbreviations as Fig.8.2.  
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labelled the OA sVUM1 neurons. There was limited colocalisation between 
R34A11-GAL4 and Tdc2-LexA outside the calyx in the brain lobes (Fig. 8.11B) 
and in the SOG region (Fig. 8.11C). As predicted from anti-OA staining of 
R34A11-GAL4, two cell bodies each in the sVMmd and sVMmx clusters (n=2; 
Fig. 8.11D-E, arrowheads) and 1 cell body in the sVMlb cluster (n=2; Fig. 
8.11C), were co-labelled by R34A11-GAL4 and Tdc2-LexA. This indicated that 
the intersection between R34A11-GAL4 and Tdc2-LexA should result in a line 
that labelled five OA-positive neurons, including the sVUM1 neurons, 1 sVUMlb 
neuron and probably another class of sVUM neurons in the md/mx clusters.  
On the other hand, there was greater variability with the double reporter 
colocalisation of R57F09-LexA and R34A11-GAL4. Two out of three brains 
showed perfect colocalisation in the calyx (Fig. 8.12A-B); while neither R34A11-
GAL4>mCD8::RFP nor R57F09-LexA>mCD8::GFP was observed in the third 
calyx (Fig. 8.12C). Moreover, individual 1 showed denser colocalised 
innervation in the calyx (Fig. 8.12A) than individual 2 (Fig. 8.12B); suggesting 
individual 2 might only label one sVUM1 neuron rather than two.  
 The observation in the calyx matched the number of cell bodies at the 
ventral midline of the SOG that co-expressed R34A11-GAL4>mCD8::RFP and 
R57F09-LexA>mCD8::GFP (Fig. 8.13). Individual 1 labelled four colocalised cell 
bodies in the SOG – two sVMmd and two sVMmx cell bodies – suggesting that 
both sVUMmd1 and sVUMmx1 neurons were labelled (Fig. 8.13A-B). Individual 
2 labelled three cell bodies that showed colocalisation – one in the sVMmd 
cluster and two in the sVMmx cluster (Fig. 8.13C-D) – consistent with the lack of 
expression of one of the sVUM1 neurons in the calyx (Fig. 8.12B), likely to be 
sVUMmd1. Individual 3 showed colocalisation only in two cell bodies, one each 
in the sVMmd and sVMmx clusters respectively (Fig. 8.13E-F). This was 
consistent with the lack of expression in both sVUMmd1 and sVUMmx1 in the 
calyx (Fig. 8.12C).  
This further suggested that there is only one sVUMmd1 neuron and one 
sVUMmx1 neuron innervating the larval MB calyx with non-overlapping 
innervation patterns. This was not previously known through clonal analysis, as 




  Figure 8.12. R34A11-GAL4 and R57F09-LexA shared expression in sVUM1 neurons 
inconsistently. Confocal projections of the calyx from three UAS-mCD8::RFP, LexAOp-
mCD8::GFP; R57F09-LexA/+; R34A11-GAL4/+ individuals. R57F09-LexA>mCD8::GFP is 
green, R34A11-GAL4>mCD8::RFP is red, anti-Dlg is blue. Anterior (A) is up, lateral (L) is right. 




Figure 8.13. R34A11-GAL4 and R57F09-LexA colocalised in a variable number of OA-
positive neurons. Confocal optical sections of the SOG from the same three UAS-
mCD8::RFP, LexAOp-mCD8::GFP; R57F09-LexA/+; R34A11-GAL4/+ individuals corresponding 
to Fig. 8.12. R57F09-LexA>GFP is green, R34A11-GAL4>RFP is red. (A-B) Individual 1; (C-D) 
Individual 2; (E-F) Individual 3. Arrowheads indicate colocalisation. Anterior is up, medial is at 
vertical mid-line. Scale bar: 20 µm. Abbreviations as Fig.8.2.  
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neuron types, suggesting that there could be more than one neuron for some 
types of OA neurons (Selcho et al., 2014). Outside of the calyx and ventral 
midline, there was little colocalisation between R34A11-GAL4 and R57F09-
LexA (Fig. 8.14).  
Given that the colocalisation outside sVUM1 neurons for the two 
combinations were similar, R34A11-GAL4 x Tdc2-LexA was more reliable for 
labelling both sVUM1 neurons in the calyx consistently; and therefore was 
chosen for generating the specific sVUM1 line using FLP-out intersection.   
 
8.2.3. A Tdc2-LexA x R34A11-GAL4 sVUM1 intersectional line 
A genetic intersection cross between Tdc2-LexA and R34A11-GAL4 was 
generated (C.O’Kane, personal communication) using the FLP-out 
intersectional approach (Lee and Luo, 1999). The principle is that GAL4 
inhibitor GAL80 flanked by FRT sites was ubiquitously expressed, preventing 
GAL4 expression. FLP recombinase was driven in Tdc2-LexA neurons, 
enabling FLP recombination at FRT sites flanking the GAL80 sequence. GAL80 
was excised in these neurons, relieving its inhibition of GAL4 in neurons co-
expressing Tdc2-LexA and R34A11-GAL4. UAS-Chrimson::mVenus (Klapoetke 
et al., 2014) was used as the reporter, as Chrimson would be used to 
optogenetically activate sVUM1 neurons in future imaging or behavioural 
experiments.  
Five neurons were consistently labelled in the FRT-GAL80/+; LexAOp-
FLP/Tdc2-LexA; UAS-Chrimson::mVenus/R34A11-GAL4 intersection line (n=9; 
Fig. 8.15A), including two sVUMmd neurons, two sVUMmx neurons and one 
sVUMlb neuron. This included the two sVUMmd1 and sVUMmx1 neurons as 
Tdc2-LexA x R34A11-GAL4 showed innervation in the calyx (Fig. 8.15B) as well 
as AL (Fig. 8.15C). The additional pattern observed in the brain lobe resembled 
that of sVUM2 neurons (Selcho et al., 2014), especially as the larval optic 
neuropil is labelled in the intersection (Fig. 8.15A). This suggested that 
sVUMmd2 and sVUMmx2 neurons, and a sVUMlb neuron of unknown identity, 
were likely to be the only other OA neurons strongly and consistently labelled in 
this line. There are also occasionally very few additional cell bodies weakly 
labelled in the brain lobe or SOG region. However, they do not appear to send 
projections or processes.  
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Figure 8.14. R34A11-GAL4 and R57F09-LexA did not share expression outside sVUM 
neurons. UAS-mCD8::RFP, LexAOp-mCD8::GFP; R57F09-LexA/+; R34A11-GAL4/+  
Individual 1 from Fig. 8.12, 8.13. Tdc2-LexA>GFP is green, R34A11-GAL4>RFP is red, anti-Dlg 
is blue. (A-B) Confocal projections of the dorsal brain lobe (A) and ventral SOG (B). Anterior (A) 




Figure 8.15. R34A11-GAL4 and Tdc2-LexA intersection labelled sVUM1 neurons and 3 
other neurons. FRT-GAL80/+; LexAOp-FLP/Tdc2-LexA; UAS-Chrimson::mVenus/R34A11-
GAL4 is green, anti-Dlg is blue. (A-C) Confocal projections of the brain lobe and ventral nerve 
cord (A), calyx (B) and AL (C). (A’’) Inset of sVMmd and sVMmx cell bodies labelled. Dorsal (D) 
is up; medial (M) is at vertical mid-line for (A) and right for (B-C). Scale bar: 100 μm in (A), 10 
µm in (A’’,C) and 50 μm in (B). Abbreviation: lon, larval optic neuropil. 
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8.2.4. Labelling candidate lines for single neurons innervating the calyx 
Six GAL4/LexA lines that potentially label single calyx innervating neurons were 
selected from the Janelia FlyLight collection (Jennett et al., 2012; L. Masuda-
Nakagawa, personal communication). Four of these lines labelled one or two 
neurons innervating the calyx; while two other lines – R74G04(GABA-B-R1)-
GAL4 and R76B09(GABA-B-R3)-GAL4 labelled only KCs in the calyx (Table 
8.2).  
R76C06(GABA-B-R3)-GAL4 labelled two cell bodies that innervated the 
non-glomerular region of the calyx (Fig. 8.16A-D, arrowheads) and around the 
medial lobes (Fig. 8.16E); similar to Odd-like neurons (Slater et al. 2015). This 
line also labelled KCs (Fig. 8.16A-B).  
 R68C01(Octβ2R)-GAL4 and R68B12(Octβ2R)-GAL4 both labelled one 
neuron that showed characteristic innervation of the calyx and MB lobes similar 
to Odd-like neurons (Fig. 8.17, 8.18, arrowheads). Both lines also labelled KCs 
weakly. Overall, R68C01(Octβ2R)-GAL4 labelled many more additional neurons 
(Fig. 8.17A) compared to R68B12(Octβ2R)-GAL4 (Fig.8.18A).  
 R68B12(Octβ2R)-LexA, which shared the same promoter fragment as 
R68B12(Octβ2R)-GAL4, strongly labelled one neuron in each brain lobe (Fig. 
8.19, arrowhead). This line did not label other neurons in the brain lobes, 
although additional labelling was observed in the SOG region (Fig. 8.19A). This 
was the most specific line identified for Odd-like neurons; and would be very 
useful for functional and behavioural analyses if the SOG and ventral nerve 
cord expression could be effectively blocked.  
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Figure 8.16. R76C06-GAL4 labelled two calyx-innervating neurons. Confocal projections of 
the full dorsal brain lobe expression pattern (A), calyx (B) and MB lobes (E), and confocal 
optical sections of the calyx (C-D), of R76C06-GAL4>UAS-mCD8::GFP (green). Anti-Dlg is 
blue. Cell bodies sending projections to calyx indicated with arrowheads. Posterior (P) is up, 





  Figure 8.17. R68C01-GAL4 labelled a single calyx-innervating neuron. Confocal projections 
of the full dorsal brain lobe expression pattern (A), calyx (B) and MB lobes (D), and a confocal 
optical section of the calyx (C), of R68C01-GAL4>UAS-mCD8::GFP (green). Anti-Dlg is blue. 
Cell body projecting to calyx indicated with arrowhead. Posterior (P) is up, medial (M) is right. 






Figure 8.18. R68B12-GAL4 labelled a single calyx-innervating neuron. Confocal projections 
of the full dorsal brain lobe expression pattern (A), calyx (B) and MB lobes (D), and a confocal 
optical section of the calyx (C), of R68B12-GAL4>UAS-mCD8::GFP (green). Anti-Dlg is blue. 
Cell body projecting to calyx indicated with arrowhead. Posterior (P) is up, medial (M) is right. 





Figure 8.19. R68B12-LexA labelled a single calyx-innervating neuron. Confocal projections 
of the brain lobes from the frontal orientation (A) and MB calyx and lobes (B), and a confocal 
optical section of the calyx (C), of R68B12-LexA>LexAOp-mCD8::GFP (green). Anti-Dlg is blue. 
Cell body projecting to calyx indicated with arrowhead. Ventral is up, medial is at vertical mid-
line for (A). Posterior (P) is up and medial (M) is right for (B-C). Scale bar: 50 µm for (A) and 20 






8.3.1. A more specific sVUM1 driver line  
The Tdc2-GAL4 line, which has traditionally been used to study the functions of 
OA neurons, labels the majority of OA/TA neurons which project to diverse 
regions of the adult and larval brains (Busch et al., 2009; Selcho et al., 2014). It 
is therefore impossible to discern the function of a particular OA neuron within a 
specific circuit using Tdc2-GAL4. Moreover, some effects of OA signalling might 
be obscured by signalling from neurons which only express TA, also labelled by 
the Tdc2-GAL4 line (Selcho et al., 2014). TA itself can act as a neurotransmitter 
in insects (Roeder, 1999); and has been shown to oppose OA effects in larval 
locomotion (Saraswati et al., 2004).  
To differentiate the effects of OA from TA, some studies have used the 
Tβh mutant which is defective for OA synthesis from TA (Schwaerzel et al., 
2003). However, this is also problematic as Tβh mutants overexpress TA, which 
might cause confounding effects for studying OA function. 
 A previous attempt to restrict expression of Tdc2-GAL4 by using tsh-
GAL80 to block GAL4 expression in the ventral nerve cord allowed for the 
disassociation between OA/TA neurons in the ventral nerve cord from OA/TA 
neurons in the brain hemisphere and SOG in larval locomotion and memory 
formation respectively (Selcho et al., 2012, 2014). NP7088-GAL4 has also been 
used with Tdc2-LexA in intersection to generate an OA neuron line that 
excluded the calyx-innervating OA-VPM5 neuron amongst others in the adult 
brain (Busch et al., 2009; Burke et al., 2012). Therefore, the Tdc2-LexA x 
R34A11-GAL4 intersectional line from this study is the most specific sVUM1 
driver line to date.  
However, this intersection line still labels three other OA neurons that do 
not innervate the calyx or MB. Furthermore, this line does not differentiate 
between sVUMmd1 and sVUMmx1, which may have different functions, as 
laser ablation of sVUMmd and sVUMmx neurons resulted in opposing effects in 
starvation-dependent larval feeding behaviour (Zhang et al., 2013a).  
Nevertheless, the Tdc2-LexA x R34A11-GAL4 intersectional line will be 
an improvement from using the general OA neuron lines – Tdc2-GAL4/Tdc2-
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LexA –for more specific manipulations of the sVUM1 neurons in the larval calyx 
circuitry.  
 
8.3.2. Single calyx-innervating neuron lines 
The four single calyx-innervating neuron lines will be useful in dissecting the 
function of the relatively uncharacterised Odd-like neurons in the calyx circuitry; 
in particular, how they are potentially modulated by OA signalling. These driver 
lines label one or two Odd-like neurons whose tracts could be followed to the 
calyx. 
According to Slater et al. (2015), three Odd neurons with distinctive 
innervation patterns have been identified using clonal analysis from the Odd-
GAL4 line. Two of these neurons extended both ipsilateral and contralateral 
projections, but the authors did not further elaborate on how they could be 
distinguished from each other. The third neuron only extended ipsilateral 
projections. From the new driver lines, there appears to be at least two Odd-like 
neurons.  
 The availability of multiple single neuron driver lines for Odd-like neurons 
that label different populations of neurons is useful for attributing phenotypes to 
Odd-like neurons, such as their requirements for odour discrimination, rather 
than to the other neurons that may be labelled as well. The R68B12-LexA line is 
especially useful: not only is it specific, it is also the first and only LexA line 
known to label Odd-like neurons.  
  
8.3.3. Variable expression of promoter-fragment transcriptional drivers 
I examined several GAL4 lines under different promoter fragments of the same 
gene. For example, only one out of five Tβh-GAL4 lines screened showed 
expression in all of the OA neurons, despite containing a promoter fragment for 
the enzyme required for OA synthesis. Instead, different Tβh-GAL4 lines 
displayed a wide range of expression patterns. This has been previously 
observed for OAMB-GAL4 lines as well (Jenett et al., 2012; El-Kholy et al., 
2015; Watanabe et al., 2017).  
On the other hand, GAL4 and LexA lines under the control of the same 
promoter fragments, for example R34A11-GAL4/LexA or R68B12-GAL4/LexA, 
did not show exactly the same expression pattern. For example, R68B12-LexA 
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labelled fewer neurons in the brain lobe compared to R68B12-GAL4. There may 
also be intrinsic variation of GAL4/LexA expression. For example, the R57F09-
LexA; R34A11-GAL4 construct sometimes did not label both of the sVUM1 
neurons (n=2 out of 3).  
This large variation in expression between different promoter fragment 
driver lines suggests that it is unlikely that a single promoter-fragment 
transcriptional line can accurately represent the expression pattern of the gene 
the promoter fragment is associated with. For example, it cannot be inferred 
that Odd-like neurons expresses the GABA-B-R3 receptor because 
76C06(GABA-B-R3)-GAL4 labelled Odd-like neurons, while R76B09(GABA-B-
R3)-GAL4 did not. On the other hand, some Tβh-GAL4 lines indeed labelled the 
majority of OA-positive neurons; and Odd-like neurons were labelled in two 
Octβ2R-GAL4 lines.  
Therefore, promoter fragment GAL4/LexA lines should only act as rough 
guide to gene expression patterns, which must be corroborated with alternative 
methods such as protein traps or antibody labelling.  
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Chapter 9. General discussion 
 
To understand the logic of higher brain circuitry, much of the current work has 
focused on constructing a complete map of the synaptic connections in the 
brain. Some of these projects, such as the Drosophila olfactory connectome of 
the first instar larva, are beginning to come to fruition (Berck et al., 2016; Eichler 
et al., 2017). While these projects have revealed many novel connections and 
network motifs, they do not represent the full extent of neuromodulation, which 
can often act at long-range targets that would not be detected using EM. It 
might also be challenging to translate such large-scale reconstruction efforts to 
functional testing, as many of the neurons are yet to be characterised, and there 
are no readily available tools to manipulate these neurons.  
 Here I presented an alternative approach in mapping the 
neuromodulation circuit of a higher sensory pathway. Through using the already 
well-characterised Drosophila larval MB calyx, I aimed to identify potential 
postsynaptic partners to the OA sVUM1 neurons and map all the known OA 
receptors to each of the known calyx-innervating neurons. To date, 
neuromodulatory receptor maps have only been achieved in lower invertebrates 
such as C.elegans (Bentley et al., 2016); but have not yet been attempted in 
higher order sensory circuits in Drosophila. The goal of this neuromodulatory 
map would be to identify all potential OA targets in the calyx, and to predict the 
possible effects of OA signalling based on the receptor expressed. Such a map 
would provide a framework for testing the effects of OA signalling from sVUM1 
neurons on individual neurons via specific types of receptors, and how 
individual effects could interact to form a complete neuromodulatory network.  
 In this chapter, I first discuss the extent to which I achieved my aims of 
developing a preliminary OA neuromodulatory map of the larval MB calyx, 
evaluate the methods used in this study, and propose alternative approaches in 
how to continue developing this map. Next, I will focus on my key findings and 
their implications, how they could be validated and how they fit into our 
understanding of the MB calyx circuitry in Drosophila larvae, adults and other 
insects. Based on this, I will propose a model on how OA modulates the odour 
discrimination circuitry in the MB calyx, and how this model can be 
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experimentally tested. Finally, I will discuss how my findings change our 
understanding of how neuromodulatory circuitry is organised for modulating 
sensory processing.   
 
9.1. Mapping sVUM1 targets in the larval MB calyx 
To identify potential sVUM1 targets subjected to OA neuromodulation in the 
larval MB calyx, I used GRASP-OA colocalisation experiments to identify 
putative postsynaptic partners of sVUM1 neurons, and EGFP-tagged receptors 
generated from MiMIC insertion lines to visualise the localisation pattern of the 
five known OA receptors in the calyx and identify the neurons they were present 
on. I also used EGFP-tagged GABA receptors to determine whether GABAAR 
and GABABR localised to the sVUM1 terminals in the larval MB calyx for 
mediating APL signalling to sVUM1 neurons. The full results from this study are 
summarised in Figure 9.1 and Table 9.1.  
 Building on my MPhil work (H.W., MPhil Thesis 2014), I found that 
potential synapses between sVUM1 neurons and PNs, the APL neuron and 
Odd-like neurons colocalised with OA terminals in the calyx – suggesting that 
they may be postsynaptic to sVUM1 neurons and probably receive OA 
neuromodulation (Fig. 9.1). These were consistent with L1 EM connectivity data 
that became publically available two years after these experiments were 
completed (Eichler et al., 2017; Https://neuronlp.larva.fruitflybrain.org/). 
Contrary to L1 EM and adult GRASP results (Zhou et al., 2012; Pech et al., 
2013; Eichler et al., 2017), I only detected limited KC-sVUM1 connections in the 
larval MB calyx; which may be due to developmental reasons. While EM data 
are better for visualising synapses than GRASP, my data showed GRASP 
colocalisaton with OA, hence indicating potential postsynaptic sites that are 
probably modulated by OA signalling. This is important as OA neurons may co-
release TA and neuropeptides, and EM data do not directly show the 
neurotransmitter released at synaptic connections.  
 My main discoveries from this study centre around the characterisation of 
expression patterns of OA/GABA receptors in the larval MB calyx, both in terms 
of cell type and subcellular distribution (Fig. 9.1; Table 9.1). For the first time, I 





Figure 9.1. Summary diagram of proposed OA and GABA receptor localisation in the 
larval MB calyx circuitry. Abbreviations: ACh, acetylcholine; AL, antennal lobe; CPM, 
centroposterior medial compartment; KC, Kenyon Cell; LH, lateral horn; MB, mushroom body; 





 KCs PNs APL sVUM1 Odd-like 
OAMB - + - - - 
Octα2R* - +* N/A +* N/A 
Octβ1R + (Likely) - - - - 




Octβ3R - - - - - 
Rdl* +* Likely N/A +* N/A 
GABABR1 Likely Likely N/A - N/A 
Table 9.1. Summary table of OA and GABA receptor localisation to neurons innervating 
the larval MB calyx. + indicates the presence of the receptor, - indicates the absence of the 
receptor, and N/A indicates there are no available data. * indicates that it is unclear whether the 
receptor is localised to calyx terminals of the neurons they are expressed in.  
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terminals of olfactory PNs in the larval MB calyx; 2) the β-adrenergic-like 
Octβ1R probably localised to KC dendrites in the calyx; 3) the α2-adrenergic-
like Octα2R and β-adrenergic-like Octβ2R both localised to a subset of the 
olfactory PN cell bodies, although their subcellular localisation was unclear; and 
4) Octα2R and the ionotropic GABAAR subunit Rdl localised to all OA-positive 
cell bodies at the SOG, including the sVUM1 neurons, even though again it was 
unclear whether these receptors localised to their calyx terminals. I will discuss 
these new findings and their implications in the MB calyx circuitry in detail in 
Section 9.2.  
There are still many gaps to fill in this preliminary map. These mainly 
arise from technical challenges that have prevented me from systematically 
mapping all of the known OA receptors to calyx-innervating neurons. Firstly, 
EGFP fusion proteins generated from MiMIC insertions did not always show 
subcellular localisation. Octα2R::EGFP, Octβ2R::EGFP and Rdl::EGFP did not 
localise to membrane terminals (marked with * in Table 9.1); while neither 
Octβ3R::EGFP fusions showed any signals in the larval brain. Secondly, weak 
signal to noise ratio, high background labelling, and bleed through from 
mCD8::RFP to the GFP channel, has led to ambiguous and inconsistent results 
for receptor localisation. Finally, there is a possibility that the EGFP insertion 
within receptor proteins could cause receptor mislocalisation. I will discuss 
these limitations of MiMIC protein traps, possible alternative methods and 
further validation experiments in the following sections. 
Nevertheless, I have developed a preliminary map for OA and GABA 
receptor localisation of the larval MB calyx; which I hope can form the 
foundation to build and expand upon for the understanding of how 
neuromodulatory circuitry is anatomically organised.  
  
9.1.1. Advantages and limitations of mapping connectivity with GRASP  
GRASP is an established method for mapping potential synaptic connectivity in 
the Drosophila brain (Gordon and Scott, 2009; Venken et al., 2011b). It is 
simple and straightforward to conduct, provided that there are suitable GAL4 
and LexA lines available to drive split GFP halves in the neuronal populations of 
interest. Results can be easily replicated to demonstrate experimental 
consistency or compare individual variation, which is difficult to achieve in time-
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consuming and labour-intensive EM reconstruction projects. While EM 
reconstruction represents a systematic unbiased approach for mapping synaptic 
connectivity, GRASP provides a more hypothesis- or circuit-based alternative to 
determine whether specific populations of neurons synapse with each other. 
GFP reconstitution signals can be detected in unfixed brains with a 
fluorescence or confocal microscope, and therefore used in live imaging, which 
is not possible in EM. GRASP can also be detected in fixed and immunolabelled 
brains, which allow for co-labelling with antibodies labelling neuropils, synaptic 
proteins, neurotransmitters and other membrane proteins; hence providing 
additional information about the putative synapses that may not be easily 
accessible with EM data.  
The most pertinent issue of the GRASP method is that it cannot be used 
to directly visualise synapses, such that non-synaptic membrane contacts may 
be mistaken for synapses. These false positives may be reduced by comparing 
GRASP signals with synaptic marker or neurotransmitter labelling, or by fusing 
spGFP halves to synaptic markers (Karuppudurai et al., 2014), which may also 
help to determine the direction of synaptic transmission. However, EM remains 
the best and only method for confirming synaptic connections (Meinertzhagen 
and Lee, 2012). GRASP also does not reveal extrasynaptic connectivity or 
volume transmission – a common feature of neuromodulator signalling (Trueta 
and De-Miguel, 2012). While dense core vesicles associated with volume 
transmission can be identified in EM sections (Eichler et al., 2017), examining 
receptor localisation to non-synaptic sites would provide the strongest evidence 
for extrasynaptic signalling. Finally, GRASP relies on specific transcriptional 
driver lines, which may not always be available. These lines are not required to 
map connectivity using systematic EM reconstruction, but will nonetheless 
hinder functional validation of these connections at a later stage.  
 
9.1.2. Advantages and limitations of mapping receptor localisation with 
MiMIC protein traps 
While there have been other studies that examined OA receptor localisation in 
the Drosophila brain, this is the first study to use EGFP-tagged OA receptors. 
This method was chosen to visualise native levels of receptor expression and 
localisation within the neuron, which is difficult to achieve without the availability 
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of a specific antibody. In one instance, the protein trap proved to be superior to 
antibody labelling, as the GABA-B-R1::EGFP labelled cell bodies expressing 
GABABR1 that were previously not observed with the anti-GABABR antibody 
(Enell et al., 2007).  
While mRNA localisation and promoter-GAL4 constructs have been used 
to identify neurons that express OA receptors (Han et al., 1998; Ohhara et al., 
2012; El-Kholy et al., 2015), neither approach can reflect the pattern of 
subcellular localisation. It is also difficult to determine which promoter-GAL4 line 
showed the most accurate expression pattern due to the large variations of 
expression, as observed in Chapter 8. Even when the full promoter sequence is 
fused to GAL4 (El-Kholy et al., 2015), this ignores distal regulatory elements 
that may affect protein expression patterns.  
  Moreover, to verify receptor localisation in particular neuronal types, the 
use of the EGFP-RNAi or deGradFP systems (Caussinus et al., 2011; 
Neumüller et al., 2012) in conjunction with EGFP-tagged protein receptors, 
could bypass the need of a strong RNAi line against a specific protein. The 
EGFP tag can also be used to assay the efficacy of the knockdown, which is 
more representative of protein levels post-knockdown compared to measuring 
number of transcripts using qPCR.  
While one of the main strengths of protein trapping is the ability to 
visualise the subcellular localisation of OA receptors, not all of the 
MiMIC::EGFP lines target the receptor protein-EGFP fusion to terminals. In this 
study, Octα2R::EGFP, Octβ2R::EGFP and Rdl::EGFP signals were retained in 
cell bodies; and therefore it remains uncertain whether these receptors are 
normally targeted to the calyx terminals of the neurons they are expressed in. It 
is also unclear whether the fusion proteins are accumulated and degraded in 
the ER (Sections 6.2.6. and 6.3.4). Octβ3R::EGFP also did not appear to be 
expressed in the larval brain, even though Octβ3R transcripts were present 
(Ohhara et al., 2012). These problems may be due to the random nature of 
MiMIC insertion, as certain conserved sites of the receptor protein may affect 
targeting to their membrane locations.  
Additionally, neither OAMB::EGFP nor Octβ1R::EGFP produced 
functional receptor proteins, as neither stock can be maintained as 
homozygous. This suggests that even when the EGFP-tagged receptors are 
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localised to terminals, the EGFP insertion may interfere with normal receptor 
function without affecting localisation; for example, by obscuring or causing 
steric hindrance to active domains such as G-protein binding domains or 
phosphorylation sites. It is also possible that the EGFP insertion rendered these 
fusion proteins non-functional by preventing their removal from the plasma 
membrane by endocytosis. In this case, the EGFP-tagged receptors are 
localised to the same locations as endogenous receptors initially but 
accumulate at plasma membrane terminals. There is also a slight possibility that 
the EGFP insertion could actively misdirect subcellular protein localisation in a 
gain-of-function scenario; but it is more likely that misfolded fusion proteins are 
recognised in the ER for retention and degradation before they can reach any 
neuronal terminals.  
The other major issue is the intrinsically weak signal from the EGFP-
tagged receptors, which together with non-specific polyclonal GFP antibody 
binding used to amplify these EGFP signals, led to many of the ambiguous 
results in this study. To enhance the signal to background ratio for visualising 
receptor fusion proteins, I have tested three different GFP antibodies and 
introduced an antibody preincubation step for immunolabelling. As I observed 
that larvae heterozygous for the EGFP-tagged receptors usually have a much 
weaker signal than that of larvae homozygous for the protein trap, I attempted 
to maintain homozygosity for EGFP protein traps whenever possible. However, 
this was not possible for the homozygous lethal Octβ1R::EGFP stock, or when 
there was a lack of appropriate transcriptional drivers in alternative 
chromosomes for colocalisation experiments.  
 
9.1.3. Alternative methods for mapping OA neuromodulatory circuitry 
The main gap in our knowledge of neuromodulatory circuitry organisation is how 
receptors are distributed within a sensory processing network. This is because 
synaptic connectomes cannot fully represent the nuances of neuromodulation; 
most notably, the variable effects caused by differential receptor expression, 
and potential long-range signalling effects. While I have attempted to bridge this 
gap by beginning to map OA neuromodulatory circuitry of the larval MB calyx, 
there is still much work to be done to generate a comprehensive 
neuromodulatory map. As dicussed in Section 9.1.2, the main problems of the 
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MiMIC EGFP fusion proteins used in this study were the possibilities of protein 
misfolding or mislocalisation, disrupted receptor function and weak signal to 
background ratio. It was also sometimes difficult to isolate specific neurons 
where fusion proteins are localised. Here I propose modifications to this method 
and alternative approaches to continue developing the OA neuromodulatory 
map in the calyx as well as other neuromodulatory circuits in the fly brain.  
Currently, the only method for detecting subcellular receptor localisation 
without compromising protein function or localisation is to use strong and 
specific antibodies – of which few are available and are difficult to develop 
(Nagarkar-Jaiswal et al., 2015). From the OA receptors in flies, only anti-OAMB 
and anti-Octβ2R have been developed; and the signal-to-background ratio for 
anti-OAMB is poor and inconsistent in the adult fly brain (Han et al., 1998; Kim 
et al., 2013; Wu et al., 2013). Therefore, it is better to optimise the protein 
trapping method instead for visualising endogenous protein localisation. 
Protein misfolding, mislocalisation or loss-of-function are probably 
caused by the EGFP insertion within fusion proteins. This can potentially be 
resolved by targeting the EGFP insertion to a site with a lower probability of 
interfering with protein localisation or function using the CRISPR/Cas9 method 
(Gratz et al., 2013). This would commonly be at the C- or N- terminals of 
proteins (Koles et al., 2016; Kanca et al., 2017) to reduce the risk of protein 
misfolding or disrupt membrane insertion. However, as these terminals contain 
motifs that regulate G-protein coupled receptor trafficking (Dong et al., 2007), 
EGFP insertion at these sites may cause mislocalisation. Therefore, it may be 
useful to generate multiple protein traps for the same receptor, as EGFP 
inserted at different locations may maximise the recovery of functional EGFP-
tagged receptors. This may be achieved if multiple MiMIC lines for the same 
receptor were available, or by directing CRISPR/Cas9 knock-in to multiple sites. 
The rapid improvement in CRISPR/Cas technologies for reporter knock-ins in 
Drosophila suggest that targeted EGFP insertion using CRISPR/Cas methods 
would be increasingly advantageous in the future (Mohr et al., 2014; Xue et al., 
2014).  
Another approach to reduce protein misfolding and mislocalisation is to 
modify the existing protein trap: by increasing the length of flexible peptide 
linkers flanking the EGFP insertion already used in MiMIC recombinants 
290 
(Venken et al., 2011a; Nagarkar-Jaiswal et al., 2015); or using multiple copies 
of short epitope tags rather than a larger fluorescent protein.  
 The next challenge is to increase the signal to noise ratio of fusion 
proteins. In addition to EGFP, the MiMIC fusion proteins used in this study are 
also tagged with streptavidin and FLAG (Venken et al., 2011a; Nagarkar-
Jaiswal et al., 2015); such that concurrent immunolabelling with anti-GFP, biotin 
and anti-FLAG respectively may be able to maximise fusion protein signal. 
Using chemical tags with a fluorescent substrate may also be a useful 
alternative for maximising EGFP signal and reducing background caused by 
polyclonal GFP antibodies (Kohl et al., 2014).  
 There are also a series of alternative epitope and fluorescence tag 
combinations developed for the MiMIC system which may be able to give 
stronger signals (Venken et al., 2011a). As homozygous larvae with two copies 
of EGFP showed stronger signals than heterozygous larvae, increasing the 
number of copies of EGFP inserted in the protein may also maximise signals; 
although this may simultaneously increase the risk of protein misfolding and 
mislocalisation. Replacing the MiMIC EGFP reporter with a spaghetti monster 
fluroscent protein (smFP) may also help increase fusion protein signals. smFP 
contains 10-15 copies of commonly used epitope tags attached to a fluorescent 
protein scaffold, and has been shown to strongly label neurons in the 
multicolour FLP-out approach (Nern et al., 2015; Viswanathan et al., 2015). In 
this method, the fluorescent protein can also be made non-fluorescent (Nern et 
al., 2015), which could be used to restrict spectral profile and cross-reactivity in 
immunolabelling and imaging. However, as smFP requires a fluorescent protein 
scaffold, it would have similar effects in protein misfolding and function as the 
EGFP insertion.   
 There are also alternative approaches directed to uncovering the identity 
of the neurons expressing OA receptors. T2A-GAL4, T2A-LexA or other T2A-
based binary transcription factors can be inserted in receptor genes using 
RMCE with existing MiMIC lines or targeted CRISPR knockins, such that binary 
transcriptional systems are placed under the control of the endogenous 
promoter and regulatory elements of these genes (Diao et al., 2015; Gnerer et 
al., 2015). These would show more accurate expression patterns than existing 
promoter-GAL4 lines (Pfeiffer et al., 2010; El-Kholy et al., 2015). T2A is a 
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ribosomal skipping site that allows transcription factors such as GAL4 and LexA 
to be translated together but released from the receptor protein and bind to 
downstream effectors (Diao and White, 2012). Therefore, this method can be 
used to visualise and manipulate neurons expressing the receptors of interest; 
although it cannot be used to detect subcellular localisation patterns. 
Nevertheless, T2A-GAL4/LexA-driven UAS-mCD8::GFP showed stronger 
signals than the EGFP fusion proteins they are derived from (Diao et al., 2015; 
Gnerer et al., 2015). T2A-GAL4/LexA can be inserted in the coding region intron 
to produce a truncated mutant protein; or at the C-terminal to produce a full 
length and probably functional protein (Diao et al., 2015). Similarly, T2A-EGFP 
can be inserted at the C-terminal of the receptor protein to produce a full length 
and more likely functional receptor rather than a fusion protein; but this also 
cannot be used to reflect subcellular localisation.  
 It may also be possible to tag or manipulate receptor proteins in specific 
or even single cells using tissue-specific or conditional tags, which would make 
it easier to isolate and/or manipulate specific neurons that express 
neuromodulatory receptors. The majority of tissue-specific and conditional tags 
use the FLP-FRT recombination system (Chen et al., 2014; Fisher et al., 2017; 
Nagarkar-Jaiswal et al., 2017; Lee et al., 2018); although alternative 
recombinases such as Cre-lox or Rippase-RRS can also be used (Koles et al., 
2016). The general logic is to include recombinase recognition sites and a 
transcriptional stop site in the knockin cassette: the EGFP reporter, T2A-
GAL4/LexA or other epitope tags; and express the recombinase in a specific 
population of neurons labelled by transcriptional driver lines or randomly under 
conditional activation such as heat shock treatments. This allows for knockin 
tags to be only expressed in neurons which are able to undergo recombinase-
mediated excision of the transcriptional stop sites (Chen et al., 2014; Koles et 
al., 2016; Lee et al., 2018). Tagging receptors in single cells is particularly 
useful for determining receptor localisation to pre- or post-synaptic terminals, in 
which presynaptic terminals can also be specifically labelled in the same 
manner using the synaptic tagging with recombination method (Chen et al., 
2014).  
 The other source of difficulty for mapping receptors to calyx-innervating 
neurons is the bleed through of mCD8::RFP signal to the GFP channel in 
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colocalisation experiments. As discussed in detail in Section 5.3.4, this may be 
resolved by using alternative tools to label calyx-innervating neurons and by 
restricting spectral overlap detected by the confocal microscope.  
 
9.2. sVUM1 connectivity in the larval MB calyx and their implications 
In this study, I have identified candidate neurons that receive OA 
neuromodulation from sVUM1 neurons in the larval MB calyx, some of the OA 
receptors they express, and that sVUM1 neurons themselves express OA and 
GABA receptors. Here I discuss these discoveries in the context of what we 
know about the MB calyx circuitry in larvae and whether they are likely to be 
conserved. Based on the known cellular effects of OA receptor and their NA 
counterparts, I also hypothesise how sVUM1 signalling may affect the activity of 
each type of calyx-innervating neurons.  
It is important to be cautious with these speculations, as the effects of 
OA receptor activation on the physiology of Drosophila neurons in vivo are not 
well-characterised, and the activation of the same receptors could result in 
different responses dependent on downstream signalling targets expressed in 
each neuronal type. For example, Octβ1R activation increases cAMP when 
expressed in vitro or in mice hippocampal neurons in vivo (Balfanz et al., 2005; 
Maqueira et al., 2005; Havekes et al., 2014), but decreases cAMP levels of 
Type II motorneurons at the larval NMJ (Koon and Budnik, 2012). Therefore, I 
will also discuss how to test these hypotheses.  
 
9.2.1. OA modulation of olfactory PNs 
I have shown that olfactory PNs are putative postsynaptic partners to OA 
terminals of sVUM1 neurons in the larval MB calyx, the majority of which 
express the α1-adrenergic-like OAMB receptor at their calyx terminals (Fig. 9.1; 
Table 9.1). OAMB localised to more calyx glomeruli than the number of 
synapses detected between sVUM1 neurons and PNs in the calyx, and in a 
broader pattern, indicating possible evidence for extrasynaptic OA signalling. 
However, it is unknown whether synaptic and extrasynaptic OA signalling to 
PNs have any functional differences, which may be an interesting question for 
future investigation.  
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A subset of olfactory PNs may also express the α2-adrenergic-like 
Octα2R and β-adrenergic-like Octβ2R, although it is unclear whethere they are 
localised to the calyx, lateral horn or AL (Fig. 9.1; Table 9.1). The identity of the 
PNs expressing Octα2R and Octβ2R is also currently unclear, but I hypothesise 
that they may be grouped based on primary odour qualities conferred by 
specific PNs. This can be validated by converting Octα2R and Octβ2R fusion 
proteins to T2A-GAL4/LexA lines (Diao et al., 2015; Gnerer et al., 2015), and 
mapping them to specific calyx glomeruli, each of which is stereotypically 
innervated by a PN (Masuda-Nakagawa et al., 2009), or with colocalisation with 
specific PN driver lines (Masuda-Nakagawa et al., 2010).  
Overall, this suggested that olfactory PNs were subjected to OA 
signalling from sVUM1 neurons via OAMB, and possibly Octα2R and Octβ2R, 
in the larval MB calyx. 
Olfactory PNs as postsynaptic partners of sVUM1 neurons is consistent 
with L1 connectome data (Eichler et al., 2017; 
Https://neuronlp.larva.fruitflybrain.org/). OAMB localisation to PNs is consistent 
with the unpublished data suggesting that OAMB localised to extrinsic neurons 
in the adult MB calyx (Kim et al., 2013); while cAMP increase observed upon 
OA application to PN axons in adult flies (Tomchik and Davis, 2009) is in 
agreement with the possible effects of OAMB and/or Octβ2R activation in PNs. 
On the contrary, the OAMB homologue in honeybees AmOA1 did not localise to 
uniglomerular olfactory PN terminals in the honeybee calyx, which instead 
express the honeybee TA receptor AmTyr1(Sinakevitch et al., 2013, 2017). This 
suggests PNs are modulated by OA in the fly MB calyx, but possibly by TA in 
the honeybee calyx.  
 Pharmacological studies have previously shown that OAMB 
predominantly increases intracellular calcium, but also shows a cAMP response 
at higher concentrations (Han et al., 1998; Balfanz et al., 2005; Morita et al., 
2006), Octβ2R also increases cAMP levels (Maqueira et al., 2005), while 
Octα2R instead decreases cAMP levels (Qi et al., 2017).  
 The calcium-activated potassium channel slowpoke may be one of the 
downstream targets for controlling PN excitability and presynaptic 
neurotransmitter release (Warbington et al., 1996). In Drosophila pars 
intercerebralis neurons, OA inhibits slowpoke channels in an OAMB-dependent 
294 
manner, resulting in prolonged depolarisation and increased excitability 
(Crocker et al., 2010). As Octβ2R increases intracellular cAMP levels, this could 
activate PKA, which would go on to inhibit slowpoke channels through 
phosphorylation (Zhou et al., 2002). Conversely, this could be counteracted by 
Octα2R which would decrease intracellular cAMP concentration (Qi et al., 
2017). This mechanism could be tested by assaying cAMP levels using epac1-
camps (Nikolaev et al., 2004), as well as measuring whole-cell outward currents 
when slowpoke channels are blocked using the potassium channel blocker 
tetraethylammonium (Crocker et al., 2010), upon specifically activating or 
inhibiting OAMB, Octα2R and Octβ2R respectively on PNs.  
OAMB activation at PN axons could also increase neurotransmitter 
release through the PKC activated by the Gq pathway. For example, PKC may 
increase neurotransmitter release probability, the availability of vesicles for 
release, as well as open N-type Ca2+ channels; all of which were observed for 
α1-adrenergic-mediated facilitation of glutamatergic release in rat medial 
prefrontal cortex neurons (Luo et al., 2015). OAMB-mediated increase of 
intracellular calcium may also facilitate neurotransmitter release from directly 
interacting with calcium-sensitive components of synaptic vesicles, such as 
synaptotagmin (Brose et al., 1992; Südhof, 2013). Octβ2R-mediated increase of 
cAMP could contribute to increased neurotransmitter release at PN axons. For 
example, this could be mediated by cAMP modulation of voltage-gated K+/Ca2+ 
ether-a-go-go channels or cyclic nucleotide-gated Ca2+ channels which would 
mediate calcium entry to presynaptic terminals required for vesicle release 
(Brüggemann et al., 1993; Pavot et al., 2015). Again, Octα2R-mediated 
decrease of cAMP levels would lead to the opposite effects and probably 
decrease neurotransmitter release at PN terminals. The individual effects of 
these OA receptors on acetylcholine release from PN axons in the calyx can be 
measured using synapto-pHluorin (Ng et al., 2002) when they are specifically 
activated or inhibited in PNs.  
In general, I hypothesise that both OAMB and Octβ2R are likely to have 
excitatory cellular effects on PNs, which is likely to increase neurotransmitter 
release at PN axons, and therefore increase inputs from PNs to KCs in the 
larval MB calyx, while Octα2R would have the opposite effect in a subset of 
PNs. Therefore, OAMB and Octβ2R activation on PNs is likely to impair odour 
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discrimination, while Octα2R improves it. This can be tested by manipulating 
OA receptor signalling selectively in olfactory PNs and examining their 
consequences on PN activity using electrophysiological methods or functional 
imaging, such as GCaMP (Tian et al., 2009; Akerboom et al., 2012), and 
neurotransmitter release using synapto-pHluorin (Ng et al., 2002) at the larval 
MB calyx; as well as odour discrimination and generalisation behaviour in 
larvae.   
 
9.2.2. OA modulation of KCs 
While I only observed limited GRASP between sVUM1 neurons and KCs in the 
larval MB calyx, I found that β-adrenergic-like Octβ1R may localise to KC 
dendrites, although this requires further validation (Fig. 9.1; Table 9.1). This 
suggested that KC dendrites innervating the larval MB calyx may receive OA 
signalling extrasynaptically from sVUM1 neurons. The lack of KC-OA 
connectivity in the larval MB calyx is different to previous observations in the L1 
and adult calyces (Zhou et al., 2012; Pech et al., 2013; Eichler et al., 2017) – 
suggesting that KC-OA connectivity may be plastic over development. However, 
this may be less significant because larval KCs are still able to receive OA 
signalling if they expressed Octβ1R. On the other hand, Octβ1R localisation to 
larval KCs is consistent with Octβ1R transcripts detected in adult KCs (Crocker 
et al., 2016); suggesting that this may be conserved from larvae to adults.  
Octβ1R is predominantly associated with the Gs pathway, which 
activates the adenyl cyclase production of cAMP (Balfanz et al., 2005; Maqueira 
et al., 2005). This is consistent with the OA-induced increase of cAMP 
previously observed in KC dendrites the adult MB calyx (Tomchik and Davis, 
2009). The aforementioned cAMP modulation of Na+, K+ and Ca2+ channels 
may increase neuronal excitability in KCs (Gordon et al., 1990; Brüggemann et 
al., 1993; Zhou et al., 2002; Pavot et al., 2015). Octβ1R may also couple to the 
inhibitory Go pathway which decreases cAMP production (Koon and Budnik, 
2012); resulting in similar cellular effects to the α2-adrenoceptor which is 
canonically coupled to Gi/o pathways. This is likely to result in hyperpolarisation 
of KCs through inhibiting voltage-gated Ca2+ channels, opening K+ channels 
and blocking cyclic nucleotide-gated channels (Marzo et al., 2009). The 
simultaneous coupling to Gs and Gi has been previously observed with 
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mammalian β2-adrenoceptors in the heart, which appears to have functional 
roles in compartmentalising cAMP signal (Xiao, 2001). Therefore, Octβ1R may 
take on a similar role in KCs to maintain site-specific cAMP localisation. 
Whether Octβ1R in KC dendrites are coupled to increase or decrease of 
intracellular cAMP, and thus excitability or inhibition respectively, which can be 
assayed using epac1-camps in KCs (Nikolaev et al., 2004).  
 The co-application of acetylcholine at KC dendrites (calyx) and OA at KC 
axons (MB lobes) showed an additive cAMP response in the adult MB calyx 
(Tomchik and Davis, 2009). However, it is unclear whether co-application of 
acetylcholine and OA at the calyx would have the same response, as OA 
application on its own results in spatially-specific cAMP responses in the adult 
calyx and lobes (Tomchik and Davis, 2009). In vitro, the co-application of 
acetylcholine and OA results in a synergistic increase in calcium responses of 
cultured KCs (Leyton et al., 2014). This suggests that OA is capable of 
potentiating acetylcholine responses; but it is unknown whether this effect is 
mediated by Octβ1R or other OA receptors which may be localised to the MB 
lobes in vivo. This can be tested by measuring the cAMP and GCaMP 
(Akerboom et al., 2012) response in KC dendrites when KCs and sVUM1 
neurons are activated, and compare the difference when Octβ1R is functional 
versus when it is blocked.  
 As β-adrenergic signalling and its downstream cAMP effector are closely 
associated with synaptic plasticity regulation, Octβ1R signalling could also 
result in long-term synaptic changes at KC dendrites. For example, β-
adrenoceptors promote long-term potentiation at mammalian hippocampal 
neurons by activating postsynaptic glutamate receptors and inhibiting dendritic 
potassium channels (Thomas et al., 1996; Seol et al., 2007; O’Dell et al., 2015; 
Liu et al., 2017). At the Drosophila NMJ, cAMP signalling via Octβ1R and 
Octβ2R regulate the structural plasticity of synaptic boutons (Koon et al., 2011; 
Koon and Budnik, 2012; Maiellaro et al., 2016).  
 Considering OA application on adult and cultured KCs increases cAMP 
and potentiates acetylcholine responses, I propose that Octβ1R activation in 
larval KCs would increase KC excitability and reduce odour discrimination 
ability. This can be tested by manipulating Octβ1R signalling specifically in KCs, 
and measuring how this affects KC activity using GCaMP (Akerboom et al., 
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2013);  especially how this changes the sparseness and correlation of KC 
activity in a population for different odours (Lin et al., 2014). An odour 
discrimination assay can also be applied to larvae in which Octβ1R is 
specifically activated or blocked in KCs, to validate whether their odour 
discrimination ability is impaired.  
 
9.2.3. Modulation of sVUM1 neurons 
I also found that all OA-positive cell bodies, including sVUM1 cell bodies, 
expressed Octα2R and the ionotropic GABAAR subunit Rdl (Fig. 9.1; Table 9.1). 
This suggested that sVUM1 neurons may be subjected to OA and GABA 
modulation, although it was unclear whether this is at the calyx, AL or SOG 
region. Nevertheless, this is a novel finding as we currently do now know the 
inputs to sVUM1 neurons and how sVUM1 activity is regulated. As sVUM1 
neurons and the APL neuron show GRASP in the larval MB calyx (H.W., MPhil 
Thesis 2014), this suggested that the APL neuron could be modulating sVUM1 
neurons via Rdl. On the other hand, Octα2R expression suggested that sVUM1 
neurons may be subjected to neuromodulation from themselves, each other, or 
other OA neurons. L1 connectivity data show that the APL neuron has 
reciprocal synapses with sVUM1 neurons, while sVUM1 neurons also synapse 
with each other (Eichler et al., 2017; Https://neuronlp.larva.fruitflybrain.org/); but 
cannot reveal whether sVUM1 neurons are autoregulated.  
I predict that Octα2R localised to the presynaptic terminals of sVUM1 
neurons in the larval calyx, similar to the presynaptic localisation of α2-
adrenocepters on NA neurons (Aoki et al., 1994). This suggests that Octα2R 
could act as an autoreceptor inhibiting OA release from sVUM1 neurons 
presynaptically in the calyx – constituting a negative feedback mechanism for 
OA release. Octα2R could also mediate local inhibition of OA release between 
the two types of sVUM1 neurons innervating the calyx – sVUMmd1 and 
sVUMmx1. This can be validated by measuring neuronal activity of sVUM1 
neurons using GCaMP and neurotransmitter release using synapto-pHluorin 
when sVUM1 activity and Octα2R signalling on sVUM1 neurons are 
manipulated respectively. It would be particularly valuable if sVUMmd1 and 
sVUMmx1 neurons can be individually manipulated and visualised to determine 
whether the effects are autoinhibitory or local inhibitory. I predict that OA-
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mediated feedback is a homeostatic mechanism and does not have a profound 
effect in odour discrimination – which should be validated using odour 
discrimination assays. On the other hand, dendritic localisation of Octα2R would 
suggest that sVUM1 neurons receive inhibitory OA inputs that may possibly 
underlie the context-dependent activity of sVUM1 neurons. However, it is 
currently unclear whether sVUM1 neurons are subjected to other sources of OA 
modulation outside the calyx.  
Rdl expression in sVUM1 neurons suggests that the APL neuron 
provides fast inhibitory GABAergic inputs to sVUM1 neurons in the calyx and/or 
reflect context-depedent inhibitory inputs to sVUM1 neurons at the AL and 
SOG, depending on the subcellular localisation of the GABAAR. As the APL is 
activated by KC output (Lin et al., 2014; Masuda-Nakagawa et al., 2014), this 
suggests that KC outputs could indirectly inhibit sVUM1 activity via the APL 
neuron, forming a feedback inhibitory loop between KCs and sVUM1 neurons. 
This can be tested by activating or blocking APL activity and determining its 
effects on sVUM1 activity visualised using GCaMP in the calyx, and whether 
this affects OA release using synapto-pHluorin. Rdl signalling can also be 
manipulated in these experiments to validate its potential role in sVUM1 
neurons.  
 
9.2.4. OA modulation of the APL and Odd-like neurons 
Using OA-GRASP colocalisation, I identified APL and Odd-like neurons are also 
putative postsynaptic partners to sVUM1 neurons in the larval MB calyx (Fig. 
9.1). This is consistent with L1 connectivity data. However, I have yet to identify 
an OA receptor that localised to these neurons (Table 9.1). While there are no 
data in the adult or larval fly yet to show whether these types of neurons 
express OA receptors, the honeybee counterparts of the APL neuron express 
AmOA1 – the honeybee homologue of OAMB (Sinakevitch et al., 2013).  
While it is clear that OAMB and Octβ1R do not localise to the calyx 
terminals of the APL or Odd-like neurons, it remains possible that these 
neurons could express Octα2R or Octβ2R (Table 9.1). This has not yet been 
tested due to technical challenges and the lack of available tools; but should be 
attempted in the future using the modified approaches proposed in Section 
9.1.3. OA modulation of the APL and Odd-like neurons can also be functionally 
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validated by optogentically manipulating sVUM1 signalling using the sVUM1 
intersectional line (Chapter 8), and measuring neuronal activity using GCaMP in 
the APL neuron and Odd-like neurons. However, given that I do not know the 
type of OA receptors expressed in these neurons, I cannot predict what the 
possible effects would be and how this may impact on odour discrimination. 
Moreover, this method cannot differentiate sVUM1 modulation from OA or other 
neurotransmitters that are co-released by sVUM1 neurons. The most likely 
examples being TA, a precursor to OA present in OA neurons that is a 
neurotransmitter in its own right (Saraswati et al., 2004), or neuropeptides. 
Therefore, it is possible that the APL neuron or Odd-like neurons postsynaptic 
to sVUM1 neurons may express one of the three types of TA receptors, which 
could also be activated by OA at a high concentration (Arakawa et al., 1990; 
Saudou et al., 1990; Bayliss et al., 2013), or neuropeptide receptors.  
It is also possible that OA signalling from sVUM1 neurons does not 
modulate the APL or Odd-like neurons despite the GRASP results for the below 
reasons. Firstly, the GRASP signal observed between sVUM1 neurons and 
these neurons may be false positives indicative of membrane contacts but not 
synapses; suggesting that these neurons are not synaptic partners of sVUM1 
neurons in the calyx. This is unlikely due to colocalisation observed at OA 
terminals. Secondly, the sVUM1-APL neuron may not be reciprocal; and that 
GRASP colocalised with OA because the APL neuron is presynaptic to sVUM1 
terminals where OA is released (Section 9.2.3). This does not apply to Odd-like 
neurons which are predominantly postsynaptic in the MB calyx (L.M.N., 
unpublished).  
 
9.2.5. Tools for validating OA neuromodulatory circuitry  
In addition to mapping the OA neuromodulatory circuitry in the larval MB calyx, I 
examined and tested tools that would be useful for validating the hypotheses for 
OA neuromodulation mechanisms discussed above. This includes selecting and 
verifying more specific transcriptional drivers for sVUM1 neurons and Odd-like 
neurons, as well as testing OAMB knockdown lines.  
The new sVUM1 intersectional line, which consistently labels the sVUM1 
neurons with only three extra neurons, is currently the most specific line 
available for manipulating sVUM1 neuronal activity. This line can be used to 
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conditionally activate or knock down sVUM1 neurons using optogenetic or 
thermogenetic methods. On the other hand, the Odd-like neuron lines would be 
useful for confirming the presence of receptor localisation to Odd-like neuron 
cell bodies, especially when the protein trap signal is restricted only to cell 
bodies and not to terminals. In this study, I also identified the first LexA line that 
only labels one Odd-like neuron in each brain – which would be valuable to use 
in a dual binary transcriptional system in conjunction with another neuronal type 
labelled in a GAL4 line to understand their interactions. None of these lines 
have been reported in the most recent single-cell functional study of MB 
extrinsic neurons in L3 larvae (Saumweber et al., 2018).  
 To examine the function of OAMB signalling in PNs, I found that the most 
efficient OAMB-RNAi knockdown line showed around 50% OAMB::EGFP signal 
compared to that of the non-knockdown control, while the other lines did not 
show observable knockdown. This level of efficacy may be further optimised by 
the use of UAS-Dicer to increase processing of dsRNA into siRNA; or 
increasing GAL4/UAS expression by raising the temperature. I also found that it 
was more desirable to knock down functionally intact EGFP-tagged OA 
receptors using EGFP-shRNA or deGradFP, which targets GFP-tagged protein 
for ubiquitination and degradation (Caussinus et al., 2011; Neumüller et al., 
2012; Nagarkar-jaiswal et al., 2015). The EGFP-shRNA.3 construct (Neumüller 
et al., 2012) tested in this study showed the strongest and most consistent 
knockdown of OAMB::EGFP signal in calyx glomeruli labelled by NP225-GAL4, 
compared to the three other OAMB-RNAi lines tested, with around 80% of the 
OAMB::EGFP signal knocked down. However, this method cannot be applied to 
the fusion proteins in this study as they are not fully functional.  
The deGradFP system is also theoretically superior to RNAi knockdown, 
as it directly targets proteins rather than transcripts. This system uses NSlmb-
vhhGFP4, a fusion protein made of a F-box domain required for ubiquitination 
and a single-domain antibody fragment against GFP, under UAS control 
(Caussinus et al., 2011). It may be possible to repurpose this system by using 
antibody fragments against OA receptors instead to facilitate the degradation of 




9.3. Organisation of OA neuromodulatory circuitry in the MB calyx 
GRASP and receptor localisation data suggest that all of the known calyx-
innervating neurons, including KCs, PNs, the APL neuron, Odd-like neurons, 
and even sVUM1 neurons themselves, are probably targets of OA signalling 
from sVUM1 neurons. OA connectivity in L3 larvae is consistent with the L1 
connectivity data recently made public on the NeuroNLP server ( 
https://neuronlp.larva.fruitflybrain.org/; Berck et al., 2016; Eichler et al., 2017). 
Compared to previous studies that have largely focused on how OA directly 
modulates KCs (Burke et al., 2012; Kim et al., 2013; Pech et al., 2013), this 
provides new insights into how OA modulation is also indirectly regulating KC 
activity through a strongly interconnected network of multiple cell types all 
subjected to OA neuromodulation.  
 While this is the first study to examine OA receptor localisation in non-KC 
neurons innervating the fly MB calyx, OA/TA receptor localisation patterns have 
been previously examined in the honeybee calyx. While OAMB and its 
honeybee homologue AmOA1 both localised to the MB calyx, they are 
expressed on different types of neurons: OAMB in uniglomerular PNs versus 
AmOA1 in GABAergic interneurons and multiglomerular PNs (Sinakevitch et al., 
2011, 2013). It is even more interesting that the honeybee α2-adrenergic-like 
TA receptor AmTyr1 – homologous to the fly TA receptor Oct-TyrR – appears to 
share similar localisation patterns to the larval fly OAMB receptor: both of which 
localised to uniglomerular olfactory PN axons, and probably KC axons but not 
KC dendrites (Sinakevitch et al., 2017). This suggests that TA/AmTyr1 in 
honeybees and OA/OAMB in fruitfly larvae may have similar roles in modulating 
their corresponding MB calyx circuitries. However, the lack of connectivity and 
functional data in the honeybee, and receptor localisation data in the adult fly 
and other insects have made it difficult to assess to what extent MB calyx 
neuromodulatory circuitry is conserved.  
  
9.3.1. Distribution of OA receptor types in the larval MB calyx 
From the five known types of OA receptors in Drosophila, OAMB and Octβ1R 
localised to the larval MB calyx; while Octβ2R and Octα2R are expressed in the 
cell bodies of calyx-innervating neurons, and may therefore localise to the calyx 
as well. This demonstrates that multiple types of OA receptors are involved in 
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the larval MB calyx circuitry. This is expected as this allows for a single source 
of OA to differentially modulate different targets to generate a coordinated effect 
within the circuit – an example being the mammalian olfactory bulb which 
requires α- and β-adrenoceptors for odour discrimination behaviours 
(Mandairon et al., 2008).  
  Co-expression of OA receptors was also observed in PNs. A subset of 
PNs appeared to express Octα2R and/or Octβ2R, in addition to the widely 
expressed OAMB. Similarly, preliminary data show that Octβ1R and OAMB may 
both be expressed in KCs, although unlike Octβ1R, OAMB appeared to only 
localise to KC axons in the MB lobes but not to KC dendrites in the calyx. As the 
subcellular localisation of Octβ2R is unclear, it might be localised to a different 
subcellular compartment to the calyx-localised OA receptors. The differential 
subcellular localisation of OA receptors in a single neuron could facilitate 
compartment-specific effects of OA signalling.  
Alternatively, if more than one type of OA receptor localised to the same 
neuronal terminals in the larval calyx, they could allow differential effects of OA 
modulation depending on the concentration of OA in the environment. For 
example, the co-expression of Octβ1R and Octβ2R on OA neurons at the larval 
NMJ regulates synaptic growth antagonistically (Koon et al., 2011; Koon and 
Budnik, 2012). In the mammalian NA system, different dosages of NA is 
required to activate the different types of adrenoceptors; and this is proposed to 
generate different behaviours suitable for the context (Atzori et al., 2016). 
Similarly, OA could also have different affinities for OA receptors in Drosophila. 
In HEK-cells transfected with OA receptors in culture, Octα2R appear to have 
the highest affinity to OA (EC50=10
-10M), followed by Octβ1R (EC50=3x10
-8M) 
and OAMB (10-8M for Ca2+ response and EC50=6x10
-7M for cAMP response) 
(Han et al., 1998; Balfanz et al., 2005; Qi et al., 2017).  
The concentration-dependent activation of OA receptors should be 
tested in Drosophila neurons in vivo. This may be done in a mutant receptor 
background, in which individual OA receptor types are rescued by cDNA and 
assayed for activation with variable injected OA concentrations to the calyx or 




9.3.2. Extrasynaptic targets of OA signalling in the larval MB calyx 
The other interesting feature of the OA neuromodulatory circuitry in the larval 
MB calyx is the possibility of extrasynaptic OA receptors in KCs and PNs. While 
extrasynaptic receptors are common for neuromodulators and OA extrasynaptic 
receptors have been detected in C.elegans (Trueta and De-Miguel, 2012; 
Bentley et al., 2016), this is the first study to explore the possibility of 
extrasynaptic OA receptors in Drosophila. However, this matches with the large 
dense core vesicles associated with volume transmission that have been 
identified in OA neurons (Eichler et al., 2017).  
It is currently unknown whether there are differences between synaptic 
and non-synaptic neuromodulation; although there is evidence that changing 
the distribution of Drosophila vesicular monoamine transporter in synaptic 
vesicles and large dense core vesicles involved in extrasynaptic release in OA 
neurons impaired larval locomotion (Grygoruk et al., 2014). Additionally, there 
could be differences in OA dosages required or the timescale of the modulation, 
or potential co-release of OA with another peptidergic modulator.  
The observation of extrasynaptic receptors in the larval MB calyx circuitry 
confirms that OA released from sVUM1 neurons is likely to reach longer-range 
non-synaptic targets in the calyx. However, it is still unknown how far reaching 
OA signalling in the larval CNS could be, which would depend on its active 
concentration, the localisation of degradation enzymes and reuptake 
transporters, as well as the presence of diffusion barriers such as glia 
surrounding the larval calyx (Omoto et al., 2015).  
 
9.4. Possible functions of OA neuromodulation in the MB calyx  
 
9.4.1. A proposed model for sVUM1 signalling in the larval MB calyx 
The different patterns of OA signalling, as a result of a behavioural state or 
external cue, could lead to the activation of different OA receptors in the calyx. 
Based on mammalian models of NA activation (Atzori et al., 2016) and the 
affinity of OA receptors towards OA (Han et al., 1998; Balfanz et al., 2005; 
Maqueira et al., 2005; Qi et al., 2017), I hypothesise that low levels of OA 
signalling would activate Octα2R, intermediate levels would recruit OAMB, and 
high levels would further activate OctβRs (Fig. 9.2).  
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Figure 9.2. Proposed model of OA neuromodulation in the Drosophila larval MB calyx.  
Abbreviations: ACh, acetylcholine; KC, Kenyon Cell; MB, mushroom body; N, number; OA, 
octopamine; PN, projection neuron.  
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At low levels of OA signalling, I propose that OA is self-inhibitory and also inhibit 
the activity of a subset of PNs via Octα2R, and therefore restrict PN inputs to 
KCs. Odour-evoked activation of KCs would further suppress OA activity via Rdl 
mediating GABAergic inhibition from the APL neuron. This would ensure 
decorrelated odour representations in KCs for odour discrimination. Upon  
intermediate levels of OA signalling, OA inhibition on PNs via Octα2R would be 
counteracted by OAMB activation in most olfactory PNs, in which their olfactory 
inputs to KCs are increased. This would increase the number of active KCs, 
resulting in more overlap in odour representations and a decrease in odour 
discrimination. The highest level of OA signalling would increase neuronal 
excitability in both PNs via OAMB and Octβ2R, and KC dendrites via Octβ1R, 
through a feedforward loop, further increasing overlap between odour 
representations and impairing odour discrimination, and may mediate a shift to 
odour generalisation. This model is illustrated in Fig. 9.2. 
 In this model, the feedback inhibition from the APL neuron is decisive as 
to whether sparse odour representations can be maintained under increased 
PN and KC activity. If APL activity is sufficient to maintain sparseness in KCs, 
then sVUM1 signalling is likely to increase the sensitivity of odour detection, 
allowing the detection of previously subthreshold stimuli, but without losing 
odour discrimination. If the APL fails to generate adequate inhibition on KCs, 
this would impair odour discrimination. APL activity may be suppressed by 
sVUM1 signalling as well, possibly through the inhibitory Octα2R, which is yet to 
be tested. This would then reduce KC sparseness and selectivity and impair 
odour discrimination.  
 
9.4.2. sVUM1 regulation of odour discrimination-generalisation balance 
Depending on how two similar odours are presented in olfactory learning tasks, 
Drosophila larvae are capable of producing either a discriminatory or a 
generalised response (Mishra et al., 2010; Barth et al., 2014; Chen and Gerber, 
2014). The perceptual distance between odours in discrimination and 
generalisation tasks are correlated (Chen and Gerber, 2014); suggesting that 
there may be an external input to shift the balance between discrimination and 
generalisation. Studies in adult Drosophila also suggest that both discrimination 
and generalisation depends on odour representations in KCs (Campbell et al., 
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2013). While it is important for animals to be able to learn to discriminate 
between two similar odours, odour generalisation can also confer benefits to the 
animal’s survival. When faced with a novel odour, the ability to generalise 
allows the animal to compute the most appropriate behavioural response based 
on similar odours that it has previously encountered. For example, the 
conditioned fear response in rodents, which is important for responding to 
potential dangerous stimuli, can be generalised (Ito et al., 2009; Chen et al., 
2011b). Generalisation is also important to allow the animal to recognise 
biologically relevant stimulus from a noisy and variable background. An 
example being adult flies learning to generalise across different visual contexts 
to identify the conditioned pattern – an ability that requires the MBs (Liu et al., 
1999). While not necessarily advantageous, stressful contexts also impair odour 
discrimination. In rodents, this involves NA modulation of the olfactory bulb 
(Manella et al., 2013).  
As mathematical modelling has shown that the trade-off between 
discrimination and generalisation is dependent on the sparseness of randomly 
connected neurons in a network (Barak et al., 2013); based on my model, I 
hypothesise that increasing OA signalling from sVUM1 neurons will reduce 
sparseness and increase correlation in KC odour responses, and therefore 
promote generalisation over discrimination (Fig. 9.2).  
 
9.4.3. Testing proposed model for sVUM1 regulation of odour 
discrimination 
Testing this model for OA neuromodulation in the larval MB calyx circuitry 
requires several critical steps. Firstly, the effects of OA modulation on each of 
their target neuronal types must be validated. This can be achieved by 
measuring the change in the electrical properties of neurons such as membrane 
potentials or firing frequencies using electrophysiological methods, neuronal 
activity using functional calcium imaging (GCaMP) and neurotransmitter release 
using synapto-pHluorin in these neuronal types when sVUM1 and/or OA 
receptor signalling is specifically manipulated – the details of which have been 
discussed in Section 9.2.  
Next, it is necessary to establish the relationship between OA 
concentration or sVUM1 activity and OA receptor activation in the MB calyx. 
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This may be done be injecting increasing concentrations of OA into the calyx, or 
increasing electrical or optogenetic stimulation of sVUM1 neurons, and 
measuring how the electrical or calcium responses changes in the different 
neuronal types. Responses should only be seen in neurons that express the 
corresponding receptor types and should disappear if the receptors are mutated 
or blocked. Alternatively, this could also be conducted in a background where 
all receptors are mutated and only one type is rescued at a time. This can 
reveal the concentrations or sVUM1 activation required to activate individual 
receptor types on the neurons they are normally expressed on.  
Finally, the net output of different levels of OA signalling on KC activity 
and odour discrimination behaviour should be assayed. OA signalling levels 
should be controlled by manipulating sVUM1 activity (electrically, 
thermogenetically or optogenetically), manipulating receptor signalling on 
individual neurons or by varying injected OA concentrations. Functional GCaMP 
imaging can be used to measure the activation of KCs as a population and how 
the sparseness and correlation of perceptually similar odour representations 
varies with OA activity (Lin et al., 2014) – in which KC responses are expected 
to be less sparse and less decorrelated with increasing levels of OA signalling. 
Behavioural phenotypes associated with variable OA activity can be assayed 
using odour discrimination and generalisation assays. In brief, larvae can be 
trained to associate odours with reward. In generalisation tasks, they would be 
tested for their response to an untrained but perceptually similar odour; while in 
discrimination tasks, they would be presented with a choice between the paired 
odour and a similar but explicitly unpaired odour (Mishra et al., 2010; Chen et 
al., 2011a). I would expect that larvae exposed to low levels of OA signalling to 
perform better at discrimination tasks, while those exposed to high levels of OA 
signalling to perform better at generalisation tasks.  
 
9.4.4. Possible contexts conveyed by sVUM1 neurons 
Another question integral to this model is the type of signals that sVUM1 
neurons are bringing to the larval MB calyx to elicit the changes in odour 
representations in KCs. As neuromodulatory neurons, it is likely that OA sVUM1 
neurons show variable firing patterns depending on context. Mammalian NA 
neurons show both tonic and phasic activation patterns: tonic activation is 
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associated with arousal and behavioural states; while phasic activation is 
associated with novel, unexpected or salient stimuli (Rajkowski et al., 1994; 
Vankov et al., 1995). In the context of associative learning, NA neurons are 
active specifically during the presentation of the CS+, especially with food 
reinforcement; or when there is a change in stimulus contingency, such as in 
reversal learning (Sara and Segal, 1991; Rajkowski et al., 1994; Aston-Jones et 
al., 1997).  
 The honeybee counterpart of sVUM1 neurons, the VUMmx1 neuron, 
shows phasic activation in response to sucrose and odours and that VUMmx1 
odour response increases after forward odour pairing (Hammer, 1993). This 
suggests that similar to NA neurons, OA neurons in insects can respond to 
salient stimuli and show plasticity in learning.  
 It is likely that sVUM1 neurons may also convey arousal or satiety states. 
The OA receptor Octβ2R was required for the formation of artificial reward 
memories only in satiated but not hungry flies (Burke et al., 2012). Moreover, 
four of the known OA receptors were differentially expressed in the antennae of 
starved versus fed flies (Ko et al., 2015). This suggested that OA might provide 
a link between satiety signals and the olfactory pathway. As OA also controls 
arousal and starvation-induced locomotion in Drosophila (Crocker et al., 2010; 
Koon et al., 2011; Yang et al., 2015); this suggests that OA may be able to 
regulate sensory circuits depending on arousal and satiety states of the animal.  
 Nevertheless, to understand the signals that may be regulating odour 
discrimination in the larval MB calyx, future experiments are required to validate 
the type of stimuli that can activate sVUM1 neurons, identify the inputs to 
sVUM1 neurons and determine how sVUM1 activity varies with behavioural 
states.  
 
9.4.5. Tyraminergic and peptidergic signalling from sVUM1 neurons 
In addition to OA, activation of sVUM1 neurons may also release TA and 
possibly neuropeptides in the larval MB calyx – both of which may add 
additional layers to sVUM1 regulation of olfactory processing circuitry.  
TA is an OA precursor which also acts as a neurotransmitter in 
Drosophila and preferentially activates TA receptors (Arakawa et al., 1990; 
Saudou et al., 1990; Saraswati et al., 2004; Bayliss et al., 2013). High 
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concentrations of OA can activate TA receptors, and high concentrations of TA 
can activate OA receptors (Arakawa et al., 1990; Saudou et al., 1990; Han et 
al., 1998; Maqueira et al., 2005; Qi et al., 2017). Recent reports revealed that 
VUMmd1 and VUMmx1 neurons project tyraminergic inputs to the honeybee 
MB calyx, which is strongly immunoreactive against a honeybee TA receptor 
AmTyr1/AmTAR1; and that AmTyr1 is localised to the axons of honeybee 
uniglomerular olfactory PNs in the calyx (Sinakevitch et al., 2017; Thamm et al., 
2017). This suggests that sVUM1 neurons, their Drosophila larval counterparts, 
may also mediate tyraminergic signalling in the larval MB calyx. So far, I have 
found that the TyrRII::EGFP fusion from the Gene Disruption Project (Nagarkar-
jaiswal et al., 2015) did not show any signal in the larval CNS (H.W., 
unpublished observations). However, it is uncertain whether this is because 
TyrRII expression was disrupted by the EGFP cassette insertion. In the future, it 
would be useful to investigate whether TA is released at the larval calyx and 
whether calyx-innervating neurons express corresponding TA receptors.  
 The presence of dense core vesicles in Drosophila sVUM1 neurons not 
only suggest the possibility of volume transmission of OA, but also the 
possibility of co-transmission of neuropeptides (Nässel, 2009; Grygoruk et al., 
2014; Eichler et al., 2017). Neuropeptides including NPF and tachykinin have 
been implicated in appetitive olfactory and satiety behaviours in fruit flies (Root 
et al., 2011; Wang et al., 2013; Zhang et al., 2013a; Ko et al., 2015); suggesting 
that their pathways may intersect with OA neurons which also modulate 
relevant behaviours. Therefore, it would also be interesting to determine what 
type of neuropeptides, if any, are co-expressed in sVUM1 neurons to 
understand how this may further modulate the larval MB calyx circuitry.  
 
9.5. Implications on the organisation of neuromodulatory circuitry 
The preliminary OA neuromodulatory map of the larval MB calyx I developed in 
this study reveal three major design features that enable effective 
neuromodulation of sensory discrimination pathways:  
 Firstly, I found that OA neuromodulation targets several interconnected 
neuronal types in the larval MB calyx. As neuromodulatory innervation is usually 
widespread and distributed (Bargmann and Marder, 2013), their effects can be 
optimised by having multiple targets within the same pathway. This reiterates 
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the need to investigate neuromodulation in the context of a circuit in order to 
understand its output behaviour.  
 Secondly, I demonstrated the possibility of extrasynaptic OAMB and 
Octβ1R receptors in PNs and KCs respectively. Although it is well-known that 
neuromodulation can act extrasynaptically, this is the first evidence to my 
knowledge of extrasynaptic OA receptors in Drosophila. This is functionally 
useful as it allows neuromodulators to exert long-distance effects without the 
need to form physical synapses; and also economical, as it reduces the need 
for numerous synapses provided the appropriate receptors are expressed. This 
also demonstrates why it is important to consider neuromodulation beyond the 
synaptic connectome. It will also be interesting to explore whether there are 
functional differences between synaptic and extrasynaptic transmission by 
neuromodulators.  
 Thirdly, and most importantly, I have shown that different types of OA 
receptors are distributed among their putative targets; such that a single source 
of OA in the larval MB calyx is able to differentially modulate multiple neuronal 
types within the same circuit. Based on the model I proposed, the distribution of 
OA receptors with variable affinities to OA on different types of calyx-innervating 
neurons is integral in mediating the context-dependent changes in OA signalling 
by sVUM1 neurons in the larval MB calyx. This model remains to be validated 
(Section 9.4.3), and it remains to be seen whether this is conserved across 
other neuromodulatory circuits in different organisms. Differential receptor 
distribution supports the mechanisms behind how phasic and tonic 
neuromodulatory activities can have different effects on their target neurons, a 
phenomenon previously observed for NA modulation of the rodent 
somatosensory cortex (Devilbiss and Waterhouse, 2011). This suggests that 
the pattern of receptor expression can form the framework in understanding 
how circuits as a whole can respond to changing levels of neuromodulator 
signalling in a coordinated manner, and how this may affect how we perceive 
sensory stimuli and behavioural response under different circumstances.  
 
9.6. Concluding remarks 
To understand the anatomical organisation of higher brain neuromodulatory 
circuits, I studied the OA modulatory circuitry in the fly larval MB calyx by 
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identifying putative postsynaptic partners of OA neurons and mapping OA and 
GABA receptors to calyx-innervating neurons. While this map is by no means 
complete, I hope this preliminary receptor localisation data can guide future 
experiments in investigating the mechanisms and effects of OA on their various 
targets in the MB calyx, and how this translates to the coordinated modulation 
of odour discrimination behaviour.   
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Appendix 1 – Supplemental Figures 
 












B. MI12417 5’ flanking end alignment with MiMIC sequences 
 
 













  Figure S1. MI12417 5’ PCR product aligned to MiMIC and OAMB sequences. (A) 
Sequenced PCR product for MI12417 5’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to OAMB sequences in grey and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI12417 5’ PCR products to MiMIC (B) and 
Drosophila melanogaster (C) sequences using Nucleotide BLAST.  
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B. MI12417 3’ flanking end alignment with MiMIC sequences 
 
C. MI12417 3’ flanking end alignment with OAMB sequences
 
  Figure S2. MI12417 3’ PCR product aligned to MiMIC and OAMB sequences. (A) 
Sequenced PCR product for MI12417 3’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to OAMB sequences in grey and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI12417 3’ PCR products to MiMIC (B) and 
Drosophila melanogaster (C) sequences using Nucleotide BLAST.  
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Figure S3. MI05807 5’ PCR product aligned to MiMIC sequences. (A) Sequenced PCR 
product for MI05807 5’ flanking end. Alignment to MiMIC sequences is indicated in yellow. (B) 
Alignment of MI05807 5’ PCR products to MiMIC sequences using Nucleotide BLAST. 
Drosophila genomic sequences could not detected because the primer used against the 
Octβ1R sequences was too close (5 bp) to the MiMIC insertion site, and therefore not reported 
in the sequenced product. 
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B. MI05807 3’ flanking end alignment with MiMIC sequences 
 
C. MI05807 3’ flanking end alignment with Octβ1R sequences
 
  Figure S4. MI05807 3’ PCR product aligned to MiMIC and Octβ1R sequences. (A) 
Sequenced PCR product for MI05807 3’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to Octβ1R sequences in grey, and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI05807 3’ PCR products to MiMIC (B) and 
Drosophila melanogaster (C) sequences using Nucleotide BLAST. 
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B. MI13416 3’ flanking end alignment with MiMIC sequences 
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C. MI13416 3’ flanking end alignment with Octβ2R sequences
 
  Figure S5. MI13416 3’ PCR product aligned to MiMIC and Octβ2R sequences. (A) 
Sequenced PCR product for MI13416 3’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to Octβ2R sequences in grey, overlapping alignment at the 
MiMIC insertion site (TA) in red, and an unidentified sequence indicated in green. (B-C) 
Alignment of MI13416 3’ PCR products to MiMIC (B) and Drosophila melanogaster (C) 
sequences using Nucleotide BLAST. 
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Figure S6. MI06217 5’ PCR product aligned to MiMIC and Octβ3R sequences. (A) 
Sequenced PCR product for MI06217 5’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to Octβ3R sequences in grey, and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI06217 5’ PCR products to MiMIC (B) and 
Drosophila melanogaster (C) sequences using Nucleotide BLAST. 
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B. MI06217 3’ flanking end alignment with MiMIC sequences 
 
 
C. MI06217 3’ flanking end alignment with Octβ3R sequences
 
  Figure S7. MI06217 3’ PCR product aligned to MiMIC and Octβ3R sequences. (A) 
Sequenced PCR product for MI06217 3’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to Octβ3R sequences in grey, and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI06217 3’ PCR products to MiMIC (B) and 
Drosophila melanogaster (C) sequences using Nucleotide BLAST. 
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Figure S8. MI10227 5’ PCR product aligned to MiMIC and CG18208 sequences. (A) 
Sequenced PCR product for MI10227 5’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to CG18208 sequences in grey, and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI10227 5’ PCR product to MiMIC (B) and 
Drosophila melanogaster (C) sequences using Nucleotide BLAST. 
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C. MI10227 3’ flanking end alignment with CG18208 sequences 
  
Figure S9. MI10227 3’ PCR product aligned to MiMIC and CG18208 sequences. (A) 
Sequenced PCR product for MI10227 3’ flanking end. Alignment to MiMIC sequences is 
indicated in yellow, alignment to CG18208 sequences in grey, and overlapping alignment at the 
MiMIC insertion site (TA) in red. (B-C) Alignment of MI10227 3’ PCR products to MiMIC (B) and 
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